Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:5-oxoprolinase deficiency'
(id=6767614 ; fe=en:5-oxoprolinase deficiency ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=78281.50994873047 creation date=2017-06-24 touchdate=2025-12-19 19:45:56.000)
≈ 1958 relations sortantes

  1. en:5-oxoprolinase deficiency -- r_associated #0: 32 / 1 -> déficit en pyroglutamate hydrolase
    n1=en:5-oxoprolinase deficiency | n2=déficit en pyroglutamate hydrolase | rel=r_associated | relid=0 | w=32
  2. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:2-hydroxyglutaric aciduria
    n1=en:5-oxoprolinase deficiency | n2=en:2-hydroxyglutaric aciduria | rel=r_associated | relid=0 | w=30
  3. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:3-methylglutaconic aciduria type 3
    n1=en:5-oxoprolinase deficiency | n2=en:3-methylglutaconic aciduria type 3 | rel=r_associated | relid=0 | w=30
  4. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:3-methylglutaconic aciduria type 5
    n1=en:5-oxoprolinase deficiency | n2=en:3-methylglutaconic aciduria type 5 | rel=r_associated | relid=0 | w=30
  5. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:3-methylglutaconic aciduria type iv
    n1=en:5-oxoprolinase deficiency | n2=en:3-methylglutaconic aciduria type iv | rel=r_associated | relid=0 | w=30
  6. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:alpha-1 antitrypsin deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:alpha-1 antitrypsin deficiency | rel=r_associated | relid=0 | w=30
  7. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:autosomal recessive ocular albinism
    n1=en:5-oxoprolinase deficiency | n2=en:autosomal recessive ocular albinism | rel=r_associated | relid=0 | w=30
  8. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:autosomal recessive scid
    n1=en:5-oxoprolinase deficiency | n2=en:autosomal recessive scid | rel=r_associated | relid=0 | w=30
  9. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:autosomal recessive sideroblastic anemia
    n1=en:5-oxoprolinase deficiency | n2=en:autosomal recessive sideroblastic anemia | rel=r_associated | relid=0 | w=30
  10. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:bowen-conradi syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:bowen-conradi syndrome | rel=r_associated | relid=0 | w=30
  11. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:cerebellar ataxia, cayman type
    n1=en:5-oxoprolinase deficiency | n2=en:cerebellar ataxia, cayman type | rel=r_associated | relid=0 | w=30
  12. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:congenital muscular dystrophy with infantile cataract and hypogonadism syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:congenital muscular dystrophy with infantile cataract and hypogonadism syndrome | rel=r_associated | relid=0 | w=30
  13. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:congenital pancreatic enterokinase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:congenital pancreatic enterokinase deficiency | rel=r_associated | relid=0 | w=30
  14. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:crigler-najjar syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:crigler-najjar syndrome | rel=r_associated | relid=0 | w=30
  15. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:donnai-barrow syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:donnai-barrow syndrome | rel=r_associated | relid=0 | w=30
  16. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:ectodermal dysplasia/ skin fragility syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:ectodermal dysplasia/ skin fragility syndrome | rel=r_associated | relid=0 | w=30
  17. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:ehlers-danlos syndrome, type vi
    n1=en:5-oxoprolinase deficiency | n2=en:ehlers-danlos syndrome, type vi | rel=r_associated | relid=0 | w=30
  18. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:ethanolaminosis
    n1=en:5-oxoprolinase deficiency | n2=en:ethanolaminosis | rel=r_associated | relid=0 | w=30
  19. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:factor v and factor viii, combined deficiency of
    n1=en:5-oxoprolinase deficiency | n2=en:factor v and factor viii, combined deficiency of | rel=r_associated | relid=0 | w=30
  20. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:familial renal iminoglycinuria
    n1=en:5-oxoprolinase deficiency | n2=en:familial renal iminoglycinuria | rel=r_associated | relid=0 | w=30
  21. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:fructose-1,6-bisphosphatase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:fructose-1,6-bisphosphatase deficiency | rel=r_associated | relid=0 | w=30
  22. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:glycine dehydrogenase (decarboxylating) deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:glycine dehydrogenase (decarboxylating) deficiency | rel=r_associated | relid=0 | w=30
  23. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:glycogen storage disease type vii
    n1=en:5-oxoprolinase deficiency | n2=en:glycogen storage disease type vii | rel=r_associated | relid=0 | w=30
  24. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:hereditary factor xi deficiency disease
    n1=en:5-oxoprolinase deficiency | n2=en:hereditary factor xi deficiency disease | rel=r_associated | relid=0 | w=30
  25. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:hypermanganesemia with dystonia polycythemia and cirrhosis
    n1=en:5-oxoprolinase deficiency | n2=en:hypermanganesemia with dystonia polycythemia and cirrhosis | rel=r_associated | relid=0 | w=30
  26. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:infantile globoid cell leukodystrophy
    n1=en:5-oxoprolinase deficiency | n2=en:infantile globoid cell leukodystrophy | rel=r_associated | relid=0 | w=30
  27. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:isaacs syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:isaacs syndrome | rel=r_associated | relid=0 | w=30
  28. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation
    n1=en:5-oxoprolinase deficiency | n2=en:leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation | rel=r_associated | relid=0 | w=30
  29. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:lysosomal storage disease
    n1=en:5-oxoprolinase deficiency | n2=en:lysosomal storage disease | rel=r_associated | relid=0 | w=30
  30. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:methylmalonyl-coenzyme a mutase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:methylmalonyl-coenzyme a mutase deficiency | rel=r_associated | relid=0 | w=30
  31. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:microcephaly, amish type (disorder)
    n1=en:5-oxoprolinase deficiency | n2=en:microcephaly, amish type (disorder) | rel=r_associated | relid=0 | w=30
  32. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:multiple sulfatase deficiency disease
    n1=en:5-oxoprolinase deficiency | n2=en:multiple sulfatase deficiency disease | rel=r_associated | relid=0 | w=30
  33. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:muscle-eye-brain disease, congenital muscular dystrophy
    n1=en:5-oxoprolinase deficiency | n2=en:muscle-eye-brain disease, congenital muscular dystrophy | rel=r_associated | relid=0 | w=30
  34. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:neonatal progeroid syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:neonatal progeroid syndrome | rel=r_associated | relid=0 | w=30
  35. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:neurodegeneration with brain iron accumulation 4
    n1=en:5-oxoprolinase deficiency | n2=en:neurodegeneration with brain iron accumulation 4 | rel=r_associated | relid=0 | w=30
  36. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:ornithine carbamoyltransferase deficiency disease
    n1=en:5-oxoprolinase deficiency | n2=en:ornithine carbamoyltransferase deficiency disease | rel=r_associated | relid=0 | w=30
  37. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:otoonychoperoneal syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:otoonychoperoneal syndrome | rel=r_associated | relid=0 | w=30
  38. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:persistent mullerian duct syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:persistent mullerian duct syndrome | rel=r_associated | relid=0 | w=30
  39. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:placental steroid sulfatase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:placental steroid sulfatase deficiency | rel=r_associated | relid=0 | w=30
  40. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:prader-willi habitus, osteopenia, and camptodactyly
    n1=en:5-oxoprolinase deficiency | n2=en:prader-willi habitus, osteopenia, and camptodactyly | rel=r_associated | relid=0 | w=30
  41. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:prickle1-related progressive myoclonus epilepsy with ataxia
    n1=en:5-oxoprolinase deficiency | n2=en:prickle1-related progressive myoclonus epilepsy with ataxia | rel=r_associated | relid=0 | w=30
  42. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:prolonged electroretinal response suppression
    n1=en:5-oxoprolinase deficiency | n2=en:prolonged electroretinal response suppression | rel=r_associated | relid=0 | w=30
  43. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:severe steroid 21-hydroxylase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:severe steroid 21-hydroxylase deficiency | rel=r_associated | relid=0 | w=30
  44. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:sulfite oxidase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:sulfite oxidase deficiency | rel=r_associated | relid=0 | w=30
  45. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:tungland bellman syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:tungland bellman syndrome | rel=r_associated | relid=0 | w=30
  46. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:upper limb defect with eye and ear abnormalities syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:upper limb defect with eye and ear abnormalities syndrome | rel=r_associated | relid=0 | w=30
  47. en:5-oxoprolinase deficiency -- r_associated #0: 30 / 0.938 -> en:wolman disease
    n1=en:5-oxoprolinase deficiency | n2=en:wolman disease | rel=r_associated | relid=0 | w=30
  48. en:5-oxoprolinase deficiency -- r_associated #0: 29 / 0.906 -> en:acrodermatitis enteropathica
    n1=en:5-oxoprolinase deficiency | n2=en:acrodermatitis enteropathica | rel=r_associated | relid=0 | w=29
  49. en:5-oxoprolinase deficiency -- r_associated #0: 29 / 0.906 -> en:ateliotic dwarfism without insulinopenia
    n1=en:5-oxoprolinase deficiency | n2=en:ateliotic dwarfism without insulinopenia | rel=r_associated | relid=0 | w=29
  50. en:5-oxoprolinase deficiency -- r_associated #0: 29 / 0.906 -> en:autosomal recessive primary microcephaly
    n1=en:5-oxoprolinase deficiency | n2=en:autosomal recessive primary microcephaly | rel=r_associated | relid=0 | w=29
  51. en:5-oxoprolinase deficiency -- r_associated #0: 29 / 0.906 -> en:bardet-biedl syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:bardet-biedl syndrome | rel=r_associated | relid=0 | w=29
  52. en:5-oxoprolinase deficiency -- r_associated #0: 29 / 0.906 -> en:bothnia retinal dystrophy
    n1=en:5-oxoprolinase deficiency | n2=en:bothnia retinal dystrophy | rel=r_associated | relid=0 | w=29
  53. en:5-oxoprolinase deficiency -- r_associated #0: 29 / 0.906 -> en:charcot-marie-tooth disease type 4
    n1=en:5-oxoprolinase deficiency | n2=en:charcot-marie-tooth disease type 4 | rel=r_associated | relid=0 | w=29
  54. en:5-oxoprolinase deficiency -- r_associated #0: 29 / 0.906 -> en:congenital
    n1=en:5-oxoprolinase deficiency | n2=en:congenital | rel=r_associated | relid=0 | w=29
  55. en:5-oxoprolinase deficiency -- r_associated #0: 29 / 0.906 -> en:congenital nonspherocytic hemolytic anemia due to inborn error of metabolism
    n1=en:5-oxoprolinase deficiency | n2=en:congenital nonspherocytic hemolytic anemia due to inborn error of metabolism | rel=r_associated | relid=0 | w=29
  56. en:5-oxoprolinase deficiency -- r_associated #0: 29 / 0.906 -> en:cryptophthalmos syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:cryptophthalmos syndrome | rel=r_associated | relid=0 | w=29
  57. en:5-oxoprolinase deficiency -- r_associated #0: 29 / 0.906 -> en:deficiency aspects
    n1=en:5-oxoprolinase deficiency | n2=en:deficiency aspects | rel=r_associated | relid=0 | w=29
  58. en:5-oxoprolinase deficiency -- r_associated #0: 29 / 0.906 -> en:dubin-johnson syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:dubin-johnson syndrome | rel=r_associated | relid=0 | w=29
  59. en:5-oxoprolinase deficiency -- r_associated #0: 29 / 0.906 -> en:enterokinase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:enterokinase deficiency | rel=r_associated | relid=0 | w=29
  60. en:5-oxoprolinase deficiency -- r_associated #0: 29 / 0.906 -> en:epiphyseal dysplasia, multiple, 4
    n1=en:5-oxoprolinase deficiency | n2=en:epiphyseal dysplasia, multiple, 4 | rel=r_associated | relid=0 | w=29
  61. en:5-oxoprolinase deficiency -- r_associated #0: 29 / 0.906 -> en:fibular hypoplasia and complex brachydactyly
    n1=en:5-oxoprolinase deficiency | n2=en:fibular hypoplasia and complex brachydactyly | rel=r_associated | relid=0 | w=29
  62. en:5-oxoprolinase deficiency -- r_associated #0: 29 / 0.906 -> en:glycogen storage disease type i
    n1=en:5-oxoprolinase deficiency | n2=en:glycogen storage disease type i | rel=r_associated | relid=0 | w=29
  63. en:5-oxoprolinase deficiency -- r_associated #0: 29 / 0.906 -> en:hnsha due to aldolase a deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:hnsha due to aldolase a deficiency | rel=r_associated | relid=0 | w=29
  64. en:5-oxoprolinase deficiency -- r_associated #0: 29 / 0.906 -> en:isovaleric acidemia
    n1=en:5-oxoprolinase deficiency | n2=en:isovaleric acidemia | rel=r_associated | relid=0 | w=29
  65. en:5-oxoprolinase deficiency -- r_associated #0: 29 / 0.906 -> en:knobloch syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:knobloch syndrome | rel=r_associated | relid=0 | w=29
  66. en:5-oxoprolinase deficiency -- r_associated #0: 29 / 0.906 -> en:laboratory abnormalities
    n1=en:5-oxoprolinase deficiency | n2=en:laboratory abnormalities | rel=r_associated | relid=0 | w=29
  67. en:5-oxoprolinase deficiency -- r_associated #0: 29 / 0.906 -> en:lethal congenital contracture syndrome 1
    n1=en:5-oxoprolinase deficiency | n2=en:lethal congenital contracture syndrome 1 | rel=r_associated | relid=0 | w=29
  68. en:5-oxoprolinase deficiency -- r_associated #0: 29 / 0.906 -> en:lethal congenital contracture syndrome type 3
    n1=en:5-oxoprolinase deficiency | n2=en:lethal congenital contracture syndrome type 3 | rel=r_associated | relid=0 | w=29
  69. en:5-oxoprolinase deficiency -- r_associated #0: 29 / 0.906 -> en:lipid metabolism, inborn errors
    n1=en:5-oxoprolinase deficiency | n2=en:lipid metabolism, inborn errors | rel=r_associated | relid=0 | w=29
  70. en:5-oxoprolinase deficiency -- r_associated #0: 29 / 0.906 -> en:microcephalic primordial dwarfism toriello type
    n1=en:5-oxoprolinase deficiency | n2=en:microcephalic primordial dwarfism toriello type | rel=r_associated | relid=0 | w=29
  71. en:5-oxoprolinase deficiency -- r_associated #0: 29 / 0.906 -> en:microscopic hematuria
    n1=en:5-oxoprolinase deficiency | n2=en:microscopic hematuria | rel=r_associated | relid=0 | w=29
  72. en:5-oxoprolinase deficiency -- r_associated #0: 29 / 0.906 -> en:morquio syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:morquio syndrome | rel=r_associated | relid=0 | w=29
  73. en:5-oxoprolinase deficiency -- r_associated #0: 29 / 0.906 -> en:netherton syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:netherton syndrome | rel=r_associated | relid=0 | w=29
  74. en:5-oxoprolinase deficiency -- r_associated #0: 29 / 0.906 -> en:nonaka myopathy
    n1=en:5-oxoprolinase deficiency | n2=en:nonaka myopathy | rel=r_associated | relid=0 | w=29
  75. en:5-oxoprolinase deficiency -- r_associated #0: 29 / 0.906 -> en:pelizaeus merzbacher like disease
    n1=en:5-oxoprolinase deficiency | n2=en:pelizaeus merzbacher like disease | rel=r_associated | relid=0 | w=29
  76. en:5-oxoprolinase deficiency -- r_associated #0: 29 / 0.906 -> en:presentey anomaly
    n1=en:5-oxoprolinase deficiency | n2=en:presentey anomaly | rel=r_associated | relid=0 | w=29
  77. en:5-oxoprolinase deficiency -- r_associated #0: 29 / 0.906 -> en:sitosterolemia with xanthomatosis
    n1=en:5-oxoprolinase deficiency | n2=en:sitosterolemia with xanthomatosis | rel=r_associated | relid=0 | w=29
  78. en:5-oxoprolinase deficiency -- r_associated #0: 29 / 0.906 -> en:spondylocarpotarsal synostosis syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:spondylocarpotarsal synostosis syndrome | rel=r_associated | relid=0 | w=29
  79. en:5-oxoprolinase deficiency -- r_associated #0: 29 / 0.906 -> en:spondyloenchondrodysplasia
    n1=en:5-oxoprolinase deficiency | n2=en:spondyloenchondrodysplasia | rel=r_associated | relid=0 | w=29
  80. en:5-oxoprolinase deficiency -- r_associated #0: 29 / 0.906 -> en:tmem70 related mitochondrial encephalo-cardio-myopathy
    n1=en:5-oxoprolinase deficiency | n2=en:tmem70 related mitochondrial encephalo-cardio-myopathy | rel=r_associated | relid=0 | w=29
  81. en:5-oxoprolinase deficiency -- r_associated #0: 29 / 0.906 -> en:walker-warburg syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:walker-warburg syndrome | rel=r_associated | relid=0 | w=29
  82. en:5-oxoprolinase deficiency -- r_associated #0: 29 / 0.906 -> entéro-colite
    n1=en:5-oxoprolinase deficiency | n2=entéro-colite | rel=r_associated | relid=0 | w=29
  83. en:5-oxoprolinase deficiency -- r_associated #0: 28 / 0.875 -> déficit en 5-oxoprolinase
    n1=en:5-oxoprolinase deficiency | n2=déficit en 5-oxoprolinase | rel=r_associated | relid=0 | w=28
  84. en:5-oxoprolinase deficiency -- r_associated #0: 28 / 0.875 -> en:allgrove syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:allgrove syndrome | rel=r_associated | relid=0 | w=28
  85. en:5-oxoprolinase deficiency -- r_associated #0: 28 / 0.875 -> en:amino acid metabolism disorder
    n1=en:5-oxoprolinase deficiency | n2=en:amino acid metabolism disorder | rel=r_associated | relid=0 | w=28
  86. en:5-oxoprolinase deficiency -- r_associated #0: 28 / 0.875 -> en:autosomal recessive distal osteolysis syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:autosomal recessive distal osteolysis syndrome | rel=r_associated | relid=0 | w=28
  87. en:5-oxoprolinase deficiency -- r_associated #0: 28 / 0.875 -> en:basal ganglia disease, biotin-responsive
    n1=en:5-oxoprolinase deficiency | n2=en:basal ganglia disease, biotin-responsive | rel=r_associated | relid=0 | w=28
  88. en:5-oxoprolinase deficiency -- r_associated #0: 28 / 0.875 -> en:brody myopathy
    n1=en:5-oxoprolinase deficiency | n2=en:brody myopathy | rel=r_associated | relid=0 | w=28
  89. en:5-oxoprolinase deficiency -- r_associated #0: 28 / 0.875 -> en:chondrodysplasia punctata syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:chondrodysplasia punctata syndrome | rel=r_associated | relid=0 | w=28
  90. en:5-oxoprolinase deficiency -- r_associated #0: 28 / 0.875 -> en:congenital disorder of glycosylation type ig
    n1=en:5-oxoprolinase deficiency | n2=en:congenital disorder of glycosylation type ig | rel=r_associated | relid=0 | w=28
  91. en:5-oxoprolinase deficiency -- r_associated #0: 28 / 0.875 -> en:congenital plasminogen activator inhibitor deficiency type 1
    n1=en:5-oxoprolinase deficiency | n2=en:congenital plasminogen activator inhibitor deficiency type 1 | rel=r_associated | relid=0 | w=28
  92. en:5-oxoprolinase deficiency -- r_associated #0: 28 / 0.875 -> en:deafness, congenital, with inner ear agenesis, microtia, and microdontia
    n1=en:5-oxoprolinase deficiency | n2=en:deafness, congenital, with inner ear agenesis, microtia, and microdontia | rel=r_associated | relid=0 | w=28
  93. en:5-oxoprolinase deficiency -- r_associated #0: 28 / 0.875 -> en:deafness, progressive, with stapes fixation
    n1=en:5-oxoprolinase deficiency | n2=en:deafness, progressive, with stapes fixation | rel=r_associated | relid=0 | w=28
  94. en:5-oxoprolinase deficiency -- r_associated #0: 28 / 0.875 -> en:geroderma osteodysplastica
    n1=en:5-oxoprolinase deficiency | n2=en:geroderma osteodysplastica | rel=r_associated | relid=0 | w=28
  95. en:5-oxoprolinase deficiency -- r_associated #0: 28 / 0.875 -> en:glycogen storage disease type vi
    n1=en:5-oxoprolinase deficiency | n2=en:glycogen storage disease type vi | rel=r_associated | relid=0 | w=28
  96. en:5-oxoprolinase deficiency -- r_associated #0: 28 / 0.875 -> en:hereditary adrenal unresponsiveness to corticotropin
    n1=en:5-oxoprolinase deficiency | n2=en:hereditary adrenal unresponsiveness to corticotropin | rel=r_associated | relid=0 | w=28
  97. en:5-oxoprolinase deficiency -- r_associated #0: 28 / 0.875 -> en:hnsha due to glutathione reductase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:hnsha due to glutathione reductase deficiency | rel=r_associated | relid=0 | w=28
  98. en:5-oxoprolinase deficiency -- r_associated #0: 28 / 0.875 -> en:hnsha due to pyrimidine-5'-nucleotidase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:hnsha due to pyrimidine-5'-nucleotidase deficiency | rel=r_associated | relid=0 | w=28
  99. en:5-oxoprolinase deficiency -- r_associated #0: 28 / 0.875 -> en:hyperlysinemia
    n1=en:5-oxoprolinase deficiency | n2=en:hyperlysinemia | rel=r_associated | relid=0 | w=28
  100. en:5-oxoprolinase deficiency -- r_associated #0: 28 / 0.875 -> en:hypokalemia, familial
    n1=en:5-oxoprolinase deficiency | n2=en:hypokalemia, familial | rel=r_associated | relid=0 | w=28
  101. en:5-oxoprolinase deficiency -- r_associated #0: 28 / 0.875 -> en:isolated hyperchlorhidrosis
    n1=en:5-oxoprolinase deficiency | n2=en:isolated hyperchlorhidrosis | rel=r_associated | relid=0 | w=28
  102. en:5-oxoprolinase deficiency -- r_associated #0: 28 / 0.875 -> en:lethal congenital contracture syndrome 2
    n1=en:5-oxoprolinase deficiency | n2=en:lethal congenital contracture syndrome 2 | rel=r_associated | relid=0 | w=28
  103. en:5-oxoprolinase deficiency -- r_associated #0: 28 / 0.875 -> en:macular corneal dystrophy
    n1=en:5-oxoprolinase deficiency | n2=en:macular corneal dystrophy | rel=r_associated | relid=0 | w=28
  104. en:5-oxoprolinase deficiency -- r_associated #0: 28 / 0.875 -> en:odontohypophosphatasia (disorder)
    n1=en:5-oxoprolinase deficiency | n2=en:odontohypophosphatasia (disorder) | rel=r_associated | relid=0 | w=28
  105. en:5-oxoprolinase deficiency -- r_associated #0: 28 / 0.875 -> en:polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy
    n1=en:5-oxoprolinase deficiency | n2=en:polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy | rel=r_associated | relid=0 | w=28
  106. en:5-oxoprolinase deficiency -- r_associated #0: 28 / 0.875 -> en:pseudotrisomy 13 syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:pseudotrisomy 13 syndrome | rel=r_associated | relid=0 | w=28
  107. en:5-oxoprolinase deficiency -- r_associated #0: 28 / 0.875 -> en:purine-pyrimidine metabolism, inborn errors
    n1=en:5-oxoprolinase deficiency | n2=en:purine-pyrimidine metabolism, inborn errors | rel=r_associated | relid=0 | w=28
  108. en:5-oxoprolinase deficiency -- r_associated #0: 28 / 0.875 -> en:retinitis punctata albescens (disorder)
    n1=en:5-oxoprolinase deficiency | n2=en:retinitis punctata albescens (disorder) | rel=r_associated | relid=0 | w=28
  109. en:5-oxoprolinase deficiency -- r_associated #0: 28 / 0.875 -> en:rna polymerase iii-related leukodystrophy
    n1=en:5-oxoprolinase deficiency | n2=en:rna polymerase iii-related leukodystrophy | rel=r_associated | relid=0 | w=28
  110. en:5-oxoprolinase deficiency -- r_associated #0: 28 / 0.875 -> en:saito kuba tsuruta syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:saito kuba tsuruta syndrome | rel=r_associated | relid=0 | w=28
  111. en:5-oxoprolinase deficiency -- r_associated #0: 28 / 0.875 -> en:sonoda syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:sonoda syndrome | rel=r_associated | relid=0 | w=28
  112. en:5-oxoprolinase deficiency -- r_associated #0: 28 / 0.875 -> en:transcobalamin ii deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:transcobalamin ii deficiency | rel=r_associated | relid=0 | w=28
  113. en:5-oxoprolinase deficiency -- r_associated #0: 28 / 0.875 -> en:valinemia
    n1=en:5-oxoprolinase deficiency | n2=en:valinemia | rel=r_associated | relid=0 | w=28
  114. en:5-oxoprolinase deficiency -- r_associated #0: 28 / 0.875 -> en:vomiting
    n1=en:5-oxoprolinase deficiency | n2=en:vomiting | rel=r_associated | relid=0 | w=28
  115. en:5-oxoprolinase deficiency -- r_associated #0: 28 / 0.875 -> syndrome de Walker-Warburg
    n1=en:5-oxoprolinase deficiency | n2=syndrome de Walker-Warburg | rel=r_associated | relid=0 | w=28
  116. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:adenylosuccinate lyase deficiency (disorder)
    n1=en:5-oxoprolinase deficiency | n2=en:adenylosuccinate lyase deficiency (disorder) | rel=r_associated | relid=0 | w=27
  117. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:al awadi syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:al awadi syndrome | rel=r_associated | relid=0 | w=27
  118. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:alpha-fetoprotein deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:alpha-fetoprotein deficiency | rel=r_associated | relid=0 | w=27
  119. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:alpha, alpha-trehalase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:alpha, alpha-trehalase deficiency | rel=r_associated | relid=0 | w=27
  120. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:aminoacylase 1 deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:aminoacylase 1 deficiency | rel=r_associated | relid=0 | w=27
  121. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:arginine:glycine amidinotransferase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:arginine:glycine amidinotransferase deficiency | rel=r_associated | relid=0 | w=27
  122. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:ataxia with vitamin e deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:ataxia with vitamin e deficiency | rel=r_associated | relid=0 | w=27
  123. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:autosomal recessive asexual dwarfism
    n1=en:5-oxoprolinase deficiency | n2=en:autosomal recessive asexual dwarfism | rel=r_associated | relid=0 | w=27
  124. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:autosomal recessive spastic paraplegia type 11
    n1=en:5-oxoprolinase deficiency | n2=en:autosomal recessive spastic paraplegia type 11 | rel=r_associated | relid=0 | w=27
  125. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:beta-aminoisobutyricaciduria
    n1=en:5-oxoprolinase deficiency | n2=en:beta-aminoisobutyricaciduria | rel=r_associated | relid=0 | w=27
  126. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:brown-vialetto-van laere syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:brown-vialetto-van laere syndrome | rel=r_associated | relid=0 | w=27
  127. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:childhood hypophosphatasia (disorder)
    n1=en:5-oxoprolinase deficiency | n2=en:childhood hypophosphatasia (disorder) | rel=r_associated | relid=0 | w=27
  128. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:childhood myocerebrohepatopathy spectrum
    n1=en:5-oxoprolinase deficiency | n2=en:childhood myocerebrohepatopathy spectrum | rel=r_associated | relid=0 | w=27
  129. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:congenital cataracts, facial dysmorphism, and neuropathy
    n1=en:5-oxoprolinase deficiency | n2=en:congenital cataracts, facial dysmorphism, and neuropathy | rel=r_associated | relid=0 | w=27
  130. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:familial c3b inhibitor deficiency syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:familial c3b inhibitor deficiency syndrome | rel=r_associated | relid=0 | w=27
  131. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:fronto-facio-nasal dysplasia
    n1=en:5-oxoprolinase deficiency | n2=en:fronto-facio-nasal dysplasia | rel=r_associated | relid=0 | w=27
  132. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:glutamate formiminotransferase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:glutamate formiminotransferase deficiency | rel=r_associated | relid=0 | w=27
  133. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:glycogen storage disease type x
    n1=en:5-oxoprolinase deficiency | n2=en:glycogen storage disease type x | rel=r_associated | relid=0 | w=27
  134. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:hereditary angioedema
    n1=en:5-oxoprolinase deficiency | n2=en:hereditary angioedema | rel=r_associated | relid=0 | w=27
  135. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:hnsha due to diphosphoglycerate mutase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:hnsha due to diphosphoglycerate mutase deficiency | rel=r_associated | relid=0 | w=27
  136. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:hnsha due to glucose phosphate isomerase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:hnsha due to glucose phosphate isomerase deficiency | rel=r_associated | relid=0 | w=27
  137. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:hyperimmunoglobulin e syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:hyperimmunoglobulin e syndrome | rel=r_associated | relid=0 | w=27
  138. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:hyperinsulinemic hypoglycemia, familial, 7
    n1=en:5-oxoprolinase deficiency | n2=en:hyperinsulinemic hypoglycemia, familial, 7 | rel=r_associated | relid=0 | w=27
  139. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:hyperphosphatasia with mental retardation
    n1=en:5-oxoprolinase deficiency | n2=en:hyperphosphatasia with mental retardation | rel=r_associated | relid=0 | w=27
  140. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:hypophosphatemic rickets with hypercalciuria, hereditary
    n1=en:5-oxoprolinase deficiency | n2=en:hypophosphatemic rickets with hypercalciuria, hereditary | rel=r_associated | relid=0 | w=27
  141. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:igg deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:igg deficiency | rel=r_associated | relid=0 | w=27
  142. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:jankovic rivera syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:jankovic rivera syndrome | rel=r_associated | relid=0 | w=27
  143. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:mannosidosis
    n1=en:5-oxoprolinase deficiency | n2=en:mannosidosis | rel=r_associated | relid=0 | w=27
  144. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:maple syrup urine disease
    n1=en:5-oxoprolinase deficiency | n2=en:maple syrup urine disease | rel=r_associated | relid=0 | w=27
  145. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:miller-mckusick-malvaux-syndrome (3m syndrome)
    n1=en:5-oxoprolinase deficiency | n2=en:miller-mckusick-malvaux-syndrome (3m syndrome) | rel=r_associated | relid=0 | w=27
  146. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:neuroacanthocytosis
    n1=en:5-oxoprolinase deficiency | n2=en:neuroacanthocytosis | rel=r_associated | relid=0 | w=27
  147. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:papillon-lefevre syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:papillon-lefevre syndrome | rel=r_associated | relid=0 | w=27
  148. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:phenylketonuria ii
    n1=en:5-oxoprolinase deficiency | n2=en:phenylketonuria ii | rel=r_associated | relid=0 | w=27
  149. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:pontocerebellar hypoplasia type 2
    n1=en:5-oxoprolinase deficiency | n2=en:pontocerebellar hypoplasia type 2 | rel=r_associated | relid=0 | w=27
  150. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:premature aging syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:premature aging syndrome | rel=r_associated | relid=0 | w=27
  151. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:pyogenic bacterial infection due to deficiency of myeloid differentiation primary response 88
    n1=en:5-oxoprolinase deficiency | n2=en:pyogenic bacterial infection due to deficiency of myeloid differentiation primary response 88 | rel=r_associated | relid=0 | w=27
  152. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:rapadilino syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:rapadilino syndrome | rel=r_associated | relid=0 | w=27
  153. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:severe early childhood onset retinal dystrophy
    n1=en:5-oxoprolinase deficiency | n2=en:severe early childhood onset retinal dystrophy | rel=r_associated | relid=0 | w=27
  154. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:sudden infant death with dysgenesis of the testes syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:sudden infant death with dysgenesis of the testes syndrome | rel=r_associated | relid=0 | w=27
  155. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:trichohepatoenteric syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:trichohepatoenteric syndrome | rel=r_associated | relid=0 | w=27
  156. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:urocanase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:urocanase deficiency | rel=r_associated | relid=0 | w=27
  157. en:5-oxoprolinase deficiency -- r_associated #0: 27 / 0.844 -> en:uv-sensitive syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:uv-sensitive syndrome | rel=r_associated | relid=0 | w=27
  158. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:3-methylglutaconic aciduria type 1
    n1=en:5-oxoprolinase deficiency | n2=en:3-methylglutaconic aciduria type 1 | rel=r_associated | relid=0 | w=26
  159. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:acid phosphatase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:acid phosphatase deficiency | rel=r_associated | relid=0 | w=26
  160. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:acyl-coa dehydrogenase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:acyl-coa dehydrogenase deficiency | rel=r_associated | relid=0 | w=26
  161. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:alpha-methylacyl-coa racemase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:alpha-methylacyl-coa racemase deficiency | rel=r_associated | relid=0 | w=26
  162. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:ataxia telangiectasia syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:ataxia telangiectasia syndrome | rel=r_associated | relid=0 | w=26
  163. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia
    n1=en:5-oxoprolinase deficiency | n2=en:ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia | rel=r_associated | relid=0 | w=26
  164. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:behr syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:behr syndrome | rel=r_associated | relid=0 | w=26
  165. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:bietti crystalline corneoretinal dystrophy
    n1=en:5-oxoprolinase deficiency | n2=en:bietti crystalline corneoretinal dystrophy | rel=r_associated | relid=0 | w=26
  166. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:chorioretinal dystrophy, spinocerebellar ataxia, and hypogonadotropic hypogonadism
    n1=en:5-oxoprolinase deficiency | n2=en:chorioretinal dystrophy, spinocerebellar ataxia, and hypogonadotropic hypogonadism | rel=r_associated | relid=0 | w=26
  167. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:chylomicron retention disease
    n1=en:5-oxoprolinase deficiency | n2=en:chylomicron retention disease | rel=r_associated | relid=0 | w=26
  168. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:citrin deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:citrin deficiency | rel=r_associated | relid=0 | w=26
  169. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:combined malonic and methylmalonic aciduria
    n1=en:5-oxoprolinase deficiency | n2=en:combined malonic and methylmalonic aciduria | rel=r_associated | relid=0 | w=26
  170. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:congenital bowing of long bone
    n1=en:5-oxoprolinase deficiency | n2=en:congenital bowing of long bone | rel=r_associated | relid=0 | w=26
  171. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:congenital dyserythropoietic anemia, type ii
    n1=en:5-oxoprolinase deficiency | n2=en:congenital dyserythropoietic anemia, type ii | rel=r_associated | relid=0 | w=26
  172. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:congenital sucrase-isomaltase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:congenital sucrase-isomaltase deficiency | rel=r_associated | relid=0 | w=26
  173. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:congenital transferrin deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:congenital transferrin deficiency | rel=r_associated | relid=0 | w=26
  174. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:crisponi syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:crisponi syndrome | rel=r_associated | relid=0 | w=26
  175. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:cystathionine beta-synthase deficiency disease
    n1=en:5-oxoprolinase deficiency | n2=en:cystathionine beta-synthase deficiency disease | rel=r_associated | relid=0 | w=26
  176. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:deficiency of glucosyltransferase 1
    n1=en:5-oxoprolinase deficiency | n2=en:deficiency of glucosyltransferase 1 | rel=r_associated | relid=0 | w=26
  177. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:disorder of glycosaminoglycan metabolism
    n1=en:5-oxoprolinase deficiency | n2=en:disorder of glycosaminoglycan metabolism | rel=r_associated | relid=0 | w=26
  178. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:enterocolitis
    n1=en:5-oxoprolinase deficiency | n2=en:enterocolitis | rel=r_associated | relid=0 | w=26
  179. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:familial hypoaldosteronism
    n1=en:5-oxoprolinase deficiency | n2=en:familial hypoaldosteronism | rel=r_associated | relid=0 | w=26
  180. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:fucosidosis
    n1=en:5-oxoprolinase deficiency | n2=en:fucosidosis | rel=r_associated | relid=0 | w=26
  181. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:glutathione synthetase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:glutathione synthetase deficiency | rel=r_associated | relid=0 | w=26
  182. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:hawkinsinuria
    n1=en:5-oxoprolinase deficiency | n2=en:hawkinsinuria | rel=r_associated | relid=0 | w=26
  183. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:hemolytic anemia due to pyruvate kinase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:hemolytic anemia due to pyruvate kinase deficiency | rel=r_associated | relid=0 | w=26
  184. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:hmg-coa lyase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:hmg-coa lyase deficiency | rel=r_associated | relid=0 | w=26
  185. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:hyperprolinemia type 2
    n1=en:5-oxoprolinase deficiency | n2=en:hyperprolinemia type 2 | rel=r_associated | relid=0 | w=26
  186. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:hypomagnesemia 1, intestinal
    n1=en:5-oxoprolinase deficiency | n2=en:hypomagnesemia 1, intestinal | rel=r_associated | relid=0 | w=26
  187. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:hypomyelination and congenital cataract
    n1=en:5-oxoprolinase deficiency | n2=en:hypomyelination and congenital cataract | rel=r_associated | relid=0 | w=26
  188. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:increased renal tubular phosphate reabsorption
    n1=en:5-oxoprolinase deficiency | n2=en:increased renal tubular phosphate reabsorption | rel=r_associated | relid=0 | w=26
  189. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:kuskokwim disease
    n1=en:5-oxoprolinase deficiency | n2=en:kuskokwim disease | rel=r_associated | relid=0 | w=26
  190. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:lactase deficiency, congenital
    n1=en:5-oxoprolinase deficiency | n2=en:lactase deficiency, congenital | rel=r_associated | relid=0 | w=26
  191. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:lissencephaly syndrome, norman-roberts type
    n1=en:5-oxoprolinase deficiency | n2=en:lissencephaly syndrome, norman-roberts type | rel=r_associated | relid=0 | w=26
  192. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:macdermot winter syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:macdermot winter syndrome | rel=r_associated | relid=0 | w=26
  193. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:maroteaux-lamy syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:maroteaux-lamy syndrome | rel=r_associated | relid=0 | w=26
  194. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:methionine adenosyltransferase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:methionine adenosyltransferase deficiency | rel=r_associated | relid=0 | w=26
  195. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:microcephaly cervical spine fusion anomalies
    n1=en:5-oxoprolinase deficiency | n2=en:microcephaly cervical spine fusion anomalies | rel=r_associated | relid=0 | w=26
  196. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:morm syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:morm syndrome | rel=r_associated | relid=0 | w=26
  197. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:n-acetylglutamate synthase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:n-acetylglutamate synthase deficiency | rel=r_associated | relid=0 | w=26
  198. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:oculocerebral hypopigmentation syndrome type preus
    n1=en:5-oxoprolinase deficiency | n2=en:oculocerebral hypopigmentation syndrome type preus | rel=r_associated | relid=0 | w=26
  199. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:oculocutaneous albinism type 4
    n1=en:5-oxoprolinase deficiency | n2=en:oculocutaneous albinism type 4 | rel=r_associated | relid=0 | w=26
  200. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:propionic acidemia
    n1=en:5-oxoprolinase deficiency | n2=en:propionic acidemia | rel=r_associated | relid=0 | w=26
  201. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:pseudocholinesterase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:pseudocholinesterase deficiency | rel=r_associated | relid=0 | w=26
  202. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:pyruvate carboxylase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:pyruvate carboxylase deficiency | rel=r_associated | relid=0 | w=26
  203. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:sarcosinemia
    n1=en:5-oxoprolinase deficiency | n2=en:sarcosinemia | rel=r_associated | relid=0 | w=26
  204. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:sensory ataxic neuropathy, dysarthria, and ophthalmoparesis
    n1=en:5-oxoprolinase deficiency | n2=en:sensory ataxic neuropathy, dysarthria, and ophthalmoparesis | rel=r_associated | relid=0 | w=26
  205. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:smith-mccort dysplasia
    n1=en:5-oxoprolinase deficiency | n2=en:smith-mccort dysplasia | rel=r_associated | relid=0 | w=26
  206. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:spinocerebellar ataxia with epilepsy
    n1=en:5-oxoprolinase deficiency | n2=en:spinocerebellar ataxia with epilepsy | rel=r_associated | relid=0 | w=26
  207. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:spondylo-ocular syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:spondylo-ocular syndrome | rel=r_associated | relid=0 | w=26
  208. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:spondyloepiphyseal dysplasia, omani type
    n1=en:5-oxoprolinase deficiency | n2=en:spondyloepiphyseal dysplasia, omani type | rel=r_associated | relid=0 | w=26
  209. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:type ii acrocephalopolysyndactyly
    n1=en:5-oxoprolinase deficiency | n2=en:type ii acrocephalopolysyndactyly | rel=r_associated | relid=0 | w=26
  210. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:tyrosinemia, type iii
    n1=en:5-oxoprolinase deficiency | n2=en:tyrosinemia, type iii | rel=r_associated | relid=0 | w=26
  211. en:5-oxoprolinase deficiency -- r_associated #0: 26 / 0.813 -> en:verloes bourguignon syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:verloes bourguignon syndrome | rel=r_associated | relid=0 | w=26
  212. en:5-oxoprolinase deficiency -- r_associated #0: 25 / 0.781 -> en:21-hydroxylase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:21-hydroxylase deficiency | rel=r_associated | relid=0 | w=25
  213. en:5-oxoprolinase deficiency -- r_associated #0: 25 / 0.781 -> en:aminomethyltransferase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:aminomethyltransferase deficiency | rel=r_associated | relid=0 | w=25
  214. en:5-oxoprolinase deficiency -- r_associated #0: 25 / 0.781 -> en:argininemia
    n1=en:5-oxoprolinase deficiency | n2=en:argininemia | rel=r_associated | relid=0 | w=25
  215. en:5-oxoprolinase deficiency -- r_associated #0: 25 / 0.781 -> en:congenital disorder of glycosylation type ia
    n1=en:5-oxoprolinase deficiency | n2=en:congenital disorder of glycosylation type ia | rel=r_associated | relid=0 | w=25
  216. en:5-oxoprolinase deficiency -- r_associated #0: 25 / 0.781 -> en:congenital leptin deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:congenital leptin deficiency | rel=r_associated | relid=0 | w=25
  217. en:5-oxoprolinase deficiency -- r_associated #0: 25 / 0.781 -> en:desmosterolosis
    n1=en:5-oxoprolinase deficiency | n2=en:desmosterolosis | rel=r_associated | relid=0 | w=25
  218. en:5-oxoprolinase deficiency -- r_associated #0: 25 / 0.781 -> en:dicarboxylicaminoaciduria
    n1=en:5-oxoprolinase deficiency | n2=en:dicarboxylicaminoaciduria | rel=r_associated | relid=0 | w=25
  219. en:5-oxoprolinase deficiency -- r_associated #0: 25 / 0.781 -> en:east (epilepsy, ataxia, sensorineural deafness, and tubulopathy) syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:east (epilepsy, ataxia, sensorineural deafness, and tubulopathy) syndrome | rel=r_associated | relid=0 | w=25
  220. en:5-oxoprolinase deficiency -- r_associated #0: 25 / 0.781 -> en:encephalopathy due to sulfite oxidase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:encephalopathy due to sulfite oxidase deficiency | rel=r_associated | relid=0 | w=25
  221. en:5-oxoprolinase deficiency -- r_associated #0: 25 / 0.781 -> en:familial acantholysis
    n1=en:5-oxoprolinase deficiency | n2=en:familial acantholysis | rel=r_associated | relid=0 | w=25
  222. en:5-oxoprolinase deficiency -- r_associated #0: 25 / 0.781 -> en:folinic acid responsive seizure syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:folinic acid responsive seizure syndrome | rel=r_associated | relid=0 | w=25
  223. en:5-oxoprolinase deficiency -- r_associated #0: 25 / 0.781 -> en:fryns macrocephaly
    n1=en:5-oxoprolinase deficiency | n2=en:fryns macrocephaly | rel=r_associated | relid=0 | w=25
  224. en:5-oxoprolinase deficiency -- r_associated #0: 25 / 0.781 -> en:gamma-glutamyltransferase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:gamma-glutamyltransferase deficiency | rel=r_associated | relid=0 | w=25
  225. en:5-oxoprolinase deficiency -- r_associated #0: 25 / 0.781 -> en:glucose-6-phosphate dehydrogenase deficiency anemia
    n1=en:5-oxoprolinase deficiency | n2=en:glucose-6-phosphate dehydrogenase deficiency anemia | rel=r_associated | relid=0 | w=25
  226. en:5-oxoprolinase deficiency -- r_associated #0: 25 / 0.781 -> en:gurrieri sammito bellussi syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:gurrieri sammito bellussi syndrome | rel=r_associated | relid=0 | w=25
  227. en:5-oxoprolinase deficiency -- r_associated #0: 25 / 0.781 -> en:hemophilia b
    n1=en:5-oxoprolinase deficiency | n2=en:hemophilia b | rel=r_associated | relid=0 | w=25
  228. en:5-oxoprolinase deficiency -- r_associated #0: 25 / 0.781 -> en:hereditary factor x deficiency disease
    n1=en:5-oxoprolinase deficiency | n2=en:hereditary factor x deficiency disease | rel=r_associated | relid=0 | w=25
  229. en:5-oxoprolinase deficiency -- r_associated #0: 25 / 0.781 -> en:hyperlipidemia
    n1=en:5-oxoprolinase deficiency | n2=en:hyperlipidemia | rel=r_associated | relid=0 | w=25
  230. en:5-oxoprolinase deficiency -- r_associated #0: 25 / 0.781 -> en:infantile hypophosphatasia
    n1=en:5-oxoprolinase deficiency | n2=en:infantile hypophosphatasia | rel=r_associated | relid=0 | w=25
  231. en:5-oxoprolinase deficiency -- r_associated #0: 25 / 0.781 -> en:isolated hypoplasia of the right ventricle
    n1=en:5-oxoprolinase deficiency | n2=en:isolated hypoplasia of the right ventricle | rel=r_associated | relid=0 | w=25
  232. en:5-oxoprolinase deficiency -- r_associated #0: 25 / 0.781 -> en:jervell and lange nielsen syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:jervell and lange nielsen syndrome | rel=r_associated | relid=0 | w=25
  233. en:5-oxoprolinase deficiency -- r_associated #0: 25 / 0.781 -> en:mendelian susceptibility to mycobacterial disease due to complete interleukin 12 receptor beta 1 deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:mendelian susceptibility to mycobacterial disease due to complete interleukin 12 receptor beta 1 deficiency | rel=r_associated | relid=0 | w=25
  234. en:5-oxoprolinase deficiency -- r_associated #0: 25 / 0.781 -> en:mitochondrial dna depletion syndrome 2 (myopathic type)
    n1=en:5-oxoprolinase deficiency | n2=en:mitochondrial dna depletion syndrome 2 (myopathic type) | rel=r_associated | relid=0 | w=25
  235. en:5-oxoprolinase deficiency -- r_associated #0: 25 / 0.781 -> en:nathalie syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:nathalie syndrome | rel=r_associated | relid=0 | w=25
  236. en:5-oxoprolinase deficiency -- r_associated #0: 25 / 0.781 -> en:neutral lipid storage disease with myopathy
    n1=en:5-oxoprolinase deficiency | n2=en:neutral lipid storage disease with myopathy | rel=r_associated | relid=0 | w=25
  237. en:5-oxoprolinase deficiency -- r_associated #0: 25 / 0.781 -> en:pancreatic triacylglycerol lipase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:pancreatic triacylglycerol lipase deficiency | rel=r_associated | relid=0 | w=25
  238. en:5-oxoprolinase deficiency -- r_associated #0: 25 / 0.781 -> en:peeling skin syndrome, acral type
    n1=en:5-oxoprolinase deficiency | n2=en:peeling skin syndrome, acral type | rel=r_associated | relid=0 | w=25
  239. en:5-oxoprolinase deficiency -- r_associated #0: 25 / 0.781 -> en:porphobilinogen synthase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:porphobilinogen synthase deficiency | rel=r_associated | relid=0 | w=25
  240. en:5-oxoprolinase deficiency -- r_associated #0: 25 / 0.781 -> en:prolidase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:prolidase deficiency | rel=r_associated | relid=0 | w=25
  241. en:5-oxoprolinase deficiency -- r_associated #0: 25 / 0.781 -> en:spondyloenchondrodysplasia with immune dysregulation
    n1=en:5-oxoprolinase deficiency | n2=en:spondyloenchondrodysplasia with immune dysregulation | rel=r_associated | relid=0 | w=25
  242. en:5-oxoprolinase deficiency -- r_associated #0: 25 / 0.781 -> en:spondyloepiphyseal dysplasia tarda, toledo type
    n1=en:5-oxoprolinase deficiency | n2=en:spondyloepiphyseal dysplasia tarda, toledo type | rel=r_associated | relid=0 | w=25
  243. en:5-oxoprolinase deficiency -- r_associated #0: 25 / 0.781 -> en:vrozené poruchy metabolismu nec in mdrcze18_1
    n1=en:5-oxoprolinase deficiency | n2=en:vrozené poruchy metabolismu nec in mdrcze18_1 | rel=r_associated | relid=0 | w=25
  244. en:5-oxoprolinase deficiency -- r_associated #0: 25 / 0.781 -> en:werdnig-hoffmann disease
    n1=en:5-oxoprolinase deficiency | n2=en:werdnig-hoffmann disease | rel=r_associated | relid=0 | w=25
  245. en:5-oxoprolinase deficiency -- r_associated #0: 24 / 0.75 -> en:arthrogryposis multiplex congenita, neurogenic type (disorder)
    n1=en:5-oxoprolinase deficiency | n2=en:arthrogryposis multiplex congenita, neurogenic type (disorder) | rel=r_associated | relid=0 | w=24
  246. en:5-oxoprolinase deficiency -- r_associated #0: 24 / 0.75 -> en:atrophoderma vermiculatum
    n1=en:5-oxoprolinase deficiency | n2=en:atrophoderma vermiculatum | rel=r_associated | relid=0 | w=24
  247. en:5-oxoprolinase deficiency -- r_associated #0: 24 / 0.75 -> en:behrens baumann dust syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:behrens baumann dust syndrome | rel=r_associated | relid=0 | w=24
  248. en:5-oxoprolinase deficiency -- r_associated #0: 24 / 0.75 -> en:chitty hall baraitser syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:chitty hall baraitser syndrome | rel=r_associated | relid=0 | w=24
  249. en:5-oxoprolinase deficiency -- r_associated #0: 24 / 0.75 -> en:cohen syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:cohen syndrome | rel=r_associated | relid=0 | w=24
  250. en:5-oxoprolinase deficiency -- r_associated #0: 24 / 0.75 -> en:congenital disorder of glycosylation type ic
    n1=en:5-oxoprolinase deficiency | n2=en:congenital disorder of glycosylation type ic | rel=r_associated | relid=0 | w=24
  251. en:5-oxoprolinase deficiency -- r_associated #0: 24 / 0.75 -> en:congenital dyserythropoietic anemia, type i
    n1=en:5-oxoprolinase deficiency | n2=en:congenital dyserythropoietic anemia, type i | rel=r_associated | relid=0 | w=24
  252. en:5-oxoprolinase deficiency -- r_associated #0: 24 / 0.75 -> en:diarrhea
    n1=en:5-oxoprolinase deficiency | n2=en:diarrhea | rel=r_associated | relid=0 | w=24
  253. en:5-oxoprolinase deficiency -- r_associated #0: 24 / 0.75 -> en:fatal infantile lactic acidosis with methylmalonic aciduria
    n1=en:5-oxoprolinase deficiency | n2=en:fatal infantile lactic acidosis with methylmalonic aciduria | rel=r_associated | relid=0 | w=24
  254. en:5-oxoprolinase deficiency -- r_associated #0: 24 / 0.75 -> en:fatty acid hydroxylase-associated neurodegeneration
    n1=en:5-oxoprolinase deficiency | n2=en:fatty acid hydroxylase-associated neurodegeneration | rel=r_associated | relid=0 | w=24
  255. en:5-oxoprolinase deficiency -- r_associated #0: 24 / 0.75 -> en:gaze palsy, familial horizontal, with progressive scoliosis
    n1=en:5-oxoprolinase deficiency | n2=en:gaze palsy, familial horizontal, with progressive scoliosis | rel=r_associated | relid=0 | w=24
  256. en:5-oxoprolinase deficiency -- r_associated #0: 24 / 0.75 -> en:gracile syndrome (disorder)
    n1=en:5-oxoprolinase deficiency | n2=en:gracile syndrome (disorder) | rel=r_associated | relid=0 | w=24
  257. en:5-oxoprolinase deficiency -- r_associated #0: 24 / 0.75 -> en:histidinemia
    n1=en:5-oxoprolinase deficiency | n2=en:histidinemia | rel=r_associated | relid=0 | w=24
  258. en:5-oxoprolinase deficiency -- r_associated #0: 24 / 0.75 -> en:hypercalciuria
    n1=en:5-oxoprolinase deficiency | n2=en:hypercalciuria | rel=r_associated | relid=0 | w=24
  259. en:5-oxoprolinase deficiency -- r_associated #0: 24 / 0.75 -> en:hyperoxalaemia
    n1=en:5-oxoprolinase deficiency | n2=en:hyperoxalaemia | rel=r_associated | relid=0 | w=24
  260. en:5-oxoprolinase deficiency -- r_associated #0: 24 / 0.75 -> en:inherited disorder of thyroid metabolism
    n1=en:5-oxoprolinase deficiency | n2=en:inherited disorder of thyroid metabolism | rel=r_associated | relid=0 | w=24
  261. en:5-oxoprolinase deficiency -- r_associated #0: 24 / 0.75 -> en:laurence-moon syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:laurence-moon syndrome | rel=r_associated | relid=0 | w=24
  262. en:5-oxoprolinase deficiency -- r_associated #0: 24 / 0.75 -> en:majeed syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:majeed syndrome | rel=r_associated | relid=0 | w=24
  263. en:5-oxoprolinase deficiency -- r_associated #0: 24 / 0.75 -> en:microcephaly-capillary malformation syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:microcephaly-capillary malformation syndrome | rel=r_associated | relid=0 | w=24
  264. en:5-oxoprolinase deficiency -- r_associated #0: 24 / 0.75 -> en:neuronal ceroid lipofuscinosis
    n1=en:5-oxoprolinase deficiency | n2=en:neuronal ceroid lipofuscinosis | rel=r_associated | relid=0 | w=24
  265. en:5-oxoprolinase deficiency -- r_associated #0: 24 / 0.75 -> en:northern epilepsy syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:northern epilepsy syndrome | rel=r_associated | relid=0 | w=24
  266. en:5-oxoprolinase deficiency -- r_associated #0: 24 / 0.75 -> en:pseudohypoaldosteronism, type 1, recessive form
    n1=en:5-oxoprolinase deficiency | n2=en:pseudohypoaldosteronism, type 1, recessive form | rel=r_associated | relid=0 | w=24
  267. en:5-oxoprolinase deficiency -- r_associated #0: 24 / 0.75 -> en:spastic ataxia, charlevoix-saguenay type
    n1=en:5-oxoprolinase deficiency | n2=en:spastic ataxia, charlevoix-saguenay type | rel=r_associated | relid=0 | w=24
  268. en:5-oxoprolinase deficiency -- r_associated #0: 24 / 0.75 -> en:thomas syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:thomas syndrome | rel=r_associated | relid=0 | w=24
  269. en:5-oxoprolinase deficiency -- r_associated #0: 24 / 0.75 -> en:waardenburg anophthalmia syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:waardenburg anophthalmia syndrome | rel=r_associated | relid=0 | w=24
  270. en:5-oxoprolinase deficiency -- r_associated #0: 24 / 0.75 -> en:xanthinuria, type i
    n1=en:5-oxoprolinase deficiency | n2=en:xanthinuria, type i | rel=r_associated | relid=0 | w=24
  271. en:5-oxoprolinase deficiency -- r_associated #0: 23 / 0.719 -> en:5 alpha steroid reductase 2 deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:5 alpha steroid reductase 2 deficiency | rel=r_associated | relid=0 | w=23
  272. en:5-oxoprolinase deficiency -- r_associated #0: 23 / 0.719 -> en:acid-base imbalance
    n1=en:5-oxoprolinase deficiency | n2=en:acid-base imbalance | rel=r_associated | relid=0 | w=23
  273. en:5-oxoprolinase deficiency -- r_associated #0: 23 / 0.719 -> en:acrocallosal syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:acrocallosal syndrome | rel=r_associated | relid=0 | w=23
  274. en:5-oxoprolinase deficiency -- r_associated #0: 23 / 0.719 -> en:aldosterone synthase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:aldosterone synthase deficiency | rel=r_associated | relid=0 | w=23
  275. en:5-oxoprolinase deficiency -- r_associated #0: 23 / 0.719 -> en:amelogenesis imperfecta - recessive - rough
    n1=en:5-oxoprolinase deficiency | n2=en:amelogenesis imperfecta - recessive - rough | rel=r_associated | relid=0 | w=23
  276. en:5-oxoprolinase deficiency -- r_associated #0: 23 / 0.719 -> en:amelogenesis imperfecta and gingival hyperplasia syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:amelogenesis imperfecta and gingival hyperplasia syndrome | rel=r_associated | relid=0 | w=23
  277. en:5-oxoprolinase deficiency -- r_associated #0: 23 / 0.719 -> en:arterial tortuosity syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:arterial tortuosity syndrome | rel=r_associated | relid=0 | w=23
  278. en:5-oxoprolinase deficiency -- r_associated #0: 23 / 0.719 -> en:becker generalized myotonia
    n1=en:5-oxoprolinase deficiency | n2=en:becker generalized myotonia | rel=r_associated | relid=0 | w=23
  279. en:5-oxoprolinase deficiency -- r_associated #0: 23 / 0.719 -> en:cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy
    n1=en:5-oxoprolinase deficiency | n2=en:cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy | rel=r_associated | relid=0 | w=23
  280. en:5-oxoprolinase deficiency -- r_associated #0: 23 / 0.719 -> en:cerebroretinal microangiopathy with calcifications and cysts (disorder)
    n1=en:5-oxoprolinase deficiency | n2=en:cerebroretinal microangiopathy with calcifications and cysts (disorder) | rel=r_associated | relid=0 | w=23
  281. en:5-oxoprolinase deficiency -- r_associated #0: 23 / 0.719 -> en:deafness, sensorineural, and male infertility
    n1=en:5-oxoprolinase deficiency | n2=en:deafness, sensorineural, and male infertility | rel=r_associated | relid=0 | w=23
  282. en:5-oxoprolinase deficiency -- r_associated #0: 23 / 0.719 -> en:dyskeratosis congenita, autosomal recessive
    n1=en:5-oxoprolinase deficiency | n2=en:dyskeratosis congenita, autosomal recessive | rel=r_associated | relid=0 | w=23
  283. en:5-oxoprolinase deficiency -- r_associated #0: 23 / 0.719 -> en:epidermolysis bullosa simplex with pyloric atresia
    n1=en:5-oxoprolinase deficiency | n2=en:epidermolysis bullosa simplex with pyloric atresia | rel=r_associated | relid=0 | w=23
  284. en:5-oxoprolinase deficiency -- r_associated #0: 23 / 0.719 -> en:familial erythrocytosis due to diphosphoglycerate mutase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:familial erythrocytosis due to diphosphoglycerate mutase deficiency | rel=r_associated | relid=0 | w=23
  285. en:5-oxoprolinase deficiency -- r_associated #0: 23 / 0.719 -> en:glutamate-cysteine ligase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:glutamate-cysteine ligase deficiency | rel=r_associated | relid=0 | w=23
  286. en:5-oxoprolinase deficiency -- r_associated #0: 23 / 0.719 -> en:glutathione s-transferase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:glutathione s-transferase deficiency | rel=r_associated | relid=0 | w=23
  287. en:5-oxoprolinase deficiency -- r_associated #0: 23 / 0.719 -> en:glycogen storage disease type v
    n1=en:5-oxoprolinase deficiency | n2=en:glycogen storage disease type v | rel=r_associated | relid=0 | w=23
  288. en:5-oxoprolinase deficiency -- r_associated #0: 23 / 0.719 -> en:hereditary palmoplantar keratoderma gamborg nielsen type
    n1=en:5-oxoprolinase deficiency | n2=en:hereditary palmoplantar keratoderma gamborg nielsen type | rel=r_associated | relid=0 | w=23
  289. en:5-oxoprolinase deficiency -- r_associated #0: 23 / 0.719 -> en:hnsha due to glutathione synthetase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:hnsha due to glutathione synthetase deficiency | rel=r_associated | relid=0 | w=23
  290. en:5-oxoprolinase deficiency -- r_associated #0: 23 / 0.719 -> en:hnsha due to nadh diaphorase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:hnsha due to nadh diaphorase deficiency | rel=r_associated | relid=0 | w=23
  291. en:5-oxoprolinase deficiency -- r_associated #0: 23 / 0.719 -> en:hypernatremia
    n1=en:5-oxoprolinase deficiency | n2=en:hypernatremia | rel=r_associated | relid=0 | w=23
  292. en:5-oxoprolinase deficiency -- r_associated #0: 23 / 0.719 -> en:hyperprolinemia type 1
    n1=en:5-oxoprolinase deficiency | n2=en:hyperprolinemia type 1 | rel=r_associated | relid=0 | w=23
  293. en:5-oxoprolinase deficiency -- r_associated #0: 23 / 0.719 -> en:marles greenberg persaud syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:marles greenberg persaud syndrome | rel=r_associated | relid=0 | w=23
  294. en:5-oxoprolinase deficiency -- r_associated #0: 23 / 0.719 -> en:megalencephalic leukoencephalopathy with subcortical cysts
    n1=en:5-oxoprolinase deficiency | n2=en:megalencephalic leukoencephalopathy with subcortical cysts | rel=r_associated | relid=0 | w=23
  295. en:5-oxoprolinase deficiency -- r_associated #0: 23 / 0.719 -> en:mendelian susceptibility to mycobacterial disease due to complete interferon gamma receptor 1 deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:mendelian susceptibility to mycobacterial disease due to complete interferon gamma receptor 1 deficiency | rel=r_associated | relid=0 | w=23
  296. en:5-oxoprolinase deficiency -- r_associated #0: 23 / 0.719 -> en:muscle amp deaminase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:muscle amp deaminase deficiency | rel=r_associated | relid=0 | w=23
  297. en:5-oxoprolinase deficiency -- r_associated #0: 23 / 0.719 -> en:muscle l-lactate dehydrogenase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:muscle l-lactate dehydrogenase deficiency | rel=r_associated | relid=0 | w=23
  298. en:5-oxoprolinase deficiency -- r_associated #0: 23 / 0.719 -> en:myopathy with exercise intolerance, swedish type
    n1=en:5-oxoprolinase deficiency | n2=en:myopathy with exercise intolerance, swedish type | rel=r_associated | relid=0 | w=23
  299. en:5-oxoprolinase deficiency -- r_associated #0: 23 / 0.719 -> en:naxos disease
    n1=en:5-oxoprolinase deficiency | n2=en:naxos disease | rel=r_associated | relid=0 | w=23
  300. en:5-oxoprolinase deficiency -- r_associated #0: 23 / 0.719 -> en:neuraminidase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:neuraminidase deficiency | rel=r_associated | relid=0 | w=23
  301. en:5-oxoprolinase deficiency -- r_associated #0: 23 / 0.719 -> en:primary hyperoxaluria
    n1=en:5-oxoprolinase deficiency | n2=en:primary hyperoxaluria | rel=r_associated | relid=0 | w=23
  302. en:5-oxoprolinase deficiency -- r_associated #0: 23 / 0.719 -> en:reardon hall slaney syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:reardon hall slaney syndrome | rel=r_associated | relid=0 | w=23
  303. en:5-oxoprolinase deficiency -- r_associated #0: 23 / 0.719 -> en:sanfilippo syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:sanfilippo syndrome | rel=r_associated | relid=0 | w=23
  304. en:5-oxoprolinase deficiency -- r_associated #0: 23 / 0.719 -> en:sly syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:sly syndrome | rel=r_associated | relid=0 | w=23
  305. en:5-oxoprolinase deficiency -- r_associated #0: 23 / 0.719 -> en:succinic semialdehyde dehydrogenase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:succinic semialdehyde dehydrogenase deficiency | rel=r_associated | relid=0 | w=23
  306. en:5-oxoprolinase deficiency -- r_associated #0: 23 / 0.719 -> en:tay-sachs disease
    n1=en:5-oxoprolinase deficiency | n2=en:tay-sachs disease | rel=r_associated | relid=0 | w=23
  307. en:5-oxoprolinase deficiency -- r_associated #0: 23 / 0.719 -> vomissement
    n1=en:5-oxoprolinase deficiency | n2=vomissement | rel=r_associated | relid=0 | w=23
  308. en:5-oxoprolinase deficiency -- r_associated #0: 22 / 0.688 -> en:adenine phosphoribosyltransferase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:adenine phosphoribosyltransferase deficiency | rel=r_associated | relid=0 | w=22
  309. en:5-oxoprolinase deficiency -- r_associated #0: 22 / 0.688 -> en:anemia, hypochromic microcytic, with iron overload
    n1=en:5-oxoprolinase deficiency | n2=en:anemia, hypochromic microcytic, with iron overload | rel=r_associated | relid=0 | w=22
  310. en:5-oxoprolinase deficiency -- r_associated #0: 22 / 0.688 -> en:argininosuccinic aciduria
    n1=en:5-oxoprolinase deficiency | n2=en:argininosuccinic aciduria | rel=r_associated | relid=0 | w=22
  311. en:5-oxoprolinase deficiency -- r_associated #0: 22 / 0.688 -> en:autosomal recessive muscular dystrophy with limb girdle distribution
    n1=en:5-oxoprolinase deficiency | n2=en:autosomal recessive muscular dystrophy with limb girdle distribution | rel=r_associated | relid=0 | w=22
  312. en:5-oxoprolinase deficiency -- r_associated #0: 22 / 0.688 -> en:carnitine palmitoyltransferase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:carnitine palmitoyltransferase deficiency | rel=r_associated | relid=0 | w=22
  313. en:5-oxoprolinase deficiency -- r_associated #0: 22 / 0.688 -> en:cleft lip/palate-ectodermal dysplasia syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:cleft lip/palate-ectodermal dysplasia syndrome | rel=r_associated | relid=0 | w=22
  314. en:5-oxoprolinase deficiency -- r_associated #0: 22 / 0.688 -> en:congenital amegakaryocytic thrombocytopenia
    n1=en:5-oxoprolinase deficiency | n2=en:congenital amegakaryocytic thrombocytopenia | rel=r_associated | relid=0 | w=22
  315. en:5-oxoprolinase deficiency -- r_associated #0: 22 / 0.688 -> en:cutis laxa, autosomal recessive
    n1=en:5-oxoprolinase deficiency | n2=en:cutis laxa, autosomal recessive | rel=r_associated | relid=0 | w=22
  316. en:5-oxoprolinase deficiency -- r_associated #0: 22 / 0.688 -> en:cytochrome-c oxidase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:cytochrome-c oxidase deficiency | rel=r_associated | relid=0 | w=22
  317. en:5-oxoprolinase deficiency -- r_associated #0: 22 / 0.688 -> en:glutathione synthase deficiency without 5-oxoprolinuria
    n1=en:5-oxoprolinase deficiency | n2=en:glutathione synthase deficiency without 5-oxoprolinuria | rel=r_associated | relid=0 | w=22
  318. en:5-oxoprolinase deficiency -- r_associated #0: 22 / 0.688 -> en:hereditary fructose intolerance
    n1=en:5-oxoprolinase deficiency | n2=en:hereditary fructose intolerance | rel=r_associated | relid=0 | w=22
  319. en:5-oxoprolinase deficiency -- r_associated #0: 22 / 0.688 -> en:hereditary orotic aciduria
    n1=en:5-oxoprolinase deficiency | n2=en:hereditary orotic aciduria | rel=r_associated | relid=0 | w=22
  320. en:5-oxoprolinase deficiency -- r_associated #0: 22 / 0.688 -> en:hereditary spastic paralysis, infantile onset ascending
    n1=en:5-oxoprolinase deficiency | n2=en:hereditary spastic paralysis, infantile onset ascending | rel=r_associated | relid=0 | w=22
  321. en:5-oxoprolinase deficiency -- r_associated #0: 22 / 0.688 -> en:i-cell disease
    n1=en:5-oxoprolinase deficiency | n2=en:i-cell disease | rel=r_associated | relid=0 | w=22
  322. en:5-oxoprolinase deficiency -- r_associated #0: 22 / 0.688 -> en:interleukin-1 receptor-associated kinase 4 deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:interleukin-1 receptor-associated kinase 4 deficiency | rel=r_associated | relid=0 | w=22
  323. en:5-oxoprolinase deficiency -- r_associated #0: 22 / 0.688 -> en:laron syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:laron syndrome | rel=r_associated | relid=0 | w=22
  324. en:5-oxoprolinase deficiency -- r_associated #0: 22 / 0.688 -> en:leukotriene c4 synthase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:leukotriene c4 synthase deficiency | rel=r_associated | relid=0 | w=22
  325. en:5-oxoprolinase deficiency -- r_associated #0: 22 / 0.688 -> en:mucopolysaccharidosis type i
    n1=en:5-oxoprolinase deficiency | n2=en:mucopolysaccharidosis type i | rel=r_associated | relid=0 | w=22
  326. en:5-oxoprolinase deficiency -- r_associated #0: 22 / 0.688 -> en:multicentric osteolysis nodulosis arthropathy spectrum
    n1=en:5-oxoprolinase deficiency | n2=en:multicentric osteolysis nodulosis arthropathy spectrum | rel=r_associated | relid=0 | w=22
  327. en:5-oxoprolinase deficiency -- r_associated #0: 22 / 0.688 -> en:myopathy, early-onset, with fatal cardiomyopathy
    n1=en:5-oxoprolinase deficiency | n2=en:myopathy, early-onset, with fatal cardiomyopathy | rel=r_associated | relid=0 | w=22
  328. en:5-oxoprolinase deficiency -- r_associated #0: 22 / 0.688 -> en:niemann-pick disease
    n1=en:5-oxoprolinase deficiency | n2=en:niemann-pick disease | rel=r_associated | relid=0 | w=22
  329. en:5-oxoprolinase deficiency -- r_associated #0: 22 / 0.688 -> en:renal tubulopathy with encephalopathy and liver failure syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:renal tubulopathy with encephalopathy and liver failure syndrome | rel=r_associated | relid=0 | w=22
  330. en:5-oxoprolinase deficiency -- r_associated #0: 22 / 0.688 -> en:spinocerebellar ataxia, autosomal recessive 2
    n1=en:5-oxoprolinase deficiency | n2=en:spinocerebellar ataxia, autosomal recessive 2 | rel=r_associated | relid=0 | w=22
  331. en:5-oxoprolinase deficiency -- r_associated #0: 22 / 0.688 -> en:zellweger syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:zellweger syndrome | rel=r_associated | relid=0 | w=22
  332. en:5-oxoprolinase deficiency -- r_associated #0: 21 / 0.656 -> en:autosomal recessive idiopathic familial dystonia
    n1=en:5-oxoprolinase deficiency | n2=en:autosomal recessive idiopathic familial dystonia | rel=r_associated | relid=0 | w=21
  333. en:5-oxoprolinase deficiency -- r_associated #0: 21 / 0.656 -> en:carbamoyl-phosphate synthetase i deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:carbamoyl-phosphate synthetase i deficiency | rel=r_associated | relid=0 | w=21
  334. en:5-oxoprolinase deficiency -- r_associated #0: 21 / 0.656 -> en:cerebellar ataxia ectodermal dysplasia
    n1=en:5-oxoprolinase deficiency | n2=en:cerebellar ataxia ectodermal dysplasia | rel=r_associated | relid=0 | w=21
  335. en:5-oxoprolinase deficiency -- r_associated #0: 21 / 0.656 -> en:cerebrotendinous xanthomatosis
    n1=en:5-oxoprolinase deficiency | n2=en:cerebrotendinous xanthomatosis | rel=r_associated | relid=0 | w=21
  336. en:5-oxoprolinase deficiency -- r_associated #0: 21 / 0.656 -> en:congenital adrenal hyperplasia
    n1=en:5-oxoprolinase deficiency | n2=en:congenital adrenal hyperplasia | rel=r_associated | relid=0 | w=21
  337. en:5-oxoprolinase deficiency -- r_associated #0: 21 / 0.656 -> en:congenital alpha-2-antiplasmin deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:congenital alpha-2-antiplasmin deficiency | rel=r_associated | relid=0 | w=21
  338. en:5-oxoprolinase deficiency -- r_associated #0: 21 / 0.656 -> en:corpus callosum agenesis neuronopathy
    n1=en:5-oxoprolinase deficiency | n2=en:corpus callosum agenesis neuronopathy | rel=r_associated | relid=0 | w=21
  339. en:5-oxoprolinase deficiency -- r_associated #0: 21 / 0.656 -> en:craniodiaphyseal dysplasia
    n1=en:5-oxoprolinase deficiency | n2=en:craniodiaphyseal dysplasia | rel=r_associated | relid=0 | w=21
  340. en:5-oxoprolinase deficiency -- r_associated #0: 21 / 0.656 -> en:gaucher disease
    n1=en:5-oxoprolinase deficiency | n2=en:gaucher disease | rel=r_associated | relid=0 | w=21
  341. en:5-oxoprolinase deficiency -- r_associated #0: 21 / 0.656 -> en:hereditary methemoglobinemia, enzymatic type
    n1=en:5-oxoprolinase deficiency | n2=en:hereditary methemoglobinemia, enzymatic type | rel=r_associated | relid=0 | w=21
  342. en:5-oxoprolinase deficiency -- r_associated #0: 21 / 0.656 -> en:hydroxykynureninuria
    n1=en:5-oxoprolinase deficiency | n2=en:hydroxykynureninuria | rel=r_associated | relid=0 | w=21
  343. en:5-oxoprolinase deficiency -- r_associated #0: 21 / 0.656 -> en:hypospadias-mental retardation syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:hypospadias-mental retardation syndrome | rel=r_associated | relid=0 | w=21
  344. en:5-oxoprolinase deficiency -- r_associated #0: 21 / 0.656 -> en:lipid metabolism disorder
    n1=en:5-oxoprolinase deficiency | n2=en:lipid metabolism disorder | rel=r_associated | relid=0 | w=21
  345. en:5-oxoprolinase deficiency -- r_associated #0: 21 / 0.656 -> en:methylene thf reductase deficiency and homocystinuria
    n1=en:5-oxoprolinase deficiency | n2=en:methylene thf reductase deficiency and homocystinuria | rel=r_associated | relid=0 | w=21
  346. en:5-oxoprolinase deficiency -- r_associated #0: 21 / 0.656 -> en:mitochondrial neurogastrointestinal encephalomyopathy syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:mitochondrial neurogastrointestinal encephalomyopathy syndrome | rel=r_associated | relid=0 | w=21
  347. en:5-oxoprolinase deficiency -- r_associated #0: 21 / 0.656 -> en:moderate steroid 21-hydroxylase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:moderate steroid 21-hydroxylase deficiency | rel=r_associated | relid=0 | w=21
  348. en:5-oxoprolinase deficiency -- r_associated #0: 21 / 0.656 -> en:neurodegeneration due to cerebral folate transport deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:neurodegeneration due to cerebral folate transport deficiency | rel=r_associated | relid=0 | w=21
  349. en:5-oxoprolinase deficiency -- r_associated #0: 21 / 0.656 -> en:north american indian childhood cirrhosis
    n1=en:5-oxoprolinase deficiency | n2=en:north american indian childhood cirrhosis | rel=r_associated | relid=0 | w=21
  350. en:5-oxoprolinase deficiency -- r_associated #0: 21 / 0.656 -> en:purine-nucleoside phosphorylase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:purine-nucleoside phosphorylase deficiency | rel=r_associated | relid=0 | w=21
  351. en:5-oxoprolinase deficiency -- r_associated #0: 21 / 0.656 -> en:richards-rundle syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:richards-rundle syndrome | rel=r_associated | relid=0 | w=21
  352. en:5-oxoprolinase deficiency -- r_associated #0: 21 / 0.656 -> en:sinus histiocytosis with massive lymphadenopathy
    n1=en:5-oxoprolinase deficiency | n2=en:sinus histiocytosis with massive lymphadenopathy | rel=r_associated | relid=0 | w=21
  353. en:5-oxoprolinase deficiency -- r_associated #0: 21 / 0.656 -> en:spastic paraplegia 15, autosomal recessive
    n1=en:5-oxoprolinase deficiency | n2=en:spastic paraplegia 15, autosomal recessive | rel=r_associated | relid=0 | w=21
  354. en:5-oxoprolinase deficiency -- r_associated #0: 21 / 0.656 -> en:spinal muscular atrophy with respiratory distress 1
    n1=en:5-oxoprolinase deficiency | n2=en:spinal muscular atrophy with respiratory distress 1 | rel=r_associated | relid=0 | w=21
  355. en:5-oxoprolinase deficiency -- r_associated #0: 21 / 0.656 -> en:syndrome of apparent mineralocorticoid excess
    n1=en:5-oxoprolinase deficiency | n2=en:syndrome of apparent mineralocorticoid excess | rel=r_associated | relid=0 | w=21
  356. en:5-oxoprolinase deficiency -- r_associated #0: 21 / 0.656 -> en:thyroid dyshormonogenesis 4
    n1=en:5-oxoprolinase deficiency | n2=en:thyroid dyshormonogenesis 4 | rel=r_associated | relid=0 | w=21
  357. en:5-oxoprolinase deficiency -- r_associated #0: 21 / 0.656 -> en:tyrosinemia type ii
    n1=en:5-oxoprolinase deficiency | n2=en:tyrosinemia type ii | rel=r_associated | relid=0 | w=21
  358. en:5-oxoprolinase deficiency -- r_associated #0: 21 / 0.656 -> en:warsaw breakage syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:warsaw breakage syndrome | rel=r_associated | relid=0 | w=21
  359. en:5-oxoprolinase deficiency -- r_associated #0: 21 / 0.656 -> en:xeroderma pigmentosum
    n1=en:5-oxoprolinase deficiency | n2=en:xeroderma pigmentosum | rel=r_associated | relid=0 | w=21
  360. en:5-oxoprolinase deficiency -- r_associated #0: 21 / 0.656 -> entérocolite
    n1=en:5-oxoprolinase deficiency | n2=entérocolite | rel=r_associated | relid=0 | w=21
  361. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> a-bêta-lipoprotéinémie
    n1=en:5-oxoprolinase deficiency | n2=a-bêta-lipoprotéinémie | rel=r_associated | relid=0 | w=20
  362. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> abêtalipoprotéinémie
    n1=en:5-oxoprolinase deficiency | n2=abêtalipoprotéinémie | rel=r_associated | relid=0 | w=20
  363. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> acidémie glutarique de type 1
    n1=en:5-oxoprolinase deficiency | n2=acidémie glutarique de type 1 | rel=r_associated | relid=0 | w=20
  364. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> acido-cétose
    n1=en:5-oxoprolinase deficiency | n2=acido-cétose | rel=r_associated | relid=0 | w=20
  365. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> acidocétose
    n1=en:5-oxoprolinase deficiency | n2=acidocétose | rel=r_associated | relid=0 | w=20
  366. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> acidurie dicarboxylique
    n1=en:5-oxoprolinase deficiency | n2=acidurie dicarboxylique | rel=r_associated | relid=0 | w=20
  367. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> acidurie glutarique
    n1=en:5-oxoprolinase deficiency | n2=acidurie glutarique | rel=r_associated | relid=0 | w=20
  368. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> acidurie glutarique de type 1
    n1=en:5-oxoprolinase deficiency | n2=acidurie glutarique de type 1 | rel=r_associated | relid=0 | w=20
  369. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> acrodermatite entéropathique
    n1=en:5-oxoprolinase deficiency | n2=acrodermatite entéropathique | rel=r_associated | relid=0 | w=20
  370. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> acrodermatitis enteropathica
    n1=en:5-oxoprolinase deficiency | n2=acrodermatitis enteropathica | rel=r_associated | relid=0 | w=20
  371. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> agrégation des plaquettes diminuée
    n1=en:5-oxoprolinase deficiency | n2=agrégation des plaquettes diminuée | rel=r_associated | relid=0 | w=20
  372. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> agrégation plaquettaire sai diminuée
    n1=en:5-oxoprolinase deficiency | n2=agrégation plaquettaire sai diminuée | rel=r_associated | relid=0 | w=20
  373. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> albinisme
    n1=en:5-oxoprolinase deficiency | n2=albinisme | rel=r_associated | relid=0 | w=20
  374. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> avitaminose D
    n1=en:5-oxoprolinase deficiency | n2=avitaminose D | rel=r_associated | relid=0 | w=20
  375. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> avitaminose d
    n1=en:5-oxoprolinase deficiency | n2=avitaminose d | rel=r_associated | relid=0 | w=20
  376. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> bicarbonate sérique augmenté
    n1=en:5-oxoprolinase deficiency | n2=bicarbonate sérique augmenté | rel=r_associated | relid=0 | w=20
  377. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> calcium normal
    n1=en:5-oxoprolinase deficiency | n2=calcium normal | rel=r_associated | relid=0 | w=20
  378. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> calciurie
    n1=en:5-oxoprolinase deficiency | n2=calciurie | rel=r_associated | relid=0 | w=20
  379. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> carence en vit d
    n1=en:5-oxoprolinase deficiency | n2=carence en vit d | rel=r_associated | relid=0 | w=20
  380. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> carence en vitamine D
    n1=en:5-oxoprolinase deficiency | n2=carence en vitamine D | rel=r_associated | relid=0 | w=20
  381. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> carence en vitamine d
    n1=en:5-oxoprolinase deficiency | n2=carence en vitamine d | rel=r_associated | relid=0 | w=20
  382. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> cétoacidose
    n1=en:5-oxoprolinase deficiency | n2=cétoacidose | rel=r_associated | relid=0 | w=20
  383. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> cétoacidurie à chaînes ramifiées
    n1=en:5-oxoprolinase deficiency | n2=cétoacidurie à chaînes ramifiées | rel=r_associated | relid=0 | w=20
  384. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> cholestérol normal
    n1=en:5-oxoprolinase deficiency | n2=cholestérol normal | rel=r_associated | relid=0 | w=20
  385. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> cholestérol sanguin élevé
    n1=en:5-oxoprolinase deficiency | n2=cholestérol sanguin élevé | rel=r_associated | relid=0 | w=20
  386. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> coagulation intravasculaire disséminée
    n1=en:5-oxoprolinase deficiency | n2=coagulation intravasculaire disséminée | rel=r_associated | relid=0 | w=20
  387. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> coagulopathie intravasculaire disséminée
    n1=en:5-oxoprolinase deficiency | n2=coagulopathie intravasculaire disséminée | rel=r_associated | relid=0 | w=20
  388. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> Coagulopathie intravasculaire disséminée
    n1=en:5-oxoprolinase deficiency | n2=Coagulopathie intravasculaire disséminée | rel=r_associated | relid=0 | w=20
  389. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> congénital
    n1=en:5-oxoprolinase deficiency | n2=congénital | rel=r_associated | relid=0 | w=20
  390. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> congenital
    n1=en:5-oxoprolinase deficiency | n2=congenital | rel=r_associated | relid=0 | w=20
  391. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> congénitale
    n1=en:5-oxoprolinase deficiency | n2=congénitale | rel=r_associated | relid=0 | w=20
  392. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> déficit congénital en mégacaryocytes
    n1=en:5-oxoprolinase deficiency | n2=déficit congénital en mégacaryocytes | rel=r_associated | relid=0 | w=20
  393. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> déficit en céto-acide décarboxylase
    n1=en:5-oxoprolinase deficiency | n2=déficit en céto-acide décarboxylase | rel=r_associated | relid=0 | w=20
  394. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> déficit en cytochrome oxydase
    n1=en:5-oxoprolinase deficiency | n2=déficit en cytochrome oxydase | rel=r_associated | relid=0 | w=20
  395. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> déficit en cytochrome-c oxydase
    n1=en:5-oxoprolinase deficiency | n2=déficit en cytochrome-c oxydase | rel=r_associated | relid=0 | w=20
  396. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> déficit en neuraminidase
    n1=en:5-oxoprolinase deficiency | n2=déficit en neuraminidase | rel=r_associated | relid=0 | w=20
  397. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> déficit en prolidase
    n1=en:5-oxoprolinase deficiency | n2=déficit en prolidase | rel=r_associated | relid=0 | w=20
  398. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> déficit en pyruvate carboxylase
    n1=en:5-oxoprolinase deficiency | n2=déficit en pyruvate carboxylase | rel=r_associated | relid=0 | w=20
  399. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> déficit en semialdéhyde succinique-déshydrogénase
    n1=en:5-oxoprolinase deficiency | n2=déficit en semialdéhyde succinique-déshydrogénase | rel=r_associated | relid=0 | w=20
  400. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> déficit en sulfite-oxydase
    n1=en:5-oxoprolinase deficiency | n2=déficit en sulfite-oxydase | rel=r_associated | relid=0 | w=20
  401. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> déficit en vitamine D
    n1=en:5-oxoprolinase deficiency | n2=déficit en vitamine D | rel=r_associated | relid=0 | w=20
  402. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> dyslipémie
    n1=en:5-oxoprolinase deficiency | n2=dyslipémie | rel=r_associated | relid=0 | w=20
  403. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> dysplasie craniodiaphysaire
    n1=en:5-oxoprolinase deficiency | n2=dysplasie craniodiaphysaire | rel=r_associated | relid=0 | w=20
  404. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:'cloudy' or 'pink' blood (lipemia)
    n1=en:5-oxoprolinase deficiency | n2=en:'cloudy' or 'pink' blood (lipemia) | rel=r_associated | relid=0 | w=20
  405. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:'compensated hypothyroidism' with increased tsh and normal t4
    n1=en:5-oxoprolinase deficiency | n2=en:'compensated hypothyroidism' with increased tsh and normal t4 | rel=r_associated | relid=0 | w=20
  406. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:'ghost' peroxisomes in fibroblasts seen on immunofluorescence microscopy
    n1=en:5-oxoprolinase deficiency | n2=en:'ghost' peroxisomes in fibroblasts seen on immunofluorescence microscopy | rel=r_associated | relid=0 | w=20
  407. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:'rectilinear profiles' ultrastructurally in cells
    n1=en:5-oxoprolinase deficiency | n2=en:'rectilinear profiles' ultrastructurally in cells | rel=r_associated | relid=0 | w=20
  408. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:1,25-dihydroxyvitamin d was elevated in childhood but deficient in adulthood
    n1=en:5-oxoprolinase deficiency | n2=en:1,25-dihydroxyvitamin d was elevated in childhood but deficient in adulthood | rel=r_associated | relid=0 | w=20
  409. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:1.61- and 1.76-mb microduplication of 3q29
    n1=en:5-oxoprolinase deficiency | n2=en:1.61- and 1.76-mb microduplication of 3q29 | rel=r_associated | relid=0 | w=20
  410. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:2-aminoadipic aciduria
    n1=en:5-oxoprolinase deficiency | n2=en:2-aminoadipic aciduria | rel=r_associated | relid=0 | w=20
  411. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:2-oxoadipic aciduria
    n1=en:5-oxoprolinase deficiency | n2=en:2-oxoadipic aciduria | rel=r_associated | relid=0 | w=20
  412. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:2,8-dihydroxyadenine (dha) urinary stones
    n1=en:5-oxoprolinase deficiency | n2=en:2,8-dihydroxyadenine (dha) urinary stones | rel=r_associated | relid=0 | w=20
  413. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:3-methylglutaconic aciduria
    n1=en:5-oxoprolinase deficiency | n2=en:3-methylglutaconic aciduria | rel=r_associated | relid=0 | w=20
  414. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:3-methylglutaconic aciduria (3-mgc)
    n1=en:5-oxoprolinase deficiency | n2=en:3-methylglutaconic aciduria (3-mgc) | rel=r_associated | relid=0 | w=20
  415. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:3-methylglutaconic aciduria type 7
    n1=en:5-oxoprolinase deficiency | n2=en:3-methylglutaconic aciduria type 7 | rel=r_associated | relid=0 | w=20
  416. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:3-methylglutaric aciduria
    n1=en:5-oxoprolinase deficiency | n2=en:3-methylglutaric aciduria | rel=r_associated | relid=0 | w=20
  417. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:3-methylglutaric aciduria (3-mga)
    n1=en:5-oxoprolinase deficiency | n2=en:3-methylglutaric aciduria (3-mga) | rel=r_associated | relid=0 | w=20
  418. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:4-hydroxycyclohexylacetic aciduria (adults)
    n1=en:5-oxoprolinase deficiency | n2=en:4-hydroxycyclohexylacetic aciduria (adults) | rel=r_associated | relid=0 | w=20
  419. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:4-hydroxyphenylacetic aciduria
    n1=en:5-oxoprolinase deficiency | n2=en:4-hydroxyphenylacetic aciduria | rel=r_associated | relid=0 | w=20
  420. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:4-hydroxyphenylactic aciduria
    n1=en:5-oxoprolinase deficiency | n2=en:4-hydroxyphenylactic aciduria | rel=r_associated | relid=0 | w=20
  421. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:4-hydroxyphenylpyruvic acid dioxygenase deficiency (hpd)
    n1=en:5-oxoprolinase deficiency | n2=en:4-hydroxyphenylpyruvic acid dioxygenase deficiency (hpd) | rel=r_associated | relid=0 | w=20
  422. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:4-hydroxyphenylpyruvic aciduria
    n1=en:5-oxoprolinase deficiency | n2=en:4-hydroxyphenylpyruvic aciduria | rel=r_associated | relid=0 | w=20
  423. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:5-alpha-reductase-2 enzyme deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:5-alpha-reductase-2 enzyme deficiency | rel=r_associated | relid=0 | w=20
  424. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:5-hiaa csf may be normal or decreased
    n1=en:5-oxoprolinase deficiency | n2=en:5-hiaa csf may be normal or decreased | rel=r_associated | relid=0 | w=20
  425. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:a small minority of patients have translocations and inversions involving 16p13.3
    n1=en:5-oxoprolinase deficiency | n2=en:a small minority of patients have translocations and inversions involving 16p13.3 | rel=r_associated | relid=0 | w=20
  426. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:a subset of group b patients have absence of pc protein and mrna
    n1=en:5-oxoprolinase deficiency | n2=en:a subset of group b patients have absence of pc protein and mrna | rel=r_associated | relid=0 | w=20
  427. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abacterial leukocyturia
    n1=en:5-oxoprolinase deficiency | n2=en:abacterial leukocyturia | rel=r_associated | relid=0 | w=20
  428. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abetalipoproteinemia
    n1=en:5-oxoprolinase deficiency | n2=en:abetalipoproteinemia | rel=r_associated | relid=0 | w=20
  429. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abetalipoproteinemia (lab finding)
    n1=en:5-oxoprolinase deficiency | n2=en:abetalipoproteinemia (lab finding) | rel=r_associated | relid=0 | w=20
  430. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal bone marrow karyotype, t(8,21)
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal bone marrow karyotype, t(8,21) | rel=r_associated | relid=0 | w=20
  431. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal cartilage collagen on em
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal cartilage collagen on em | rel=r_associated | relid=0 | w=20
  432. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal cholesterol homeostasis
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal cholesterol homeostasis | rel=r_associated | relid=0 | w=20
  433. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal columnization of chondrocytes
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal columnization of chondrocytes | rel=r_associated | relid=0 | w=20
  434. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal dystrophin on muscle biopsy
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal dystrophin on muscle biopsy | rel=r_associated | relid=0 | w=20
  435. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal eeg in 25% hospitalized patients
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal eeg in 25% hospitalized patients | rel=r_associated | relid=0 | w=20
  436. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal extrarenal response to ddavp (no increase in von willebrand factor or factor viii)
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal extrarenal response to ddavp (no increase in von willebrand factor or factor viii) | rel=r_associated | relid=0 | w=20
  437. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal glycosylation of serum transferrin, type 1 pattern
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal glycosylation of serum transferrin, type 1 pattern | rel=r_associated | relid=0 | w=20
  438. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal igfr1 function
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal igfr1 function | rel=r_associated | relid=0 | w=20
  439. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal isoelectric focusing of serum transferrin
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal isoelectric focusing of serum transferrin | rel=r_associated | relid=0 | w=20
  440. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal isoelectric focusing of serum transferrin (type 1 pattern without increase of asialotransferrin)
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal isoelectric focusing of serum transferrin (type 1 pattern without increase of asialotransferrin) | rel=r_associated | relid=0 | w=20
  441. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal isoelectric focusing of serum transferrin (type 1 pattern)
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal isoelectric focusing of serum transferrin (type 1 pattern) | rel=r_associated | relid=0 | w=20
  442. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal isoelectric focusing of serum transferrin (type 1 pattern) (in 1 patient)
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal isoelectric focusing of serum transferrin (type 1 pattern) (in 1 patient) | rel=r_associated | relid=0 | w=20
  443. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal isoelectric focusing of serum transferrin (type 2 pattern)
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal isoelectric focusing of serum transferrin (type 2 pattern) | rel=r_associated | relid=0 | w=20
  444. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal isoelectric focusing of serum transferrin, type 2 pattern
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal isoelectric focusing of serum transferrin, type 2 pattern | rel=r_associated | relid=0 | w=20
  445. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal karyotype in 3 patients involving distal 6p
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal karyotype in 3 patients involving distal 6p | rel=r_associated | relid=0 | w=20
  446. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal lipid profile
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal lipid profile | rel=r_associated | relid=0 | w=20
  447. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal liver enzymes (1 patient)
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal liver enzymes (1 patient) | rel=r_associated | relid=0 | w=20
  448. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal liver enzymes (in some patients)
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal liver enzymes (in some patients) | rel=r_associated | relid=0 | w=20
  449. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal liver enzymes (rare)
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal liver enzymes (rare) | rel=r_associated | relid=0 | w=20
  450. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal liver enzymes in those with hepatic cysts or fibrosis
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal liver enzymes in those with hepatic cysts or fibrosis | rel=r_associated | relid=0 | w=20
  451. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal liver enzymes, intermittent
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal liver enzymes, intermittent | rel=r_associated | relid=0 | w=20
  452. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal liver enzymes, intermittent (1 patient)
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal liver enzymes, intermittent (1 patient) | rel=r_associated | relid=0 | w=20
  453. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal liver function tests (in some patients)
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal liver function tests (in some patients) | rel=r_associated | relid=0 | w=20
  454. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal liver function tests (less common)
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal liver function tests (less common) | rel=r_associated | relid=0 | w=20
  455. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal liver function tests (sgot, sgpt)
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal liver function tests (sgot, sgpt) | rel=r_associated | relid=0 | w=20
  456. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal myelination in sural nerve biopsies
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal myelination in sural nerve biopsies | rel=r_associated | relid=0 | w=20
  457. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal n-glycosylation of transferrin
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal n-glycosylation of transferrin | rel=r_associated | relid=0 | w=20
  458. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal nasal potential difference
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal nasal potential difference | rel=r_associated | relid=0 | w=20
  459. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal oral glucose tolerance
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal oral glucose tolerance | rel=r_associated | relid=0 | w=20
  460. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal phosphatidylglycerol profile (increased 34-to-1 and decreased 36-to-1 ratio)
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal phosphatidylglycerol profile (increased 34-to-1 and decreased 36-to-1 ratio) | rel=r_associated | relid=0 | w=20
  461. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal phospholipid profile
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal phospholipid profile | rel=r_associated | relid=0 | w=20
  462. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal response of 25-hydroxyvitamin d-1-alpha-hydroxylase activity (609506) to hypophosphatemia
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal response of 25-hydroxyvitamin d-1-alpha-hydroxylase activity (609506) to hypophosphatemia | rel=r_associated | relid=0 | w=20
  463. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal response to human chorionic gonadotropin indicates decreased testosterone
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal response to human chorionic gonadotropin indicates decreased testosterone | rel=r_associated | relid=0 | w=20
  464. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal schilling test (not normalized by addition of intrinsic factor)
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal schilling test (not normalized by addition of intrinsic factor) | rel=r_associated | relid=0 | w=20
  465. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal secretin test
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal secretin test | rel=r_associated | relid=0 | w=20
  466. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal serum glycoproteins
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal serum glycoproteins | rel=r_associated | relid=0 | w=20
  467. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal serum lipoprotein levels (in 3 of 10 patients)
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal serum lipoprotein levels (in 3 of 10 patients) | rel=r_associated | relid=0 | w=20
  468. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal serum liver enzyme levels
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal serum liver enzyme levels | rel=r_associated | relid=0 | w=20
  469. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal serum protein electrophoresis (elevated alpha-2 band)
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal serum protein electrophoresis (elevated alpha-2 band) | rel=r_associated | relid=0 | w=20
  470. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal serum transferrin pattern (in some patients)
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal serum transferrin pattern (in some patients) | rel=r_associated | relid=0 | w=20
  471. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal serum transferrin pattern by isoelectric focusing (hyposialylation)
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal serum transferrin pattern by isoelectric focusing (hyposialylation) | rel=r_associated | relid=0 | w=20
  472. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal spinocerebellar tracts, dorsal columns, pyramidal tracts, cerebellum and brainstem
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal spinocerebellar tracts, dorsal columns, pyramidal tracts, cerebellum and brainstem | rel=r_associated | relid=0 | w=20
  473. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal transaminases (1 patient)
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal transaminases (1 patient) | rel=r_associated | relid=0 | w=20
  474. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal urinary collagen-derived pyridinium crosslinks (absent glc-gal-pyd)
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal urinary collagen-derived pyridinium crosslinks (absent glc-gal-pyd) | rel=r_associated | relid=0 | w=20
  475. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal urinary mucopolysaccharides (elevated unsaturated nonsulfated disaccharides and decreased unsaturated 6-sulfated disaccharides)
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal urinary mucopolysaccharides (elevated unsaturated nonsulfated disaccharides and decreased unsaturated 6-sulfated disaccharides) | rel=r_associated | relid=0 | w=20
  476. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormal urinary oligosaccharides
    n1=en:5-oxoprolinase deficiency | n2=en:abnormal urinary oligosaccharides | rel=r_associated | relid=0 | w=20
  477. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormality of nucleobase metabolism
    n1=en:5-oxoprolinase deficiency | n2=en:abnormality of nucleobase metabolism | rel=r_associated | relid=0 | w=20
  478. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormality of superoxide metabolism
    n1=en:5-oxoprolinase deficiency | n2=en:abnormality of superoxide metabolism | rel=r_associated | relid=0 | w=20
  479. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormally low cerebrospinal fluid cystatin c
    n1=en:5-oxoprolinase deficiency | n2=en:abnormally low cerebrospinal fluid cystatin c | rel=r_associated | relid=0 | w=20
  480. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:abnormally triglyceride-rich low and high density lipoproteins and beta-migrating very low density lipoproteins
    n1=en:5-oxoprolinase deficiency | n2=en:abnormally triglyceride-rich low and high density lipoproteins and beta-migrating very low density lipoproteins | rel=r_associated | relid=0 | w=20
  481. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:absence of cd59 expression on red cells
    n1=en:5-oxoprolinase deficiency | n2=en:absence of cd59 expression on red cells | rel=r_associated | relid=0 | w=20
  482. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:absence of chylomicrons in lymph and plasma
    n1=en:5-oxoprolinase deficiency | n2=en:absence of chylomicrons in lymph and plasma | rel=r_associated | relid=0 | w=20
  483. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:absence of cpt ii protein
    n1=en:5-oxoprolinase deficiency | n2=en:absence of cpt ii protein | rel=r_associated | relid=0 | w=20
  484. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:absence of emerin by immunohistochemistry on muscle biopsy
    n1=en:5-oxoprolinase deficiency | n2=en:absence of emerin by immunohistochemistry on muscle biopsy | rel=r_associated | relid=0 | w=20
  485. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:absence of hepatic udp-glucuronyl-transferase
    n1=en:5-oxoprolinase deficiency | n2=en:absence of hepatic udp-glucuronyl-transferase | rel=r_associated | relid=0 | w=20
  486. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:absence of protein-bound lipoic acid
    n1=en:5-oxoprolinase deficiency | n2=en:absence of protein-bound lipoic acid | rel=r_associated | relid=0 | w=20
  487. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:absent 7-dehydrocholesterol
    n1=en:5-oxoprolinase deficiency | n2=en:absent 7-dehydrocholesterol | rel=r_associated | relid=0 | w=20
  488. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:absent alkyl-dhap synthase activity
    n1=en:5-oxoprolinase deficiency | n2=en:absent alkyl-dhap synthase activity | rel=r_associated | relid=0 | w=20
  489. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:absent anti-insulin receptor antibodies
    n1=en:5-oxoprolinase deficiency | n2=en:absent anti-insulin receptor antibodies | rel=r_associated | relid=0 | w=20
  490. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:absent axonal flare response to intradermal histamine injection
    n1=en:5-oxoprolinase deficiency | n2=en:absent axonal flare response to intradermal histamine injection | rel=r_associated | relid=0 | w=20
  491. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:absent ch50 activity in complete c4 deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:absent ch50 activity in complete c4 deficiency | rel=r_associated | relid=0 | w=20
  492. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:absent dystrophin on muscle biopsy
    n1=en:5-oxoprolinase deficiency | n2=en:absent dystrophin on muscle biopsy | rel=r_associated | relid=0 | w=20
  493. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:absent enteric ganglia beginning at rectum and extending proximally by varying degrees
    n1=en:5-oxoprolinase deficiency | n2=en:absent enteric ganglia beginning at rectum and extending proximally by varying degrees | rel=r_associated | relid=0 | w=20
  494. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:absent igg2 subclass
    n1=en:5-oxoprolinase deficiency | n2=en:absent igg2 subclass | rel=r_associated | relid=0 | w=20
  495. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:absent or severely reduced levels of serum immunoglobulins
    n1=en:5-oxoprolinase deficiency | n2=en:absent or severely reduced levels of serum immunoglobulins | rel=r_associated | relid=0 | w=20
  496. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:absent platelet agglutination in presence of ristocetin
    n1=en:5-oxoprolinase deficiency | n2=en:absent platelet agglutination in presence of ristocetin | rel=r_associated | relid=0 | w=20
  497. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:absent pro alpha 2(i) chain synthesis (fibroblasts)
    n1=en:5-oxoprolinase deficiency | n2=en:absent pro alpha 2(i) chain synthesis (fibroblasts) | rel=r_associated | relid=0 | w=20
  498. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:absent-decreased prolyl 3-hydroxylation at collagen i alpha-1 pro986
    n1=en:5-oxoprolinase deficiency | n2=en:absent-decreased prolyl 3-hydroxylation at collagen i alpha-1 pro986 | rel=r_associated | relid=0 | w=20
  499. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:absent/reduced free proteins and absent total protein s
    n1=en:5-oxoprolinase deficiency | n2=en:absent/reduced free proteins and absent total protein s | rel=r_associated | relid=0 | w=20
  500. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:accumulation of cholesterol esters in various tissues
    n1=en:5-oxoprolinase deficiency | n2=en:accumulation of cholesterol esters in various tissues | rel=r_associated | relid=0 | w=20
  501. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:accumulation of guanidinoacetate in brain
    n1=en:5-oxoprolinase deficiency | n2=en:accumulation of guanidinoacetate in brain | rel=r_associated | relid=0 | w=20
  502. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:accumulation of sulfatides, glycosaminoglycans, sphingolipids, and steroid sulfates in tissues and body fluids
    n1=en:5-oxoprolinase deficiency | n2=en:accumulation of sulfatides, glycosaminoglycans, sphingolipids, and steroid sulfates in tissues and body fluids | rel=r_associated | relid=0 | w=20
  503. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:accumulation of truncated oligosaccharides man(5)glcnac2 and man(9)glcnac(2)
    n1=en:5-oxoprolinase deficiency | n2=en:accumulation of truncated oligosaccharides man(5)glcnac2 and man(9)glcnac(2) | rel=r_associated | relid=0 | w=20
  504. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:accumulation of unprocessed mt-trna intermediates in skeletal muscle cells and fibroblasts
    n1=en:5-oxoprolinase deficiency | n2=en:accumulation of unprocessed mt-trna intermediates in skeletal muscle cells and fibroblasts | rel=r_associated | relid=0 | w=20
  505. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:acetyl coa:alpha-glucosaminidase n-acetyltransferase deficiency in fibroblasts
    n1=en:5-oxoprolinase deficiency | n2=en:acetyl coa:alpha-glucosaminidase n-acetyltransferase deficiency in fibroblasts | rel=r_associated | relid=0 | w=20
  506. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:acetylcholinesterase staining reveals nerve trunk hypertrophy
    n1=en:5-oxoprolinase deficiency | n2=en:acetylcholinesterase staining reveals nerve trunk hypertrophy | rel=r_associated | relid=0 | w=20
  507. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:acquired lactase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:acquired lactase deficiency | rel=r_associated | relid=0 | w=20
  508. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:acrorenal mandibular syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:acrorenal mandibular syndrome | rel=r_associated | relid=0 | w=20
  509. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:acth normal
    n1=en:5-oxoprolinase deficiency | n2=en:acth normal | rel=r_associated | relid=0 | w=20
  510. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:acute hyperammonemia
    n1=en:5-oxoprolinase deficiency | n2=en:acute hyperammonemia | rel=r_associated | relid=0 | w=20
  511. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:acute infantile liver failure due to synthesis defect of mitochondrial deoxyribonucleic acid encoded protein
    n1=en:5-oxoprolinase deficiency | n2=en:acute infantile liver failure due to synthesis defect of mitochondrial deoxyribonucleic acid encoded protein | rel=r_associated | relid=0 | w=20
  512. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:acyl-coa:dihydroxyacetonephosphate acyltransferase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:acyl-coa:dihydroxyacetonephosphate acyltransferase deficiency | rel=r_associated | relid=0 | w=20
  513. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:acylglycinuria
    n1=en:5-oxoprolinase deficiency | n2=en:acylglycinuria | rel=r_associated | relid=0 | w=20
  514. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:adducted thumbs and arthrogryposis syndrome christian type
    n1=en:5-oxoprolinase deficiency | n2=en:adducted thumbs and arthrogryposis syndrome christian type | rel=r_associated | relid=0 | w=20
  515. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:adenylosuccinase deficiency (finding)
    n1=en:5-oxoprolinase deficiency | n2=en:adenylosuccinase deficiency (finding) | rel=r_associated | relid=0 | w=20
  516. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:adrenocorticotropic hormone, increased
    n1=en:5-oxoprolinase deficiency | n2=en:adrenocorticotropic hormone, increased | rel=r_associated | relid=0 | w=20
  517. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:affected mother has reduced zinc levels in breast milk (may be up to 40% less than normal breast milk)
    n1=en:5-oxoprolinase deficiency | n2=en:affected mother has reduced zinc levels in breast milk (may be up to 40% less than normal breast milk) | rel=r_associated | relid=0 | w=20
  518. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:agammaglobulinemia
    n1=en:5-oxoprolinase deficiency | n2=en:agammaglobulinemia | rel=r_associated | relid=0 | w=20
  519. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:agammaglobulinemia, microcephaly, craniosynostosis, severe dermatitis syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:agammaglobulinemia, microcephaly, craniosynostosis, severe dermatitis syndrome | rel=r_associated | relid=0 | w=20
  520. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:albinism
    n1=en:5-oxoprolinase deficiency | n2=en:albinism | rel=r_associated | relid=0 | w=20
  521. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:aldolase a deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:aldolase a deficiency | rel=r_associated | relid=0 | w=20
  522. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:aldosterone level increased above normal
    n1=en:5-oxoprolinase deficiency | n2=en:aldosterone level increased above normal | rel=r_associated | relid=0 | w=20
  523. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:alkaline phosphatase decreased
    n1=en:5-oxoprolinase deficiency | n2=en:alkaline phosphatase decreased | rel=r_associated | relid=0 | w=20
  524. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:alkaline phosphatase normal
    n1=en:5-oxoprolinase deficiency | n2=en:alkaline phosphatase normal | rel=r_associated | relid=0 | w=20
  525. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:alkaline phosphatase serum increased
    n1=en:5-oxoprolinase deficiency | n2=en:alkaline phosphatase serum increased | rel=r_associated | relid=0 | w=20
  526. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:alkaptonuria
    n1=en:5-oxoprolinase deficiency | n2=en:alkaptonuria | rel=r_associated | relid=0 | w=20
  527. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:allelic loss on 16p13.3 in angiomyolipoma, cardiac rhabdomyoma, cortical tuber, and giant cell astrocytoma
    n1=en:5-oxoprolinase deficiency | n2=en:allelic loss on 16p13.3 in angiomyolipoma, cardiac rhabdomyoma, cortical tuber, and giant cell astrocytoma | rel=r_associated | relid=0 | w=20
  528. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:alpha fetoprotein increased
    n1=en:5-oxoprolinase deficiency | n2=en:alpha fetoprotein increased | rel=r_associated | relid=0 | w=20
  529. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:alpha ketoadipic aciduria
    n1=en:5-oxoprolinase deficiency | n2=en:alpha ketoadipic aciduria | rel=r_associated | relid=0 | w=20
  530. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:alpha-galactosidase a deficiency in plasma, leukocytes, or fibroblasts
    n1=en:5-oxoprolinase deficiency | n2=en:alpha-galactosidase a deficiency in plasma, leukocytes, or fibroblasts | rel=r_associated | relid=0 | w=20
  531. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:amino acid transport disorders, inborn
    n1=en:5-oxoprolinase deficiency | n2=en:amino acid transport disorders, inborn | rel=r_associated | relid=0 | w=20
  532. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:aminoaciduria (1 patient)
    n1=en:5-oxoprolinase deficiency | n2=en:aminoaciduria (1 patient) | rel=r_associated | relid=0 | w=20
  533. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:aminoaciduria (less common)
    n1=en:5-oxoprolinase deficiency | n2=en:aminoaciduria (less common) | rel=r_associated | relid=0 | w=20
  534. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:aminoaciduria, intermittent
    n1=en:5-oxoprolinase deficiency | n2=en:aminoaciduria, intermittent | rel=r_associated | relid=0 | w=20
  535. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:aminoaciduria, mild (in some patients)
    n1=en:5-oxoprolinase deficiency | n2=en:aminoaciduria, mild (in some patients) | rel=r_associated | relid=0 | w=20
  536. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:aminoadipic semialdehyde synthase (aass) deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:aminoadipic semialdehyde synthase (aass) deficiency | rel=r_associated | relid=0 | w=20
  537. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:amorphous hyaline substance (skin biopsy and visceral organs)
    n1=en:5-oxoprolinase deficiency | n2=en:amorphous hyaline substance (skin biopsy and visceral organs) | rel=r_associated | relid=0 | w=20
  538. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:amylo(1,4 - 1,6) transglucosidase deficiency (brancher enzyme)
    n1=en:5-oxoprolinase deficiency | n2=en:amylo(1,4 - 1,6) transglucosidase deficiency (brancher enzyme) | rel=r_associated | relid=0 | w=20
  539. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:amyloidosis, (iowa type 107680.0010, nonneuropathic 107680.0016)
    n1=en:5-oxoprolinase deficiency | n2=en:amyloidosis, (iowa type 107680.0010, nonneuropathic 107680.0016) | rel=r_associated | relid=0 | w=20
  540. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:anauxetic dysplasia
    n1=en:5-oxoprolinase deficiency | n2=en:anauxetic dysplasia | rel=r_associated | relid=0 | w=20
  541. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:androgens increased
    n1=en:5-oxoprolinase deficiency | n2=en:androgens increased | rel=r_associated | relid=0 | w=20
  542. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:anomalies of cholesterol levels
    n1=en:5-oxoprolinase deficiency | n2=en:anomalies of cholesterol levels | rel=r_associated | relid=0 | w=20
  543. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:anti-ds dna antibody
    n1=en:5-oxoprolinase deficiency | n2=en:anti-ds dna antibody | rel=r_associated | relid=0 | w=20
  544. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:anti-factor viii positive
    n1=en:5-oxoprolinase deficiency | n2=en:anti-factor viii positive | rel=r_associated | relid=0 | w=20
  545. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:anti-ssb positive
    n1=en:5-oxoprolinase deficiency | n2=en:anti-ssb positive | rel=r_associated | relid=0 | w=20
  546. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:anti-tissue transglutaminase antibodies (anti-ttg)
    n1=en:5-oxoprolinase deficiency | n2=en:anti-tissue transglutaminase antibodies (anti-ttg) | rel=r_associated | relid=0 | w=20
  547. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:antineutrophil antibody positivity
    n1=en:5-oxoprolinase deficiency | n2=en:antineutrophil antibody positivity | rel=r_associated | relid=0 | w=20
  548. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:antineutrophil cytoplasmic antibody
    n1=en:5-oxoprolinase deficiency | n2=en:antineutrophil cytoplasmic antibody | rel=r_associated | relid=0 | w=20
  549. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:antiphospholipid antibody
    n1=en:5-oxoprolinase deficiency | n2=en:antiphospholipid antibody | rel=r_associated | relid=0 | w=20
  550. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:antiribonuclear protein positive
    n1=en:5-oxoprolinase deficiency | n2=en:antiribonuclear protein positive | rel=r_associated | relid=0 | w=20
  551. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:appropriately increased serum 1,25-dihydroxyvitamin d3
    n1=en:5-oxoprolinase deficiency | n2=en:appropriately increased serum 1,25-dihydroxyvitamin d3 | rel=r_associated | relid=0 | w=20
  552. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:arakawa syndrome ii
    n1=en:5-oxoprolinase deficiency | n2=en:arakawa syndrome ii | rel=r_associated | relid=0 | w=20
  553. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:arylsulfatase b deficiency in fibroblasts and white blood cells
    n1=en:5-oxoprolinase deficiency | n2=en:arylsulfatase b deficiency in fibroblasts and white blood cells | rel=r_associated | relid=0 | w=20
  554. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:associated with serum anti-phospholipid antibodies in about 50% of patients
    n1=en:5-oxoprolinase deficiency | n2=en:associated with serum anti-phospholipid antibodies in about 50% of patients | rel=r_associated | relid=0 | w=20
  555. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:atrial abnormalities on electrocardiogram
    n1=en:5-oxoprolinase deficiency | n2=en:atrial abnormalities on electrocardiogram | rel=r_associated | relid=0 | w=20
  556. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:autosomal recessive inheritance
    n1=en:5-oxoprolinase deficiency | n2=en:autosomal recessive inheritance | rel=r_associated | relid=0 | w=20
  557. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:autosomal recessive spastic paraplegia type 39
    n1=en:5-oxoprolinase deficiency | n2=en:autosomal recessive spastic paraplegia type 39 | rel=r_associated | relid=0 | w=20
  558. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:avitaminosis D
    n1=en:5-oxoprolinase deficiency | n2=en:avitaminosis D | rel=r_associated | relid=0 | w=20
  559. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:axonemes show normal structure
    n1=en:5-oxoprolinase deficiency | n2=en:axonemes show normal structure | rel=r_associated | relid=0 | w=20
  560. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:azotemia
    n1=en:5-oxoprolinase deficiency | n2=en:azotemia | rel=r_associated | relid=0 | w=20
  561. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:b lymphocytopenia
    n1=en:5-oxoprolinase deficiency | n2=en:b lymphocytopenia | rel=r_associated | relid=0 | w=20
  562. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:balanced translocation carrier 46,xy,+(11:18)(p13:q21)mat
    n1=en:5-oxoprolinase deficiency | n2=en:balanced translocation carrier 46,xy,+(11:18)(p13:q21)mat | rel=r_associated | relid=0 | w=20
  563. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:ballooned neurons
    n1=en:5-oxoprolinase deficiency | n2=en:ballooned neurons | rel=r_associated | relid=0 | w=20
  564. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:bamforth syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:bamforth syndrome | rel=r_associated | relid=0 | w=20
  565. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:bestrophinopathy, autosomal recessive
    n1=en:5-oxoprolinase deficiency | n2=en:bestrophinopathy, autosomal recessive | rel=r_associated | relid=0 | w=20
  566. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:beta-galactosidase deficiency in fibroblasts and white blood cells
    n1=en:5-oxoprolinase deficiency | n2=en:beta-galactosidase deficiency in fibroblasts and white blood cells | rel=r_associated | relid=0 | w=20
  567. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:beta-glucuronidase deficiency in fibroblasts and leukocytes
    n1=en:5-oxoprolinase deficiency | n2=en:beta-glucuronidase deficiency in fibroblasts and leukocytes | rel=r_associated | relid=0 | w=20
  568. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:bicarbonaturia
    n1=en:5-oxoprolinase deficiency | n2=en:bicarbonaturia | rel=r_associated | relid=0 | w=20
  569. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:bile shows increased cholesterol/phospholipid ratio
    n1=en:5-oxoprolinase deficiency | n2=en:bile shows increased cholesterol/phospholipid ratio | rel=r_associated | relid=0 | w=20
  570. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:bilirubin conjugated increased
    n1=en:5-oxoprolinase deficiency | n2=en:bilirubin conjugated increased | rel=r_associated | relid=0 | w=20
  571. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:bilirubin may or may not be increased
    n1=en:5-oxoprolinase deficiency | n2=en:bilirubin may or may not be increased | rel=r_associated | relid=0 | w=20
  572. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:biotinidase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:biotinidase deficiency | rel=r_associated | relid=0 | w=20
  573. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:bisphosphoglycerate mutase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:bisphosphoglycerate mutase deficiency | rel=r_associated | relid=0 | w=20
  574. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:blood glucose normal
    n1=en:5-oxoprolinase deficiency | n2=en:blood glucose normal | rel=r_associated | relid=0 | w=20
  575. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:blood urea nitrogen increased
    n1=en:5-oxoprolinase deficiency | n2=en:blood urea nitrogen increased | rel=r_associated | relid=0 | w=20
  576. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:blunted cortisol response to adrenocorticotropic hormone (acth)
    n1=en:5-oxoprolinase deficiency | n2=en:blunted cortisol response to adrenocorticotropic hormone (acth) | rel=r_associated | relid=0 | w=20
  577. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:bone marrow hypoplasia (in some patients)
    n1=en:5-oxoprolinase deficiency | n2=en:bone marrow hypoplasia (in some patients) | rel=r_associated | relid=0 | w=20
  578. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:borderline elevated low-density lipoprotein
    n1=en:5-oxoprolinase deficiency | n2=en:borderline elevated low-density lipoprotein | rel=r_associated | relid=0 | w=20
  579. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:braddock syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:braddock syndrome | rel=r_associated | relid=0 | w=20
  580. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:brain calcification rajab type
    n1=en:5-oxoprolinase deficiency | n2=en:brain calcification rajab type | rel=r_associated | relid=0 | w=20
  581. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:brain diseases, metabolic, inborn
    n1=en:5-oxoprolinase deficiency | n2=en:brain diseases, metabolic, inborn | rel=r_associated | relid=0 | w=20
  582. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:branched chain ketoaciduria (alpha-keto isocaproate, alpha-keto-beta methylisovalerate, alpha-keto isovalerate)
    n1=en:5-oxoprolinase deficiency | n2=en:branched chain ketoaciduria (alpha-keto isocaproate, alpha-keto-beta methylisovalerate, alpha-keto isovalerate) | rel=r_associated | relid=0 | w=20
  583. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:branched-chain ketoaciduria
    n1=en:5-oxoprolinase deficiency | n2=en:branched-chain ketoaciduria | rel=r_associated | relid=0 | w=20
  584. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:breastfed offspring have transient decrease of plasma zinc levels
    n1=en:5-oxoprolinase deficiency | n2=en:breastfed offspring have transient decrease of plasma zinc levels | rel=r_associated | relid=0 | w=20
  585. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:broad tissue deposition of amylopectin-like material
    n1=en:5-oxoprolinase deficiency | n2=en:broad tissue deposition of amylopectin-like material | rel=r_associated | relid=0 | w=20
  586. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:bromosulfophthalein test - secondary rise at 90 minutes
    n1=en:5-oxoprolinase deficiency | n2=en:bromosulfophthalein test - secondary rise at 90 minutes | rel=r_associated | relid=0 | w=20
  587. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:c-band karyotype shows 'railroad track' appearance
    n1=en:5-oxoprolinase deficiency | n2=en:c-band karyotype shows 'railroad track' appearance | rel=r_associated | relid=0 | w=20
  588. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:calcium normal
    n1=en:5-oxoprolinase deficiency | n2=en:calcium normal | rel=r_associated | relid=0 | w=20
  589. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:calciuria
    n1=en:5-oxoprolinase deficiency | n2=en:calciuria | rel=r_associated | relid=0 | w=20
  590. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:carbohydrate metabolism, inborn errors
    n1=en:5-oxoprolinase deficiency | n2=en:carbohydrate metabolism, inborn errors | rel=r_associated | relid=0 | w=20
  591. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:carnitine palmitoyltransferase ii deficiency (25% of controls)
    n1=en:5-oxoprolinase deficiency | n2=en:carnitine palmitoyltransferase ii deficiency (25% of controls) | rel=r_associated | relid=0 | w=20
  592. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:carriers have balanced constitutional translocation - 46,xx(or xy), +(11:22)(q23:q11)
    n1=en:5-oxoprolinase deficiency | n2=en:carriers have balanced constitutional translocation - 46,xx(or xy), +(11:22)(q23:q11) | rel=r_associated | relid=0 | w=20
  593. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:cd4+/cd8+ ratio often reversed
    n1=en:5-oxoprolinase deficiency | n2=en:cd4+/cd8+ ratio often reversed | rel=r_associated | relid=0 | w=20
  594. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:cell studies show increased dna breakage
    n1=en:5-oxoprolinase deficiency | n2=en:cell studies show increased dna breakage | rel=r_associated | relid=0 | w=20
  595. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:cells show defective transcription-coupled nucleotide excision repair (tc-ner) after uv irradiation
    n1=en:5-oxoprolinase deficiency | n2=en:cells show defective transcription-coupled nucleotide excision repair (tc-ner) after uv irradiation | rel=r_associated | relid=0 | w=20
  596. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:cellular arrest at g2 of the cell cycle
    n1=en:5-oxoprolinase deficiency | n2=en:cellular arrest at g2 of the cell cycle | rel=r_associated | relid=0 | w=20
  597. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:cerebrospinal fluid lymphocytosis
    n1=en:5-oxoprolinase deficiency | n2=en:cerebrospinal fluid lymphocytosis | rel=r_associated | relid=0 | w=20
  598. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:ceruloplasmin decreased
    n1=en:5-oxoprolinase deficiency | n2=en:ceruloplasmin decreased | rel=r_associated | relid=0 | w=20
  599. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:cervical hypertrichosis and peripheral neuropathy syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:cervical hypertrichosis and peripheral neuropathy syndrome | rel=r_associated | relid=0 | w=20
  600. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:characteristic spheroids can be found in peripheral tissue, such as skin and conjunctiva
    n1=en:5-oxoprolinase deficiency | n2=en:characteristic spheroids can be found in peripheral tissue, such as skin and conjunctiva | rel=r_associated | relid=0 | w=20
  601. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:characteristic urinary coproporphyrin pattern (mostly isomer i (80%) instead of isomer iii)
    n1=en:5-oxoprolinase deficiency | n2=en:characteristic urinary coproporphyrin pattern (mostly isomer i (80%) instead of isomer iii) | rel=r_associated | relid=0 | w=20
  602. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:cholesterol low
    n1=en:5-oxoprolinase deficiency | n2=en:cholesterol low | rel=r_associated | relid=0 | w=20
  603. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:cholesterol normal
    n1=en:5-oxoprolinase deficiency | n2=en:cholesterol normal | rel=r_associated | relid=0 | w=20
  604. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:chondroitin 4-, 6-sulfate excretion in urine
    n1=en:5-oxoprolinase deficiency | n2=en:chondroitin 4-, 6-sulfate excretion in urine | rel=r_associated | relid=0 | w=20
  605. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:chondroitin 6-sulfate excretion in urine
    n1=en:5-oxoprolinase deficiency | n2=en:chondroitin 6-sulfate excretion in urine | rel=r_associated | relid=0 | w=20
  606. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:chromosomal instability
    n1=en:5-oxoprolinase deficiency | n2=en:chromosomal instability | rel=r_associated | relid=0 | w=20
  607. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:chromosomal mosaicism in cultured cells
    n1=en:5-oxoprolinase deficiency | n2=en:chromosomal mosaicism in cultured cells | rel=r_associated | relid=0 | w=20
  608. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:chromosomal mosaicism in fibroblast and/or peripheral lymphocytes no consistent karyotypic finding
    n1=en:5-oxoprolinase deficiency | n2=en:chromosomal mosaicism in fibroblast and/or peripheral lymphocytes no consistent karyotypic finding | rel=r_associated | relid=0 | w=20
  609. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:chromosomal rearrangement
    n1=en:5-oxoprolinase deficiency | n2=en:chromosomal rearrangement | rel=r_associated | relid=0 | w=20
  610. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:chromosomal translocations involving c-myc (190080, 8q24) and the immunoglobin heavy chain (147100, 14q32) locus
    n1=en:5-oxoprolinase deficiency | n2=en:chromosomal translocations involving c-myc (190080, 8q24) and the immunoglobin heavy chain (147100, 14q32) locus | rel=r_associated | relid=0 | w=20
  611. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:chromosomal translocations involving c-myc (190080, 8q24) and the immunoglobin lambda light chain (147220, 22q11.2) locus
    n1=en:5-oxoprolinase deficiency | n2=en:chromosomal translocations involving c-myc (190080, 8q24) and the immunoglobin lambda light chain (147220, 22q11.2) locus | rel=r_associated | relid=0 | w=20
  612. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:chromosome 11q23.3 deletion
    n1=en:5-oxoprolinase deficiency | n2=en:chromosome 11q23.3 deletion | rel=r_associated | relid=0 | w=20
  613. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:chromosome deletion extending from 8q24.11 to 8q24.13
    n1=en:5-oxoprolinase deficiency | n2=en:chromosome deletion extending from 8q24.11 to 8q24.13 | rel=r_associated | relid=0 | w=20
  614. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:chromosome instability (hypo-/hyperdiploidy, chromosomal breaks, premature centromere division)
    n1=en:5-oxoprolinase deficiency | n2=en:chromosome instability (hypo-/hyperdiploidy, chromosomal breaks, premature centromere division) | rel=r_associated | relid=0 | w=20
  615. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:chromosome inversion - inv2(p12q14) in 2 patients
    n1=en:5-oxoprolinase deficiency | n2=en:chromosome inversion - inv2(p12q14) in 2 patients | rel=r_associated | relid=0 | w=20
  616. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:chronic hypercapnia
    n1=en:5-oxoprolinase deficiency | n2=en:chronic hypercapnia | rel=r_associated | relid=0 | w=20
  617. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:chronic hypoxemia
    n1=en:5-oxoprolinase deficiency | n2=en:chronic hypoxemia | rel=r_associated | relid=0 | w=20
  618. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:chylomicronemia, refractory fasting
    n1=en:5-oxoprolinase deficiency | n2=en:chylomicronemia, refractory fasting | rel=r_associated | relid=0 | w=20
  619. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:cilia may also be static, with slow activity
    n1=en:5-oxoprolinase deficiency | n2=en:cilia may also be static, with slow activity | rel=r_associated | relid=0 | w=20
  620. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:cilia show inner and outer dynein arm defects
    n1=en:5-oxoprolinase deficiency | n2=en:cilia show inner and outer dynein arm defects | rel=r_associated | relid=0 | w=20
  621. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:cilia show nonflexible and hyperkinetic beating of axonemes
    n1=en:5-oxoprolinase deficiency | n2=en:cilia show nonflexible and hyperkinetic beating of axonemes | rel=r_associated | relid=0 | w=20
  622. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:circulating enzyme deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:circulating enzyme deficiency | rel=r_associated | relid=0 | w=20
  623. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:classical maple syrup urine disease
    n1=en:5-oxoprolinase deficiency | n2=en:classical maple syrup urine disease | rel=r_associated | relid=0 | w=20
  624. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:coagulopathy (inr = 2.2 - 3.5)
    n1=en:5-oxoprolinase deficiency | n2=en:coagulopathy (inr = 2.2 - 3.5) | rel=r_associated | relid=0 | w=20
  625. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:complex organic aciduria
    n1=en:5-oxoprolinase deficiency | n2=en:complex organic aciduria | rel=r_associated | relid=0 | w=20
  626. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:congenital analbuminemia
    n1=en:5-oxoprolinase deficiency | n2=en:congenital analbuminemia | rel=r_associated | relid=0 | w=20
  627. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:congenital cataract with ataxia and deafness syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:congenital cataract with ataxia and deafness syndrome | rel=r_associated | relid=0 | w=20
  628. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:congenital disorder of glycosylation type 1h
    n1=en:5-oxoprolinase deficiency | n2=en:congenital disorder of glycosylation type 1h | rel=r_associated | relid=0 | w=20
  629. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:congenital disorder of glycosylation type 2e
    n1=en:5-oxoprolinase deficiency | n2=en:congenital disorder of glycosylation type 2e | rel=r_associated | relid=0 | w=20
  630. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:congenital disorder of glycosylation type id
    n1=en:5-oxoprolinase deficiency | n2=en:congenital disorder of glycosylation type id | rel=r_associated | relid=0 | w=20
  631. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:congenital disorder of glycosylation type ie
    n1=en:5-oxoprolinase deficiency | n2=en:congenital disorder of glycosylation type ie | rel=r_associated | relid=0 | w=20
  632. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:congenital disorder of glycosylation, type if
    n1=en:5-oxoprolinase deficiency | n2=en:congenital disorder of glycosylation, type if | rel=r_associated | relid=0 | w=20
  633. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:continuous urinary iodine loss
    n1=en:5-oxoprolinase deficiency | n2=en:continuous urinary iodine loss | rel=r_associated | relid=0 | w=20
  634. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:cooper jabs syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:cooper jabs syndrome | rel=r_associated | relid=0 | w=20
  635. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:cortisol does not decrease on dexamethasone suppression test
    n1=en:5-oxoprolinase deficiency | n2=en:cortisol does not decrease on dexamethasone suppression test | rel=r_associated | relid=0 | w=20
  636. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:craniofacial ulnar renal syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:craniofacial ulnar renal syndrome | rel=r_associated | relid=0 | w=20
  637. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:creatine kinase levels may normalize with disease progression
    n1=en:5-oxoprolinase deficiency | n2=en:creatine kinase levels may normalize with disease progression | rel=r_associated | relid=0 | w=20
  638. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:creatine kinase normal between episodes
    n1=en:5-oxoprolinase deficiency | n2=en:creatine kinase normal between episodes | rel=r_associated | relid=0 | w=20
  639. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:creatine phosphokinase increased
    n1=en:5-oxoprolinase deficiency | n2=en:creatine phosphokinase increased | rel=r_associated | relid=0 | w=20
  640. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:creatine phosphokinase serum increased
    n1=en:5-oxoprolinase deficiency | n2=en:creatine phosphokinase serum increased | rel=r_associated | relid=0 | w=20
  641. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:csf pleocytosis, particularly of lymphocytes
    n1=en:5-oxoprolinase deficiency | n2=en:csf pleocytosis, particularly of lymphocytes | rel=r_associated | relid=0 | w=20
  642. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:curvilinear intracellular accumulation of autofluorescent lipopigment storage material
    n1=en:5-oxoprolinase deficiency | n2=en:curvilinear intracellular accumulation of autofluorescent lipopigment storage material | rel=r_associated | relid=0 | w=20
  643. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:cutaneous anergy
    n1=en:5-oxoprolinase deficiency | n2=en:cutaneous anergy | rel=r_associated | relid=0 | w=20
  644. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:cutaneous photosensitivity and lethal colitis syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:cutaneous photosensitivity and lethal colitis syndrome | rel=r_associated | relid=0 | w=20
  645. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:cystathioninuria (lab finding)
    n1=en:5-oxoprolinase deficiency | n2=en:cystathioninuria (lab finding) | rel=r_associated | relid=0 | w=20
  646. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:cytochrome c oxidase deficiency in skeletal muscle and brain
    n1=en:5-oxoprolinase deficiency | n2=en:cytochrome c oxidase deficiency in skeletal muscle and brain | rel=r_associated | relid=0 | w=20
  647. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:cytogenetic breakpoints range from 10q23.3-q26.2
    n1=en:5-oxoprolinase deficiency | n2=en:cytogenetic breakpoints range from 10q23.3-q26.2 | rel=r_associated | relid=0 | w=20
  648. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:cytogenetic deletion of chromosome 17p13.3
    n1=en:5-oxoprolinase deficiency | n2=en:cytogenetic deletion of chromosome 17p13.3 | rel=r_associated | relid=0 | w=20
  649. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:cytogenetic deletion of chromosome 19q13
    n1=en:5-oxoprolinase deficiency | n2=en:cytogenetic deletion of chromosome 19q13 | rel=r_associated | relid=0 | w=20
  650. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:cytogenetic deletion of the terminal region of chromosome 10 (del(10)(q23.3-qter))
    n1=en:5-oxoprolinase deficiency | n2=en:cytogenetic deletion of the terminal region of chromosome 10 (del(10)(q23.3-qter)) | rel=r_associated | relid=0 | w=20
  651. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:cytogenetics - recombinant chromosome 8 characterized by duplication of 8q22.1-qter and deletion of 8pter-p23.1
    n1=en:5-oxoprolinase deficiency | n2=en:cytogenetics - recombinant chromosome 8 characterized by duplication of 8q22.1-qter and deletion of 8pter-p23.1 | rel=r_associated | relid=0 | w=20
  652. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:cytoplasmic lamellar concentric inclusions
    n1=en:5-oxoprolinase deficiency | n2=en:cytoplasmic lamellar concentric inclusions | rel=r_associated | relid=0 | w=20
  653. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:cytoplasmic lamellar inclusions consistent with neuronal ceroid lipofuscinosis (in some patients)
    n1=en:5-oxoprolinase deficiency | n2=en:cytoplasmic lamellar inclusions consistent with neuronal ceroid lipofuscinosis (in some patients) | rel=r_associated | relid=0 | w=20
  654. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:cytosolic phosphoenolpyruvate carboxykinase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:cytosolic phosphoenolpyruvate carboxykinase deficiency | rel=r_associated | relid=0 | w=20
  655. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:d-2-hydroxyglutaric aciduria
    n1=en:5-oxoprolinase deficiency | n2=en:d-2-hydroxyglutaric aciduria | rel=r_associated | relid=0 | w=20
  656. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:deafness and myopia syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:deafness and myopia syndrome | rel=r_associated | relid=0 | w=20
  657. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decrease or absence of cathepsin d (ctsd) protein immunostaining
    n1=en:5-oxoprolinase deficiency | n2=en:decrease or absence of cathepsin d (ctsd) protein immunostaining | rel=r_associated | relid=0 | w=20
  658. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased 3-beta-hydroxysteroid-delta-5-desaturase (sc5d)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased 3-beta-hydroxysteroid-delta-5-desaturase (sc5d) | rel=r_associated | relid=0 | w=20
  659. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased 5-hydroxyindoleacetic acid (5-hiaa) in csf
    n1=en:5-oxoprolinase deficiency | n2=en:decreased 5-hydroxyindoleacetic acid (5-hiaa) in csf | rel=r_associated | relid=0 | w=20
  660. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased acetyl-coa carboxylase activity
    n1=en:5-oxoprolinase deficiency | n2=en:decreased acetyl-coa carboxylase activity | rel=r_associated | relid=0 | w=20
  661. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased acid beta galactosidase protein and activity
    n1=en:5-oxoprolinase deficiency | n2=en:decreased acid beta galactosidase protein and activity | rel=r_associated | relid=0 | w=20
  662. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased acid sphingomyelinase activity
    n1=en:5-oxoprolinase deficiency | n2=en:decreased acid sphingomyelinase activity | rel=r_associated | relid=0 | w=20
  663. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased acid sphingomyelinase activity (less than 5%)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased acid sphingomyelinase activity (less than 5%) | rel=r_associated | relid=0 | w=20
  664. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased activities of multiple sulfatases
    n1=en:5-oxoprolinase deficiency | n2=en:decreased activities of multiple sulfatases | rel=r_associated | relid=0 | w=20
  665. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased activities of the pyruvate dehydrogenase complex, the alpha-ketoglutarate dehydrogenase complex, and the branched-chain alpha-keto acid dehydrogenase complex
    n1=en:5-oxoprolinase deficiency | n2=en:decreased activities of the pyruvate dehydrogenase complex, the alpha-ketoglutarate dehydrogenase complex, and the branched-chain alpha-keto acid dehydrogenase complex | rel=r_associated | relid=0 | w=20
  666. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased activity of 2-methyl-3-hydroxybutyryl co-a dehydrogenase
    n1=en:5-oxoprolinase deficiency | n2=en:decreased activity of 2-methyl-3-hydroxybutyryl co-a dehydrogenase | rel=r_associated | relid=0 | w=20
  667. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased activity of 2-oxoacid dehydrogenases
    n1=en:5-oxoprolinase deficiency | n2=en:decreased activity of 2-oxoacid dehydrogenases | rel=r_associated | relid=0 | w=20
  668. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased activity of 3-hydroxyacyl-coa dehydrogenase in various tissues (liver, muscle, fibroblasts)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased activity of 3-hydroxyacyl-coa dehydrogenase in various tissues (liver, muscle, fibroblasts) | rel=r_associated | relid=0 | w=20
  669. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased activity of 3-methylcrotonyl-coa carboxylase (less than 2%)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased activity of 3-methylcrotonyl-coa carboxylase (less than 2%) | rel=r_associated | relid=0 | w=20
  670. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased activity of alpha-ketoglutarate dehydrogenase (alpha-kgdh)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased activity of alpha-ketoglutarate dehydrogenase (alpha-kgdh) | rel=r_associated | relid=0 | w=20
  671. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased activity of ampd1 in skeletal muscle increased serum creatine kinase
    n1=en:5-oxoprolinase deficiency | n2=en:decreased activity of ampd1 in skeletal muscle increased serum creatine kinase | rel=r_associated | relid=0 | w=20
  672. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased activity of aromatic l-amino acid decarboxylase (aadc)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased activity of aromatic l-amino acid decarboxylase (aadc) | rel=r_associated | relid=0 | w=20
  673. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased activity of branched-chain ketoacid dehydrogenase (bckdh)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased activity of branched-chain ketoacid dehydrogenase (bckdh) | rel=r_associated | relid=0 | w=20
  674. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased activity of coenzyme q10-dependent respiratory chain complexes
    n1=en:5-oxoprolinase deficiency | n2=en:decreased activity of coenzyme q10-dependent respiratory chain complexes | rel=r_associated | relid=0 | w=20
  675. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased activity of complement factor d
    n1=en:5-oxoprolinase deficiency | n2=en:decreased activity of complement factor d | rel=r_associated | relid=0 | w=20
  676. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased activity of cytochrome c oxidase in muscle and fibroblasts
    n1=en:5-oxoprolinase deficiency | n2=en:decreased activity of cytochrome c oxidase in muscle and fibroblasts | rel=r_associated | relid=0 | w=20
  677. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased activity of dihydrofolate reductase
    n1=en:5-oxoprolinase deficiency | n2=en:decreased activity of dihydrofolate reductase | rel=r_associated | relid=0 | w=20
  678. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased activity of galactocerebrosidase
    n1=en:5-oxoprolinase deficiency | n2=en:decreased activity of galactocerebrosidase | rel=r_associated | relid=0 | w=20
  679. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased activity of glycosylceramidase, galactosylceramidase, ceramidase, and other lysosomal enzymes
    n1=en:5-oxoprolinase deficiency | n2=en:decreased activity of glycosylceramidase, galactosylceramidase, ceramidase, and other lysosomal enzymes | rel=r_associated | relid=0 | w=20
  680. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased activity of long-chain 3-hydroxyacyl-coa dehydrogenase, long-chain 3-oxoacyl-coa thiolase, and long-chain 2-enoyl-coa hydratase
    n1=en:5-oxoprolinase deficiency | n2=en:decreased activity of long-chain 3-hydroxyacyl-coa dehydrogenase, long-chain 3-oxoacyl-coa thiolase, and long-chain 2-enoyl-coa hydratase | rel=r_associated | relid=0 | w=20
  681. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased activity of mitochondrial complex i
    n1=en:5-oxoprolinase deficiency | n2=en:decreased activity of mitochondrial complex i | rel=r_associated | relid=0 | w=20
  682. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased activity of mitochondrial respiratory chain complex i
    n1=en:5-oxoprolinase deficiency | n2=en:decreased activity of mitochondrial respiratory chain complex i | rel=r_associated | relid=0 | w=20
  683. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased activity of mitochondrial respiratory complexes
    n1=en:5-oxoprolinase deficiency | n2=en:decreased activity of mitochondrial respiratory complexes | rel=r_associated | relid=0 | w=20
  684. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased activity of mitochondrial respiratory complexes i, ii+iii, iv, and v
    n1=en:5-oxoprolinase deficiency | n2=en:decreased activity of mitochondrial respiratory complexes i, ii+iii, iv, and v | rel=r_associated | relid=0 | w=20
  685. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased activity of mitochondrial respiratory complexes i, iii, and iv
    n1=en:5-oxoprolinase deficiency | n2=en:decreased activity of mitochondrial respiratory complexes i, iii, and iv | rel=r_associated | relid=0 | w=20
  686. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased activity of nadph oxidase
    n1=en:5-oxoprolinase deficiency | n2=en:decreased activity of nadph oxidase | rel=r_associated | relid=0 | w=20
  687. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased activity of phosphoglycerate kinase 1
    n1=en:5-oxoprolinase deficiency | n2=en:decreased activity of phosphoglycerate kinase 1 | rel=r_associated | relid=0 | w=20
  688. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased activity of ppt1
    n1=en:5-oxoprolinase deficiency | n2=en:decreased activity of ppt1 | rel=r_associated | relid=0 | w=20
  689. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased activity of pyruvate dehydrogenase complex
    n1=en:5-oxoprolinase deficiency | n2=en:decreased activity of pyruvate dehydrogenase complex | rel=r_associated | relid=0 | w=20
  690. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased activity of succinic semialdehyde dehydrogenase (ssadh, aldh5a1), less than 5% of control values
    n1=en:5-oxoprolinase deficiency | n2=en:decreased activity of succinic semialdehyde dehydrogenase (ssadh, aldh5a1), less than 5% of control values | rel=r_associated | relid=0 | w=20
  691. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased activity of the e2 subunit (lipoyl transacetylase, 608770) of the pdh
    n1=en:5-oxoprolinase deficiency | n2=en:decreased activity of the e2 subunit (lipoyl transacetylase, 608770) of the pdh | rel=r_associated | relid=0 | w=20
  692. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased activity of the pdh phosphatase
    n1=en:5-oxoprolinase deficiency | n2=en:decreased activity of the pdh phosphatase | rel=r_associated | relid=0 | w=20
  693. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased activity of the pyruvate dehydrogenase (pdh) complex
    n1=en:5-oxoprolinase deficiency | n2=en:decreased activity of the pyruvate dehydrogenase (pdh) complex | rel=r_associated | relid=0 | w=20
  694. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased activity of thiopurine s-methyltransferase
    n1=en:5-oxoprolinase deficiency | n2=en:decreased activity of thiopurine s-methyltransferase | rel=r_associated | relid=0 | w=20
  695. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased activity of thymidine phosphorylase
    n1=en:5-oxoprolinase deficiency | n2=en:decreased activity of thymidine phosphorylase | rel=r_associated | relid=0 | w=20
  696. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased activity of triosephosphate isomerase
    n1=en:5-oxoprolinase deficiency | n2=en:decreased activity of triosephosphate isomerase | rel=r_associated | relid=0 | w=20
  697. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased activity of tyrosine hydroxylase
    n1=en:5-oxoprolinase deficiency | n2=en:decreased activity of tyrosine hydroxylase | rel=r_associated | relid=0 | w=20
  698. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased adenosylcobalamin
    n1=en:5-oxoprolinase deficiency | n2=en:decreased adenosylcobalamin | rel=r_associated | relid=0 | w=20
  699. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased adiponectin
    n1=en:5-oxoprolinase deficiency | n2=en:decreased adiponectin | rel=r_associated | relid=0 | w=20
  700. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased agt activity
    n1=en:5-oxoprolinase deficiency | n2=en:decreased agt activity | rel=r_associated | relid=0 | w=20
  701. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased alpha-n-acetylgalactosaminidase activity (less than 2% of control)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased alpha-n-acetylgalactosaminidase activity (less than 2% of control) | rel=r_associated | relid=0 | w=20
  702. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased alpha-n-acetylgalactosaminidase protein
    n1=en:5-oxoprolinase deficiency | n2=en:decreased alpha-n-acetylgalactosaminidase protein | rel=r_associated | relid=0 | w=20
  703. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased aminoacylase-1 activity
    n1=en:5-oxoprolinase deficiency | n2=en:decreased aminoacylase-1 activity | rel=r_associated | relid=0 | w=20
  704. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased amount and activity of mitochondrial complexes i and iv
    n1=en:5-oxoprolinase deficiency | n2=en:decreased amount and activity of mitochondrial complexes i and iv | rel=r_associated | relid=0 | w=20
  705. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased apoa-i and apoa-ii
    n1=en:5-oxoprolinase deficiency | n2=en:decreased apoa-i and apoa-ii | rel=r_associated | relid=0 | w=20
  706. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased arylsulfatase a (arsa) activity in urine, leukocytes, fibroblasts
    n1=en:5-oxoprolinase deficiency | n2=en:decreased arylsulfatase a (arsa) activity in urine, leukocytes, fibroblasts | rel=r_associated | relid=0 | w=20
  707. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased asparagine levels (in some patients)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased asparagine levels (in some patients) | rel=r_associated | relid=0 | w=20
  708. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased atp synthase in muscle, heart, liver, and brain
    n1=en:5-oxoprolinase deficiency | n2=en:decreased atp synthase in muscle, heart, liver, and brain | rel=r_associated | relid=0 | w=20
  709. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased axonal flare response after intradermal histamine injection
    n1=en:5-oxoprolinase deficiency | n2=en:decreased axonal flare response after intradermal histamine injection | rel=r_associated | relid=0 | w=20
  710. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased b cells
    n1=en:5-oxoprolinase deficiency | n2=en:decreased b cells | rel=r_associated | relid=0 | w=20
  711. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased beta-galactosidase activity
    n1=en:5-oxoprolinase deficiency | n2=en:decreased beta-galactosidase activity | rel=r_associated | relid=0 | w=20
  712. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased beta-glucocerebrosidase protein and activity
    n1=en:5-oxoprolinase deficiency | n2=en:decreased beta-glucocerebrosidase protein and activity | rel=r_associated | relid=0 | w=20
  713. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased beta-mannosidase activity in plasma, fibroblasts, and leukocytes
    n1=en:5-oxoprolinase deficiency | n2=en:decreased beta-mannosidase activity in plasma, fibroblasts, and leukocytes | rel=r_associated | relid=0 | w=20
  714. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased beta-thromboglobulin
    n1=en:5-oxoprolinase deficiency | n2=en:decreased beta-thromboglobulin | rel=r_associated | relid=0 | w=20
  715. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased blood levels of cationic amino acids
    n1=en:5-oxoprolinase deficiency | n2=en:decreased blood levels of cationic amino acids | rel=r_associated | relid=0 | w=20
  716. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased c3 antigen
    n1=en:5-oxoprolinase deficiency | n2=en:decreased c3 antigen | rel=r_associated | relid=0 | w=20
  717. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased carnitine palmitoyltransferase ii (cpt2) activity
    n1=en:5-oxoprolinase deficiency | n2=en:decreased carnitine palmitoyltransferase ii (cpt2) activity | rel=r_associated | relid=0 | w=20
  718. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased cerebrospinal fluid folic acid
    n1=en:5-oxoprolinase deficiency | n2=en:decreased cerebrospinal fluid folic acid | rel=r_associated | relid=0 | w=20
  719. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased cholesterol (less common)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased cholesterol (less common) | rel=r_associated | relid=0 | w=20
  720. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased ciliary motility
    n1=en:5-oxoprolinase deficiency | n2=en:decreased ciliary motility | rel=r_associated | relid=0 | w=20
  721. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased circulating aldosterone level
    n1=en:5-oxoprolinase deficiency | n2=en:decreased circulating aldosterone level | rel=r_associated | relid=0 | w=20
  722. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased circulating cortisol level
    n1=en:5-oxoprolinase deficiency | n2=en:decreased circulating cortisol level | rel=r_associated | relid=0 | w=20
  723. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased circulating renin level
    n1=en:5-oxoprolinase deficiency | n2=en:decreased circulating renin level | rel=r_associated | relid=0 | w=20
  724. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased clot retraction
    n1=en:5-oxoprolinase deficiency | n2=en:decreased clot retraction | rel=r_associated | relid=0 | w=20
  725. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased cobalamin in liver, kidney, and cultured fibroblasts
    n1=en:5-oxoprolinase deficiency | n2=en:decreased cobalamin in liver, kidney, and cultured fibroblasts | rel=r_associated | relid=0 | w=20
  726. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased complement factor d
    n1=en:5-oxoprolinase deficiency | n2=en:decreased complement factor d | rel=r_associated | relid=0 | w=20
  727. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased conversion of beta-carotene to vitamin a (retinol)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased conversion of beta-carotene to vitamin a (retinol) | rel=r_associated | relid=0 | w=20
  728. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased copper, iron, zinc
    n1=en:5-oxoprolinase deficiency | n2=en:decreased copper, iron, zinc | rel=r_associated | relid=0 | w=20
  729. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased coproporphyrinogen oxidase activity (hcp, lymphocytes, 50% of normal)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased coproporphyrinogen oxidase activity (hcp, lymphocytes, 50% of normal) | rel=r_associated | relid=0 | w=20
  730. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased coq10 levels in lymphoblasts or fibroblasts
    n1=en:5-oxoprolinase deficiency | n2=en:decreased coq10 levels in lymphoblasts or fibroblasts | rel=r_associated | relid=0 | w=20
  731. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased cortisol-binding globulin
    n1=en:5-oxoprolinase deficiency | n2=en:decreased cortisol-binding globulin | rel=r_associated | relid=0 | w=20
  732. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased cpt1 activity
    n1=en:5-oxoprolinase deficiency | n2=en:decreased cpt1 activity | rel=r_associated | relid=0 | w=20
  733. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased csf 3-methoxy-4-hydroxyphenylethyleneglycol (mhpg)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased csf 3-methoxy-4-hydroxyphenylethyleneglycol (mhpg) | rel=r_associated | relid=0 | w=20
  734. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased csf 5-hydroxyindoleacetic acid (5-hiaa)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased csf 5-hydroxyindoleacetic acid (5-hiaa) | rel=r_associated | relid=0 | w=20
  735. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased csf 5-hydroxyindoleacetic acid (5hiaa)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased csf 5-hydroxyindoleacetic acid (5hiaa) | rel=r_associated | relid=0 | w=20
  736. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased csf arginine
    n1=en:5-oxoprolinase deficiency | n2=en:decreased csf arginine | rel=r_associated | relid=0 | w=20
  737. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased csf ferritin despite normal serum ferritin levels
    n1=en:5-oxoprolinase deficiency | n2=en:decreased csf ferritin despite normal serum ferritin levels | rel=r_associated | relid=0 | w=20
  738. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased csf folate
    n1=en:5-oxoprolinase deficiency | n2=en:decreased csf folate | rel=r_associated | relid=0 | w=20
  739. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased csf glycine
    n1=en:5-oxoprolinase deficiency | n2=en:decreased csf glycine | rel=r_associated | relid=0 | w=20
  740. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased csf homovanillic acid (hva)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased csf homovanillic acid (hva) | rel=r_associated | relid=0 | w=20
  741. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased csf hypocretin
    n1=en:5-oxoprolinase deficiency | n2=en:decreased csf hypocretin | rel=r_associated | relid=0 | w=20
  742. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased csf methyltetrahydrofolate (mthf)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased csf methyltetrahydrofolate (mthf) | rel=r_associated | relid=0 | w=20
  743. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased csf pyridoxal
    n1=en:5-oxoprolinase deficiency | n2=en:decreased csf pyridoxal | rel=r_associated | relid=0 | w=20
  744. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased csf serine
    n1=en:5-oxoprolinase deficiency | n2=en:decreased csf serine | rel=r_associated | relid=0 | w=20
  745. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased csf tetrahydrofolate and 5-methyltetrahydrofolate
    n1=en:5-oxoprolinase deficiency | n2=en:decreased csf tetrahydrofolate and 5-methyltetrahydrofolate | rel=r_associated | relid=0 | w=20
  746. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased cytochrome c oxidase activity in skin fibroblasts, liver, and skeletal muscle
    n1=en:5-oxoprolinase deficiency | n2=en:decreased cytochrome c oxidase activity in skin fibroblasts, liver, and skeletal muscle | rel=r_associated | relid=0 | w=20
  747. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased dermal hydroxylysine content
    n1=en:5-oxoprolinase deficiency | n2=en:decreased dermal hydroxylysine content | rel=r_associated | relid=0 | w=20
  748. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased dihydroxyacetone phosphate acyltransferase (dhap-at) activity
    n1=en:5-oxoprolinase deficiency | n2=en:decreased dihydroxyacetone phosphate acyltransferase (dhap-at) activity | rel=r_associated | relid=0 | w=20
  749. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased dihydroxyacetonephosphate acyltransferase (dhap-at) activity
    n1=en:5-oxoprolinase deficiency | n2=en:decreased dihydroxyacetonephosphate acyltransferase (dhap-at) activity | rel=r_associated | relid=0 | w=20
  750. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased dna excision repair
    n1=en:5-oxoprolinase deficiency | n2=en:decreased dna excision repair | rel=r_associated | relid=0 | w=20
  751. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased dna polymerase-gamma (polg, 174763) activity
    n1=en:5-oxoprolinase deficiency | n2=en:decreased dna polymerase-gamma (polg, 174763) activity | rel=r_associated | relid=0 | w=20
  752. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased erythrocyte 2,3-diphosphoglycerate (2,3-dpg)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased erythrocyte 2,3-diphosphoglycerate (2,3-dpg) | rel=r_associated | relid=0 | w=20
  753. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased erythrocyte lactate clearance (transport), 40 to 50% of normal values
    n1=en:5-oxoprolinase deficiency | n2=en:decreased erythrocyte lactate clearance (transport), 40 to 50% of normal values | rel=r_associated | relid=0 | w=20
  754. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased erythrocyte plasmalogen
    n1=en:5-oxoprolinase deficiency | n2=en:decreased erythrocyte plasmalogen | rel=r_associated | relid=0 | w=20
  755. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased expression of glycosylphosphatidylinositol-linked proteins (e.g., cd59 107271 and cd24 600274) on hematopoietic cells
    n1=en:5-oxoprolinase deficiency | n2=en:decreased expression of glycosylphosphatidylinositol-linked proteins (e.g., cd59 107271 and cd24 600274) on hematopoietic cells | rel=r_associated | relid=0 | w=20
  756. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased expression of gpi-anchored proteins on blood cells
    n1=en:5-oxoprolinase deficiency | n2=en:decreased expression of gpi-anchored proteins on blood cells | rel=r_associated | relid=0 | w=20
  757. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased factor xi
    n1=en:5-oxoprolinase deficiency | n2=en:decreased factor xi | rel=r_associated | relid=0 | w=20
  758. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased fbp1 enzyme activity
    n1=en:5-oxoprolinase deficiency | n2=en:decreased fbp1 enzyme activity | rel=r_associated | relid=0 | w=20
  759. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased fibrillin-1 immunostaining in the dermis
    n1=en:5-oxoprolinase deficiency | n2=en:decreased fibrillin-1 immunostaining in the dermis | rel=r_associated | relid=0 | w=20
  760. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased fibrinogen (in some patients)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased fibrinogen (in some patients) | rel=r_associated | relid=0 | w=20
  761. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased fibroblast alpha-mannosidase
    n1=en:5-oxoprolinase deficiency | n2=en:decreased fibroblast alpha-mannosidase | rel=r_associated | relid=0 | w=20
  762. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased fibroblast arylsulfatase a
    n1=en:5-oxoprolinase deficiency | n2=en:decreased fibroblast arylsulfatase a | rel=r_associated | relid=0 | w=20
  763. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased fibroblast beta-hexosaminidase
    n1=en:5-oxoprolinase deficiency | n2=en:decreased fibroblast beta-hexosaminidase | rel=r_associated | relid=0 | w=20
  764. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased fibroblast iduronate sulfatase
    n1=en:5-oxoprolinase deficiency | n2=en:decreased fibroblast iduronate sulfatase | rel=r_associated | relid=0 | w=20
  765. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased formation of complex (tri-, tetra-antennary) n-glycans
    n1=en:5-oxoprolinase deficiency | n2=en:decreased formation of complex (tri-, tetra-antennary) n-glycans | rel=r_associated | relid=0 | w=20
  766. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased free t(3)/free t(4)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased free t(3)/free t(4) | rel=r_associated | relid=0 | w=20
  767. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased fumarate hydratase activity
    n1=en:5-oxoprolinase deficiency | n2=en:decreased fumarate hydratase activity | rel=r_associated | relid=0 | w=20
  768. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased galactokinase activity
    n1=en:5-oxoprolinase deficiency | n2=en:decreased galactokinase activity | rel=r_associated | relid=0 | w=20
  769. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased glomerular filtration rate (gfr)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased glomerular filtration rate (gfr) | rel=r_associated | relid=0 | w=20
  770. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased glutamine in bodily fluids
    n1=en:5-oxoprolinase deficiency | n2=en:decreased glutamine in bodily fluids | rel=r_associated | relid=0 | w=20
  771. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased glycerol kinase activity
    n1=en:5-oxoprolinase deficiency | n2=en:decreased glycerol kinase activity | rel=r_associated | relid=0 | w=20
  772. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased grhpr activity
    n1=en:5-oxoprolinase deficiency | n2=en:decreased grhpr activity | rel=r_associated | relid=0 | w=20
  773. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased gtp cyclohydrolase i activity (about 20% of normal)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased gtp cyclohydrolase i activity (about 20% of normal) | rel=r_associated | relid=0 | w=20
  774. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased hdl cholesterol
    n1=en:5-oxoprolinase deficiency | n2=en:decreased hdl cholesterol | rel=r_associated | relid=0 | w=20
  775. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased heme-heme interaction (e.g. hb kanagawa 141800.0169)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased heme-heme interaction (e.g. hb kanagawa 141800.0169) | rel=r_associated | relid=0 | w=20
  776. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased hepatic udp-glucuronyl-transferase activity
    n1=en:5-oxoprolinase deficiency | n2=en:decreased hepatic udp-glucuronyl-transferase activity | rel=r_associated | relid=0 | w=20
  777. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased hexokinase activity in red blood cells
    n1=en:5-oxoprolinase deficiency | n2=en:decreased hexokinase activity in red blood cells | rel=r_associated | relid=0 | w=20
  778. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased high molecular weight plasma factor viii/ vwf multimers
    n1=en:5-oxoprolinase deficiency | n2=en:decreased high molecular weight plasma factor viii/ vwf multimers | rel=r_associated | relid=0 | w=20
  779. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased homovanillic acid (hva) and 5-hydroxyindoleacetic acid (5hiaa) in csf
    n1=en:5-oxoprolinase deficiency | n2=en:decreased homovanillic acid (hva) and 5-hydroxyindoleacetic acid (5hiaa) in csf | rel=r_associated | relid=0 | w=20
  780. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased iga, igg, igm
    n1=en:5-oxoprolinase deficiency | n2=en:decreased iga, igg, igm | rel=r_associated | relid=0 | w=20
  781. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased insulin receptor binding
    n1=en:5-oxoprolinase deficiency | n2=en:decreased insulin receptor binding | rel=r_associated | relid=0 | w=20
  782. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased intracellular fmr protein
    n1=en:5-oxoprolinase deficiency | n2=en:decreased intracellular fmr protein | rel=r_associated | relid=0 | w=20
  783. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased lecithin:cholesterol acyltransferase mass and activity
    n1=en:5-oxoprolinase deficiency | n2=en:decreased lecithin:cholesterol acyltransferase mass and activity | rel=r_associated | relid=0 | w=20
  784. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased levels of cellular and mitochondrial fes-containing proteins
    n1=en:5-oxoprolinase deficiency | n2=en:decreased levels of cellular and mitochondrial fes-containing proteins | rel=r_associated | relid=0 | w=20
  785. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased levels of coenzyme q10 in skeletal muscle (5-35%)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased levels of coenzyme q10 in skeletal muscle (5-35%) | rel=r_associated | relid=0 | w=20
  786. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased levels of component x protein of the pdh complex
    n1=en:5-oxoprolinase deficiency | n2=en:decreased levels of component x protein of the pdh complex | rel=r_associated | relid=0 | w=20
  787. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased levels of cpt2 protein
    n1=en:5-oxoprolinase deficiency | n2=en:decreased levels of cpt2 protein | rel=r_associated | relid=0 | w=20
  788. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased levels of csf hypocretin (hcrt, 602358)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased levels of csf hypocretin (hcrt, 602358) | rel=r_associated | relid=0 | w=20
  789. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased levels of plasma factor viii
    n1=en:5-oxoprolinase deficiency | n2=en:decreased levels of plasma factor viii | rel=r_associated | relid=0 | w=20
  790. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased levels of plasma vwf antigen
    n1=en:5-oxoprolinase deficiency | n2=en:decreased levels of plasma vwf antigen | rel=r_associated | relid=0 | w=20
  791. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased levels of serum vitamin b12
    n1=en:5-oxoprolinase deficiency | n2=en:decreased levels of serum vitamin b12 | rel=r_associated | relid=0 | w=20
  792. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased levels of the e2 subunit protein
    n1=en:5-oxoprolinase deficiency | n2=en:decreased levels of the e2 subunit protein | rel=r_associated | relid=0 | w=20
  793. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased lipid-linked oligosaccharides (llo)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased lipid-linked oligosaccharides (llo) | rel=r_associated | relid=0 | w=20
  794. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased liver homogentisate 1,2-dioxygenase activity
    n1=en:5-oxoprolinase deficiency | n2=en:decreased liver homogentisate 1,2-dioxygenase activity | rel=r_associated | relid=0 | w=20
  795. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased long-chain fatty acid oxidation
    n1=en:5-oxoprolinase deficiency | n2=en:decreased long-chain fatty acid oxidation | rel=r_associated | relid=0 | w=20
  796. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased lysosomal alpha-mannosidase activity in plasma and leukocytes
    n1=en:5-oxoprolinase deficiency | n2=en:decreased lysosomal alpha-mannosidase activity in plasma and leukocytes | rel=r_associated | relid=0 | w=20
  797. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased metabolism of thiopurine drugs
    n1=en:5-oxoprolinase deficiency | n2=en:decreased metabolism of thiopurine drugs | rel=r_associated | relid=0 | w=20
  798. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased methionine synthase activity
    n1=en:5-oxoprolinase deficiency | n2=en:decreased methionine synthase activity | rel=r_associated | relid=0 | w=20
  799. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased methylmalonyl-coa mutase activity
    n1=en:5-oxoprolinase deficiency | n2=en:decreased methylmalonyl-coa mutase activity | rel=r_associated | relid=0 | w=20
  800. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased mitochondrial complex iii activity (in liver, muscle, and fibroblasts)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased mitochondrial complex iii activity (in liver, muscle, and fibroblasts) | rel=r_associated | relid=0 | w=20
  801. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased mitochondrial complex iii activity in liver and fibroblasts
    n1=en:5-oxoprolinase deficiency | n2=en:decreased mitochondrial complex iii activity in liver and fibroblasts | rel=r_associated | relid=0 | w=20
  802. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased mitochondrial complex iii activity seen in muscle
    n1=en:5-oxoprolinase deficiency | n2=en:decreased mitochondrial complex iii activity seen in muscle | rel=r_associated | relid=0 | w=20
  803. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased mitochondrial complex v assembly
    n1=en:5-oxoprolinase deficiency | n2=en:decreased mitochondrial complex v assembly | rel=r_associated | relid=0 | w=20
  804. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased mitochondrial nadp(h)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased mitochondrial nadp(h) | rel=r_associated | relid=0 | w=20
  805. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased mitochondrial respiratory chain complex (2p21del)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased mitochondrial respiratory chain complex (2p21del) | rel=r_associated | relid=0 | w=20
  806. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased mitochondrial respiratory complexes i, iii, and iv in brain, heart, and skeletal muscle
    n1=en:5-oxoprolinase deficiency | n2=en:decreased mitochondrial respiratory complexes i, iii, and iv in brain, heart, and skeletal muscle | rel=r_associated | relid=0 | w=20
  807. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased mucosal alkaline phosphatase
    n1=en:5-oxoprolinase deficiency | n2=en:decreased mucosal alkaline phosphatase | rel=r_associated | relid=0 | w=20
  808. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased n-acetylglucosamine-1-phosphotransferase (glcnac - phosphotransferase) using lysosomal enzymes
    n1=en:5-oxoprolinase deficiency | n2=en:decreased n-acetylglucosamine-1-phosphotransferase (glcnac - phosphotransferase) using lysosomal enzymes | rel=r_associated | relid=0 | w=20
  809. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased nasal nitric oxide
    n1=en:5-oxoprolinase deficiency | n2=en:decreased nasal nitric oxide | rel=r_associated | relid=0 | w=20
  810. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased natural killer cells
    n1=en:5-oxoprolinase deficiency | n2=en:decreased natural killer cells | rel=r_associated | relid=0 | w=20
  811. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased neopterin and biopterin in urine
    n1=en:5-oxoprolinase deficiency | n2=en:decreased neopterin and biopterin in urine | rel=r_associated | relid=0 | w=20
  812. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased nk cells (in some patients)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased nk cells (in some patients) | rel=r_associated | relid=0 | w=20
  813. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased number of igf1 receptors (igf1r, 147370) on cell surface
    n1=en:5-oxoprolinase deficiency | n2=en:decreased number of igf1 receptors (igf1r, 147370) on cell surface | rel=r_associated | relid=0 | w=20
  814. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased numbers of t regulatory cells
    n1=en:5-oxoprolinase deficiency | n2=en:decreased numbers of t regulatory cells | rel=r_associated | relid=0 | w=20
  815. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased or absent alpha-n-acetylgalactosaminidase activity
    n1=en:5-oxoprolinase deficiency | n2=en:decreased or absent alpha-n-acetylgalactosaminidase activity | rel=r_associated | relid=0 | w=20
  816. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased or absent alpha-n-acetylgalactosaminidase protein
    n1=en:5-oxoprolinase deficiency | n2=en:decreased or absent alpha-n-acetylgalactosaminidase protein | rel=r_associated | relid=0 | w=20
  817. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased or absent apolipoprotein a-i
    n1=en:5-oxoprolinase deficiency | n2=en:decreased or absent apolipoprotein a-i | rel=r_associated | relid=0 | w=20
  818. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased or absent d-bifunctional protein activity and protein
    n1=en:5-oxoprolinase deficiency | n2=en:decreased or absent d-bifunctional protein activity and protein | rel=r_associated | relid=0 | w=20
  819. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased or absent dihydropteridine reductase activity
    n1=en:5-oxoprolinase deficiency | n2=en:decreased or absent dihydropteridine reductase activity | rel=r_associated | relid=0 | w=20
  820. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased or absent dihydropyrimidine dehydrogenase activity
    n1=en:5-oxoprolinase deficiency | n2=en:decreased or absent dihydropyrimidine dehydrogenase activity | rel=r_associated | relid=0 | w=20
  821. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased or absent glycogen branching enzyme activity
    n1=en:5-oxoprolinase deficiency | n2=en:decreased or absent glycogen branching enzyme activity | rel=r_associated | relid=0 | w=20
  822. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased or absent histidase activity
    n1=en:5-oxoprolinase deficiency | n2=en:decreased or absent histidase activity | rel=r_associated | relid=0 | w=20
  823. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased or absent peroxisome acyl-coa oxidase activity and protein
    n1=en:5-oxoprolinase deficiency | n2=en:decreased or absent peroxisome acyl-coa oxidase activity and protein | rel=r_associated | relid=0 | w=20
  824. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased or absent pts activity
    n1=en:5-oxoprolinase deficiency | n2=en:decreased or absent pts activity | rel=r_associated | relid=0 | w=20
  825. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased or absent serum and urinary chenodeoxycholic acid and cholic acid
    n1=en:5-oxoprolinase deficiency | n2=en:decreased or absent serum and urinary chenodeoxycholic acid and cholic acid | rel=r_associated | relid=0 | w=20
  826. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased or absent serum citrulline
    n1=en:5-oxoprolinase deficiency | n2=en:decreased or absent serum citrulline | rel=r_associated | relid=0 | w=20
  827. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased or absent udp-glucuronyl-transferase activity
    n1=en:5-oxoprolinase deficiency | n2=en:decreased or absent udp-glucuronyl-transferase activity | rel=r_associated | relid=0 | w=20
  828. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased or increased serum testosterone
    n1=en:5-oxoprolinase deficiency | n2=en:decreased or increased serum testosterone | rel=r_associated | relid=0 | w=20
  829. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased or low-normal serum parathyroid hormone (pth)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased or low-normal serum parathyroid hormone (pth) | rel=r_associated | relid=0 | w=20
  830. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased or normal plasma insulin
    n1=en:5-oxoprolinase deficiency | n2=en:decreased or normal plasma insulin | rel=r_associated | relid=0 | w=20
  831. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased or normal serum c3
    n1=en:5-oxoprolinase deficiency | n2=en:decreased or normal serum c3 | rel=r_associated | relid=0 | w=20
  832. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased or normal serum factor b
    n1=en:5-oxoprolinase deficiency | n2=en:decreased or normal serum factor b | rel=r_associated | relid=0 | w=20
  833. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased or normal serum factor i
    n1=en:5-oxoprolinase deficiency | n2=en:decreased or normal serum factor i | rel=r_associated | relid=0 | w=20
  834. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased palmitate oxidation
    n1=en:5-oxoprolinase deficiency | n2=en:decreased palmitate oxidation | rel=r_associated | relid=0 | w=20
  835. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased peroxisomal fatty acid beta-oxidation
    n1=en:5-oxoprolinase deficiency | n2=en:decreased peroxisomal fatty acid beta-oxidation | rel=r_associated | relid=0 | w=20
  836. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased phgdh activity (fibroblasts)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased phgdh activity (fibroblasts) | rel=r_associated | relid=0 | w=20
  837. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased phk activity in liver
    n1=en:5-oxoprolinase deficiency | n2=en:decreased phk activity in liver | rel=r_associated | relid=0 | w=20
  838. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased phosphoglucomutase 1 (pgm1) activity (less than 10% of normal values)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased phosphoglucomutase 1 (pgm1) activity (less than 10% of normal values) | rel=r_associated | relid=0 | w=20
  839. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased phosphoglycerate mutase 1 (pgam2) activity (2 to 6% of normal values)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased phosphoglycerate mutase 1 (pgam2) activity (2 to 6% of normal values) | rel=r_associated | relid=0 | w=20
  840. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased phytanic acid oxidase activity
    n1=en:5-oxoprolinase deficiency | n2=en:decreased phytanic acid oxidase activity | rel=r_associated | relid=0 | w=20
  841. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased plasma and urinary guanidinoacetate (gaa)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased plasma and urinary guanidinoacetate (gaa) | rel=r_associated | relid=0 | w=20
  842. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased plasma and urinary ornithine
    n1=en:5-oxoprolinase deficiency | n2=en:decreased plasma and urinary ornithine | rel=r_associated | relid=0 | w=20
  843. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased plasma apolipoprotein c-ii
    n1=en:5-oxoprolinase deficiency | n2=en:decreased plasma apolipoprotein c-ii | rel=r_associated | relid=0 | w=20
  844. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased plasma arginine
    n1=en:5-oxoprolinase deficiency | n2=en:decreased plasma arginine | rel=r_associated | relid=0 | w=20
  845. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased plasma esterified cholesterol
    n1=en:5-oxoprolinase deficiency | n2=en:decreased plasma esterified cholesterol | rel=r_associated | relid=0 | w=20
  846. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased plasma free carnitine
    n1=en:5-oxoprolinase deficiency | n2=en:decreased plasma free carnitine | rel=r_associated | relid=0 | w=20
  847. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased plasma glycine
    n1=en:5-oxoprolinase deficiency | n2=en:decreased plasma glycine | rel=r_associated | relid=0 | w=20
  848. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased plasma hdl (<1/10 of normal levels)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased plasma hdl (<1/10 of normal levels) | rel=r_associated | relid=0 | w=20
  849. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased plasma lysine, glutamic acid, and glutamine
    n1=en:5-oxoprolinase deficiency | n2=en:decreased plasma lysine, glutamic acid, and glutamine | rel=r_associated | relid=0 | w=20
  850. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased plasma serine
    n1=en:5-oxoprolinase deficiency | n2=en:decreased plasma serine | rel=r_associated | relid=0 | w=20
  851. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased plasma total and free carnitine
    n1=en:5-oxoprolinase deficiency | n2=en:decreased plasma total and free carnitine | rel=r_associated | relid=0 | w=20
  852. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased plasma total cholesterol
    n1=en:5-oxoprolinase deficiency | n2=en:decreased plasma total cholesterol | rel=r_associated | relid=0 | w=20
  853. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased plasma triglycerides
    n1=en:5-oxoprolinase deficiency | n2=en:decreased plasma triglycerides | rel=r_associated | relid=0 | w=20
  854. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased plasma zinc levels
    n1=en:5-oxoprolinase deficiency | n2=en:decreased plasma zinc levels | rel=r_associated | relid=0 | w=20
  855. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased plasmalogens
    n1=en:5-oxoprolinase deficiency | n2=en:decreased plasmalogens | rel=r_associated | relid=0 | w=20
  856. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased plasminogen activity
    n1=en:5-oxoprolinase deficiency | n2=en:decreased plasminogen activity | rel=r_associated | relid=0 | w=20
  857. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased plasminogen antigen
    n1=en:5-oxoprolinase deficiency | n2=en:decreased plasminogen antigen | rel=r_associated | relid=0 | w=20
  858. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased platelet derived growth factor
    n1=en:5-oxoprolinase deficiency | n2=en:decreased platelet derived growth factor | rel=r_associated | relid=0 | w=20
  859. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased prpp synthetase activity in erythrocytes and fibroblasts
    n1=en:5-oxoprolinase deficiency | n2=en:decreased prpp synthetase activity in erythrocytes and fibroblasts | rel=r_associated | relid=0 | w=20
  860. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased pyruvate carboxylase (pc) activity (less than 5%)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased pyruvate carboxylase (pc) activity (less than 5%) | rel=r_associated | relid=0 | w=20
  861. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased renal calcium excretion
    n1=en:5-oxoprolinase deficiency | n2=en:decreased renal calcium excretion | rel=r_associated | relid=0 | w=20
  862. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased reversible oxygen-binding capacity (e.g. hb l (bombay) 141800.9999)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased reversible oxygen-binding capacity (e.g. hb l (bombay) 141800.9999) | rel=r_associated | relid=0 | w=20
  863. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased scad activity
    n1=en:5-oxoprolinase deficiency | n2=en:decreased scad activity | rel=r_associated | relid=0 | w=20
  864. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased serum 18-ohb
    n1=en:5-oxoprolinase deficiency | n2=en:decreased serum 18-ohb | rel=r_associated | relid=0 | w=20
  865. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased serum acth
    n1=en:5-oxoprolinase deficiency | n2=en:decreased serum acth | rel=r_associated | relid=0 | w=20
  866. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased serum alpha-2 macroglobulin levels
    n1=en:5-oxoprolinase deficiency | n2=en:decreased serum alpha-2 macroglobulin levels | rel=r_associated | relid=0 | w=20
  867. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased serum and salivary lactoferrin has been described in 1 family
    n1=en:5-oxoprolinase deficiency | n2=en:decreased serum and salivary lactoferrin has been described in 1 family | rel=r_associated | relid=0 | w=20
  868. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased serum androgens
    n1=en:5-oxoprolinase deficiency | n2=en:decreased serum androgens | rel=r_associated | relid=0 | w=20
  869. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased serum bun
    n1=en:5-oxoprolinase deficiency | n2=en:decreased serum bun | rel=r_associated | relid=0 | w=20
  870. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased serum c3 (atypical hus)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased serum c3 (atypical hus) | rel=r_associated | relid=0 | w=20
  871. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased serum carnitine in acute stage
    n1=en:5-oxoprolinase deficiency | n2=en:decreased serum carnitine in acute stage | rel=r_associated | relid=0 | w=20
  872. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased serum ceruloplasmin
    n1=en:5-oxoprolinase deficiency | n2=en:decreased serum ceruloplasmin | rel=r_associated | relid=0 | w=20
  873. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased serum cholesterol (in some)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased serum cholesterol (in some) | rel=r_associated | relid=0 | w=20
  874. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased serum cobalamin
    n1=en:5-oxoprolinase deficiency | n2=en:decreased serum cobalamin | rel=r_associated | relid=0 | w=20
  875. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased serum complement factor h
    n1=en:5-oxoprolinase deficiency | n2=en:decreased serum complement factor h | rel=r_associated | relid=0 | w=20
  876. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased serum factor b (atypical hus)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased serum factor b (atypical hus) | rel=r_associated | relid=0 | w=20
  877. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased serum factor h (atypical hus)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased serum factor h (atypical hus) | rel=r_associated | relid=0 | w=20
  878. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased serum factor i (atypical hus)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased serum factor i (atypical hus) | rel=r_associated | relid=0 | w=20
  879. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased serum follicle-stimulating hormone (fsh)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased serum follicle-stimulating hormone (fsh) | rel=r_associated | relid=0 | w=20
  880. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased serum free thyroxine
    n1=en:5-oxoprolinase deficiency | n2=en:decreased serum free thyroxine | rel=r_associated | relid=0 | w=20
  881. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased serum glucosyltransferase (ggt) activity
    n1=en:5-oxoprolinase deficiency | n2=en:decreased serum glucosyltransferase (ggt) activity | rel=r_associated | relid=0 | w=20
  882. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased serum haptoglobin
    n1=en:5-oxoprolinase deficiency | n2=en:decreased serum haptoglobin | rel=r_associated | relid=0 | w=20
  883. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased serum iga
    n1=en:5-oxoprolinase deficiency | n2=en:decreased serum iga | rel=r_associated | relid=0 | w=20
  884. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased serum igm
    n1=en:5-oxoprolinase deficiency | n2=en:decreased serum igm | rel=r_associated | relid=0 | w=20
  885. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased serum insulin-like growth factor-1 (igf1, 147440)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased serum insulin-like growth factor-1 (igf1, 147440) | rel=r_associated | relid=0 | w=20
  886. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased serum insulin-like growth factor-1 (igf1)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased serum insulin-like growth factor-1 (igf1) | rel=r_associated | relid=0 | w=20
  887. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased serum iron (in some patients)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased serum iron (in some patients) | rel=r_associated | relid=0 | w=20
  888. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased serum l-transferrin (heterozygous patient)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased serum l-transferrin (heterozygous patient) | rel=r_associated | relid=0 | w=20
  889. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased serum leptin
    n1=en:5-oxoprolinase deficiency | n2=en:decreased serum leptin | rel=r_associated | relid=0 | w=20
  890. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased serum luteinizing hormone (lh)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased serum luteinizing hormone (lh) | rel=r_associated | relid=0 | w=20
  891. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased serum rt3
    n1=en:5-oxoprolinase deficiency | n2=en:decreased serum rt3 | rel=r_associated | relid=0 | w=20
  892. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased serum thiamine pyrophosphate
    n1=en:5-oxoprolinase deficiency | n2=en:decreased serum thiamine pyrophosphate | rel=r_associated | relid=0 | w=20
  893. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased serum thyroxine (t4)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased serum thyroxine (t4) | rel=r_associated | relid=0 | w=20
  894. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased serum trypsinogen
    n1=en:5-oxoprolinase deficiency | n2=en:decreased serum trypsinogen | rel=r_associated | relid=0 | w=20
  895. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased serum vitamin a
    n1=en:5-oxoprolinase deficiency | n2=en:decreased serum vitamin a | rel=r_associated | relid=0 | w=20
  896. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased short/branched-chain acyl-coa dehydrogenase protein levels and enzyme activity
    n1=en:5-oxoprolinase deficiency | n2=en:decreased short/branched-chain acyl-coa dehydrogenase protein levels and enzyme activity | rel=r_associated | relid=0 | w=20
  897. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased sulfite oxidase activity
    n1=en:5-oxoprolinase deficiency | n2=en:decreased sulfite oxidase activity | rel=r_associated | relid=0 | w=20
  898. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased sulfite oxidase activity in fibroblasts
    n1=en:5-oxoprolinase deficiency | n2=en:decreased sulfite oxidase activity in fibroblasts | rel=r_associated | relid=0 | w=20
  899. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased switched memory b cells
    n1=en:5-oxoprolinase deficiency | n2=en:decreased switched memory b cells | rel=r_associated | relid=0 | w=20
  900. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased t cells
    n1=en:5-oxoprolinase deficiency | n2=en:decreased t cells | rel=r_associated | relid=0 | w=20
  901. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased telomerase activity
    n1=en:5-oxoprolinase deficiency | n2=en:decreased telomerase activity | rel=r_associated | relid=0 | w=20
  902. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased testosterone level
    n1=en:5-oxoprolinase deficiency | n2=en:decreased testosterone level | rel=r_associated | relid=0 | w=20
  903. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased tetrahydrobiopterin (bh4) in csf
    n1=en:5-oxoprolinase deficiency | n2=en:decreased tetrahydrobiopterin (bh4) in csf | rel=r_associated | relid=0 | w=20
  904. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased tetrasialo-transferrin
    n1=en:5-oxoprolinase deficiency | n2=en:decreased tetrasialo-transferrin | rel=r_associated | relid=0 | w=20
  905. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased tetrasialotransferrin levels
    n1=en:5-oxoprolinase deficiency | n2=en:decreased tetrasialotransferrin levels | rel=r_associated | relid=0 | w=20
  906. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased thrombospondin
    n1=en:5-oxoprolinase deficiency | n2=en:decreased thrombospondin | rel=r_associated | relid=0 | w=20
  907. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased tissue and serum alkaline phosphatase
    n1=en:5-oxoprolinase deficiency | n2=en:decreased tissue and serum alkaline phosphatase | rel=r_associated | relid=0 | w=20
  908. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased tissue total and free carnitine
    n1=en:5-oxoprolinase deficiency | n2=en:decreased tissue total and free carnitine | rel=r_associated | relid=0 | w=20
  909. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased transcobalamin i in saliva, serum, gastric juice, and cerebrospinal fluid
    n1=en:5-oxoprolinase deficiency | n2=en:decreased transcobalamin i in saliva, serum, gastric juice, and cerebrospinal fluid | rel=r_associated | relid=0 | w=20
  910. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased transferrin increased serum iron
    n1=en:5-oxoprolinase deficiency | n2=en:decreased transferrin increased serum iron | rel=r_associated | relid=0 | w=20
  911. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased ubiquinone-10
    n1=en:5-oxoprolinase deficiency | n2=en:decreased ubiquinone-10 | rel=r_associated | relid=0 | w=20
  912. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased udp-glcnac
    n1=en:5-oxoprolinase deficiency | n2=en:decreased udp-glcnac | rel=r_associated | relid=0 | w=20
  913. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased urinary calcium and phosphate excretion
    n1=en:5-oxoprolinase deficiency | n2=en:decreased urinary calcium and phosphate excretion | rel=r_associated | relid=0 | w=20
  914. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased urinary hva, 5-hiaa, and vanillyl mandelic acid (vma)
    n1=en:5-oxoprolinase deficiency | n2=en:decreased urinary hva, 5-hiaa, and vanillyl mandelic acid (vma) | rel=r_associated | relid=0 | w=20
  915. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased urinary sulfate
    n1=en:5-oxoprolinase deficiency | n2=en:decreased urinary sulfate | rel=r_associated | relid=0 | w=20
  916. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased urocanic acid in blood, urine, and skin cells
    n1=en:5-oxoprolinase deficiency | n2=en:decreased urocanic acid in blood, urine, and skin cells | rel=r_associated | relid=0 | w=20
  917. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased very long-chain acyl-coa dehydrogenase protein and activity
    n1=en:5-oxoprolinase deficiency | n2=en:decreased very long-chain acyl-coa dehydrogenase protein and activity | rel=r_associated | relid=0 | w=20
  918. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased von willebrand factor
    n1=en:5-oxoprolinase deficiency | n2=en:decreased von willebrand factor | rel=r_associated | relid=0 | w=20
  919. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased whole blood serotonin
    n1=en:5-oxoprolinase deficiency | n2=en:decreased whole blood serotonin | rel=r_associated | relid=0 | w=20
  920. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased xanthine dehydrogenase activity
    n1=en:5-oxoprolinase deficiency | n2=en:decreased xanthine dehydrogenase activity | rel=r_associated | relid=0 | w=20
  921. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:decreased-absent intestinal mucosa lactase activity
    n1=en:5-oxoprolinase deficiency | n2=en:decreased-absent intestinal mucosa lactase activity | rel=r_associated | relid=0 | w=20
  922. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:defect in chylomicron secretion
    n1=en:5-oxoprolinase deficiency | n2=en:defect in chylomicron secretion | rel=r_associated | relid=0 | w=20
  923. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:defect in double-stranded dna repair
    n1=en:5-oxoprolinase deficiency | n2=en:defect in double-stranded dna repair | rel=r_associated | relid=0 | w=20
  924. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:defect in mitochondrial and peroxisomal fission
    n1=en:5-oxoprolinase deficiency | n2=en:defect in mitochondrial and peroxisomal fission | rel=r_associated | relid=0 | w=20
  925. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:defect in n- and o-glycosylation
    n1=en:5-oxoprolinase deficiency | n2=en:defect in n- and o-glycosylation | rel=r_associated | relid=0 | w=20
  926. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:defect in oxidative phosphorylation
    n1=en:5-oxoprolinase deficiency | n2=en:defect in oxidative phosphorylation | rel=r_associated | relid=0 | w=20
  927. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:defect in post-translational modification of lysosomal enzymes
    n1=en:5-oxoprolinase deficiency | n2=en:defect in post-translational modification of lysosomal enzymes | rel=r_associated | relid=0 | w=20
  928. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:defect in retrograde intraflagellar transport in cilia
    n1=en:5-oxoprolinase deficiency | n2=en:defect in retrograde intraflagellar transport in cilia | rel=r_associated | relid=0 | w=20
  929. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:defective (ca2+) mobilization in t cells
    n1=en:5-oxoprolinase deficiency | n2=en:defective (ca2+) mobilization in t cells | rel=r_associated | relid=0 | w=20
  930. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:defective bile acid metabolism
    n1=en:5-oxoprolinase deficiency | n2=en:defective bile acid metabolism | rel=r_associated | relid=0 | w=20
  931. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:defective dna repair
    n1=en:5-oxoprolinase deficiency | n2=en:defective dna repair | rel=r_associated | relid=0 | w=20
  932. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:defective DNA repair
    n1=en:5-oxoprolinase deficiency | n2=en:defective DNA repair | rel=r_associated | relid=0 | w=20
  933. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:defective dna repair after ultraviolet radiation damage
    n1=en:5-oxoprolinase deficiency | n2=en:defective dna repair after ultraviolet radiation damage | rel=r_associated | relid=0 | w=20
  934. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:defective glcnac-pi synthesis
    n1=en:5-oxoprolinase deficiency | n2=en:defective glcnac-pi synthesis | rel=r_associated | relid=0 | w=20
  935. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:defective t-cell proliferative responses (in some patients)
    n1=en:5-oxoprolinase deficiency | n2=en:defective t-cell proliferative responses (in some patients) | rel=r_associated | relid=0 | w=20
  936. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:deficiency in enzyme complexes of mitochondrial respiratory chain
    n1=en:5-oxoprolinase deficiency | n2=en:deficiency in enzyme complexes of mitochondrial respiratory chain | rel=r_associated | relid=0 | w=20
  937. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:deficiency of alpha-1,4-glucosidase (acid maltase)
    n1=en:5-oxoprolinase deficiency | n2=en:deficiency of alpha-1,4-glucosidase (acid maltase) | rel=r_associated | relid=0 | w=20
  938. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:deficiency of creatine phosphate in brain
    n1=en:5-oxoprolinase deficiency | n2=en:deficiency of creatine phosphate in brain | rel=r_associated | relid=0 | w=20
  939. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:deficiency of fat-soluble vitamins
    n1=en:5-oxoprolinase deficiency | n2=en:deficiency of fat-soluble vitamins | rel=r_associated | relid=0 | w=20
  940. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:deficiency of glycoprotein (gp)iib-iiia complex
    n1=en:5-oxoprolinase deficiency | n2=en:deficiency of glycoprotein (gp)iib-iiia complex | rel=r_associated | relid=0 | w=20
  941. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:deficiency of laminin alpha-2 chain of merosin (lama2, 156225) in muscle
    n1=en:5-oxoprolinase deficiency | n2=en:deficiency of laminin alpha-2 chain of merosin (lama2, 156225) in muscle | rel=r_associated | relid=0 | w=20
  942. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:deficiency of laminin in basement membranes
    n1=en:5-oxoprolinase deficiency | n2=en:deficiency of laminin in basement membranes | rel=r_associated | relid=0 | w=20
  943. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:deficiency of mitochondrial isovaleryl-coa dehydrogenase in fibroblasts
    n1=en:5-oxoprolinase deficiency | n2=en:deficiency of mitochondrial isovaleryl-coa dehydrogenase in fibroblasts | rel=r_associated | relid=0 | w=20
  944. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:deficiency of prolidase activity in erythrocytes, leukocytes, or fibroblasts
    n1=en:5-oxoprolinase deficiency | n2=en:deficiency of prolidase activity in erythrocytes, leukocytes, or fibroblasts | rel=r_associated | relid=0 | w=20
  945. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:deficiency of saposins a, b, c, and d
    n1=en:5-oxoprolinase deficiency | n2=en:deficiency of saposins a, b, c, and d | rel=r_associated | relid=0 | w=20
  946. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:deficiency of serum properdin p factor
    n1=en:5-oxoprolinase deficiency | n2=en:deficiency of serum properdin p factor | rel=r_associated | relid=0 | w=20
  947. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:deficiency of steryl-sulfatase
    n1=en:5-oxoprolinase deficiency | n2=en:deficiency of steryl-sulfatase | rel=r_associated | relid=0 | w=20
  948. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:deficiency or absence of cytochrome b(-245)
    n1=en:5-oxoprolinase deficiency | n2=en:deficiency or absence of cytochrome b(-245) | rel=r_associated | relid=0 | w=20
  949. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:deficiency or absence of p22-phox (608508) protein
    n1=en:5-oxoprolinase deficiency | n2=en:deficiency or absence of p22-phox (608508) protein | rel=r_associated | relid=0 | w=20
  950. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:deficiency or absence of p47-phox protein (type i)
    n1=en:5-oxoprolinase deficiency | n2=en:deficiency or absence of p47-phox protein (type i) | rel=r_associated | relid=0 | w=20
  951. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:deficiency or absence of p67-phox protein (type ii)
    n1=en:5-oxoprolinase deficiency | n2=en:deficiency or absence of p67-phox protein (type ii) | rel=r_associated | relid=0 | w=20
  952. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:deficiency or absence of p91-phox (300481) protein
    n1=en:5-oxoprolinase deficiency | n2=en:deficiency or absence of p91-phox (300481) protein | rel=r_associated | relid=0 | w=20
  953. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:deficiency or absence of p91-phox protein
    n1=en:5-oxoprolinase deficiency | n2=en:deficiency or absence of p91-phox protein | rel=r_associated | relid=0 | w=20
  954. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:deficient efflux of intracellular cholesterol
    n1=en:5-oxoprolinase deficiency | n2=en:deficient efflux of intracellular cholesterol | rel=r_associated | relid=0 | w=20
  955. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:deficient fibroblast aicar-tf activity
    n1=en:5-oxoprolinase deficiency | n2=en:deficient fibroblast aicar-tf activity | rel=r_associated | relid=0 | w=20
  956. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:deficient hepatic 4-hydroxyphenylpyruvate dioxygenase
    n1=en:5-oxoprolinase deficiency | n2=en:deficient hepatic 4-hydroxyphenylpyruvate dioxygenase | rel=r_associated | relid=0 | w=20
  957. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:deficient ribose-s-phosphate isomerase (rpi) in fibroblasts
    n1=en:5-oxoprolinase deficiency | n2=en:deficient ribose-s-phosphate isomerase (rpi) in fibroblasts | rel=r_associated | relid=0 | w=20
  958. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:dehydration
    n1=en:5-oxoprolinase deficiency | n2=en:dehydration | rel=r_associated | relid=0 | w=20
  959. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:dehydroepiandrosterone (dhea) at upper level of normal range
    n1=en:5-oxoprolinase deficiency | n2=en:dehydroepiandrosterone (dhea) at upper level of normal range | rel=r_associated | relid=0 | w=20
  960. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:delayed oxidation of acetaldehyde
    n1=en:5-oxoprolinase deficiency | n2=en:delayed oxidation of acetaldehyde | rel=r_associated | relid=0 | w=20
  961. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:delayed plasma clearance of unconjugated bromsulphthalein, an anionic diagnostic dye
    n1=en:5-oxoprolinase deficiency | n2=en:delayed plasma clearance of unconjugated bromsulphthalein, an anionic diagnostic dye | rel=r_associated | relid=0 | w=20
  962. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:deletion (78kb to 1mb) of chromosome 8q24.3 including the scrib (607733) and puf60 (604819) genes
    n1=en:5-oxoprolinase deficiency | n2=en:deletion (78kb to 1mb) of chromosome 8q24.3 including the scrib (607733) and puf60 (604819) genes | rel=r_associated | relid=0 | w=20
  963. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:delta-1-pyrroline-3-hydroxy-5-carboxylate levels increased in urine
    n1=en:5-oxoprolinase deficiency | n2=en:delta-1-pyrroline-3-hydroxy-5-carboxylate levels increased in urine | rel=r_associated | relid=0 | w=20
  964. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:delta-1-pyrroline-5-carboxylate (p5c) levels increased in plasma
    n1=en:5-oxoprolinase deficiency | n2=en:delta-1-pyrroline-5-carboxylate (p5c) levels increased in plasma | rel=r_associated | relid=0 | w=20
  965. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:delta-1-pyrroline-5-carboxylate dehydrogenase activity decreased in fibroblasts or leukocytes
    n1=en:5-oxoprolinase deficiency | n2=en:delta-1-pyrroline-5-carboxylate dehydrogenase activity decreased in fibroblasts or leukocytes | rel=r_associated | relid=0 | w=20
  966. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:dentinogenesis imperfecta, short stature, hearing loss, intellectual disability syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:dentinogenesis imperfecta, short stature, hearing loss, intellectual disability syndrome | rel=r_associated | relid=0 | w=20
  967. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:depletion of mtdna (skeletal muscle, fibroblasts)
    n1=en:5-oxoprolinase deficiency | n2=en:depletion of mtdna (skeletal muscle, fibroblasts) | rel=r_associated | relid=0 | w=20
  968. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:dermatan and heparan sulfate excretion in urine
    n1=en:5-oxoprolinase deficiency | n2=en:dermatan and heparan sulfate excretion in urine | rel=r_associated | relid=0 | w=20
  969. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:dermatan sulfate excretion in urine
    n1=en:5-oxoprolinase deficiency | n2=en:dermatan sulfate excretion in urine | rel=r_associated | relid=0 | w=20
  970. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:detection by rt-pcr and southern blot analysis for primary diagnosis and follow up for residual disease
    n1=en:5-oxoprolinase deficiency | n2=en:detection by rt-pcr and southern blot analysis for primary diagnosis and follow up for residual disease | rel=r_associated | relid=0 | w=20
  971. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:detection by rt-pcr, southern blot analysis, and fish for primary diagnosis and follow up for residual disease
    n1=en:5-oxoprolinase deficiency | n2=en:detection by rt-pcr, southern blot analysis, and fish for primary diagnosis and follow up for residual disease | rel=r_associated | relid=0 | w=20
  972. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:dhea sulfotransferase below limit of detection
    n1=en:5-oxoprolinase deficiency | n2=en:dhea sulfotransferase below limit of detection | rel=r_associated | relid=0 | w=20
  973. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:di- and trihydroxycholestanoic acid accumulation
    n1=en:5-oxoprolinase deficiency | n2=en:di- and trihydroxycholestanoic acid accumulation | rel=r_associated | relid=0 | w=20
  974. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:diagnosis by exposing muscle biopsy to caffeine and/or halothane
    n1=en:5-oxoprolinase deficiency | n2=en:diagnosis by exposing muscle biopsy to caffeine and/or halothane | rel=r_associated | relid=0 | w=20
  975. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:diaminoaciduria (arginuria, lysinuria, cystinuria, ornithinuria)
    n1=en:5-oxoprolinase deficiency | n2=en:diaminoaciduria (arginuria, lysinuria, cystinuria, ornithinuria) | rel=r_associated | relid=0 | w=20
  976. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:diaphanospondylodysostosis
    n1=en:5-oxoprolinase deficiency | n2=en:diaphanospondylodysostosis | rel=r_associated | relid=0 | w=20
  977. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:dicarboxylic aciduria
    n1=en:5-oxoprolinase deficiency | n2=en:dicarboxylic aciduria | rel=r_associated | relid=0 | w=20
  978. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:diffuse deposition of calcium oxalate in various tissues
    n1=en:5-oxoprolinase deficiency | n2=en:diffuse deposition of calcium oxalate in various tissues | rel=r_associated | relid=0 | w=20
  979. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:dihydropyrimidinase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:dihydropyrimidinase deficiency | rel=r_associated | relid=0 | w=20
  980. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:dihydropyrimidine dehydrogenase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:dihydropyrimidine dehydrogenase deficiency | rel=r_associated | relid=0 | w=20
  981. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:dilated rough endoplasmic reticulum (rer)
    n1=en:5-oxoprolinase deficiency | n2=en:dilated rough endoplasmic reticulum (rer) | rel=r_associated | relid=0 | w=20
  982. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:dimethylglycine dehydrogenase (dmgdh) deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:dimethylglycine dehydrogenase (dmgdh) deficiency | rel=r_associated | relid=0 | w=20
  983. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:diminished lymphocyte response to phytohemaglutinin
    n1=en:5-oxoprolinase deficiency | n2=en:diminished lymphocyte response to phytohemaglutinin | rel=r_associated | relid=0 | w=20
  984. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:direct coombs test negative
    n1=en:5-oxoprolinase deficiency | n2=en:direct coombs test negative | rel=r_associated | relid=0 | w=20
  985. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:disorder due to cytochrome p450 enzyme variant
    n1=en:5-oxoprolinase deficiency | n2=en:disorder due to cytochrome p450 enzyme variant | rel=r_associated | relid=0 | w=20
  986. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:disorder due to n-acetyltransferase enzyme variant
    n1=en:5-oxoprolinase deficiency | n2=en:disorder due to n-acetyltransferase enzyme variant | rel=r_associated | relid=0 | w=20
  987. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:disorder of pyruvate metabolism and mitochondrial respiratory chain
    n1=en:5-oxoprolinase deficiency | n2=en:disorder of pyruvate metabolism and mitochondrial respiratory chain | rel=r_associated | relid=0 | w=20
  988. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:disorder of sialic acid metabolism
    n1=en:5-oxoprolinase deficiency | n2=en:disorder of sialic acid metabolism | rel=r_associated | relid=0 | w=20
  989. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:disorganized growth plate cartilage
    n1=en:5-oxoprolinase deficiency | n2=en:disorganized growth plate cartilage | rel=r_associated | relid=0 | w=20
  990. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:disproportionate work-related increase in blood lactate and pyruvate
    n1=en:5-oxoprolinase deficiency | n2=en:disproportionate work-related increase in blood lactate and pyruvate | rel=r_associated | relid=0 | w=20
  991. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:disseminated intravascular coagulation
    n1=en:5-oxoprolinase deficiency | n2=en:disseminated intravascular coagulation | rel=r_associated | relid=0 | w=20
  992. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:distal xp22.3 segmental monosomy
    n1=en:5-oxoprolinase deficiency | n2=en:distal xp22.3 segmental monosomy | rel=r_associated | relid=0 | w=20
  993. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:disturbed visual and brainstem auditory evoked responses indicative of cns demyelination
    n1=en:5-oxoprolinase deficiency | n2=en:disturbed visual and brainstem auditory evoked responses indicative of cns demyelination | rel=r_associated | relid=0 | w=20
  994. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:diverse tissue cell types (vascular endothelial cells, adipocytes, schwann cells, leukocytes) have membrane-lined cytoplasmic vacuoles with amorphous and filamentous material
    n1=en:5-oxoprolinase deficiency | n2=en:diverse tissue cell types (vascular endothelial cells, adipocytes, schwann cells, leukocytes) have membrane-lined cytoplasmic vacuoles with amorphous and filamentous material | rel=r_associated | relid=0 | w=20
  995. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:dolichyl-p-glc:man(9)glcnac(2)-pp-dolichyl glucosyltransferase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:dolichyl-p-glc:man(9)glcnac(2)-pp-dolichyl glucosyltransferase deficiency | rel=r_associated | relid=0 | w=20
  996. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:dolichyl-p-man:man(5)glcnac(2)-pp-dolichyl mannosyltransferase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:dolichyl-p-man:man(5)glcnac(2)-pp-dolichyl mannosyltransferase deficiency | rel=r_associated | relid=0 | w=20
  997. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:double stranded anti dna antibody
    n1=en:5-oxoprolinase deficiency | n2=en:double stranded anti dna antibody | rel=r_associated | relid=0 | w=20
  998. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:Dubin-Sprinz disease
    n1=en:5-oxoprolinase deficiency | n2=en:Dubin-Sprinz disease | rel=r_associated | relid=0 | w=20
  999. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:duplication or deletion at 11p15.5
    n1=en:5-oxoprolinase deficiency | n2=en:duplication or deletion at 11p15.5 | rel=r_associated | relid=0 | w=20
  1000. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:dyskinetic ciliary motility
    n1=en:5-oxoprolinase deficiency | n2=en:dyskinetic ciliary motility | rel=r_associated | relid=0 | w=20
  1001. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:dystonia, dopa-responsive, due to sepiapterin reductase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:dystonia, dopa-responsive, due to sepiapterin reductase deficiency | rel=r_associated | relid=0 | w=20
  1002. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:ectodermal dysplasia with blindness syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:ectodermal dysplasia with blindness syndrome | rel=r_associated | relid=0 | w=20
  1003. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:ehlers-danlos syndrome kyphoscoliotic and deafness type
    n1=en:5-oxoprolinase deficiency | n2=en:ehlers-danlos syndrome kyphoscoliotic and deafness type | rel=r_associated | relid=0 | w=20
  1004. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:electrolyte disturbances from intractable diarrhea
    n1=en:5-oxoprolinase deficiency | n2=en:electrolyte disturbances from intractable diarrhea | rel=r_associated | relid=0 | w=20
  1005. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:electrolyturia (1 patient)
    n1=en:5-oxoprolinase deficiency | n2=en:electrolyturia (1 patient) | rel=r_associated | relid=0 | w=20
  1006. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:electron microscopy of foam cells shows lamellar inclusions
    n1=en:5-oxoprolinase deficiency | n2=en:electron microscopy of foam cells shows lamellar inclusions | rel=r_associated | relid=0 | w=20
  1007. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:electron microscopy of patient respiratory cells shows absent outer dynein arms
    n1=en:5-oxoprolinase deficiency | n2=en:electron microscopy of patient respiratory cells shows absent outer dynein arms | rel=r_associated | relid=0 | w=20
  1008. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:electron microscopy of patient respiratory cells shows absent outer dynein arms in the axoneme
    n1=en:5-oxoprolinase deficiency | n2=en:electron microscopy of patient respiratory cells shows absent outer dynein arms in the axoneme | rel=r_associated | relid=0 | w=20
  1009. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:electron microscopy of patient respiratory cells shows defects in inner and outer dynein arms
    n1=en:5-oxoprolinase deficiency | n2=en:electron microscopy of patient respiratory cells shows defects in inner and outer dynein arms | rel=r_associated | relid=0 | w=20
  1010. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:electron microscopy of patient respiratory cells shows loss of ciliary outer dynein arms
    n1=en:5-oxoprolinase deficiency | n2=en:electron microscopy of patient respiratory cells shows loss of ciliary outer dynein arms | rel=r_associated | relid=0 | w=20
  1011. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:electron microscopy of patient respiratory cells shows reduced inner dynein arms and nexin links
    n1=en:5-oxoprolinase deficiency | n2=en:electron microscopy of patient respiratory cells shows reduced inner dynein arms and nexin links | rel=r_associated | relid=0 | w=20
  1012. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:electroretinogram is abnormal--rod responses are mildly abnormal and cone responses are markedly diminished
    n1=en:5-oxoprolinase deficiency | n2=en:electroretinogram is abnormal--rod responses are mildly abnormal and cone responses are markedly diminished | rel=r_associated | relid=0 | w=20
  1013. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated 1,25(oh)2 d3
    n1=en:5-oxoprolinase deficiency | n2=en:elevated 1,25(oh)2 d3 | rel=r_associated | relid=0 | w=20
  1014. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated 17-hydroxyprogesterone
    n1=en:5-oxoprolinase deficiency | n2=en:elevated 17-hydroxyprogesterone | rel=r_associated | relid=0 | w=20
  1015. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated 2-ketoglutarate (urine)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated 2-ketoglutarate (urine) | rel=r_associated | relid=0 | w=20
  1016. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated 3-hydroxypropionic acid
    n1=en:5-oxoprolinase deficiency | n2=en:elevated 3-hydroxypropionic acid | rel=r_associated | relid=0 | w=20
  1017. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated 3-methylcitric acid
    n1=en:5-oxoprolinase deficiency | n2=en:elevated 3-methylcitric acid | rel=r_associated | relid=0 | w=20
  1018. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated 7-dehydrocholesterol
    n1=en:5-oxoprolinase deficiency | n2=en:elevated 7-dehydrocholesterol | rel=r_associated | relid=0 | w=20
  1019. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated 8-dehydrocholesterol
    n1=en:5-oxoprolinase deficiency | n2=en:elevated 8-dehydrocholesterol | rel=r_associated | relid=0 | w=20
  1020. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated 8(9)-cholestenol
    n1=en:5-oxoprolinase deficiency | n2=en:elevated 8(9)-cholestenol | rel=r_associated | relid=0 | w=20
  1021. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated acth
    n1=en:5-oxoprolinase deficiency | n2=en:elevated acth | rel=r_associated | relid=0 | w=20
  1022. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated afp (endodermal sinus tumor)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated afp (endodermal sinus tumor) | rel=r_associated | relid=0 | w=20
  1023. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated alkaline phosphatase
    n1=en:5-oxoprolinase deficiency | n2=en:elevated alkaline phosphatase | rel=r_associated | relid=0 | w=20
  1024. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated alkaline phosphatase (if more than one affected site)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated alkaline phosphatase (if more than one affected site) | rel=r_associated | relid=0 | w=20
  1025. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated alkaline phosphatase (varies from 1.3-20 times age-adjusted upper limit of normal)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated alkaline phosphatase (varies from 1.3-20 times age-adjusted upper limit of normal) | rel=r_associated | relid=0 | w=20
  1026. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated alkaline phosphatase of bone origin
    n1=en:5-oxoprolinase deficiency | n2=en:elevated alkaline phosphatase of bone origin | rel=r_associated | relid=0 | w=20
  1027. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated alpha-ketoglutarate (in most patients)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated alpha-ketoglutarate (in most patients) | rel=r_associated | relid=0 | w=20
  1028. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated ammonia
    n1=en:5-oxoprolinase deficiency | n2=en:elevated ammonia | rel=r_associated | relid=0 | w=20
  1029. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated androstenedione
    n1=en:5-oxoprolinase deficiency | n2=en:elevated androstenedione | rel=r_associated | relid=0 | w=20
  1030. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated androstenedione and testosterone
    n1=en:5-oxoprolinase deficiency | n2=en:elevated androstenedione and testosterone | rel=r_associated | relid=0 | w=20
  1031. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated antinuclear antibody (ana) (speckled pattern)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated antinuclear antibody (ana) (speckled pattern) | rel=r_associated | relid=0 | w=20
  1032. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated apoa-i (1.8x normal) in homozygotes
    n1=en:5-oxoprolinase deficiency | n2=en:elevated apoa-i (1.8x normal) in homozygotes | rel=r_associated | relid=0 | w=20
  1033. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated ast (aspartate aminotransferase) and cpk (creatine phosphokinase)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated ast (aspartate aminotransferase) and cpk (creatine phosphokinase) | rel=r_associated | relid=0 | w=20
  1034. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated ast and ldh, especially infantile-onset
    n1=en:5-oxoprolinase deficiency | n2=en:elevated ast and ldh, especially infantile-onset | rel=r_associated | relid=0 | w=20
  1035. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated bilirubin (bilirubinemia)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated bilirubin (bilirubinemia) | rel=r_associated | relid=0 | w=20
  1036. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated biopterin in csf
    n1=en:5-oxoprolinase deficiency | n2=en:elevated biopterin in csf | rel=r_associated | relid=0 | w=20
  1037. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated blood spot hydroxybutyryl carnitine
    n1=en:5-oxoprolinase deficiency | n2=en:elevated blood spot hydroxybutyryl carnitine | rel=r_associated | relid=0 | w=20
  1038. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated calcitonin
    n1=en:5-oxoprolinase deficiency | n2=en:elevated calcitonin | rel=r_associated | relid=0 | w=20
  1039. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated cerebrospinal fluid (csf) protein
    n1=en:5-oxoprolinase deficiency | n2=en:elevated cerebrospinal fluid (csf) protein | rel=r_associated | relid=0 | w=20
  1040. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated cholesta-8,14-dien-3-beta-ol in cultured fibroblasts
    n1=en:5-oxoprolinase deficiency | n2=en:elevated cholesta-8,14-dien-3-beta-ol in cultured fibroblasts | rel=r_associated | relid=0 | w=20
  1041. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated circulating parathyroid hormone (pth) level
    n1=en:5-oxoprolinase deficiency | n2=en:elevated circulating parathyroid hormone (pth) level | rel=r_associated | relid=0 | w=20
  1042. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated creatine kinase (in some patients)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated creatine kinase (in some patients) | rel=r_associated | relid=0 | w=20
  1043. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated crp
    n1=en:5-oxoprolinase deficiency | n2=en:elevated crp | rel=r_associated | relid=0 | w=20
  1044. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated csf amino acids (arginine, ornithine, aspartate, threonine, glycine, and methionine)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated csf amino acids (arginine, ornithine, aspartate, threonine, glycine, and methionine) | rel=r_associated | relid=0 | w=20
  1045. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated csf/plasma glycine ratio
    n1=en:5-oxoprolinase deficiency | n2=en:elevated csf/plasma glycine ratio | rel=r_associated | relid=0 | w=20
  1046. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated d-2-hydroxyglutaric acid (urine, plasma, csf)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated d-2-hydroxyglutaric acid (urine, plasma, csf) | rel=r_associated | relid=0 | w=20
  1047. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated dihydrobiopterin in csf
    n1=en:5-oxoprolinase deficiency | n2=en:elevated dihydrobiopterin in csf | rel=r_associated | relid=0 | w=20
  1048. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated erythrocyte adenosine deaminase
    n1=en:5-oxoprolinase deficiency | n2=en:elevated erythrocyte adenosine deaminase | rel=r_associated | relid=0 | w=20
  1049. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated erythrocyte adenosine deaminase (eada)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated erythrocyte adenosine deaminase (eada) | rel=r_associated | relid=0 | w=20
  1050. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated erythrocyte adenosine deaminase activity
    n1=en:5-oxoprolinase deficiency | n2=en:elevated erythrocyte adenosine deaminase activity | rel=r_associated | relid=0 | w=20
  1051. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated erythrocyte aicar (zmp)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated erythrocyte aicar (zmp) | rel=r_associated | relid=0 | w=20
  1052. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated erythrocyte sedimentation rate (esr)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated erythrocyte sedimentation rate (esr) | rel=r_associated | relid=0 | w=20
  1053. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated erythrocyte sedimentation rate (mean 90mm/h)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated erythrocyte sedimentation rate (mean 90mm/h) | rel=r_associated | relid=0 | w=20
  1054. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated fasting glucose
    n1=en:5-oxoprolinase deficiency | n2=en:elevated fasting glucose | rel=r_associated | relid=0 | w=20
  1055. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated fasting triglycerides (seen in heterozygotes as well)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated fasting triglycerides (seen in heterozygotes as well) | rel=r_associated | relid=0 | w=20
  1056. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated fecal levels of protoporphyrin and coproporphyrin at all times
    n1=en:5-oxoprolinase deficiency | n2=en:elevated fecal levels of protoporphyrin and coproporphyrin at all times | rel=r_associated | relid=0 | w=20
  1057. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated ferritin l subunit
    n1=en:5-oxoprolinase deficiency | n2=en:elevated ferritin l subunit | rel=r_associated | relid=0 | w=20
  1058. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated fibroblast free sialic acid
    n1=en:5-oxoprolinase deficiency | n2=en:elevated fibroblast free sialic acid | rel=r_associated | relid=0 | w=20
  1059. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated free carnitine
    n1=en:5-oxoprolinase deficiency | n2=en:elevated free carnitine | rel=r_associated | relid=0 | w=20
  1060. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated gamma-glutamyltransferase
    n1=en:5-oxoprolinase deficiency | n2=en:elevated gamma-glutamyltransferase | rel=r_associated | relid=0 | w=20
  1061. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated gamma-glutamyltransferase (ggt)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated gamma-glutamyltransferase (ggt) | rel=r_associated | relid=0 | w=20
  1062. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated gastrin concentration
    n1=en:5-oxoprolinase deficiency | n2=en:elevated gastrin concentration | rel=r_associated | relid=0 | w=20
  1063. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated hcg (choriocarcinoma)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated hcg (choriocarcinoma) | rel=r_associated | relid=0 | w=20
  1064. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated hcg or afp or both (embryonal carcinoma)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated hcg or afp or both (embryonal carcinoma) | rel=r_associated | relid=0 | w=20
  1065. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated hdl (2-6x normal) in homozygotes
    n1=en:5-oxoprolinase deficiency | n2=en:elevated hdl (2-6x normal) in homozygotes | rel=r_associated | relid=0 | w=20
  1066. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated hepatic transaminases
    n1=en:5-oxoprolinase deficiency | n2=en:elevated hepatic transaminases | rel=r_associated | relid=0 | w=20
  1067. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated il1-beta
    n1=en:5-oxoprolinase deficiency | n2=en:elevated il1-beta | rel=r_associated | relid=0 | w=20
  1068. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated il6
    n1=en:5-oxoprolinase deficiency | n2=en:elevated il6 | rel=r_associated | relid=0 | w=20
  1069. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated inflammatory markers
    n1=en:5-oxoprolinase deficiency | n2=en:elevated inflammatory markers | rel=r_associated | relid=0 | w=20
  1070. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated l-2-hydroxyglutaric acid (urine)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated l-2-hydroxyglutaric acid (urine) | rel=r_associated | relid=0 | w=20
  1071. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated lathosterol
    n1=en:5-oxoprolinase deficiency | n2=en:elevated lathosterol | rel=r_associated | relid=0 | w=20
  1072. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated leukotriene e(4)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated leukotriene e(4) | rel=r_associated | relid=0 | w=20
  1073. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated levels of vitamin b12
    n1=en:5-oxoprolinase deficiency | n2=en:elevated levels of vitamin b12 | rel=r_associated | relid=0 | w=20
  1074. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated liver enzymes during episodes
    n1=en:5-oxoprolinase deficiency | n2=en:elevated liver enzymes during episodes | rel=r_associated | relid=0 | w=20
  1075. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated liver function tests
    n1=en:5-oxoprolinase deficiency | n2=en:elevated liver function tests | rel=r_associated | relid=0 | w=20
  1076. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated liver transaminases
    n1=en:5-oxoprolinase deficiency | n2=en:elevated liver transaminases | rel=r_associated | relid=0 | w=20
  1077. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated long chain fatty acids
    n1=en:5-oxoprolinase deficiency | n2=en:elevated long chain fatty acids | rel=r_associated | relid=0 | w=20
  1078. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated long-chain acylcarnitine species (in some patients)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated long-chain acylcarnitine species (in some patients) | rel=r_associated | relid=0 | w=20
  1079. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated mchc
    n1=en:5-oxoprolinase deficiency | n2=en:elevated mchc | rel=r_associated | relid=0 | w=20
  1080. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated plasma acth
    n1=en:5-oxoprolinase deficiency | n2=en:elevated plasma acth | rel=r_associated | relid=0 | w=20
  1081. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated plasma adrenocorticotropic hormone (acth)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated plasma adrenocorticotropic hormone (acth) | rel=r_associated | relid=0 | w=20
  1082. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated plasma alloisoleucine
    n1=en:5-oxoprolinase deficiency | n2=en:elevated plasma alloisoleucine | rel=r_associated | relid=0 | w=20
  1083. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated plasma ammonia
    n1=en:5-oxoprolinase deficiency | n2=en:elevated plasma ammonia | rel=r_associated | relid=0 | w=20
  1084. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated plasma and urine inorganic pyrophosphate (ppi)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated plasma and urine inorganic pyrophosphate (ppi) | rel=r_associated | relid=0 | w=20
  1085. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated plasma and urine succinylacetone
    n1=en:5-oxoprolinase deficiency | n2=en:elevated plasma and urine succinylacetone | rel=r_associated | relid=0 | w=20
  1086. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated plasma beta-sitosterol (sitosterolemia or phytosterolemia)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated plasma beta-sitosterol (sitosterolemia or phytosterolemia) | rel=r_associated | relid=0 | w=20
  1087. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated plasma branched chain amino acids (leucine, isoleucine, valine)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated plasma branched chain amino acids (leucine, isoleucine, valine) | rel=r_associated | relid=0 | w=20
  1088. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated plasma campesterol
    n1=en:5-oxoprolinase deficiency | n2=en:elevated plasma campesterol | rel=r_associated | relid=0 | w=20
  1089. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated plasma cholestanol
    n1=en:5-oxoprolinase deficiency | n2=en:elevated plasma cholestanol | rel=r_associated | relid=0 | w=20
  1090. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated plasma citrulline (citrullinemia)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated plasma citrulline (citrullinemia) | rel=r_associated | relid=0 | w=20
  1091. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated plasma desmosterol
    n1=en:5-oxoprolinase deficiency | n2=en:elevated plasma desmosterol | rel=r_associated | relid=0 | w=20
  1092. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated plasma estrogen
    n1=en:5-oxoprolinase deficiency | n2=en:elevated plasma estrogen | rel=r_associated | relid=0 | w=20
  1093. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated plasma follicle stimulating hormone (fsh)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated plasma follicle stimulating hormone (fsh) | rel=r_associated | relid=0 | w=20
  1094. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated plasma galactose (galactosemia)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated plasma galactose (galactosemia) | rel=r_associated | relid=0 | w=20
  1095. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated plasma insulin
    n1=en:5-oxoprolinase deficiency | n2=en:elevated plasma insulin | rel=r_associated | relid=0 | w=20
  1096. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated plasma luteinizing hormone (lh)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated plasma luteinizing hormone (lh) | rel=r_associated | relid=0 | w=20
  1097. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated plasma methionine (methioninemia)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated plasma methionine (methioninemia) | rel=r_associated | relid=0 | w=20
  1098. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated plasma ornithine (~10-fold)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated plasma ornithine (~10-fold) | rel=r_associated | relid=0 | w=20
  1099. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated plasma propionylcarnitine
    n1=en:5-oxoprolinase deficiency | n2=en:elevated plasma propionylcarnitine | rel=r_associated | relid=0 | w=20
  1100. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated plasma stigmasterol
    n1=en:5-oxoprolinase deficiency | n2=en:elevated plasma stigmasterol | rel=r_associated | relid=0 | w=20
  1101. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated pregnenolone
    n1=en:5-oxoprolinase deficiency | n2=en:elevated pregnenolone | rel=r_associated | relid=0 | w=20
  1102. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated progesterone
    n1=en:5-oxoprolinase deficiency | n2=en:elevated progesterone | rel=r_associated | relid=0 | w=20
  1103. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated propionate
    n1=en:5-oxoprolinase deficiency | n2=en:elevated propionate | rel=r_associated | relid=0 | w=20
  1104. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated pth (parathyroid hormone)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated pth (parathyroid hormone) | rel=r_associated | relid=0 | w=20
  1105. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated resting serum lactate, increased with exercise
    n1=en:5-oxoprolinase deficiency | n2=en:elevated resting serum lactate, increased with exercise | rel=r_associated | relid=0 | w=20
  1106. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated sed rate
    n1=en:5-oxoprolinase deficiency | n2=en:elevated sed rate | rel=r_associated | relid=0 | w=20
  1107. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated sepiapterin in csf
    n1=en:5-oxoprolinase deficiency | n2=en:elevated sepiapterin in csf | rel=r_associated | relid=0 | w=20
  1108. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated serum acid phosphatase
    n1=en:5-oxoprolinase deficiency | n2=en:elevated serum acid phosphatase | rel=r_associated | relid=0 | w=20
  1109. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated serum alkaline phosphatase during hyperplastic callus formation
    n1=en:5-oxoprolinase deficiency | n2=en:elevated serum alkaline phosphatase during hyperplastic callus formation | rel=r_associated | relid=0 | w=20
  1110. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated serum alpha-fetoprotein
    n1=en:5-oxoprolinase deficiency | n2=en:elevated serum alpha-fetoprotein | rel=r_associated | relid=0 | w=20
  1111. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated serum alpha-fetoprotein (dominant)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated serum alpha-fetoprotein (dominant) | rel=r_associated | relid=0 | w=20
  1112. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated serum angiotensin-converting enzyme (ace)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated serum angiotensin-converting enzyme (ace) | rel=r_associated | relid=0 | w=20
  1113. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated serum bile acids
    n1=en:5-oxoprolinase deficiency | n2=en:elevated serum bile acids | rel=r_associated | relid=0 | w=20
  1114. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated serum glutamic oxaloacetic transaminase (sgot)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated serum glutamic oxaloacetic transaminase (sgot) | rel=r_associated | relid=0 | w=20
  1115. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated serum glutamic pyruvic transaminase (sgpt)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated serum glutamic pyruvic transaminase (sgpt) | rel=r_associated | relid=0 | w=20
  1116. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated serum insulin-to-c-peptide ratio
    n1=en:5-oxoprolinase deficiency | n2=en:elevated serum insulin-to-c-peptide ratio | rel=r_associated | relid=0 | w=20
  1117. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated serum iron and iron binding capacity
    n1=en:5-oxoprolinase deficiency | n2=en:elevated serum iron and iron binding capacity | rel=r_associated | relid=0 | w=20
  1118. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated serum lactate
    n1=en:5-oxoprolinase deficiency | n2=en:elevated serum lactate | rel=r_associated | relid=0 | w=20
  1119. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated serum levels of adenosine
    n1=en:5-oxoprolinase deficiency | n2=en:elevated serum levels of adenosine | rel=r_associated | relid=0 | w=20
  1120. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated serum levels of follicle stimulating hormone (fsh)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated serum levels of follicle stimulating hormone (fsh) | rel=r_associated | relid=0 | w=20
  1121. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated serum levels of luteinizing hormone (lh)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated serum levels of luteinizing hormone (lh) | rel=r_associated | relid=0 | w=20
  1122. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated serum n,n-dimethylglycine (dmg)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated serum n,n-dimethylglycine (dmg) | rel=r_associated | relid=0 | w=20
  1123. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated serum parathyroid hormone (pth)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated serum parathyroid hormone (pth) | rel=r_associated | relid=0 | w=20
  1124. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated serum parathyroid hormone (pth) level
    n1=en:5-oxoprolinase deficiency | n2=en:elevated serum parathyroid hormone (pth) level | rel=r_associated | relid=0 | w=20
  1125. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated serum phosphate in heterozygotes
    n1=en:5-oxoprolinase deficiency | n2=en:elevated serum phosphate in heterozygotes | rel=r_associated | relid=0 | w=20
  1126. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated serum phosphorus
    n1=en:5-oxoprolinase deficiency | n2=en:elevated serum phosphorus | rel=r_associated | relid=0 | w=20
  1127. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated serum protein
    n1=en:5-oxoprolinase deficiency | n2=en:elevated serum protein | rel=r_associated | relid=0 | w=20
  1128. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated serum transaminase levels
    n1=en:5-oxoprolinase deficiency | n2=en:elevated serum transaminase levels | rel=r_associated | relid=0 | w=20
  1129. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated serum transaminases during infections
    n1=en:5-oxoprolinase deficiency | n2=en:elevated serum transaminases during infections | rel=r_associated | relid=0 | w=20
  1130. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated serum transferrin saturation
    n1=en:5-oxoprolinase deficiency | n2=en:elevated serum transferrin saturation | rel=r_associated | relid=0 | w=20
  1131. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated serum uric acid concentrations
    n1=en:5-oxoprolinase deficiency | n2=en:elevated serum uric acid concentrations | rel=r_associated | relid=0 | w=20
  1132. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated serum very long chain fatty acids (vlcfa)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated serum very long chain fatty acids (vlcfa) | rel=r_associated | relid=0 | w=20
  1133. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated sweat chloride
    n1=en:5-oxoprolinase deficiency | n2=en:elevated sweat chloride | rel=r_associated | relid=0 | w=20
  1134. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated sweat chloride (some)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated sweat chloride (some) | rel=r_associated | relid=0 | w=20
  1135. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated testosterone
    n1=en:5-oxoprolinase deficiency | n2=en:elevated testosterone | rel=r_associated | relid=0 | w=20
  1136. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated total cholesterol (seen in heterozygotes as well)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated total cholesterol (seen in heterozygotes as well) | rel=r_associated | relid=0 | w=20
  1137. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated uric acid on urinalysis (in some patients)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated uric acid on urinalysis (in some patients) | rel=r_associated | relid=0 | w=20
  1138. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated urinary 2-ethylhydracrylate
    n1=en:5-oxoprolinase deficiency | n2=en:elevated urinary 2-ethylhydracrylate | rel=r_associated | relid=0 | w=20
  1139. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated urinary 3-methylglutaconate
    n1=en:5-oxoprolinase deficiency | n2=en:elevated urinary 3-methylglutaconate | rel=r_associated | relid=0 | w=20
  1140. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated urinary 3-methylglutarate
    n1=en:5-oxoprolinase deficiency | n2=en:elevated urinary 3-methylglutarate | rel=r_associated | relid=0 | w=20
  1141. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated urinary 7 alpha-hydroxylated bile alcohols
    n1=en:5-oxoprolinase deficiency | n2=en:elevated urinary 7 alpha-hydroxylated bile alcohols | rel=r_associated | relid=0 | w=20
  1142. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated urinary and csf ribitol and d-arabitol
    n1=en:5-oxoprolinase deficiency | n2=en:elevated urinary and csf ribitol and d-arabitol | rel=r_associated | relid=0 | w=20
  1143. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated urinary delta-aminolevulinic acid
    n1=en:5-oxoprolinase deficiency | n2=en:elevated urinary delta-aminolevulinic acid | rel=r_associated | relid=0 | w=20
  1144. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated urinary delta-aminolevulinic acid and porphyrins
    n1=en:5-oxoprolinase deficiency | n2=en:elevated urinary delta-aminolevulinic acid and porphyrins | rel=r_associated | relid=0 | w=20
  1145. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated urinary free sialic acid (n-acetylneuraminic acid)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated urinary free sialic acid (n-acetylneuraminic acid) | rel=r_associated | relid=0 | w=20
  1146. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated urinary mevalonic acid
    n1=en:5-oxoprolinase deficiency | n2=en:elevated urinary mevalonic acid | rel=r_associated | relid=0 | w=20
  1147. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated urinary n,n-dimethylglycine (dmg)
    n1=en:5-oxoprolinase deficiency | n2=en:elevated urinary n,n-dimethylglycine (dmg) | rel=r_associated | relid=0 | w=20
  1148. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated urinary ornithine, lysine, arginine
    n1=en:5-oxoprolinase deficiency | n2=en:elevated urinary ornithine, lysine, arginine | rel=r_associated | relid=0 | w=20
  1149. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated urinary pge(2) levels
    n1=en:5-oxoprolinase deficiency | n2=en:elevated urinary pge(2) levels | rel=r_associated | relid=0 | w=20
  1150. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated urinary phosphoethanolamine
    n1=en:5-oxoprolinase deficiency | n2=en:elevated urinary phosphoethanolamine | rel=r_associated | relid=0 | w=20
  1151. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated urinary pyridinoline and deoxypyridinoline
    n1=en:5-oxoprolinase deficiency | n2=en:elevated urinary pyridinoline and deoxypyridinoline | rel=r_associated | relid=0 | w=20
  1152. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated urine ceramide levels
    n1=en:5-oxoprolinase deficiency | n2=en:elevated urine ceramide levels | rel=r_associated | relid=0 | w=20
  1153. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:elevated white blood cell cystine
    n1=en:5-oxoprolinase deficiency | n2=en:elevated white blood cell cystine | rel=r_associated | relid=0 | w=20
  1154. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:enzyme replacement therapy has not been effective
    n1=en:5-oxoprolinase deficiency | n2=en:enzyme replacement therapy has not been effective | rel=r_associated | relid=0 | w=20
  1155. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:eosinophilia, mild
    n1=en:5-oxoprolinase deficiency | n2=en:eosinophilia, mild | rel=r_associated | relid=0 | w=20
  1156. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:erythrocyte delta-aminolevulinate dehydratase (alad) deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:erythrocyte delta-aminolevulinate dehydratase (alad) deficiency | rel=r_associated | relid=0 | w=20
  1157. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:erythrocyte enolase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:erythrocyte enolase deficiency | rel=r_associated | relid=0 | w=20
  1158. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:erythrocyte porphobilinogen (pbg) deaminase deficiency (exception: type ii aip)
    n1=en:5-oxoprolinase deficiency | n2=en:erythrocyte porphobilinogen (pbg) deaminase deficiency (exception: type ii aip) | rel=r_associated | relid=0 | w=20
  1159. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:erythroid colony-forming units show spontaneous growth in the absence of epo
    n1=en:5-oxoprolinase deficiency | n2=en:erythroid colony-forming units show spontaneous growth in the absence of epo | rel=r_associated | relid=0 | w=20
  1160. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:erythropoietic protoporphyria
    n1=en:5-oxoprolinase deficiency | n2=en:erythropoietic protoporphyria | rel=r_associated | relid=0 | w=20
  1161. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:ethylmalonic aciduria
    n1=en:5-oxoprolinase deficiency | n2=en:ethylmalonic aciduria | rel=r_associated | relid=0 | w=20
  1162. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:euvolemia
    n1=en:5-oxoprolinase deficiency | n2=en:euvolemia | rel=r_associated | relid=0 | w=20
  1163. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:excessive iodide trapping
    n1=en:5-oxoprolinase deficiency | n2=en:excessive iodide trapping | rel=r_associated | relid=0 | w=20
  1164. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:excessive urinary 5-oxo-l-proline
    n1=en:5-oxoprolinase deficiency | n2=en:excessive urinary 5-oxo-l-proline | rel=r_associated | relid=0 | w=20
  1165. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:excretion of dermatan sulfate and heparan sulfate in urine
    n1=en:5-oxoprolinase deficiency | n2=en:excretion of dermatan sulfate and heparan sulfate in urine | rel=r_associated | relid=0 | w=20
  1166. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:exercise-induced myoglobinuria
    n1=en:5-oxoprolinase deficiency | n2=en:exercise-induced myoglobinuria | rel=r_associated | relid=0 | w=20
  1167. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:exercise-induced myoglobinuria in adults
    n1=en:5-oxoprolinase deficiency | n2=en:exercise-induced myoglobinuria in adults | rel=r_associated | relid=0 | w=20
  1168. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:extremely low creatine excretion
    n1=en:5-oxoprolinase deficiency | n2=en:extremely low creatine excretion | rel=r_associated | relid=0 | w=20
  1169. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:factor vii deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:factor vii deficiency | rel=r_associated | relid=0 | w=20
  1170. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:factor viii deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:factor viii deficiency | rel=r_associated | relid=0 | w=20
  1171. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:familial median cleft of upper and lower lip
    n1=en:5-oxoprolinase deficiency | n2=en:familial median cleft of upper and lower lip | rel=r_associated | relid=0 | w=20
  1172. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:farber lipogranulomatosis
    n1=en:5-oxoprolinase deficiency | n2=en:farber lipogranulomatosis | rel=r_associated | relid=0 | w=20
  1173. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:fasting chylomicronemia
    n1=en:5-oxoprolinase deficiency | n2=en:fasting chylomicronemia | rel=r_associated | relid=0 | w=20
  1174. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:fasting hyperinsulinemia
    n1=en:5-oxoprolinase deficiency | n2=en:fasting hyperinsulinemia | rel=r_associated | relid=0 | w=20
  1175. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:fasting hypoglycemia (early in disease course)
    n1=en:5-oxoprolinase deficiency | n2=en:fasting hypoglycemia (early in disease course) | rel=r_associated | relid=0 | w=20
  1176. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:fasting ketosis
    n1=en:5-oxoprolinase deficiency | n2=en:fasting ketosis | rel=r_associated | relid=0 | w=20
  1177. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:fatty acid metabolism disorder
    n1=en:5-oxoprolinase deficiency | n2=en:fatty acid metabolism disorder | rel=r_associated | relid=0 | w=20
  1178. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:fatty acid pattern of serum lecithin shows increased arachidonic acid and decreased linoleic acid
    n1=en:5-oxoprolinase deficiency | n2=en:fatty acid pattern of serum lecithin shows increased arachidonic acid and decreased linoleic acid | rel=r_associated | relid=0 | w=20
  1179. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:fatty alcohol:nad+ oxidoreductase deficiency in leukocytes and fibroblasts
    n1=en:5-oxoprolinase deficiency | n2=en:fatty alcohol:nad+ oxidoreductase deficiency in leukocytes and fibroblasts | rel=r_associated | relid=0 | w=20
  1180. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:ferritin decreased
    n1=en:5-oxoprolinase deficiency | n2=en:ferritin decreased | rel=r_associated | relid=0 | w=20
  1181. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:fibroblasts accumulate dol-pp-glcnac2man5
    n1=en:5-oxoprolinase deficiency | n2=en:fibroblasts accumulate dol-pp-glcnac2man5 | rel=r_associated | relid=0 | w=20
  1182. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:fibroblasts attach poorly
    n1=en:5-oxoprolinase deficiency | n2=en:fibroblasts attach poorly | rel=r_associated | relid=0 | w=20
  1183. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:fibroblasts demonstrate rapid growth with increased dna synthesis
    n1=en:5-oxoprolinase deficiency | n2=en:fibroblasts demonstrate rapid growth with increased dna synthesis | rel=r_associated | relid=0 | w=20
  1184. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:fibroblasts have decreased levels of ceramide, sphingomyelin, lactosylceramide, ceramide trihexoside, and globoside
    n1=en:5-oxoprolinase deficiency | n2=en:fibroblasts have decreased levels of ceramide, sphingomyelin, lactosylceramide, ceramide trihexoside, and globoside | rel=r_associated | relid=0 | w=20
  1185. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:fibroblasts have increased activity of serine palmitoyltransferase (spt, 605712)
    n1=en:5-oxoprolinase deficiency | n2=en:fibroblasts have increased activity of serine palmitoyltransferase (spt, 605712) | rel=r_associated | relid=0 | w=20
  1186. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:fibroblasts show decreased activity of mitochondrial respiratory complex i, complex iii, complex iv, and complex v
    n1=en:5-oxoprolinase deficiency | n2=en:fibroblasts show decreased activity of mitochondrial respiratory complex i, complex iii, complex iv, and complex v | rel=r_associated | relid=0 | w=20
  1187. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:fibroblasts show decreased mitochondrial complex v activity
    n1=en:5-oxoprolinase deficiency | n2=en:fibroblasts show decreased mitochondrial complex v activity | rel=r_associated | relid=0 | w=20
  1188. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:fibroblasts show decreased peroxisomes arranged in rows
    n1=en:5-oxoprolinase deficiency | n2=en:fibroblasts show decreased peroxisomes arranged in rows | rel=r_associated | relid=0 | w=20
  1189. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:fibroblasts show elongated, tangled, tubular mitochondria
    n1=en:5-oxoprolinase deficiency | n2=en:fibroblasts show elongated, tangled, tubular mitochondria | rel=r_associated | relid=0 | w=20
  1190. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:fibroblasts show global defects in multiple mitochondrial respiratory chain activities
    n1=en:5-oxoprolinase deficiency | n2=en:fibroblasts show global defects in multiple mitochondrial respiratory chain activities | rel=r_associated | relid=0 | w=20
  1191. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:fibroblasts show hypersensitivity to uv irradiation due to defect in transcription-coupled nucleotide excision repair (tc-ner)
    n1=en:5-oxoprolinase deficiency | n2=en:fibroblasts show hypersensitivity to uv irradiation due to defect in transcription-coupled nucleotide excision repair (tc-ner) | rel=r_associated | relid=0 | w=20
  1192. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:fibroblasts show increased sensitivity to apoptosis
    n1=en:5-oxoprolinase deficiency | n2=en:fibroblasts show increased sensitivity to apoptosis | rel=r_associated | relid=0 | w=20
  1193. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:fibroblasts show lamellar lysosomal inclusions on electron microscopy
    n1=en:5-oxoprolinase deficiency | n2=en:fibroblasts show lamellar lysosomal inclusions on electron microscopy | rel=r_associated | relid=0 | w=20
  1194. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:fibroblasts shows defects in oxidative phosphorylation
    n1=en:5-oxoprolinase deficiency | n2=en:fibroblasts shows defects in oxidative phosphorylation | rel=r_associated | relid=0 | w=20
  1195. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:fibronectin decreased
    n1=en:5-oxoprolinase deficiency | n2=en:fibronectin decreased | rel=r_associated | relid=0 | w=20
  1196. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:fingerprint intracellular accumulation of autofluorescent lipopigment storage material
    n1=en:5-oxoprolinase deficiency | n2=en:fingerprint intracellular accumulation of autofluorescent lipopigment storage material | rel=r_associated | relid=0 | w=20
  1197. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:fluorescence in situ hybridization specific probe for mds critical region
    n1=en:5-oxoprolinase deficiency | n2=en:fluorescence in situ hybridization specific probe for mds critical region | rel=r_associated | relid=0 | w=20
  1198. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:fluorescence of red blood cells by uv microscopy
    n1=en:5-oxoprolinase deficiency | n2=en:fluorescence of red blood cells by uv microscopy | rel=r_associated | relid=0 | w=20
  1199. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:foam cells contain polymorphic cytoplasmic inclusions consisting of lamellar osmiophilic membranes on electron microscopy
    n1=en:5-oxoprolinase deficiency | n2=en:foam cells contain polymorphic cytoplasmic inclusions consisting of lamellar osmiophilic membranes on electron microscopy | rel=r_associated | relid=0 | w=20
  1200. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:foam cells in bone marrow and renal glomeruli
    n1=en:5-oxoprolinase deficiency | n2=en:foam cells in bone marrow and renal glomeruli | rel=r_associated | relid=0 | w=20
  1201. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:foam cells in visceral organs and cns
    n1=en:5-oxoprolinase deficiency | n2=en:foam cells in visceral organs and cns | rel=r_associated | relid=0 | w=20
  1202. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:folate-dependent fragile site at xq28
    n1=en:5-oxoprolinase deficiency | n2=en:folate-dependent fragile site at xq28 | rel=r_associated | relid=0 | w=20
  1203. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:folic acid deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:folic acid deficiency | rel=r_associated | relid=0 | w=20
  1204. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:fountain syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:fountain syndrome | rel=r_associated | relid=0 | w=20
  1205. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:fragmentation of the mitochondrial network
    n1=en:5-oxoprolinase deficiency | n2=en:fragmentation of the mitochondrial network | rel=r_associated | relid=0 | w=20
  1206. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:frequent deletions of chromosome 9 in melanoma
    n1=en:5-oxoprolinase deficiency | n2=en:frequent deletions of chromosome 9 in melanoma | rel=r_associated | relid=0 | w=20
  1207. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:frequent inv(10)(q11.2q21) producing chimeric transforming sequence ret/ptc
    n1=en:5-oxoprolinase deficiency | n2=en:frequent inv(10)(q11.2q21) producing chimeric transforming sequence ret/ptc | rel=r_associated | relid=0 | w=20
  1208. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:fumarase activity (mitochondrial and cytosolic) is decreased
    n1=en:5-oxoprolinase deficiency | n2=en:fumarase activity (mitochondrial and cytosolic) is decreased | rel=r_associated | relid=0 | w=20
  1209. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:fumarase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:fumarase deficiency | rel=r_associated | relid=0 | w=20
  1210. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:fumarylacetoacetate hydrolase (fah) deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:fumarylacetoacetate hydrolase (fah) deficiency | rel=r_associated | relid=0 | w=20
  1211. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:galactocerebroside beta-galactosidase deficiency in serum, leukocytes, and fibroblasts
    n1=en:5-oxoprolinase deficiency | n2=en:galactocerebroside beta-galactosidase deficiency in serum, leukocytes, and fibroblasts | rel=r_associated | relid=0 | w=20
  1212. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:galactosuria
    n1=en:5-oxoprolinase deficiency | n2=en:galactosuria | rel=r_associated | relid=0 | w=20
  1213. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:galactosuria without galactosemia
    n1=en:5-oxoprolinase deficiency | n2=en:galactosuria without galactosemia | rel=r_associated | relid=0 | w=20
  1214. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:galactosylation defects
    n1=en:5-oxoprolinase deficiency | n2=en:galactosylation defects | rel=r_associated | relid=0 | w=20
  1215. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:galactosyltransferase i deficiency in fibroblasts
    n1=en:5-oxoprolinase deficiency | n2=en:galactosyltransferase i deficiency in fibroblasts | rel=r_associated | relid=0 | w=20
  1216. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:gamma-glutamylcysteine deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:gamma-glutamylcysteine deficiency | rel=r_associated | relid=0 | w=20
  1217. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:gamma-glutamylcysteine synthetase (glutamate-cysteine ligase) deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:gamma-glutamylcysteine synthetase (glutamate-cysteine ligase) deficiency | rel=r_associated | relid=0 | w=20
  1218. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:gangrene
    n1=en:5-oxoprolinase deficiency | n2=en:gangrene | rel=r_associated | relid=0 | w=20
  1219. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:gaucher cells, diffuse, in spleen, liver, lymph nodes, bone marrow, central nervous system
    n1=en:5-oxoprolinase deficiency | n2=en:gaucher cells, diffuse, in spleen, liver, lymph nodes, bone marrow, central nervous system | rel=r_associated | relid=0 | w=20
  1220. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:Gaucher disease
    n1=en:5-oxoprolinase deficiency | n2=en:Gaucher disease | rel=r_associated | relid=0 | w=20
  1221. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:gaucher disease, type 1
    n1=en:5-oxoprolinase deficiency | n2=en:gaucher disease, type 1 | rel=r_associated | relid=0 | w=20
  1222. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:generalized aminoaciduria
    n1=en:5-oxoprolinase deficiency | n2=en:generalized aminoaciduria | rel=r_associated | relid=0 | w=20
  1223. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:generalized amyloid deposition
    n1=en:5-oxoprolinase deficiency | n2=en:generalized amyloid deposition | rel=r_associated | relid=0 | w=20
  1224. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:generalized peeling skin syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:generalized peeling skin syndrome | rel=r_associated | relid=0 | w=20
  1225. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:giant cells (degenerating chondrocytes) in resting zone of epiphyseal cartilage
    n1=en:5-oxoprolinase deficiency | n2=en:giant cells (degenerating chondrocytes) in resting zone of epiphyseal cartilage | rel=r_associated | relid=0 | w=20
  1226. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:glcnac-transferase ii deficiency in fibroblast and mononuclear cells
    n1=en:5-oxoprolinase deficiency | n2=en:glcnac-transferase ii deficiency in fibroblast and mononuclear cells | rel=r_associated | relid=0 | w=20
  1227. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:globulin gamma serum plasma increased result
    n1=en:5-oxoprolinase deficiency | n2=en:globulin gamma serum plasma increased result | rel=r_associated | relid=0 | w=20
  1228. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:glomerular filtration rate decreased
    n1=en:5-oxoprolinase deficiency | n2=en:glomerular filtration rate decreased | rel=r_associated | relid=0 | w=20
  1229. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:glucose breath hydrogen test shows malabsorption of glucose and galactose
    n1=en:5-oxoprolinase deficiency | n2=en:glucose breath hydrogen test shows malabsorption of glucose and galactose | rel=r_associated | relid=0 | w=20
  1230. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:glucose-6-phosphate deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:glucose-6-phosphate deficiency | rel=r_associated | relid=0 | w=20
  1231. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:glucose-6-phosphate dehydrogenase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:glucose-6-phosphate dehydrogenase deficiency | rel=r_associated | relid=0 | w=20
  1232. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:glucosidase i deficiency in liver and fibroblasts
    n1=en:5-oxoprolinase deficiency | n2=en:glucosidase i deficiency in liver and fibroblasts | rel=r_associated | relid=0 | w=20
  1233. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:glucosuria, mild, intermittent
    n1=en:5-oxoprolinase deficiency | n2=en:glucosuria, mild, intermittent | rel=r_associated | relid=0 | w=20
  1234. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:glutaric acidemia type 1
    n1=en:5-oxoprolinase deficiency | n2=en:glutaric acidemia type 1 | rel=r_associated | relid=0 | w=20
  1235. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:glutaric aciduria
    n1=en:5-oxoprolinase deficiency | n2=en:glutaric aciduria | rel=r_associated | relid=0 | w=20
  1236. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:glutaric aciduria, type 1
    n1=en:5-oxoprolinase deficiency | n2=en:glutaric aciduria, type 1 | rel=r_associated | relid=0 | w=20
  1237. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:glutathione deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:glutathione deficiency | rel=r_associated | relid=0 | w=20
  1238. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:glutathionemia
    n1=en:5-oxoprolinase deficiency | n2=en:glutathionemia | rel=r_associated | relid=0 | w=20
  1239. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:glycoamino aciduria
    n1=en:5-oxoprolinase deficiency | n2=en:glycoamino aciduria | rel=r_associated | relid=0 | w=20
  1240. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:glycogen accumulation in both liver and muscle
    n1=en:5-oxoprolinase deficiency | n2=en:glycogen accumulation in both liver and muscle | rel=r_associated | relid=0 | w=20
  1241. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:glycogen storage disease
    n1=en:5-oxoprolinase deficiency | n2=en:glycogen storage disease | rel=r_associated | relid=0 | w=20
  1242. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:glycogen storage disease with severe cardiomyopathy due to glycogenin deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:glycogen storage disease with severe cardiomyopathy due to glycogenin deficiency | rel=r_associated | relid=0 | w=20
  1243. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:glycosuria (less common)
    n1=en:5-oxoprolinase deficiency | n2=en:glycosuria (less common) | rel=r_associated | relid=0 | w=20
  1244. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:glyoxalase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:glyoxalase deficiency | rel=r_associated | relid=0 | w=20
  1245. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:gm2-ganglioside accumulation
    n1=en:5-oxoprolinase deficiency | n2=en:gm2-ganglioside accumulation | rel=r_associated | relid=0 | w=20
  1246. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:gonadotrophin increased
    n1=en:5-oxoprolinase deficiency | n2=en:gonadotrophin increased | rel=r_associated | relid=0 | w=20
  1247. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:granular osmiophilic cytoplasmic deposits (grod) ultrastructurally in cells
    n1=en:5-oxoprolinase deficiency | n2=en:granular osmiophilic cytoplasmic deposits (grod) ultrastructurally in cells | rel=r_associated | relid=0 | w=20
  1248. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:granular osmiophilic cytoplasmic deposits ultrastructurally in cells
    n1=en:5-oxoprolinase deficiency | n2=en:granular osmiophilic cytoplasmic deposits ultrastructurally in cells | rel=r_associated | relid=0 | w=20
  1249. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:granular osmiophilic deposits (grod) in cells
    n1=en:5-oxoprolinase deficiency | n2=en:granular osmiophilic deposits (grod) in cells | rel=r_associated | relid=0 | w=20
  1250. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:granular osmiophilic deposits (grod) in cells resulting in 'curvilinear' profiles ultrastructurally
    n1=en:5-oxoprolinase deficiency | n2=en:granular osmiophilic deposits (grod) in cells resulting in 'curvilinear' profiles ultrastructurally | rel=r_associated | relid=0 | w=20
  1251. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:granular osmiophilic deposits (grod) in cells resulting in 'fingerprint' profiles ultrastructurally
    n1=en:5-oxoprolinase deficiency | n2=en:granular osmiophilic deposits (grod) in cells resulting in 'fingerprint' profiles ultrastructurally | rel=r_associated | relid=0 | w=20
  1252. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:granular osmiophilic deposits (grod) in cells resulting in 'rectilinear' profiles ultrastructurally
    n1=en:5-oxoprolinase deficiency | n2=en:granular osmiophilic deposits (grod) in cells resulting in 'rectilinear' profiles ultrastructurally | rel=r_associated | relid=0 | w=20
  1253. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:greatly increased dopamine in plasma, urine, csf (approximately 10-fold increase)
    n1=en:5-oxoprolinase deficiency | n2=en:greatly increased dopamine in plasma, urine, csf (approximately 10-fold increase) | rel=r_associated | relid=0 | w=20
  1254. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:green serum
    n1=en:5-oxoprolinase deficiency | n2=en:green serum | rel=r_associated | relid=0 | w=20
  1255. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:green urine
    n1=en:5-oxoprolinase deficiency | n2=en:green urine | rel=r_associated | relid=0 | w=20
  1256. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:growth cartilage disorganized, with islands of cells and abnormal collagen arrangement
    n1=en:5-oxoprolinase deficiency | n2=en:growth cartilage disorganized, with islands of cells and abnormal collagen arrangement | rel=r_associated | relid=0 | w=20
  1257. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:guanidinoacetate methyltransferase (gamt) deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:guanidinoacetate methyltransferase (gamt) deficiency | rel=r_associated | relid=0 | w=20
  1258. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hair bulb tyrosinase present
    n1=en:5-oxoprolinase deficiency | n2=en:hair bulb tyrosinase present | rel=r_associated | relid=0 | w=20
  1259. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hair bulbs will pigment when incubated with tyrosine
    n1=en:5-oxoprolinase deficiency | n2=en:hair bulbs will pigment when incubated with tyrosine | rel=r_associated | relid=0 | w=20
  1260. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hall riggs syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:hall riggs syndrome | rel=r_associated | relid=0 | w=20
  1261. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:heart defects limb shortening
    n1=en:5-oxoprolinase deficiency | n2=en:heart defects limb shortening | rel=r_associated | relid=0 | w=20
  1262. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hematuria
    n1=en:5-oxoprolinase deficiency | n2=en:hematuria | rel=r_associated | relid=0 | w=20
  1263. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hematuria (less common)
    n1=en:5-oxoprolinase deficiency | n2=en:hematuria (less common) | rel=r_associated | relid=0 | w=20
  1264. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hematuria, macroscopic and microscopic
    n1=en:5-oxoprolinase deficiency | n2=en:hematuria, macroscopic and microscopic | rel=r_associated | relid=0 | w=20
  1265. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hemizygous deletion at 4p16.3
    n1=en:5-oxoprolinase deficiency | n2=en:hemizygous deletion at 4p16.3 | rel=r_associated | relid=0 | w=20
  1266. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hemizygous deletion at 7q11.23
    n1=en:5-oxoprolinase deficiency | n2=en:hemizygous deletion at 7q11.23 | rel=r_associated | relid=0 | w=20
  1267. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hemoglobin f increased
    n1=en:5-oxoprolinase deficiency | n2=en:hemoglobin f increased | rel=r_associated | relid=0 | w=20
  1268. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hemophilia B
    n1=en:5-oxoprolinase deficiency | n2=en:hemophilia B | rel=r_associated | relid=0 | w=20
  1269. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:heparan sulfate excretion in urine
    n1=en:5-oxoprolinase deficiency | n2=en:heparan sulfate excretion in urine | rel=r_associated | relid=0 | w=20
  1270. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:heparin cofactor ii deficiency (disorder)
    n1=en:5-oxoprolinase deficiency | n2=en:heparin cofactor ii deficiency (disorder) | rel=r_associated | relid=0 | w=20
  1271. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hepatic argininosuccinase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:hepatic argininosuccinase deficiency | rel=r_associated | relid=0 | w=20
  1272. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hepatic argininosuccinate synthetase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:hepatic argininosuccinate synthetase deficiency | rel=r_associated | relid=0 | w=20
  1273. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hepatic carbamoylphosphate synthetase i deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:hepatic carbamoylphosphate synthetase i deficiency | rel=r_associated | relid=0 | w=20
  1274. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hepatic glycine cleavage defect
    n1=en:5-oxoprolinase deficiency | n2=en:hepatic glycine cleavage defect | rel=r_associated | relid=0 | w=20
  1275. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hepatic lipase deficiency (disorder)
    n1=en:5-oxoprolinase deficiency | n2=en:hepatic lipase deficiency (disorder) | rel=r_associated | relid=0 | w=20
  1276. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hepatic ornithine transcarbamylase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:hepatic ornithine transcarbamylase deficiency | rel=r_associated | relid=0 | w=20
  1277. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hereditary factor x deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:hereditary factor x deficiency | rel=r_associated | relid=0 | w=20
  1278. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hereditary factor xii deficiency disease
    n1=en:5-oxoprolinase deficiency | n2=en:hereditary factor xii deficiency disease | rel=r_associated | relid=0 | w=20
  1279. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hereditary hyperbilirubinemia
    n1=en:5-oxoprolinase deficiency | n2=en:hereditary hyperbilirubinemia | rel=r_associated | relid=0 | w=20
  1280. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:heteroplasmic partial duplication of mtdna
    n1=en:5-oxoprolinase deficiency | n2=en:heteroplasmic partial duplication of mtdna | rel=r_associated | relid=0 | w=20
  1281. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hexose-6-phosphate dehydrogenase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:hexose-6-phosphate dehydrogenase deficiency | rel=r_associated | relid=0 | w=20
  1282. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:high deoxypyridinoline/creatinine (in some patients)
    n1=en:5-oxoprolinase deficiency | n2=en:high deoxypyridinoline/creatinine (in some patients) | rel=r_associated | relid=0 | w=20
  1283. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:high ebv viral load
    n1=en:5-oxoprolinase deficiency | n2=en:high ebv viral load | rel=r_associated | relid=0 | w=20
  1284. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:high ft3/ft4 ratio
    n1=en:5-oxoprolinase deficiency | n2=en:high ft3/ft4 ratio | rel=r_associated | relid=0 | w=20
  1285. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:high m-component
    n1=en:5-oxoprolinase deficiency | n2=en:high m-component | rel=r_associated | relid=0 | w=20
  1286. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:high newborn serum levels of immunoreactive trypsinogen
    n1=en:5-oxoprolinase deficiency | n2=en:high newborn serum levels of immunoreactive trypsinogen | rel=r_associated | relid=0 | w=20
  1287. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:high nonceruloplasmin-bound serum copper
    n1=en:5-oxoprolinase deficiency | n2=en:high nonceruloplasmin-bound serum copper | rel=r_associated | relid=0 | w=20
  1288. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:high ornithine
    n1=en:5-oxoprolinase deficiency | n2=en:high ornithine | rel=r_associated | relid=0 | w=20
  1289. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:high plasma asparagine
    n1=en:5-oxoprolinase deficiency | n2=en:high plasma asparagine | rel=r_associated | relid=0 | w=20
  1290. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:high plasma citrulline (100-300 micromolar)
    n1=en:5-oxoprolinase deficiency | n2=en:high plasma citrulline (100-300 micromolar) | rel=r_associated | relid=0 | w=20
  1291. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:high plasma citrulline (1000-5000 micromolar)
    n1=en:5-oxoprolinase deficiency | n2=en:high plasma citrulline (1000-5000 micromolar) | rel=r_associated | relid=0 | w=20
  1292. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:high plasma triglyceride levels
    n1=en:5-oxoprolinase deficiency | n2=en:high plasma triglyceride levels | rel=r_associated | relid=0 | w=20
  1293. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:high resolution g- and t- banding karyotype shows reciprocal translocation of distal 9p-6q
    n1=en:5-oxoprolinase deficiency | n2=en:high resolution g- and t- banding karyotype shows reciprocal translocation of distal 9p-6q | rel=r_associated | relid=0 | w=20
  1294. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:high serum guanosine levels
    n1=en:5-oxoprolinase deficiency | n2=en:high serum guanosine levels | rel=r_associated | relid=0 | w=20
  1295. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:high serum inosine levels
    n1=en:5-oxoprolinase deficiency | n2=en:high serum inosine levels | rel=r_associated | relid=0 | w=20
  1296. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:high serum osmolality
    n1=en:5-oxoprolinase deficiency | n2=en:high serum osmolality | rel=r_associated | relid=0 | w=20
  1297. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:high sister chromatid exchange (sce) rate
    n1=en:5-oxoprolinase deficiency | n2=en:high sister chromatid exchange (sce) rate | rel=r_associated | relid=0 | w=20
  1298. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:high sweat sodium and chloride
    n1=en:5-oxoprolinase deficiency | n2=en:high sweat sodium and chloride | rel=r_associated | relid=0 | w=20
  1299. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:high urinary copper
    n1=en:5-oxoprolinase deficiency | n2=en:high urinary copper | rel=r_associated | relid=0 | w=20
  1300. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:high urinary excretion of inosine, 2'deoxyinosine, guanosine, and 2'deoxyguanosine
    n1=en:5-oxoprolinase deficiency | n2=en:high urinary excretion of inosine, 2'deoxyinosine, guanosine, and 2'deoxyguanosine | rel=r_associated | relid=0 | w=20
  1301. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:high urinary orotic acid
    n1=en:5-oxoprolinase deficiency | n2=en:high urinary orotic acid | rel=r_associated | relid=0 | w=20
  1302. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:high-normal plasma triglyceride concentration (in heterozygotes)
    n1=en:5-oxoprolinase deficiency | n2=en:high-normal plasma triglyceride concentration (in heterozygotes) | rel=r_associated | relid=0 | w=20
  1303. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:histidinaemia
    n1=en:5-oxoprolinase deficiency | n2=en:histidinaemia | rel=r_associated | relid=0 | w=20
  1304. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:histiocytic infiltration of liver, spleen, and lungs
    n1=en:5-oxoprolinase deficiency | n2=en:histiocytic infiltration of liver, spleen, and lungs | rel=r_associated | relid=0 | w=20
  1305. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hla-b27 haplotype association (95% patients)
    n1=en:5-oxoprolinase deficiency | n2=en:hla-b27 haplotype association (95% patients) | rel=r_associated | relid=0 | w=20
  1306. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hla-dqw6 association (dqb1*0602)
    n1=en:5-oxoprolinase deficiency | n2=en:hla-dqw6 association (dqb1*0602) | rel=r_associated | relid=0 | w=20
  1307. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hnsha due to hexokinase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:hnsha due to hexokinase deficiency | rel=r_associated | relid=0 | w=20
  1308. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:holocarboxylase synthetase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:holocarboxylase synthetase deficiency | rel=r_associated | relid=0 | w=20
  1309. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:homocarnosinosis
    n1=en:5-oxoprolinase deficiency | n2=en:homocarnosinosis | rel=r_associated | relid=0 | w=20
  1310. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:homocitrullinuria
    n1=en:5-oxoprolinase deficiency | n2=en:homocitrullinuria | rel=r_associated | relid=0 | w=20
  1311. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:homocysteinemia
    n1=en:5-oxoprolinase deficiency | n2=en:homocysteinemia | rel=r_associated | relid=0 | w=20
  1312. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:homocysteinemia (in some patients)
    n1=en:5-oxoprolinase deficiency | n2=en:homocysteinemia (in some patients) | rel=r_associated | relid=0 | w=20
  1313. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:homocystinemia
    n1=en:5-oxoprolinase deficiency | n2=en:homocystinemia | rel=r_associated | relid=0 | w=20
  1314. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:homocystinuria (in some patients)
    n1=en:5-oxoprolinase deficiency | n2=en:homocystinuria (in some patients) | rel=r_associated | relid=0 | w=20
  1315. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:homozygous 122kb deletion 11p15-p14
    n1=en:5-oxoprolinase deficiency | n2=en:homozygous 122kb deletion 11p15-p14 | rel=r_associated | relid=0 | w=20
  1316. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:howell-jolly bodies seen in peripheral blood smear
    n1=en:5-oxoprolinase deficiency | n2=en:howell-jolly bodies seen in peripheral blood smear | rel=r_associated | relid=0 | w=20
  1317. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hydrocortisone decreased
    n1=en:5-oxoprolinase deficiency | n2=en:hydrocortisone decreased | rel=r_associated | relid=0 | w=20
  1318. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperammonemia
    n1=en:5-oxoprolinase deficiency | n2=en:hyperammonemia | rel=r_associated | relid=0 | w=20
  1319. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperammonemia after protein intake
    n1=en:5-oxoprolinase deficiency | n2=en:hyperammonemia after protein intake | rel=r_associated | relid=0 | w=20
  1320. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperammonemia during episodes
    n1=en:5-oxoprolinase deficiency | n2=en:hyperammonemia during episodes | rel=r_associated | relid=0 | w=20
  1321. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperammonemia, asymptomatic (2-5 times normal)
    n1=en:5-oxoprolinase deficiency | n2=en:hyperammonemia, asymptomatic (2-5 times normal) | rel=r_associated | relid=0 | w=20
  1322. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperandrogenism due to non-classic 21-hydroxylase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:hyperandrogenism due to non-classic 21-hydroxylase deficiency | rel=r_associated | relid=0 | w=20
  1323. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperarginemia
    n1=en:5-oxoprolinase deficiency | n2=en:hyperarginemia | rel=r_associated | relid=0 | w=20
  1324. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperbilirubinemia in those with liver failure
    n1=en:5-oxoprolinase deficiency | n2=en:hyperbilirubinemia in those with liver failure | rel=r_associated | relid=0 | w=20
  1325. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperbilirubinemia, non-hemolytic unconjugated (may rise with fasting or dehydration)
    n1=en:5-oxoprolinase deficiency | n2=en:hyperbilirubinemia, non-hemolytic unconjugated (may rise with fasting or dehydration) | rel=r_associated | relid=0 | w=20
  1326. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperbilirubinemia, unconjugated, <20mg/dl
    n1=en:5-oxoprolinase deficiency | n2=en:hyperbilirubinemia, unconjugated, <20mg/dl | rel=r_associated | relid=0 | w=20
  1327. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperbilirubinemia, unconjugated, 20-30mg/dl
    n1=en:5-oxoprolinase deficiency | n2=en:hyperbilirubinemia, unconjugated, 20-30mg/dl | rel=r_associated | relid=0 | w=20
  1328. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypercalcemia
    n1=en:5-oxoprolinase deficiency | n2=en:hypercalcemia | rel=r_associated | relid=0 | w=20
  1329. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypercalciuria (in childhood)
    n1=en:5-oxoprolinase deficiency | n2=en:hypercalciuria (in childhood) | rel=r_associated | relid=0 | w=20
  1330. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperchloremia (mean >110 mm in both dominant and recessive)
    n1=en:5-oxoprolinase deficiency | n2=en:hyperchloremia (mean >110 mm in both dominant and recessive) | rel=r_associated | relid=0 | w=20
  1331. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperchloremia (mean 109 mm)
    n1=en:5-oxoprolinase deficiency | n2=en:hyperchloremia (mean 109 mm) | rel=r_associated | relid=0 | w=20
  1332. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperchloremia (mean 111 mm)
    n1=en:5-oxoprolinase deficiency | n2=en:hyperchloremia (mean 111 mm) | rel=r_associated | relid=0 | w=20
  1333. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperchloremia (mean 114 mm)
    n1=en:5-oxoprolinase deficiency | n2=en:hyperchloremia (mean 114 mm) | rel=r_associated | relid=0 | w=20
  1334. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperchloridura
    n1=en:5-oxoprolinase deficiency | n2=en:hyperchloridura | rel=r_associated | relid=0 | w=20
  1335. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypercholesterolemia
    n1=en:5-oxoprolinase deficiency | n2=en:hypercholesterolemia | rel=r_associated | relid=0 | w=20
  1336. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypercholesterolemia (10%)
    n1=en:5-oxoprolinase deficiency | n2=en:hypercholesterolemia (10%) | rel=r_associated | relid=0 | w=20
  1337. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypercholesterolemia (disorder)
    n1=en:5-oxoprolinase deficiency | n2=en:hypercholesterolemia (disorder) | rel=r_associated | relid=0 | w=20
  1338. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypercholesterolemia (in 75%)
    n1=en:5-oxoprolinase deficiency | n2=en:hypercholesterolemia (in 75%) | rel=r_associated | relid=0 | w=20
  1339. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypercholesterolemia (reported in 2 patients)
    n1=en:5-oxoprolinase deficiency | n2=en:hypercholesterolemia (reported in 2 patients) | rel=r_associated | relid=0 | w=20
  1340. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypercholesterolemia, 350-550 mg/l in heterozygotes, 650-1000 mg/l in homozygotes
    n1=en:5-oxoprolinase deficiency | n2=en:hypercholesterolemia, 350-550 mg/l in heterozygotes, 650-1000 mg/l in homozygotes | rel=r_associated | relid=0 | w=20
  1341. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperglutaminemia
    n1=en:5-oxoprolinase deficiency | n2=en:hyperglutaminemia | rel=r_associated | relid=0 | w=20
  1342. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperglycemias, postprandial
    n1=en:5-oxoprolinase deficiency | n2=en:hyperglycemias, postprandial | rel=r_associated | relid=0 | w=20
  1343. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperglycinemia (1 patient)
    n1=en:5-oxoprolinase deficiency | n2=en:hyperglycinemia (1 patient) | rel=r_associated | relid=0 | w=20
  1344. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperglycinuria (disorder)
    n1=en:5-oxoprolinase deficiency | n2=en:hyperglycinuria (disorder) | rel=r_associated | relid=0 | w=20
  1345. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperglycolic aciduria
    n1=en:5-oxoprolinase deficiency | n2=en:hyperglycolic aciduria | rel=r_associated | relid=0 | w=20
  1346. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperhomocystinemia
    n1=en:5-oxoprolinase deficiency | n2=en:hyperhomocystinemia | rel=r_associated | relid=0 | w=20
  1347. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperkalemia
    n1=en:5-oxoprolinase deficiency | n2=en:hyperkalemia | rel=r_associated | relid=0 | w=20
  1348. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperkalemia (>6.2 mm in both dominant and recessive)
    n1=en:5-oxoprolinase deficiency | n2=en:hyperkalemia (>6.2 mm in both dominant and recessive) | rel=r_associated | relid=0 | w=20
  1349. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperkalemia (5.8 +/- 0.8 mm)
    n1=en:5-oxoprolinase deficiency | n2=en:hyperkalemia (5.8 +/- 0.8 mm) | rel=r_associated | relid=0 | w=20
  1350. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperkalemia (6.4 +/- 0.7 mm)
    n1=en:5-oxoprolinase deficiency | n2=en:hyperkalemia (6.4 +/- 0.7 mm) | rel=r_associated | relid=0 | w=20
  1351. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperkalemia (7.5 +/- 0.9 mm)
    n1=en:5-oxoprolinase deficiency | n2=en:hyperkalemia (7.5 +/- 0.9 mm) | rel=r_associated | relid=0 | w=20
  1352. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperkalemia during attacks
    n1=en:5-oxoprolinase deficiency | n2=en:hyperkalemia during attacks | rel=r_associated | relid=0 | w=20
  1353. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperkaliaemia
    n1=en:5-oxoprolinase deficiency | n2=en:hyperkaliaemia | rel=r_associated | relid=0 | w=20
  1354. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperlipemia
    n1=en:5-oxoprolinase deficiency | n2=en:hyperlipemia | rel=r_associated | relid=0 | w=20
  1355. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperlipidaemia
    n1=en:5-oxoprolinase deficiency | n2=en:hyperlipidaemia | rel=r_associated | relid=0 | w=20
  1356. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperlipoproteinemia type i
    n1=en:5-oxoprolinase deficiency | n2=en:hyperlipoproteinemia type i | rel=r_associated | relid=0 | w=20
  1357. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperlipoproteinemia type iib
    n1=en:5-oxoprolinase deficiency | n2=en:hyperlipoproteinemia type iib | rel=r_associated | relid=0 | w=20
  1358. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypermethioninemia, progressive
    n1=en:5-oxoprolinase deficiency | n2=en:hypermethioninemia, progressive | rel=r_associated | relid=0 | w=20
  1359. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperphenylalaninemia
    n1=en:5-oxoprolinase deficiency | n2=en:hyperphenylalaninemia | rel=r_associated | relid=0 | w=20
  1360. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperphosphatemia
    n1=en:5-oxoprolinase deficiency | n2=en:hyperphosphatemia | rel=r_associated | relid=0 | w=20
  1361. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperphosphatemia, transient
    n1=en:5-oxoprolinase deficiency | n2=en:hyperphosphatemia, transient | rel=r_associated | relid=0 | w=20
  1362. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperprolinemia (10-15 times normal)
    n1=en:5-oxoprolinase deficiency | n2=en:hyperprolinemia (10-15 times normal) | rel=r_associated | relid=0 | w=20
  1363. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperprolinemia (5-10 times normal)
    n1=en:5-oxoprolinase deficiency | n2=en:hyperprolinemia (5-10 times normal) | rel=r_associated | relid=0 | w=20
  1364. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperprostaglandinuria
    n1=en:5-oxoprolinase deficiency | n2=en:hyperprostaglandinuria | rel=r_associated | relid=0 | w=20
  1365. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperthreoninemia
    n1=en:5-oxoprolinase deficiency | n2=en:hyperthreoninemia | rel=r_associated | relid=0 | w=20
  1366. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyperthreoninuria
    n1=en:5-oxoprolinase deficiency | n2=en:hyperthreoninuria | rel=r_associated | relid=0 | w=20
  1367. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypertriglyceridemia
    n1=en:5-oxoprolinase deficiency | n2=en:hypertriglyceridemia | rel=r_associated | relid=0 | w=20
  1368. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypertriglyceridemia (in some patients)
    n1=en:5-oxoprolinase deficiency | n2=en:hypertriglyceridemia (in some patients) | rel=r_associated | relid=0 | w=20
  1369. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypertriglyceridemia (rare)
    n1=en:5-oxoprolinase deficiency | n2=en:hypertriglyceridemia (rare) | rel=r_associated | relid=0 | w=20
  1370. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypertriglyceridemia, transient
    n1=en:5-oxoprolinase deficiency | n2=en:hypertriglyceridemia, transient | rel=r_associated | relid=0 | w=20
  1371. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypertryptophanemia
    n1=en:5-oxoprolinase deficiency | n2=en:hypertryptophanemia | rel=r_associated | relid=0 | w=20
  1372. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypoalbuminemia
    n1=en:5-oxoprolinase deficiency | n2=en:hypoalbuminemia | rel=r_associated | relid=0 | w=20
  1373. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypoalbuminemia (in 83%)
    n1=en:5-oxoprolinase deficiency | n2=en:hypoalbuminemia (in 83%) | rel=r_associated | relid=0 | w=20
  1374. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypobetalipoproteinemias
    n1=en:5-oxoprolinase deficiency | n2=en:hypobetalipoproteinemias | rel=r_associated | relid=0 | w=20
  1375. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypocalcemia
    n1=en:5-oxoprolinase deficiency | n2=en:hypocalcemia | rel=r_associated | relid=0 | w=20
  1376. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypocalcemia (64% of adults)
    n1=en:5-oxoprolinase deficiency | n2=en:hypocalcemia (64% of adults) | rel=r_associated | relid=0 | w=20
  1377. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypocalcemia (male)
    n1=en:5-oxoprolinase deficiency | n2=en:hypocalcemia (male) | rel=r_associated | relid=0 | w=20
  1378. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypocalcemia, transient
    n1=en:5-oxoprolinase deficiency | n2=en:hypocalcemia, transient | rel=r_associated | relid=0 | w=20
  1379. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypocalciuria or normocalciuria
    n1=en:5-oxoprolinase deficiency | n2=en:hypocalciuria or normocalciuria | rel=r_associated | relid=0 | w=20
  1380. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypofibrinogenemia
    n1=en:5-oxoprolinase deficiency | n2=en:hypofibrinogenemia | rel=r_associated | relid=0 | w=20
  1381. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypogammaglobulinemia
    n1=en:5-oxoprolinase deficiency | n2=en:hypogammaglobulinemia | rel=r_associated | relid=0 | w=20
  1382. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypogammaglobulinemia (in some patients)
    n1=en:5-oxoprolinase deficiency | n2=en:hypogammaglobulinemia (in some patients) | rel=r_associated | relid=0 | w=20
  1383. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypogammaglobulinemia, profound
    n1=en:5-oxoprolinase deficiency | n2=en:hypogammaglobulinemia, profound | rel=r_associated | relid=0 | w=20
  1384. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypoglycemia, fasting
    n1=en:5-oxoprolinase deficiency | n2=en:hypoglycemia, fasting | rel=r_associated | relid=0 | w=20
  1385. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypoglycorrhachia (low glucose in csf)
    n1=en:5-oxoprolinase deficiency | n2=en:hypoglycorrhachia (low glucose in csf) | rel=r_associated | relid=0 | w=20
  1386. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypoglycosylated serum transferrin
    n1=en:5-oxoprolinase deficiency | n2=en:hypoglycosylated serum transferrin | rel=r_associated | relid=0 | w=20
  1387. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypoglycosylation of plasma glycoproteins
    n1=en:5-oxoprolinase deficiency | n2=en:hypoglycosylation of plasma glycoproteins | rel=r_associated | relid=0 | w=20
  1388. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypokalemia during attacks
    n1=en:5-oxoprolinase deficiency | n2=en:hypokalemia during attacks | rel=r_associated | relid=0 | w=20
  1389. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypokalemia during periodic paralysis (most patients)
    n1=en:5-oxoprolinase deficiency | n2=en:hypokalemia during periodic paralysis (most patients) | rel=r_associated | relid=0 | w=20
  1390. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypokalemia occurs during paralytic attacks
    n1=en:5-oxoprolinase deficiency | n2=en:hypokalemia occurs during paralytic attacks | rel=r_associated | relid=0 | w=20
  1391. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypoketotic dicarboxylic aciduria (in some patients)
    n1=en:5-oxoprolinase deficiency | n2=en:hypoketotic dicarboxylic aciduria (in some patients) | rel=r_associated | relid=0 | w=20
  1392. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypoketotic hypoglycemia
    n1=en:5-oxoprolinase deficiency | n2=en:hypoketotic hypoglycemia | rel=r_associated | relid=0 | w=20
  1393. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypomandibular faciocranial dysostosis
    n1=en:5-oxoprolinase deficiency | n2=en:hypomandibular faciocranial dysostosis | rel=r_associated | relid=0 | w=20
  1394. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypomethylation of alpha-satellite repeats on chromosome 9
    n1=en:5-oxoprolinase deficiency | n2=en:hypomethylation of alpha-satellite repeats on chromosome 9 | rel=r_associated | relid=0 | w=20
  1395. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypomethylation of satellite repeats on chromosome 1, 9, and 16
    n1=en:5-oxoprolinase deficiency | n2=en:hypomethylation of satellite repeats on chromosome 1, 9, and 16 | rel=r_associated | relid=0 | w=20
  1396. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyponatremia
    n1=en:5-oxoprolinase deficiency | n2=en:hyponatremia | rel=r_associated | relid=0 | w=20
  1397. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyponatremia in infancy
    n1=en:5-oxoprolinase deficiency | n2=en:hyponatremia in infancy | rel=r_associated | relid=0 | w=20
  1398. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyponatremic dehydration, rarely
    n1=en:5-oxoprolinase deficiency | n2=en:hyponatremic dehydration, rarely | rel=r_associated | relid=0 | w=20
  1399. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypophosphatasia infantile
    n1=en:5-oxoprolinase deficiency | n2=en:hypophosphatasia infantile | rel=r_associated | relid=0 | w=20
  1400. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypophosphatemia (less common)
    n1=en:5-oxoprolinase deficiency | n2=en:hypophosphatemia (less common) | rel=r_associated | relid=0 | w=20
  1401. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypoprebetalipoproteinemia
    n1=en:5-oxoprolinase deficiency | n2=en:hypoprebetalipoproteinemia | rel=r_associated | relid=0 | w=20
  1402. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypoproteinemia (in 1 patient)
    n1=en:5-oxoprolinase deficiency | n2=en:hypoproteinemia (in 1 patient) | rel=r_associated | relid=0 | w=20
  1403. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypoproteinemia due to hypercatabolism
    n1=en:5-oxoprolinase deficiency | n2=en:hypoproteinemia due to hypercatabolism | rel=r_associated | relid=0 | w=20
  1404. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hyposthenuria (inability to concentrate urine normally)
    n1=en:5-oxoprolinase deficiency | n2=en:hyposthenuria (inability to concentrate urine normally) | rel=r_associated | relid=0 | w=20
  1405. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:hypouricemia
    n1=en:5-oxoprolinase deficiency | n2=en:hypouricemia | rel=r_associated | relid=0 | w=20
  1406. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:I-cell disease
    n1=en:5-oxoprolinase deficiency | n2=en:I-cell disease | rel=r_associated | relid=0 | w=20
  1407. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:iduronate sulfatase deficiency in fibroblasts, amniocytes and white blood cells
    n1=en:5-oxoprolinase deficiency | n2=en:iduronate sulfatase deficiency in fibroblasts, amniocytes and white blood cells | rel=r_associated | relid=0 | w=20
  1408. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:iga antiendomysial antibodies (ema)
    n1=en:5-oxoprolinase deficiency | n2=en:iga antiendomysial antibodies (ema) | rel=r_associated | relid=0 | w=20
  1409. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:igg, decreased
    n1=en:5-oxoprolinase deficiency | n2=en:igg, decreased | rel=r_associated | relid=0 | w=20
  1410. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:igg, elevated
    n1=en:5-oxoprolinase deficiency | n2=en:igg, elevated | rel=r_associated | relid=0 | w=20
  1411. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:igm deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:igm deficiency | rel=r_associated | relid=0 | w=20
  1412. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:iiga and igg antigliadin antibodies (aga)
    n1=en:5-oxoprolinase deficiency | n2=en:iiga and igg antigliadin antibodies (aga) | rel=r_associated | relid=0 | w=20
  1413. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:immediate (type i) skin test reactivity
    n1=en:5-oxoprolinase deficiency | n2=en:immediate (type i) skin test reactivity | rel=r_associated | relid=0 | w=20
  1414. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:immotile or weakly motile cilia
    n1=en:5-oxoprolinase deficiency | n2=en:immotile or weakly motile cilia | rel=r_associated | relid=0 | w=20
  1415. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:immunoglobulin a decreased
    n1=en:5-oxoprolinase deficiency | n2=en:immunoglobulin a decreased | rel=r_associated | relid=0 | w=20
  1416. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:immunoreactive pc protein
    n1=en:5-oxoprolinase deficiency | n2=en:immunoreactive pc protein | rel=r_associated | relid=0 | w=20
  1417. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:impaired carnitine uptake in muscle, heart, kidney, fibroblasts, and lymphocytes
    n1=en:5-oxoprolinase deficiency | n2=en:impaired carnitine uptake in muscle, heart, kidney, fibroblasts, and lymphocytes | rel=r_associated | relid=0 | w=20
  1418. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:impaired creatine uptake in fibroblasts
    n1=en:5-oxoprolinase deficiency | n2=en:impaired creatine uptake in fibroblasts | rel=r_associated | relid=0 | w=20
  1419. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:impaired long-chain fatty acid oxidation during prolonged, low-intensity exercise
    n1=en:5-oxoprolinase deficiency | n2=en:impaired long-chain fatty acid oxidation during prolonged, low-intensity exercise | rel=r_associated | relid=0 | w=20
  1420. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:impaired mitochondrial translation
    n1=en:5-oxoprolinase deficiency | n2=en:impaired mitochondrial translation | rel=r_associated | relid=0 | w=20
  1421. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:impaired n-glycosylation
    n1=en:5-oxoprolinase deficiency | n2=en:impaired n-glycosylation | rel=r_associated | relid=0 | w=20
  1422. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:impaired oxidation of pyruvate
    n1=en:5-oxoprolinase deficiency | n2=en:impaired oxidation of pyruvate | rel=r_associated | relid=0 | w=20
  1423. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:impaired response to gm-csf
    n1=en:5-oxoprolinase deficiency | n2=en:impaired response to gm-csf | rel=r_associated | relid=0 | w=20
  1424. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:impaired synthesis of fibroblast sulfated proteoglycans
    n1=en:5-oxoprolinase deficiency | n2=en:impaired synthesis of fibroblast sulfated proteoglycans | rel=r_associated | relid=0 | w=20
  1425. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:impairment of urinary concentration
    n1=en:5-oxoprolinase deficiency | n2=en:impairment of urinary concentration | rel=r_associated | relid=0 | w=20
  1426. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:in untreated patients - elevated blood galactose urine reducing substances (galactosuria), hyperchloremic metabolic acidosis, aminoaciduria, elevated liver enzymes, albuminuria
    n1=en:5-oxoprolinase deficiency | n2=en:in untreated patients - elevated blood galactose urine reducing substances (galactosuria), hyperchloremic metabolic acidosis, aminoaciduria, elevated liver enzymes, albuminuria | rel=r_associated | relid=0 | w=20
  1427. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:inactive mutant form of red cell carbonic anhydrase b in one sibship
    n1=en:5-oxoprolinase deficiency | n2=en:inactive mutant form of red cell carbonic anhydrase b in one sibship | rel=r_associated | relid=0 | w=20
  1428. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:inappropriately low urine osmolality
    n1=en:5-oxoprolinase deficiency | n2=en:inappropriately low urine osmolality | rel=r_associated | relid=0 | w=20
  1429. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:inappropriately normal serum 1,25-dihydroxyvitamin d3
    n1=en:5-oxoprolinase deficiency | n2=en:inappropriately normal serum 1,25-dihydroxyvitamin d3 | rel=r_associated | relid=0 | w=20
  1430. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:inappropriately normal to low-normal serum 1,25-dihydroxyvitamin d3
    n1=en:5-oxoprolinase deficiency | n2=en:inappropriately normal to low-normal serum 1,25-dihydroxyvitamin d3 | rel=r_associated | relid=0 | w=20
  1431. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:inborn error of lipoprotein metabolism
    n1=en:5-oxoprolinase deficiency | n2=en:inborn error of lipoprotein metabolism | rel=r_associated | relid=0 | w=20
  1432. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:inborn errors of bilirubin metabolism
    n1=en:5-oxoprolinase deficiency | n2=en:inborn errors of bilirubin metabolism | rel=r_associated | relid=0 | w=20
  1433. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:inborn errors of porphyrin metabolism
    n1=en:5-oxoprolinase deficiency | n2=en:inborn errors of porphyrin metabolism | rel=r_associated | relid=0 | w=20
  1434. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:inborn errors of steroid synthesis
    n1=en:5-oxoprolinase deficiency | n2=en:inborn errors of steroid synthesis | rel=r_associated | relid=0 | w=20
  1435. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:inclusion bodies (membrane-bound vacuoles) in fibroblasts
    n1=en:5-oxoprolinase deficiency | n2=en:inclusion bodies (membrane-bound vacuoles) in fibroblasts | rel=r_associated | relid=0 | w=20
  1436. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased 11-deoxycortisol
    n1=en:5-oxoprolinase deficiency | n2=en:increased 11-deoxycortisol | rel=r_associated | relid=0 | w=20
  1437. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased 18-hydroxycortisol
    n1=en:5-oxoprolinase deficiency | n2=en:increased 18-hydroxycortisol | rel=r_associated | relid=0 | w=20
  1438. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased 18-ohb to aldosterone ratio
    n1=en:5-oxoprolinase deficiency | n2=en:increased 18-ohb to aldosterone ratio | rel=r_associated | relid=0 | w=20
  1439. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased 18-oxocortisol
    n1=en:5-oxoprolinase deficiency | n2=en:increased 18-oxocortisol | rel=r_associated | relid=0 | w=20
  1440. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased acetylcholinesterase (ache) in amniotic fluid
    n1=en:5-oxoprolinase deficiency | n2=en:increased acetylcholinesterase (ache) in amniotic fluid | rel=r_associated | relid=0 | w=20
  1441. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased activity of the prpp synthetase 1 enzyme
    n1=en:5-oxoprolinase deficiency | n2=en:increased activity of the prpp synthetase 1 enzyme | rel=r_associated | relid=0 | w=20
  1442. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased alpha-fetoprotein in the mother during early pregnancy while carrying an affected fetus
    n1=en:5-oxoprolinase deficiency | n2=en:increased alpha-fetoprotein in the mother during early pregnancy while carrying an affected fetus | rel=r_associated | relid=0 | w=20
  1443. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased ammonia with exercise
    n1=en:5-oxoprolinase deficiency | n2=en:increased ammonia with exercise | rel=r_associated | relid=0 | w=20
  1444. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased aromatase activity
    n1=en:5-oxoprolinase deficiency | n2=en:increased aromatase activity | rel=r_associated | relid=0 | w=20
  1445. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased bile acid intermediates (dhca and thca)
    n1=en:5-oxoprolinase deficiency | n2=en:increased bile acid intermediates (dhca and thca) | rel=r_associated | relid=0 | w=20
  1446. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased bilirubin (patient b)
    n1=en:5-oxoprolinase deficiency | n2=en:increased bilirubin (patient b) | rel=r_associated | relid=0 | w=20
  1447. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased biopterin in urine and csf
    n1=en:5-oxoprolinase deficiency | n2=en:increased biopterin in urine and csf | rel=r_associated | relid=0 | w=20
  1448. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased blood alanine
    n1=en:5-oxoprolinase deficiency | n2=en:increased blood alanine | rel=r_associated | relid=0 | w=20
  1449. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased bone serum acid phosphatase
    n1=en:5-oxoprolinase deficiency | n2=en:increased bone serum acid phosphatase | rel=r_associated | relid=0 | w=20
  1450. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased c10:2-carnitine
    n1=en:5-oxoprolinase deficiency | n2=en:increased c10:2-carnitine | rel=r_associated | relid=0 | w=20
  1451. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased cerebrospinal fluid (csf) protein (>100mg/dl)
    n1=en:5-oxoprolinase deficiency | n2=en:increased cerebrospinal fluid (csf) protein (>100mg/dl) | rel=r_associated | relid=0 | w=20
  1452. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased cholesterol
    n1=en:5-oxoprolinase deficiency | n2=en:increased cholesterol | rel=r_associated | relid=0 | w=20
  1453. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased chromosomal breaks in response to cross-linking agents and ionizing radiation
    n1=en:5-oxoprolinase deficiency | n2=en:increased chromosomal breaks in response to cross-linking agents and ionizing radiation | rel=r_associated | relid=0 | w=20
  1454. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased chromosomal rearrangements (bone marrow and fibroblast culture)
    n1=en:5-oxoprolinase deficiency | n2=en:increased chromosomal rearrangements (bone marrow and fibroblast culture) | rel=r_associated | relid=0 | w=20
  1455. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased ck-mb
    n1=en:5-oxoprolinase deficiency | n2=en:increased ck-mb | rel=r_associated | relid=0 | w=20
  1456. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased creatine kinase, mild to moderate
    n1=en:5-oxoprolinase deficiency | n2=en:increased creatine kinase, mild to moderate | rel=r_associated | relid=0 | w=20
  1457. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased creatinine
    n1=en:5-oxoprolinase deficiency | n2=en:increased creatinine | rel=r_associated | relid=0 | w=20
  1458. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased csf and plasma ghb
    n1=en:5-oxoprolinase deficiency | n2=en:increased csf and plasma ghb | rel=r_associated | relid=0 | w=20
  1459. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased csf homovanillic acid (hva)
    n1=en:5-oxoprolinase deficiency | n2=en:increased csf homovanillic acid (hva) | rel=r_associated | relid=0 | w=20
  1460. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased csf immunoglobulin levels
    n1=en:5-oxoprolinase deficiency | n2=en:increased csf immunoglobulin levels | rel=r_associated | relid=0 | w=20
  1461. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased csf lactate during acute episodes
    n1=en:5-oxoprolinase deficiency | n2=en:increased csf lactate during acute episodes | rel=r_associated | relid=0 | w=20
  1462. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased csf protein during acute illness
    n1=en:5-oxoprolinase deficiency | n2=en:increased csf protein during acute illness | rel=r_associated | relid=0 | w=20
  1463. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased csf taurine
    n1=en:5-oxoprolinase deficiency | n2=en:increased csf taurine | rel=r_associated | relid=0 | w=20
  1464. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased csf threonine
    n1=en:5-oxoprolinase deficiency | n2=en:increased csf threonine | rel=r_associated | relid=0 | w=20
  1465. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased csf transferrin despite normal serum transferrin levels
    n1=en:5-oxoprolinase deficiency | n2=en:increased csf transferrin despite normal serum transferrin levels | rel=r_associated | relid=0 | w=20
  1466. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased csf, plasma, and urinary 5-hydroxytryptophan (5htp)
    n1=en:5-oxoprolinase deficiency | n2=en:increased csf, plasma, and urinary 5-hydroxytryptophan (5htp) | rel=r_associated | relid=0 | w=20
  1467. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased csf, plasma, and urinary l-dopa
    n1=en:5-oxoprolinase deficiency | n2=en:increased csf, plasma, and urinary l-dopa | rel=r_associated | relid=0 | w=20
  1468. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased d-glyceric acid in serum, urine, and csf
    n1=en:5-oxoprolinase deficiency | n2=en:increased d-glyceric acid in serum, urine, and csf | rel=r_associated | relid=0 | w=20
  1469. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased disialotransferrin and asialotransferrin levels
    n1=en:5-oxoprolinase deficiency | n2=en:increased disialotransferrin and asialotransferrin levels | rel=r_associated | relid=0 | w=20
  1470. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased erythrocyte sedimentation rate, episodic
    n1=en:5-oxoprolinase deficiency | n2=en:increased erythrocyte sedimentation rate, episodic | rel=r_associated | relid=0 | w=20
  1471. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased erythrocyte-membrane calcium-magnesium-atpase
    n1=en:5-oxoprolinase deficiency | n2=en:increased erythrocyte-membrane calcium-magnesium-atpase | rel=r_associated | relid=0 | w=20
  1472. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased excretion of urobilinogen
    n1=en:5-oxoprolinase deficiency | n2=en:increased excretion of urobilinogen | rel=r_associated | relid=0 | w=20
  1473. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased ferritin
    n1=en:5-oxoprolinase deficiency | n2=en:increased ferritin | rel=r_associated | relid=0 | w=20
  1474. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased fibroblast free sialic acid
    n1=en:5-oxoprolinase deficiency | n2=en:increased fibroblast free sialic acid | rel=r_associated | relid=0 | w=20
  1475. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased fractional excretion of urate (greater than 50%)
    n1=en:5-oxoprolinase deficiency | n2=en:increased fractional excretion of urate (greater than 50%) | rel=r_associated | relid=0 | w=20
  1476. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased fractional excretion of uric acid
    n1=en:5-oxoprolinase deficiency | n2=en:increased fractional excretion of uric acid | rel=r_associated | relid=0 | w=20
  1477. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased free erythrocyte protoporphyrin
    n1=en:5-oxoprolinase deficiency | n2=en:increased free erythrocyte protoporphyrin | rel=r_associated | relid=0 | w=20
  1478. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased frequency of premature centromere disjunction (pcd) in cultured fibroblasts, esp. chromosome 3
    n1=en:5-oxoprolinase deficiency | n2=en:increased frequency of premature centromere disjunction (pcd) in cultured fibroblasts, esp. chromosome 3 | rel=r_associated | relid=0 | w=20
  1479. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased gamma-aminobutyric acid in plasma, urine, and cerebrospinal fluid (csf)
    n1=en:5-oxoprolinase deficiency | n2=en:increased gamma-aminobutyric acid in plasma, urine, and cerebrospinal fluid (csf) | rel=r_associated | relid=0 | w=20
  1480. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased growth hormone (in 1 of 2 patients)
    n1=en:5-oxoprolinase deficiency | n2=en:increased growth hormone (in 1 of 2 patients) | rel=r_associated | relid=0 | w=20
  1481. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased hepatic parenchymal cell stainable iron
    n1=en:5-oxoprolinase deficiency | n2=en:increased hepatic parenchymal cell stainable iron | rel=r_associated | relid=0 | w=20
  1482. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased ige level
    n1=en:5-oxoprolinase deficiency | n2=en:increased ige level | rel=r_associated | relid=0 | w=20
  1483. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased igg level
    n1=en:5-oxoprolinase deficiency | n2=en:increased igg level | rel=r_associated | relid=0 | w=20
  1484. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased igm level
    n1=en:5-oxoprolinase deficiency | n2=en:increased igm level | rel=r_associated | relid=0 | w=20
  1485. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased il-6
    n1=en:5-oxoprolinase deficiency | n2=en:increased il-6 | rel=r_associated | relid=0 | w=20
  1486. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased interferon-alpha signal
    n1=en:5-oxoprolinase deficiency | n2=en:increased interferon-alpha signal | rel=r_associated | relid=0 | w=20
  1487. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased interleukin 10
    n1=en:5-oxoprolinase deficiency | n2=en:increased interleukin 10 | rel=r_associated | relid=0 | w=20
  1488. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased intracellular fmrp mrna
    n1=en:5-oxoprolinase deficiency | n2=en:increased intracellular fmrp mrna | rel=r_associated | relid=0 | w=20
  1489. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased ketone body or lactate/pyruvate plasma ratios
    n1=en:5-oxoprolinase deficiency | n2=en:increased ketone body or lactate/pyruvate plasma ratios | rel=r_associated | relid=0 | w=20
  1490. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased l-2-hydroxyglutaric acid in urine, serum, and csf
    n1=en:5-oxoprolinase deficiency | n2=en:increased l-2-hydroxyglutaric acid in urine, serum, and csf | rel=r_associated | relid=0 | w=20
  1491. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased lactate in spinal fluid
    n1=en:5-oxoprolinase deficiency | n2=en:increased lactate in spinal fluid | rel=r_associated | relid=0 | w=20
  1492. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased lactate: pyruvate ratio (group b)
    n1=en:5-oxoprolinase deficiency | n2=en:increased lactate: pyruvate ratio (group b) | rel=r_associated | relid=0 | w=20
  1493. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased levels of dihydroxyacetone phosphate (dhap) in tissues and red cells
    n1=en:5-oxoprolinase deficiency | n2=en:increased levels of dihydroxyacetone phosphate (dhap) in tissues and red cells | rel=r_associated | relid=0 | w=20
  1494. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased long-chain acylcarnitine
    n1=en:5-oxoprolinase deficiency | n2=en:increased long-chain acylcarnitine | rel=r_associated | relid=0 | w=20
  1495. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased lysine in serum and csf
    n1=en:5-oxoprolinase deficiency | n2=en:increased lysine in serum and csf | rel=r_associated | relid=0 | w=20
  1496. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased n-acetyl-l-aspartic acid (naa) in urine, csf, and blood
    n1=en:5-oxoprolinase deficiency | n2=en:increased n-acetyl-l-aspartic acid (naa) in urine, csf, and blood | rel=r_associated | relid=0 | w=20
  1497. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased nasal-potential difference (1 of 3 patients)
    n1=en:5-oxoprolinase deficiency | n2=en:increased nasal-potential difference (1 of 3 patients) | rel=r_associated | relid=0 | w=20
  1498. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased neopterin in urine and csf
    n1=en:5-oxoprolinase deficiency | n2=en:increased neopterin in urine and csf | rel=r_associated | relid=0 | w=20
  1499. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased osmotic fragility
    n1=en:5-oxoprolinase deficiency | n2=en:increased osmotic fragility | rel=r_associated | relid=0 | w=20
  1500. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased oxygen affinity (e.g. hb nunobiki 141800.0109)
    n1=en:5-oxoprolinase deficiency | n2=en:increased oxygen affinity (e.g. hb nunobiki 141800.0109) | rel=r_associated | relid=0 | w=20
  1501. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased phytanic acid in body tissues and fluids
    n1=en:5-oxoprolinase deficiency | n2=en:increased phytanic acid in body tissues and fluids | rel=r_associated | relid=0 | w=20
  1502. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased plasma 2-methylbutyrylcarnitine
    n1=en:5-oxoprolinase deficiency | n2=en:increased plasma 2-methylbutyrylcarnitine | rel=r_associated | relid=0 | w=20
  1503. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased plasma and urinary pipecolic acid
    n1=en:5-oxoprolinase deficiency | n2=en:increased plasma and urinary pipecolic acid | rel=r_associated | relid=0 | w=20
  1504. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased plasma dihydroxyphenylacetic acid (dopac)
    n1=en:5-oxoprolinase deficiency | n2=en:increased plasma dihydroxyphenylacetic acid (dopac) | rel=r_associated | relid=0 | w=20
  1505. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased plasma free cholesterol
    n1=en:5-oxoprolinase deficiency | n2=en:increased plasma free cholesterol | rel=r_associated | relid=0 | w=20
  1506. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased plasma long-chain acylcarnitines
    n1=en:5-oxoprolinase deficiency | n2=en:increased plasma long-chain acylcarnitines | rel=r_associated | relid=0 | w=20
  1507. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased plasma phytanic acid
    n1=en:5-oxoprolinase deficiency | n2=en:increased plasma phytanic acid | rel=r_associated | relid=0 | w=20
  1508. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased plasma pristanic acid
    n1=en:5-oxoprolinase deficiency | n2=en:increased plasma pristanic acid | rel=r_associated | relid=0 | w=20
  1509. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased plasma proglucagon
    n1=en:5-oxoprolinase deficiency | n2=en:increased plasma proglucagon | rel=r_associated | relid=0 | w=20
  1510. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased plasma renin activity
    n1=en:5-oxoprolinase deficiency | n2=en:increased plasma renin activity | rel=r_associated | relid=0 | w=20
  1511. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased platelet aggregation with ristocetin
    n1=en:5-oxoprolinase deficiency | n2=en:increased platelet aggregation with ristocetin | rel=r_associated | relid=0 | w=20
  1512. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased prv-1 (162860) mrna
    n1=en:5-oxoprolinase deficiency | n2=en:increased prv-1 (162860) mrna | rel=r_associated | relid=0 | w=20
  1513. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased pyruvate in serum and csf
    n1=en:5-oxoprolinase deficiency | n2=en:increased pyruvate in serum and csf | rel=r_associated | relid=0 | w=20
  1514. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased sensitivity to adrenergic and cholinergic agents
    n1=en:5-oxoprolinase deficiency | n2=en:increased sensitivity to adrenergic and cholinergic agents | rel=r_associated | relid=0 | w=20
  1515. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum 1,25-dihydroxyvitamin d
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum 1,25-dihydroxyvitamin d | rel=r_associated | relid=0 | w=20
  1516. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum 1,25-dihydroxyvitamin d3
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum 1,25-dihydroxyvitamin d3 | rel=r_associated | relid=0 | w=20
  1517. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum 18-hydroxycorticosterone (18-ohb)
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum 18-hydroxycorticosterone (18-ohb) | rel=r_associated | relid=0 | w=20
  1518. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum acyl carnitines
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum acyl carnitines | rel=r_associated | relid=0 | w=20
  1519. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum acylcarnitine during febrile crisis
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum acylcarnitine during febrile crisis | rel=r_associated | relid=0 | w=20
  1520. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum acylcarnitines
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum acylcarnitines | rel=r_associated | relid=0 | w=20
  1521. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum alkaline phosphatase activity of skeletal origin
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum alkaline phosphatase activity of skeletal origin | rel=r_associated | relid=0 | w=20
  1522. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum alpha-alanine (patient b)
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum alpha-alanine (patient b) | rel=r_associated | relid=0 | w=20
  1523. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum alpha-interferon (ifna1, 147660)
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum alpha-interferon (ifna1, 147660) | rel=r_associated | relid=0 | w=20
  1524. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum alpha-ketoglutarate
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum alpha-ketoglutarate | rel=r_associated | relid=0 | w=20
  1525. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum alpha-mannosidase
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum alpha-mannosidase | rel=r_associated | relid=0 | w=20
  1526. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum and cerebrospinal fluid levels of pipecolic acid
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum and cerebrospinal fluid levels of pipecolic acid | rel=r_associated | relid=0 | w=20
  1527. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum and csf lactate
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum and csf lactate | rel=r_associated | relid=0 | w=20
  1528. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum and urinary 2-oxoglutarate
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum and urinary 2-oxoglutarate | rel=r_associated | relid=0 | w=20
  1529. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum aryl-sulfatase a (10-20x)
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum aryl-sulfatase a (10-20x) | rel=r_associated | relid=0 | w=20
  1530. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum arylsulfatase a (10-20x)
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum arylsulfatase a (10-20x) | rel=r_associated | relid=0 | w=20
  1531. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum beta-carotene
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum beta-carotene | rel=r_associated | relid=0 | w=20
  1532. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum beta-hexosaminidase
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum beta-hexosaminidase | rel=r_associated | relid=0 | w=20
  1533. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum bile acid concentration during pregnancy, resolves postpartum
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum bile acid concentration during pregnancy, resolves postpartum | rel=r_associated | relid=0 | w=20
  1534. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum bile acids
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum bile acids | rel=r_associated | relid=0 | w=20
  1535. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum bilirubin due to hemolysis
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum bilirubin due to hemolysis | rel=r_associated | relid=0 | w=20
  1536. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum butyryl carnitine
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum butyryl carnitine | rel=r_associated | relid=0 | w=20
  1537. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum c-reactive protein, episodic
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum c-reactive protein, episodic | rel=r_associated | relid=0 | w=20
  1538. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum c26-bile-acid intermediates
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum c26-bile-acid intermediates | rel=r_associated | relid=0 | w=20
  1539. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum c4 and c5 acylcarnitine esters
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum c4 and c5 acylcarnitine esters | rel=r_associated | relid=0 | w=20
  1540. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum cholesterol (in 3 of 10 patients)
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum cholesterol (in 3 of 10 patients) | rel=r_associated | relid=0 | w=20
  1541. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum citrulline (group b)
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum citrulline (group b) | rel=r_associated | relid=0 | w=20
  1542. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum creatine kinase (1 family)
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum creatine kinase (1 family) | rel=r_associated | relid=0 | w=20
  1543. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum creatine kinase (less common)
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum creatine kinase (less common) | rel=r_associated | relid=0 | w=20
  1544. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum creatine kinase during episodes
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum creatine kinase during episodes | rel=r_associated | relid=0 | w=20
  1545. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum creatine kinase in acute stage
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum creatine kinase in acute stage | rel=r_associated | relid=0 | w=20
  1546. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum creatine kinase, mild
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum creatine kinase, mild | rel=r_associated | relid=0 | w=20
  1547. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum erythropoietin (epo, 133170)
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum erythropoietin (epo, 133170) | rel=r_associated | relid=0 | w=20
  1548. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum fgf23
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum fgf23 | rel=r_associated | relid=0 | w=20
  1549. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum gamma-ggt (231950)
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum gamma-ggt (231950) | rel=r_associated | relid=0 | w=20
  1550. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum glutamine
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum glutamine | rel=r_associated | relid=0 | w=20
  1551. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum glutamine (patient a)
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum glutamine (patient a) | rel=r_associated | relid=0 | w=20
  1552. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum iduronate sulfatase (10-20x)
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum iduronate sulfatase (10-20x) | rel=r_associated | relid=0 | w=20
  1553. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum ige
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum ige | rel=r_associated | relid=0 | w=20
  1554. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum insulin-like growth factor 1 {comment=hpo:probinson}
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum insulin-like growth factor 1 {comment=hpo:probinson} | rel=r_associated | relid=0 | w=20
  1555. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum lactate
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum lactate | rel=r_associated | relid=0 | w=20
  1556. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum lactate dehydrogenase (in 1 family)
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum lactate dehydrogenase (in 1 family) | rel=r_associated | relid=0 | w=20
  1557. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum lactate dehydrogenase (ldh)
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum lactate dehydrogenase (ldh) | rel=r_associated | relid=0 | w=20
  1558. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum lactate during metabolic crisis
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum lactate during metabolic crisis | rel=r_associated | relid=0 | w=20
  1559. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum lactate in acute stage
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum lactate in acute stage | rel=r_associated | relid=0 | w=20
  1560. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum levels of free plasma thyroid hormones
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum levels of free plasma thyroid hormones | rel=r_associated | relid=0 | w=20
  1561. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum lipoproteins
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum lipoproteins | rel=r_associated | relid=0 | w=20
  1562. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum lysine (group b)
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum lysine (group b) | rel=r_associated | relid=0 | w=20
  1563. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum methionine (reported in 2 cases)
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum methionine (reported in 2 cases) | rel=r_associated | relid=0 | w=20
  1564. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum osteocalcin
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum osteocalcin | rel=r_associated | relid=0 | w=20
  1565. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum pancreatic secretory trypsin inhibitor (psti)
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum pancreatic secretory trypsin inhibitor (psti) | rel=r_associated | relid=0 | w=20
  1566. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum parathyroid hormone (pth)
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum parathyroid hormone (pth) | rel=r_associated | relid=0 | w=20
  1567. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum plasminogen activator inhibitor-1 (pai1, 173360)
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum plasminogen activator inhibitor-1 (pai1, 173360) | rel=r_associated | relid=0 | w=20
  1568. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum pyruvate
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum pyruvate | rel=r_associated | relid=0 | w=20
  1569. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum pyruvate in acute stage
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum pyruvate in acute stage | rel=r_associated | relid=0 | w=20
  1570. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum s-adenosylhomocysteine
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum s-adenosylhomocysteine | rel=r_associated | relid=0 | w=20
  1571. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum serotonin in 25%
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum serotonin in 25% | rel=r_associated | relid=0 | w=20
  1572. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum thrombopoietin may occur
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum thrombopoietin may occur | rel=r_associated | relid=0 | w=20
  1573. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum thymidine
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum thymidine | rel=r_associated | relid=0 | w=20
  1574. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum thyroid-stimulating hormone (tsh)
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum thyroid-stimulating hormone (tsh) | rel=r_associated | relid=0 | w=20
  1575. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum total cholesterol
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum total cholesterol | rel=r_associated | relid=0 | w=20
  1576. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum transaminases (in 1 of 3 patients)
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum transaminases (in 1 of 3 patients) | rel=r_associated | relid=0 | w=20
  1577. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum triglycerides (in some patients)
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum triglycerides (in some patients) | rel=r_associated | relid=0 | w=20
  1578. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum triiodothyronine (t3)
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum triiodothyronine (t3) | rel=r_associated | relid=0 | w=20
  1579. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum unconjugated bilirubin
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum unconjugated bilirubin | rel=r_associated | relid=0 | w=20
  1580. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum uric acid
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum uric acid | rel=r_associated | relid=0 | w=20
  1581. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum vitamin b12
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum vitamin b12 | rel=r_associated | relid=0 | w=20
  1582. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum, cerebrospinal fluid, and urinary levels of alpha-aminoadipic semialdehyde
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum, cerebrospinal fluid, and urinary levels of alpha-aminoadipic semialdehyde | rel=r_associated | relid=0 | w=20
  1583. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased serum, urinary, and csf lysine
    n1=en:5-oxoprolinase deficiency | n2=en:increased serum, urinary, and csf lysine | rel=r_associated | relid=0 | w=20
  1584. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased sodium-potassium pump activity
    n1=en:5-oxoprolinase deficiency | n2=en:increased sodium-potassium pump activity | rel=r_associated | relid=0 | w=20
  1585. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased succinyladenosine (s-ado) in serum, urine, and csf
    n1=en:5-oxoprolinase deficiency | n2=en:increased succinyladenosine (s-ado) in serum, urine, and csf | rel=r_associated | relid=0 | w=20
  1586. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased thymine and dihydrothymine in bodily fluids
    n1=en:5-oxoprolinase deficiency | n2=en:increased thymine and dihydrothymine in bodily fluids | rel=r_associated | relid=0 | w=20
  1587. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased thyroid-stimulating hormone (tsh)
    n1=en:5-oxoprolinase deficiency | n2=en:increased thyroid-stimulating hormone (tsh) | rel=r_associated | relid=0 | w=20
  1588. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased tissue levels of free fatty acids
    n1=en:5-oxoprolinase deficiency | n2=en:increased tissue levels of free fatty acids | rel=r_associated | relid=0 | w=20
  1589. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased tissue levels of triglycerides
    n1=en:5-oxoprolinase deficiency | n2=en:increased tissue levels of triglycerides | rel=r_associated | relid=0 | w=20
  1590. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased tissue long-chain acylcarnitines
    n1=en:5-oxoprolinase deficiency | n2=en:increased tissue long-chain acylcarnitines | rel=r_associated | relid=0 | w=20
  1591. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased total bilirubin may occur
    n1=en:5-oxoprolinase deficiency | n2=en:increased total bilirubin may occur | rel=r_associated | relid=0 | w=20
  1592. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased toxic thioguanine nucleotides (tgns) on standard doses of thiopurine drugs
    n1=en:5-oxoprolinase deficiency | n2=en:increased toxic thioguanine nucleotides (tgns) on standard doses of thiopurine drugs | rel=r_associated | relid=0 | w=20
  1593. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased triglycerides (less common)
    n1=en:5-oxoprolinase deficiency | n2=en:increased triglycerides (less common) | rel=r_associated | relid=0 | w=20
  1594. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased uracil and dihydrouracil in bodily fluids
    n1=en:5-oxoprolinase deficiency | n2=en:increased uracil and dihydrouracil in bodily fluids | rel=r_associated | relid=0 | w=20
  1595. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary 2-butanone
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary 2-butanone | rel=r_associated | relid=0 | w=20
  1596. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary 2-hydroxybutyrate
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary 2-hydroxybutyrate | rel=r_associated | relid=0 | w=20
  1597. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary 2-methyl-3 hydroxybutyrate
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary 2-methyl-3 hydroxybutyrate | rel=r_associated | relid=0 | w=20
  1598. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary 2-methyl-3-hydroxybutyric acid
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary 2-methyl-3-hydroxybutyric acid | rel=r_associated | relid=0 | w=20
  1599. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary 2-methylacetoacetic acid
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary 2-methylacetoacetic acid | rel=r_associated | relid=0 | w=20
  1600. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary 2-methylbutyryl glycine
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary 2-methylbutyryl glycine | rel=r_associated | relid=0 | w=20
  1601. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary 2-oxoglutaric acid
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary 2-oxoglutaric acid | rel=r_associated | relid=0 | w=20
  1602. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary 3-methylglutaconic acid
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary 3-methylglutaconic acid | rel=r_associated | relid=0 | w=20
  1603. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary 7-biopterin (primapterin)
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary 7-biopterin (primapterin) | rel=r_associated | relid=0 | w=20
  1604. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary acetoacetic acid
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary acetoacetic acid | rel=r_associated | relid=0 | w=20
  1605. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary adenosine
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary adenosine | rel=r_associated | relid=0 | w=20
  1606. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary alpha-ketoglutaric acid, intermittent
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary alpha-ketoglutaric acid, intermittent | rel=r_associated | relid=0 | w=20
  1607. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary and serum glycine
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary and serum glycine | rel=r_associated | relid=0 | w=20
  1608. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary carnitine
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary carnitine | rel=r_associated | relid=0 | w=20
  1609. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary carnitine esters
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary carnitine esters | rel=r_associated | relid=0 | w=20
  1610. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary catecholamines
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary catecholamines | rel=r_associated | relid=0 | w=20
  1611. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary citric acid cycle intermediates
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary citric acid cycle intermediates | rel=r_associated | relid=0 | w=20
  1612. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary collagen type i n-telopeptide excretion (ntx) during hyperplastic callus formation
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary collagen type i n-telopeptide excretion (ntx) during hyperplastic callus formation | rel=r_associated | relid=0 | w=20
  1613. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary creatine-to-creatinine ratio
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary creatine-to-creatinine ratio | rel=r_associated | relid=0 | w=20
  1614. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary cross-linked n-telopetide of type i collagen
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary cross-linked n-telopetide of type i collagen | rel=r_associated | relid=0 | w=20
  1615. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary cyclic amp (camp) in response to ddavp administration
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary cyclic amp (camp) in response to ddavp administration | rel=r_associated | relid=0 | w=20
  1616. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary cystine, arginine, lysine, and ornithine (hcs and 2p21del)
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary cystine, arginine, lysine, and ornithine (hcs and 2p21del) | rel=r_associated | relid=0 | w=20
  1617. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary delta-aminolevulinic acid (ala) and porphobilinogen (pbg) during acute attacks
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary delta-aminolevulinic acid (ala) and porphobilinogen (pbg) during acute attacks | rel=r_associated | relid=0 | w=20
  1618. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary dicarboxylic acid, transient
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary dicarboxylic acid, transient | rel=r_associated | relid=0 | w=20
  1619. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary dihydropyrimidines
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary dihydropyrimidines | rel=r_associated | relid=0 | w=20
  1620. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary dopamine
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary dopamine | rel=r_associated | relid=0 | w=20
  1621. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary dopamine and dopamine metabolites (paradoxical)
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary dopamine and dopamine metabolites (paradoxical) | rel=r_associated | relid=0 | w=20
  1622. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary excretion of camp
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary excretion of camp | rel=r_associated | relid=0 | w=20
  1623. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary excretion of coproporphyrin i
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary excretion of coproporphyrin i | rel=r_associated | relid=0 | w=20
  1624. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary excretion of cystine
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary excretion of cystine | rel=r_associated | relid=0 | w=20
  1625. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary formiminoglutamic acid (figlu)
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary formiminoglutamic acid (figlu) | rel=r_associated | relid=0 | w=20
  1626. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary free sialic acid (n-acetylneuraminic acid, 20-200x normal)
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary free sialic acid (n-acetylneuraminic acid, 20-200x normal) | rel=r_associated | relid=0 | w=20
  1627. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary glycerol
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary glycerol | rel=r_associated | relid=0 | w=20
  1628. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary glyoxylate (1 patient)
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary glyoxylate (1 patient) | rel=r_associated | relid=0 | w=20
  1629. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary hga
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary hga | rel=r_associated | relid=0 | w=20
  1630. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary homovanillic acid (hva)
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary homovanillic acid (hva) | rel=r_associated | relid=0 | w=20
  1631. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary hydroxyisovaleric acid
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary hydroxyisovaleric acid | rel=r_associated | relid=0 | w=20
  1632. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary hypoxanthine
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary hypoxanthine | rel=r_associated | relid=0 | w=20
  1633. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary ketones
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary ketones | rel=r_associated | relid=0 | w=20
  1634. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary levels of maoa substrates (endogenous bioamines)
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary levels of maoa substrates (endogenous bioamines) | rel=r_associated | relid=0 | w=20
  1635. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary malic acid
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary malic acid | rel=r_associated | relid=0 | w=20
  1636. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary n-acetylated amino acids
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary n-acetylated amino acids | rel=r_associated | relid=0 | w=20
  1637. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary neopterin
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary neopterin | rel=r_associated | relid=0 | w=20
  1638. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary o-hydroxyphenylacetic acid, phenylpyruvic acid, phenylacetic acid and phenylacetylglutamine
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary o-hydroxyphenylacetic acid, phenylpyruvic acid, phenylacetic acid and phenylacetylglutamine | rel=r_associated | relid=0 | w=20
  1639. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary o-linked sialopeptides
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary o-linked sialopeptides | rel=r_associated | relid=0 | w=20
  1640. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary oligosaccharides
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary oligosaccharides | rel=r_associated | relid=0 | w=20
  1641. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary organic acids (in some patients)
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary organic acids (in some patients) | rel=r_associated | relid=0 | w=20
  1642. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary orotic acid (in some patients)
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary orotic acid (in some patients) | rel=r_associated | relid=0 | w=20
  1643. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary oxylate
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary oxylate | rel=r_associated | relid=0 | w=20
  1644. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary porphyrin precursors porphobilinogen (pbg) and delta-aminolevulinic acid (ala) during acute attacks
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary porphyrin precursors porphobilinogen (pbg) and delta-aminolevulinic acid (ala) during acute attacks | rel=r_associated | relid=0 | w=20
  1645. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary potassium
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary potassium | rel=r_associated | relid=0 | w=20
  1646. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary prostaglandin e2
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary prostaglandin e2 | rel=r_associated | relid=0 | w=20
  1647. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary s-(2-carboxypropyl)cysteine
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary s-(2-carboxypropyl)cysteine | rel=r_associated | relid=0 | w=20
  1648. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary sialylglycopeptides
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary sialylglycopeptides | rel=r_associated | relid=0 | w=20
  1649. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary succinic acid
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary succinic acid | rel=r_associated | relid=0 | w=20
  1650. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary thiosulfate
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary thiosulfate | rel=r_associated | relid=0 | w=20
  1651. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary thymine
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary thymine | rel=r_associated | relid=0 | w=20
  1652. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary tricarboxylic acid intermediates
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary tricarboxylic acid intermediates | rel=r_associated | relid=0 | w=20
  1653. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary uracil
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary uracil | rel=r_associated | relid=0 | w=20
  1654. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary vanillylmandelic acid (vma)
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary vanillylmandelic acid (vma) | rel=r_associated | relid=0 | w=20
  1655. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary, plasma, and csf d-2-hydroxyglutaric acid
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary, plasma, and csf d-2-hydroxyglutaric acid | rel=r_associated | relid=0 | w=20
  1656. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary, plasma, and csf dihydrothymine
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary, plasma, and csf dihydrothymine | rel=r_associated | relid=0 | w=20
  1657. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urinary, plasma, and csf n-carbamyl-beta-alanine
    n1=en:5-oxoprolinase deficiency | n2=en:increased urinary, plasma, and csf n-carbamyl-beta-alanine | rel=r_associated | relid=0 | w=20
  1658. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased urine vanillactic acid (vla)
    n1=en:5-oxoprolinase deficiency | n2=en:increased urine vanillactic acid (vla) | rel=r_associated | relid=0 | w=20
  1659. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:increased vitamin e (alpha-tocopherol) levels
    n1=en:5-oxoprolinase deficiency | n2=en:increased vitamin e (alpha-tocopherol) levels | rel=r_associated | relid=0 | w=20
  1660. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:incresased urinary pyruvate
    n1=en:5-oxoprolinase deficiency | n2=en:incresased urinary pyruvate | rel=r_associated | relid=0 | w=20
  1661. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:indirect bilirubin increased
    n1=en:5-oxoprolinase deficiency | n2=en:indirect bilirubin increased | rel=r_associated | relid=0 | w=20
  1662. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:indirect hyperbilirubinemia
    n1=en:5-oxoprolinase deficiency | n2=en:indirect hyperbilirubinemia | rel=r_associated | relid=0 | w=20
  1663. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:inherited disorder of bilirubin metabolism
    n1=en:5-oxoprolinase deficiency | n2=en:inherited disorder of bilirubin metabolism | rel=r_associated | relid=0 | w=20
  1664. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:inherited disorder of folate metabolism
    n1=en:5-oxoprolinase deficiency | n2=en:inherited disorder of folate metabolism | rel=r_associated | relid=0 | w=20
  1665. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:insulin growth factor i deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:insulin growth factor i deficiency | rel=r_associated | relid=0 | w=20
  1666. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:intermediary metabolism disorder
    n1=en:5-oxoprolinase deficiency | n2=en:intermediary metabolism disorder | rel=r_associated | relid=0 | w=20
  1667. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:intermediate level of cellular sensitivity to uv light
    n1=en:5-oxoprolinase deficiency | n2=en:intermediate level of cellular sensitivity to uv light | rel=r_associated | relid=0 | w=20
  1668. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:intermittent 3-methylglutaconic aciduria
    n1=en:5-oxoprolinase deficiency | n2=en:intermittent 3-methylglutaconic aciduria | rel=r_associated | relid=0 | w=20
  1669. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:intermittent ethylmalonic aciduria
    n1=en:5-oxoprolinase deficiency | n2=en:intermittent ethylmalonic aciduria | rel=r_associated | relid=0 | w=20
  1670. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:intermittent increase of urinary ethylmalonic acid
    n1=en:5-oxoprolinase deficiency | n2=en:intermittent increase of urinary ethylmalonic acid | rel=r_associated | relid=0 | w=20
  1671. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:interstitial deletion of 17p11.2 (most common is 3.7mb)
    n1=en:5-oxoprolinase deficiency | n2=en:interstitial deletion of 17p11.2 (most common is 3.7mb) | rel=r_associated | relid=0 | w=20
  1672. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:interstitial or terminal deletion of 18q
    n1=en:5-oxoprolinase deficiency | n2=en:interstitial or terminal deletion of 18q | rel=r_associated | relid=0 | w=20
  1673. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:intracellular accumulation of unesterified cholesterol
    n1=en:5-oxoprolinase deficiency | n2=en:intracellular accumulation of unesterified cholesterol | rel=r_associated | relid=0 | w=20
  1674. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:intracellular fingerprint profiles on ultrastructural analysis
    n1=en:5-oxoprolinase deficiency | n2=en:intracellular fingerprint profiles on ultrastructural analysis | rel=r_associated | relid=0 | w=20
  1675. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:intracellular glycosphingolipid deposition in all tissues of the body
    n1=en:5-oxoprolinase deficiency | n2=en:intracellular glycosphingolipid deposition in all tissues of the body | rel=r_associated | relid=0 | w=20
  1676. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:intracellular pas-positive polyglucosan inclusion bodies ('lafora' bodies) can be found in various tissues (brain, liver, muscle, heart, skin)
    n1=en:5-oxoprolinase deficiency | n2=en:intracellular pas-positive polyglucosan inclusion bodies ('lafora' bodies) can be found in various tissues (brain, liver, muscle, heart, skin) | rel=r_associated | relid=0 | w=20
  1677. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:intracellular redox disturbance (reduced cytoplasm and oxidized mitochondria (group b))
    n1=en:5-oxoprolinase deficiency | n2=en:intracellular redox disturbance (reduced cytoplasm and oxidized mitochondria (group b)) | rel=r_associated | relid=0 | w=20
  1678. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:iodine depletion
    n1=en:5-oxoprolinase deficiency | n2=en:iodine depletion | rel=r_associated | relid=0 | w=20
  1679. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:iron low
    n1=en:5-oxoprolinase deficiency | n2=en:iron low | rel=r_associated | relid=0 | w=20
  1680. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:iron overload (in some patients)
    n1=en:5-oxoprolinase deficiency | n2=en:iron overload (in some patients) | rel=r_associated | relid=0 | w=20
  1681. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:irregular distribution of chondrocytes, enlarged chondrocyte lacunae, excessive fibrous matrix, perilacunar loss of glycosaminoglycan, excessive collagen aggregation
    n1=en:5-oxoprolinase deficiency | n2=en:irregular distribution of chondrocytes, enlarged chondrocyte lacunae, excessive fibrous matrix, perilacunar loss of glycosaminoglycan, excessive collagen aggregation | rel=r_associated | relid=0 | w=20
  1682. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:isochromosome 12p (i(12p))
    n1=en:5-oxoprolinase deficiency | n2=en:isochromosome 12p (i(12p)) | rel=r_associated | relid=0 | w=20
  1683. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:isochromosome often missing in lymphocyte
    n1=en:5-oxoprolinase deficiency | n2=en:isochromosome often missing in lymphocyte | rel=r_associated | relid=0 | w=20
  1684. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:isovalericaciduria
    n1=en:5-oxoprolinase deficiency | n2=en:isovalericaciduria | rel=r_associated | relid=0 | w=20
  1685. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:isovalerylglycinuria
    n1=en:5-oxoprolinase deficiency | n2=en:isovalerylglycinuria | rel=r_associated | relid=0 | w=20
  1686. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:kallman syndrome with heart disease
    n1=en:5-oxoprolinase deficiency | n2=en:kallman syndrome with heart disease | rel=r_associated | relid=0 | w=20
  1687. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:karyomegaly may be found in other visceral organs
    n1=en:5-oxoprolinase deficiency | n2=en:karyomegaly may be found in other visceral organs | rel=r_associated | relid=0 | w=20
  1688. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:karyotype analysis normal finding
    n1=en:5-oxoprolinase deficiency | n2=en:karyotype analysis normal finding | rel=r_associated | relid=0 | w=20
  1689. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:keratan sulfate excretion in urine that decreases with age
    n1=en:5-oxoprolinase deficiency | n2=en:keratan sulfate excretion in urine that decreases with age | rel=r_associated | relid=0 | w=20
  1690. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:keratan sulfaturia in some patients
    n1=en:5-oxoprolinase deficiency | n2=en:keratan sulfaturia in some patients | rel=r_associated | relid=0 | w=20
  1691. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:ketoacidosis
    n1=en:5-oxoprolinase deficiency | n2=en:ketoacidosis | rel=r_associated | relid=0 | w=20
  1692. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:ketonuria (1 patient)
    n1=en:5-oxoprolinase deficiency | n2=en:ketonuria (1 patient) | rel=r_associated | relid=0 | w=20
  1693. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:ketonuria, acute
    n1=en:5-oxoprolinase deficiency | n2=en:ketonuria, acute | rel=r_associated | relid=0 | w=20
  1694. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:ketoses, metabolic
    n1=en:5-oxoprolinase deficiency | n2=en:ketoses, metabolic | rel=r_associated | relid=0 | w=20
  1695. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:kypokalemia
    n1=en:5-oxoprolinase deficiency | n2=en:kypokalemia | rel=r_associated | relid=0 | w=20
  1696. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:lack of ciliary motility
    n1=en:5-oxoprolinase deficiency | n2=en:lack of ciliary motility | rel=r_associated | relid=0 | w=20
  1697. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:lack of excessive parenchymal iron storage
    n1=en:5-oxoprolinase deficiency | n2=en:lack of excessive parenchymal iron storage | rel=r_associated | relid=0 | w=20
  1698. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:lack of lysosomal inclusions in visceral organs
    n1=en:5-oxoprolinase deficiency | n2=en:lack of lysosomal inclusions in visceral organs | rel=r_associated | relid=0 | w=20
  1699. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:lactate dehydrogenase increased
    n1=en:5-oxoprolinase deficiency | n2=en:lactate dehydrogenase increased | rel=r_associated | relid=0 | w=20
  1700. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:lactate high
    n1=en:5-oxoprolinase deficiency | n2=en:lactate high | rel=r_associated | relid=0 | w=20
  1701. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:lactic acidemia (2p21del)
    n1=en:5-oxoprolinase deficiency | n2=en:lactic acidemia (2p21del) | rel=r_associated | relid=0 | w=20
  1702. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:lactose intolerance, adult type
    n1=en:5-oxoprolinase deficiency | n2=en:lactose intolerance, adult type | rel=r_associated | relid=0 | w=20
  1703. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:lacunar halos around chondrocytes in skeletal cartilage
    n1=en:5-oxoprolinase deficiency | n2=en:lacunar halos around chondrocytes in skeletal cartilage | rel=r_associated | relid=0 | w=20
  1704. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:large spermatozoa
    n1=en:5-oxoprolinase deficiency | n2=en:large spermatozoa | rel=r_associated | relid=0 | w=20
  1705. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:late-onset junctional epidermolysis bullosa
    n1=en:5-oxoprolinase deficiency | n2=en:late-onset junctional epidermolysis bullosa | rel=r_associated | relid=0 | w=20
  1706. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:Laurence-Moon's syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:Laurence-Moon's syndrome | rel=r_associated | relid=0 | w=20
  1707. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:Leroy's i-cell disease
    n1=en:5-oxoprolinase deficiency | n2=en:Leroy's i-cell disease | rel=r_associated | relid=0 | w=20
  1708. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:lethal larsen-like syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:lethal larsen-like syndrome | rel=r_associated | relid=0 | w=20
  1709. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:leucinosis
    n1=en:5-oxoprolinase deficiency | n2=en:leucinosis | rel=r_associated | relid=0 | w=20
  1710. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:leukocyte inclusion bodies (em) - intermediate filaments and ribosome clusters irregularly dispersed in cytoplasm
    n1=en:5-oxoprolinase deficiency | n2=en:leukocyte inclusion bodies (em) - intermediate filaments and ribosome clusters irregularly dispersed in cytoplasm | rel=r_associated | relid=0 | w=20
  1711. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:lipoid congenital adrenal hyperplasia
    n1=en:5-oxoprolinase deficiency | n2=en:lipoid congenital adrenal hyperplasia | rel=r_associated | relid=0 | w=20
  1712. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:lipopigment in extraneuronal cells
    n1=en:5-oxoprolinase deficiency | n2=en:lipopigment in extraneuronal cells | rel=r_associated | relid=0 | w=20
  1713. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:lissencephaly type 3 familial fetal akinesia sequence syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:lissencephaly type 3 familial fetal akinesia sequence syndrome | rel=r_associated | relid=0 | w=20
  1714. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:little to absent aspartylglucosaminuria activity
    n1=en:5-oxoprolinase deficiency | n2=en:little to absent aspartylglucosaminuria activity | rel=r_associated | relid=0 | w=20
  1715. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:liver enzymes abnormal
    n1=en:5-oxoprolinase deficiency | n2=en:liver enzymes abnormal | rel=r_associated | relid=0 | w=20
  1716. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:liver phosphorylase kinase (phk) deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:liver phosphorylase kinase (phk) deficiency | rel=r_associated | relid=0 | w=20
  1717. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:long-chain dicarboxylic aciduria
    n1=en:5-oxoprolinase deficiency | n2=en:long-chain dicarboxylic aciduria | rel=r_associated | relid=0 | w=20
  1718. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:loss of heterozygosity in giant cell astrocytomas, angiomyolipomas, rhabdomyomas
    n1=en:5-oxoprolinase deficiency | n2=en:loss of heterozygosity in giant cell astrocytomas, angiomyolipomas, rhabdomyomas | rel=r_associated | relid=0 | w=20
  1719. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low 25-oh-vitamin d level
    n1=en:5-oxoprolinase deficiency | n2=en:low 25-oh-vitamin d level | rel=r_associated | relid=0 | w=20
  1720. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low acth level
    n1=en:5-oxoprolinase deficiency | n2=en:low acth level | rel=r_associated | relid=0 | w=20
  1721. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low alkaline phosphatase
    n1=en:5-oxoprolinase deficiency | n2=en:low alkaline phosphatase | rel=r_associated | relid=0 | w=20
  1722. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low cholesterol esterification rates
    n1=en:5-oxoprolinase deficiency | n2=en:low cholesterol esterification rates | rel=r_associated | relid=0 | w=20
  1723. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low copper and ceruloplasmin
    n1=en:5-oxoprolinase deficiency | n2=en:low copper and ceruloplasmin | rel=r_associated | relid=0 | w=20
  1724. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low csf creatine
    n1=en:5-oxoprolinase deficiency | n2=en:low csf creatine | rel=r_associated | relid=0 | w=20
  1725. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low csf creatinine
    n1=en:5-oxoprolinase deficiency | n2=en:low csf creatinine | rel=r_associated | relid=0 | w=20
  1726. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low fasting glucose (in some patients)
    n1=en:5-oxoprolinase deficiency | n2=en:low fasting glucose (in some patients) | rel=r_associated | relid=0 | w=20
  1727. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low free carnitine
    n1=en:5-oxoprolinase deficiency | n2=en:low free carnitine | rel=r_associated | relid=0 | w=20
  1728. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low growth hormone levels
    n1=en:5-oxoprolinase deficiency | n2=en:low growth hormone levels | rel=r_associated | relid=0 | w=20
  1729. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low ldl cholesterol
    n1=en:5-oxoprolinase deficiency | n2=en:low ldl cholesterol | rel=r_associated | relid=0 | w=20
  1730. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low leukocyte alkaline phosphatase activity
    n1=en:5-oxoprolinase deficiency | n2=en:low leukocyte alkaline phosphatase activity | rel=r_associated | relid=0 | w=20
  1731. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low level of c4 and c2
    n1=en:5-oxoprolinase deficiency | n2=en:low level of c4 and c2 | rel=r_associated | relid=0 | w=20
  1732. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low levels of serum mg(2+) in the absence of other electrolyte disturbances
    n1=en:5-oxoprolinase deficiency | n2=en:low levels of serum mg(2+) in the absence of other electrolyte disturbances | rel=r_associated | relid=0 | w=20
  1733. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low maximal oxygen uptake on exercise testing
    n1=en:5-oxoprolinase deficiency | n2=en:low maximal oxygen uptake on exercise testing | rel=r_associated | relid=0 | w=20
  1734. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low or absent adrenocorticotropic hormone (acth) in some patients
    n1=en:5-oxoprolinase deficiency | n2=en:low or absent adrenocorticotropic hormone (acth) in some patients | rel=r_associated | relid=0 | w=20
  1735. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low or absent follicle stimulating hormone (fsh)
    n1=en:5-oxoprolinase deficiency | n2=en:low or absent follicle stimulating hormone (fsh) | rel=r_associated | relid=0 | w=20
  1736. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low or absent iga levels
    n1=en:5-oxoprolinase deficiency | n2=en:low or absent iga levels | rel=r_associated | relid=0 | w=20
  1737. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low or absent prolactin (pl)
    n1=en:5-oxoprolinase deficiency | n2=en:low or absent prolactin (pl) | rel=r_associated | relid=0 | w=20
  1738. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low or absent thyroid-stimulating hormone (tsh)
    n1=en:5-oxoprolinase deficiency | n2=en:low or absent thyroid-stimulating hormone (tsh) | rel=r_associated | relid=0 | w=20
  1739. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low or absent thyrotropin (tsh)
    n1=en:5-oxoprolinase deficiency | n2=en:low or absent thyrotropin (tsh) | rel=r_associated | relid=0 | w=20
  1740. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low or low-normal serum t4
    n1=en:5-oxoprolinase deficiency | n2=en:low or low-normal serum t4 | rel=r_associated | relid=0 | w=20
  1741. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low or normal serum calcium
    n1=en:5-oxoprolinase deficiency | n2=en:low or normal serum calcium | rel=r_associated | relid=0 | w=20
  1742. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low or normal serum erythropoietin
    n1=en:5-oxoprolinase deficiency | n2=en:low or normal serum erythropoietin | rel=r_associated | relid=0 | w=20
  1743. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low or normal serum igm
    n1=en:5-oxoprolinase deficiency | n2=en:low or normal serum igm | rel=r_associated | relid=0 | w=20
  1744. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low or undetectable c-peptide
    n1=en:5-oxoprolinase deficiency | n2=en:low or undetectable c-peptide | rel=r_associated | relid=0 | w=20
  1745. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low or undetectable insulin
    n1=en:5-oxoprolinase deficiency | n2=en:low or undetectable insulin | rel=r_associated | relid=0 | w=20
  1746. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low plasma arginine
    n1=en:5-oxoprolinase deficiency | n2=en:low plasma arginine | rel=r_associated | relid=0 | w=20
  1747. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low plasma citrulline
    n1=en:5-oxoprolinase deficiency | n2=en:low plasma citrulline | rel=r_associated | relid=0 | w=20
  1748. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low plasma methionine
    n1=en:5-oxoprolinase deficiency | n2=en:low plasma methionine | rel=r_associated | relid=0 | w=20
  1749. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low plasma triglyceride level
    n1=en:5-oxoprolinase deficiency | n2=en:low plasma triglyceride level | rel=r_associated | relid=0 | w=20
  1750. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low plasma tryptophan (inflammatory type b)
    n1=en:5-oxoprolinase deficiency | n2=en:low plasma tryptophan (inflammatory type b) | rel=r_associated | relid=0 | w=20
  1751. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low pyruvate carboxylase activity in liver and cultured fibroblasts
    n1=en:5-oxoprolinase deficiency | n2=en:low pyruvate carboxylase activity in liver and cultured fibroblasts | rel=r_associated | relid=0 | w=20
  1752. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low rai (radioactive iodine) uptake
    n1=en:5-oxoprolinase deficiency | n2=en:low rai (radioactive iodine) uptake | rel=r_associated | relid=0 | w=20
  1753. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low serum alkaline phosphatase in heterozygotes
    n1=en:5-oxoprolinase deficiency | n2=en:low serum alkaline phosphatase in heterozygotes | rel=r_associated | relid=0 | w=20
  1754. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low serum alpha-fetoprotein (recessive)
    n1=en:5-oxoprolinase deficiency | n2=en:low serum alpha-fetoprotein (recessive) | rel=r_associated | relid=0 | w=20
  1755. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low serum ceruloplasmin
    n1=en:5-oxoprolinase deficiency | n2=en:low serum ceruloplasmin | rel=r_associated | relid=0 | w=20
  1756. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low serum igg and iga
    n1=en:5-oxoprolinase deficiency | n2=en:low serum igg and iga | rel=r_associated | relid=0 | w=20
  1757. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low serum levels of branched-chain amino acids
    n1=en:5-oxoprolinase deficiency | n2=en:low serum levels of branched-chain amino acids | rel=r_associated | relid=0 | w=20
  1758. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low serum levels of ketone bodies
    n1=en:5-oxoprolinase deficiency | n2=en:low serum levels of ketone bodies | rel=r_associated | relid=0 | w=20
  1759. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low serum magnesium
    n1=en:5-oxoprolinase deficiency | n2=en:low serum magnesium | rel=r_associated | relid=0 | w=20
  1760. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low to normal plasma methionine
    n1=en:5-oxoprolinase deficiency | n2=en:low to normal plasma methionine | rel=r_associated | relid=0 | w=20
  1761. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low to normal tsh (values may vary depending on the measurement methods used)
    n1=en:5-oxoprolinase deficiency | n2=en:low to normal tsh (values may vary depending on the measurement methods used) | rel=r_associated | relid=0 | w=20
  1762. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low to very low hdl cholesterol
    n1=en:5-oxoprolinase deficiency | n2=en:low to very low hdl cholesterol | rel=r_associated | relid=0 | w=20
  1763. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low urinary excretion of neutral 17-ketosteroids
    n1=en:5-oxoprolinase deficiency | n2=en:low urinary excretion of neutral 17-ketosteroids | rel=r_associated | relid=0 | w=20
  1764. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low urinary orotic acid
    n1=en:5-oxoprolinase deficiency | n2=en:low urinary orotic acid | rel=r_associated | relid=0 | w=20
  1765. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low-molecular-weight proteinuria
    n1=en:5-oxoprolinase deficiency | n2=en:low-molecular-weight proteinuria | rel=r_associated | relid=0 | w=20
  1766. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low-normal igm
    n1=en:5-oxoprolinase deficiency | n2=en:low-normal igm | rel=r_associated | relid=0 | w=20
  1767. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low-normal platelet count (89-290 x 10(9)/l)
    n1=en:5-oxoprolinase deficiency | n2=en:low-normal platelet count (89-290 x 10(9)/l) | rel=r_associated | relid=0 | w=20
  1768. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:low-to-normal platelet count
    n1=en:5-oxoprolinase deficiency | n2=en:low-to-normal platelet count | rel=r_associated | relid=0 | w=20
  1769. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:lower total cholesterol
    n1=en:5-oxoprolinase deficiency | n2=en:lower total cholesterol | rel=r_associated | relid=0 | w=20
  1770. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:lysosomal-like storage vacuoles in various tissues
    n1=en:5-oxoprolinase deficiency | n2=en:lysosomal-like storage vacuoles in various tissues | rel=r_associated | relid=0 | w=20
  1771. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:lysyl hydroxylase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:lysyl hydroxylase deficiency | rel=r_associated | relid=0 | w=20
  1772. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:manouvrier syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:manouvrier syndrome | rel=r_associated | relid=0 | w=20
  1773. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:maple-tree syrup disease
    n1=en:5-oxoprolinase deficiency | n2=en:maple-tree syrup disease | rel=r_associated | relid=0 | w=20
  1774. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:marked elevation of erythrocyte sedimentation rate
    n1=en:5-oxoprolinase deficiency | n2=en:marked elevation of erythrocyte sedimentation rate | rel=r_associated | relid=0 | w=20
  1775. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:marked elevation of serum c-reactive protein level (crp 123260)
    n1=en:5-oxoprolinase deficiency | n2=en:marked elevation of serum c-reactive protein level (crp 123260) | rel=r_associated | relid=0 | w=20
  1776. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:marked hypoalphalipoproteinemia (in some patients)
    n1=en:5-oxoprolinase deficiency | n2=en:marked hypoalphalipoproteinemia (in some patients) | rel=r_associated | relid=0 | w=20
  1777. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:marked hypobetalipoproteinemia
    n1=en:5-oxoprolinase deficiency | n2=en:marked hypobetalipoproteinemia | rel=r_associated | relid=0 | w=20
  1778. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:markedly decreased coproporphyrinogen oxidase activity (harderoporphyria, lymphocytes)
    n1=en:5-oxoprolinase deficiency | n2=en:markedly decreased coproporphyrinogen oxidase activity (harderoporphyria, lymphocytes) | rel=r_associated | relid=0 | w=20
  1779. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:markedly decreased or absent serum 1,25-dihydroxyvitamin d3
    n1=en:5-oxoprolinase deficiency | n2=en:markedly decreased or absent serum 1,25-dihydroxyvitamin d3 | rel=r_associated | relid=0 | w=20
  1780. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:markedly increased serum creatine kinase
    n1=en:5-oxoprolinase deficiency | n2=en:markedly increased serum creatine kinase | rel=r_associated | relid=0 | w=20
  1781. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:markedly reduced igg levels
    n1=en:5-oxoprolinase deficiency | n2=en:markedly reduced igg levels | rel=r_associated | relid=0 | w=20
  1782. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:mean platelet volume (mpv) 12.6fl
    n1=en:5-oxoprolinase deficiency | n2=en:mean platelet volume (mpv) 12.6fl | rel=r_associated | relid=0 | w=20
  1783. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:median mean platelet volume (mpv) 12.5fl
    n1=en:5-oxoprolinase deficiency | n2=en:median mean platelet volume (mpv) 12.5fl | rel=r_associated | relid=0 | w=20
  1784. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:median mean platelet volume (mpv) 18fl
    n1=en:5-oxoprolinase deficiency | n2=en:median mean platelet volume (mpv) 18fl | rel=r_associated | relid=0 | w=20
  1785. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:mendelian susceptibility to mycobacterial disease due to complete interleukin 12 subunit beta deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:mendelian susceptibility to mycobacterial disease due to complete interleukin 12 subunit beta deficiency | rel=r_associated | relid=0 | w=20
  1786. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:mesoaxial synostotic syndactyly with phalangeal reduction syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:mesoaxial synostotic syndactyly with phalangeal reduction syndrome | rel=r_associated | relid=0 | w=20
  1787. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:methemoglobinemia
    n1=en:5-oxoprolinase deficiency | n2=en:methemoglobinemia | rel=r_associated | relid=0 | w=20
  1788. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:microcephaly albinism digital anomalies syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:microcephaly albinism digital anomalies syndrome | rel=r_associated | relid=0 | w=20
  1789. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:moyamoya disease with early onset achalasia
    n1=en:5-oxoprolinase deficiency | n2=en:moyamoya disease with early onset achalasia | rel=r_associated | relid=0 | w=20
  1790. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:mucopolysaccharidosis i
    n1=en:5-oxoprolinase deficiency | n2=en:mucopolysaccharidosis i | rel=r_associated | relid=0 | w=20
  1791. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:multiple acyl-coa dehydrogenase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:multiple acyl-coa dehydrogenase deficiency | rel=r_associated | relid=0 | w=20
  1792. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:muscle d-lactate dehydrogenase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:muscle d-lactate dehydrogenase deficiency | rel=r_associated | relid=0 | w=20
  1793. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:myoglobinuria, recurrent
    n1=en:5-oxoprolinase deficiency | n2=en:myoglobinuria, recurrent | rel=r_associated | relid=0 | w=20
  1794. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:najjar syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:najjar syndrome | rel=r_associated | relid=0 | w=20
  1795. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:Niemann-Pick disease
    n1=en:5-oxoprolinase deficiency | n2=en:Niemann-Pick disease | rel=r_associated | relid=0 | w=20
  1796. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:nonketotic hypoglycemia
    n1=en:5-oxoprolinase deficiency | n2=en:nonketotic hypoglycemia | rel=r_associated | relid=0 | w=20
  1797. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:oculocutaneous albinism type 6
    n1=en:5-oxoprolinase deficiency | n2=en:oculocutaneous albinism type 6 | rel=r_associated | relid=0 | w=20
  1798. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:oplah gene
    n1=en:5-oxoprolinase deficiency | n2=en:oplah gene | rel=r_associated | relid=0 | w=20
  1799. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:oplah, 1-bp ins, 2601c
    n1=en:5-oxoprolinase deficiency | n2=en:oplah, 1-bp ins, 2601c | rel=r_associated | relid=0 | w=20
  1800. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:oplah, ser323arg
    n1=en:5-oxoprolinase deficiency | n2=en:oplah, ser323arg | rel=r_associated | relid=0 | w=20
  1801. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:oplah, val1089ile (dbsnp rs185836803)
    n1=en:5-oxoprolinase deficiency | n2=en:oplah, val1089ile (dbsnp rs185836803) | rel=r_associated | relid=0 | w=20
  1802. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:palmoplantar keratoderma, 46,xx sex reversal, predisposition to squamous cell carcinoma syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:palmoplantar keratoderma, 46,xx sex reversal, predisposition to squamous cell carcinoma syndrome | rel=r_associated | relid=0 | w=20
  1803. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:pancreatic alpha-amylase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:pancreatic alpha-amylase deficiency | rel=r_associated | relid=0 | w=20
  1804. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:parathyroid hormone level increased
    n1=en:5-oxoprolinase deficiency | n2=en:parathyroid hormone level increased | rel=r_associated | relid=0 | w=20
  1805. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:pelviscapular dysplasia
    n1=en:5-oxoprolinase deficiency | n2=en:pelviscapular dysplasia | rel=r_associated | relid=0 | w=20
  1806. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:peroxisomal disorder
    n1=en:5-oxoprolinase deficiency | n2=en:peroxisomal disorder | rel=r_associated | relid=0 | w=20
  1807. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:pili torti onychodysplasia syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:pili torti onychodysplasia syndrome | rel=r_associated | relid=0 | w=20
  1808. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:plasma aldosterone normal
    n1=en:5-oxoprolinase deficiency | n2=en:plasma aldosterone normal | rel=r_associated | relid=0 | w=20
  1809. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:platelet aggregation decreased
    n1=en:5-oxoprolinase deficiency | n2=en:platelet aggregation decreased | rel=r_associated | relid=0 | w=20
  1810. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:platelet function test normal
    n1=en:5-oxoprolinase deficiency | n2=en:platelet function test normal | rel=r_associated | relid=0 | w=20
  1811. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:polycythemia
    n1=en:5-oxoprolinase deficiency | n2=en:polycythemia | rel=r_associated | relid=0 | w=20
  1812. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:positive antinuclear antibody test
    n1=en:5-oxoprolinase deficiency | n2=en:positive antinuclear antibody test | rel=r_associated | relid=0 | w=20
  1813. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:premature separation of centromeric heterochromatin
    n1=en:5-oxoprolinase deficiency | n2=en:premature separation of centromeric heterochromatin | rel=r_associated | relid=0 | w=20
  1814. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:primary immunodeficiency syndrome due to p14 deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:primary immunodeficiency syndrome due to p14 deficiency | rel=r_associated | relid=0 | w=20
  1815. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:progeria
    n1=en:5-oxoprolinase deficiency | n2=en:progeria | rel=r_associated | relid=0 | w=20
  1816. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:prolonged partial thromboplastin time
    n1=en:5-oxoprolinase deficiency | n2=en:prolonged partial thromboplastin time | rel=r_associated | relid=0 | w=20
  1817. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:prothrombin time increased
    n1=en:5-oxoprolinase deficiency | n2=en:prothrombin time increased | rel=r_associated | relid=0 | w=20
  1818. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:pseudohypoparathyroidism
    n1=en:5-oxoprolinase deficiency | n2=en:pseudohypoparathyroidism | rel=r_associated | relid=0 | w=20
  1819. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:pyridoxine dependency syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:pyridoxine dependency syndrome | rel=r_associated | relid=0 | w=20
  1820. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:pyruvate dehydrogenase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:pyruvate dehydrogenase deficiency | rel=r_associated | relid=0 | w=20
  1821. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:pyruvate kinase deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:pyruvate kinase deficiency | rel=r_associated | relid=0 | w=20
  1822. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:raised tsh level
    n1=en:5-oxoprolinase deficiency | n2=en:raised tsh level | rel=r_associated | relid=0 | w=20
  1823. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:reactive hypoglycemia
    n1=en:5-oxoprolinase deficiency | n2=en:reactive hypoglycemia | rel=r_associated | relid=0 | w=20
  1824. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:renal dysplasia - limb defects syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:renal dysplasia - limb defects syndrome | rel=r_associated | relid=0 | w=20
  1825. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:resistance to activated protein c due to factor v leiden
    n1=en:5-oxoprolinase deficiency | n2=en:resistance to activated protein c due to factor v leiden | rel=r_associated | relid=0 | w=20
  1826. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:reticulocytosis
    n1=en:5-oxoprolinase deficiency | n2=en:reticulocytosis | rel=r_associated | relid=0 | w=20
  1827. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:robinow-like syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:robinow-like syndrome | rel=r_associated | relid=0 | w=20
  1828. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:secondarily decreased activity of the pyruvate dehydrogenase complex (pdc)
    n1=en:5-oxoprolinase deficiency | n2=en:secondarily decreased activity of the pyruvate dehydrogenase complex (pdc) | rel=r_associated | relid=0 | w=20
  1829. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:serum bicarbonate increased
    n1=en:5-oxoprolinase deficiency | n2=en:serum bicarbonate increased | rel=r_associated | relid=0 | w=20
  1830. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:serum cholesterol raised
    n1=en:5-oxoprolinase deficiency | n2=en:serum cholesterol raised | rel=r_associated | relid=0 | w=20
  1831. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:serum growth hormone increased
    n1=en:5-oxoprolinase deficiency | n2=en:serum growth hormone increased | rel=r_associated | relid=0 | w=20
  1832. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:serum iron normal
    n1=en:5-oxoprolinase deficiency | n2=en:serum iron normal | rel=r_associated | relid=0 | w=20
  1833. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:serum transaminase increased
    n1=en:5-oxoprolinase deficiency | n2=en:serum transaminase increased | rel=r_associated | relid=0 | w=20
  1834. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:specific enzyme deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:specific enzyme deficiency | rel=r_associated | relid=0 | w=20
  1835. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:split-hand/foot malformation 3
    n1=en:5-oxoprolinase deficiency | n2=en:split-hand/foot malformation 3 | rel=r_associated | relid=0 | w=20
  1836. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:spondyloepiphyseal dysplasia tarda kohn type
    n1=en:5-oxoprolinase deficiency | n2=en:spondyloepiphyseal dysplasia tarda kohn type | rel=r_associated | relid=0 | w=20
  1837. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:spondylometaphyseal dysplasia with cone-rod dystrophy syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:spondylometaphyseal dysplasia with cone-rod dystrophy syndrome | rel=r_associated | relid=0 | w=20
  1838. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:steroid metabolism, inborn errors
    n1=en:5-oxoprolinase deficiency | n2=en:steroid metabolism, inborn errors | rel=r_associated | relid=0 | w=20
  1839. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:sweat test normal
    n1=en:5-oxoprolinase deficiency | n2=en:sweat test normal | rel=r_associated | relid=0 | w=20
  1840. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:Tay-Sachs disease
    n1=en:5-oxoprolinase deficiency | n2=en:Tay-Sachs disease | rel=r_associated | relid=0 | w=20
  1841. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:thiamin-responsive maple syrup urine disease
    n1=en:5-oxoprolinase deficiency | n2=en:thiamin-responsive maple syrup urine disease | rel=r_associated | relid=0 | w=20
  1842. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:thrombocytopenia
    n1=en:5-oxoprolinase deficiency | n2=en:thrombocytopenia | rel=r_associated | relid=0 | w=20
  1843. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:thrombopenia
    n1=en:5-oxoprolinase deficiency | n2=en:thrombopenia | rel=r_associated | relid=0 | w=20
  1844. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:thyroid dyshormonogenesis 3
    n1=en:5-oxoprolinase deficiency | n2=en:thyroid dyshormonogenesis 3 | rel=r_associated | relid=0 | w=20
  1845. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:thyroid dyshormonogenesis 5
    n1=en:5-oxoprolinase deficiency | n2=en:thyroid dyshormonogenesis 5 | rel=r_associated | relid=0 | w=20
  1846. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:transaminitis
    n1=en:5-oxoprolinase deficiency | n2=en:transaminitis | rel=r_associated | relid=0 | w=20
  1847. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:transferase deficiency galactosemia
    n1=en:5-oxoprolinase deficiency | n2=en:transferase deficiency galactosemia | rel=r_associated | relid=0 | w=20
  1848. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:transferrin saturation increased
    n1=en:5-oxoprolinase deficiency | n2=en:transferrin saturation increased | rel=r_associated | relid=0 | w=20
  1849. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:triglyceride decreased
    n1=en:5-oxoprolinase deficiency | n2=en:triglyceride decreased | rel=r_associated | relid=0 | w=20
  1850. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:type a 14
    n1=en:5-oxoprolinase deficiency | n2=en:type a 14 | rel=r_associated | relid=0 | w=20
  1851. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:tyrosinemia type II
    n1=en:5-oxoprolinase deficiency | n2=en:tyrosinemia type II | rel=r_associated | relid=0 | w=20
  1852. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:ugt1a1*28 polymorphism
    n1=en:5-oxoprolinase deficiency | n2=en:ugt1a1*28 polymorphism | rel=r_associated | relid=0 | w=20
  1853. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:unclassified metabolic disorder
    n1=en:5-oxoprolinase deficiency | n2=en:unclassified metabolic disorder | rel=r_associated | relid=0 | w=20
  1854. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:urea cycle metabolism disorder
    n1=en:5-oxoprolinase deficiency | n2=en:urea cycle metabolism disorder | rel=r_associated | relid=0 | w=20
  1855. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:vitamin d deficiency
    n1=en:5-oxoprolinase deficiency | n2=en:vitamin d deficiency | rel=r_associated | relid=0 | w=20
  1856. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:vomitus
    n1=en:5-oxoprolinase deficiency | n2=en:vomitus | rel=r_associated | relid=0 | w=20
  1857. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:wolman's disease
    n1=en:5-oxoprolinase deficiency | n2=en:wolman's disease | rel=r_associated | relid=0 | w=20
  1858. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:Wolman's disease
    n1=en:5-oxoprolinase deficiency | n2=en:Wolman's disease | rel=r_associated | relid=0 | w=20
  1859. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:xanthine nephrolithiasis
    n1=en:5-oxoprolinase deficiency | n2=en:xanthine nephrolithiasis | rel=r_associated | relid=0 | w=20
  1860. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:yemenite deaf-blind hypopigmentation syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:yemenite deaf-blind hypopigmentation syndrome | rel=r_associated | relid=0 | w=20
  1861. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:Zellweger syndrome
    n1=en:5-oxoprolinase deficiency | n2=en:Zellweger syndrome | rel=r_associated | relid=0 | w=20
  1862. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> en:zellweger-like syndrome without peroxisomal anomaly
    n1=en:5-oxoprolinase deficiency | n2=en:zellweger-like syndrome without peroxisomal anomaly | rel=r_associated | relid=0 | w=20
  1863. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> fucosidose
    n1=en:5-oxoprolinase deficiency | n2=fucosidose | rel=r_associated | relid=0 | w=20
  1864. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> galactosurie
    n1=en:5-oxoprolinase deficiency | n2=galactosurie | rel=r_associated | relid=0 | w=20
  1865. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> glutathionémie
    n1=en:5-oxoprolinase deficiency | n2=glutathionémie | rel=r_associated | relid=0 | w=20
  1866. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> glycogénose
    n1=en:5-oxoprolinase deficiency | n2=glycogénose | rel=r_associated | relid=0 | w=20
  1867. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> hématurie macroscopique
    n1=en:5-oxoprolinase deficiency | n2=hématurie macroscopique | rel=r_associated | relid=0 | w=20
  1868. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> hématurie microscopique
    n1=en:5-oxoprolinase deficiency | n2=hématurie microscopique | rel=r_associated | relid=0 | w=20
  1869. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> hérédité autosomale récessive
    n1=en:5-oxoprolinase deficiency | n2=hérédité autosomale récessive | rel=r_associated | relid=0 | w=20
  1870. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> histidinémie
    n1=en:5-oxoprolinase deficiency | n2=histidinémie | rel=r_associated | relid=0 | w=20
  1871. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> histiocytose sinusale hémophagocytaire
    n1=en:5-oxoprolinase deficiency | n2=histiocytose sinusale hémophagocytaire | rel=r_associated | relid=0 | w=20
  1872. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> homocarnosinose
    n1=en:5-oxoprolinase deficiency | n2=homocarnosinose | rel=r_associated | relid=0 | w=20
  1873. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> homocystéinémie
    n1=en:5-oxoprolinase deficiency | n2=homocystéinémie | rel=r_associated | relid=0 | w=20
  1874. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> hydrocortisone diminuée
    n1=en:5-oxoprolinase deficiency | n2=hydrocortisone diminuée | rel=r_associated | relid=0 | w=20
  1875. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> hypercalcémie
    n1=en:5-oxoprolinase deficiency | n2=hypercalcémie | rel=r_associated | relid=0 | w=20
  1876. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> hypercalciurie
    n1=en:5-oxoprolinase deficiency | n2=hypercalciurie | rel=r_associated | relid=0 | w=20
  1877. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> hyperlipémie
    n1=en:5-oxoprolinase deficiency | n2=hyperlipémie | rel=r_associated | relid=0 | w=20
  1878. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> hyperlipidémie
    n1=en:5-oxoprolinase deficiency | n2=hyperlipidémie | rel=r_associated | relid=0 | w=20
  1879. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> hyperoxalémie
    n1=en:5-oxoprolinase deficiency | n2=hyperoxalémie | rel=r_associated | relid=0 | w=20
  1880. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> hyperoxalurie primaire
    n1=en:5-oxoprolinase deficiency | n2=hyperoxalurie primaire | rel=r_associated | relid=0 | w=20
  1881. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> hyperoxalurie primitive
    n1=en:5-oxoprolinase deficiency | n2=hyperoxalurie primitive | rel=r_associated | relid=0 | w=20
  1882. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> hyperphosphatémie
    n1=en:5-oxoprolinase deficiency | n2=hyperphosphatémie | rel=r_associated | relid=0 | w=20
  1883. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> hyperplasie congénitale des surrénales
    n1=en:5-oxoprolinase deficiency | n2=hyperplasie congénitale des surrénales | rel=r_associated | relid=0 | w=20
  1884. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> hypertriglycéridémie
    n1=en:5-oxoprolinase deficiency | n2=hypertriglycéridémie | rel=r_associated | relid=0 | w=20
  1885. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> hypo-albuminémie
    n1=en:5-oxoprolinase deficiency | n2=hypo-albuminémie | rel=r_associated | relid=0 | w=20
  1886. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> hypo-bêta-lipoprotéinémie
    n1=en:5-oxoprolinase deficiency | n2=hypo-bêta-lipoprotéinémie | rel=r_associated | relid=0 | w=20
  1887. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> hypo-bêtalipoprotéinémie
    n1=en:5-oxoprolinase deficiency | n2=hypo-bêtalipoprotéinémie | rel=r_associated | relid=0 | w=20
  1888. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> hypo-intense (signal IRM)
    n1=en:5-oxoprolinase deficiency | n2=hypo-intense (signal IRM) | rel=r_associated | relid=0 | w=20
  1889. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> hypo-uricémie
    n1=en:5-oxoprolinase deficiency | n2=hypo-uricémie | rel=r_associated | relid=0 | w=20
  1890. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> hypoalbuminémie
    n1=en:5-oxoprolinase deficiency | n2=hypoalbuminémie | rel=r_associated | relid=0 | w=20
  1891. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> hypobêtalipoprotéinémie
    n1=en:5-oxoprolinase deficiency | n2=hypobêtalipoprotéinémie | rel=r_associated | relid=0 | w=20
  1892. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> hypocalcémie
    n1=en:5-oxoprolinase deficiency | n2=hypocalcémie | rel=r_associated | relid=0 | w=20
  1893. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> hypofibrinogénémie
    n1=en:5-oxoprolinase deficiency | n2=hypofibrinogénémie | rel=r_associated | relid=0 | w=20
  1894. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> hypogammaglobulinémie
    n1=en:5-oxoprolinase deficiency | n2=hypogammaglobulinémie | rel=r_associated | relid=0 | w=20
  1895. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> hyponatrémie
    n1=en:5-oxoprolinase deficiency | n2=hyponatrémie | rel=r_associated | relid=0 | w=20
  1896. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> hypophosphatasie foetale
    n1=en:5-oxoprolinase deficiency | n2=hypophosphatasie foetale | rel=r_associated | relid=0 | w=20
  1897. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> hypophosphatasie infantile
    n1=en:5-oxoprolinase deficiency | n2=hypophosphatasie infantile | rel=r_associated | relid=0 | w=20
  1898. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> intolérance au fructose
    n1=en:5-oxoprolinase deficiency | n2=intolérance au fructose | rel=r_associated | relid=0 | w=20
  1899. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> lactate augmenté
    n1=en:5-oxoprolinase deficiency | n2=lactate augmenté | rel=r_associated | relid=0 | w=20
  1900. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> lactate élevé
    n1=en:5-oxoprolinase deficiency | n2=lactate élevé | rel=r_associated | relid=0 | w=20
  1901. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> leucinose
    n1=en:5-oxoprolinase deficiency | n2=leucinose | rel=r_associated | relid=0 | w=20
  1902. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> lipofuscinose neuronale céroïde
    n1=en:5-oxoprolinase deficiency | n2=lipofuscinose neuronale céroïde | rel=r_associated | relid=0 | w=20
  1903. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> lipofuscinose neuronale céroïde infantile finlandaise
    n1=en:5-oxoprolinase deficiency | n2=lipofuscinose neuronale céroïde infantile finlandaise | rel=r_associated | relid=0 | w=20
  1904. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> maladie de dubin-johnson
    n1=en:5-oxoprolinase deficiency | n2=maladie de dubin-johnson | rel=r_associated | relid=0 | w=20
  1905. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> maladie de Niemann-Pick
    n1=en:5-oxoprolinase deficiency | n2=maladie de Niemann-Pick | rel=r_associated | relid=0 | w=20
  1906. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> maladie de Tay-Sachs
    n1=en:5-oxoprolinase deficiency | n2=maladie de Tay-Sachs | rel=r_associated | relid=0 | w=20
  1907. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> maladie de tay-sachs
    n1=en:5-oxoprolinase deficiency | n2=maladie de tay-sachs | rel=r_associated | relid=0 | w=20
  1908. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> maladie de Tay-sachs
    n1=en:5-oxoprolinase deficiency | n2=maladie de Tay-sachs | rel=r_associated | relid=0 | w=20
  1909. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> maladie de wolman
    n1=en:5-oxoprolinase deficiency | n2=maladie de wolman | rel=r_associated | relid=0 | w=20
  1910. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> maladie de Wolman
    n1=en:5-oxoprolinase deficiency | n2=maladie de Wolman | rel=r_associated | relid=0 | w=20
  1911. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> maladie des urines à l'odeur de sirop d'érable
    n1=en:5-oxoprolinase deficiency | n2=maladie des urines à l'odeur de sirop d'érable | rel=r_associated | relid=0 | w=20
  1912. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> maladie des urines avec odeur de sirop erable
    n1=en:5-oxoprolinase deficiency | n2=maladie des urines avec odeur de sirop erable | rel=r_associated | relid=0 | w=20
  1913. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> maladie du sirop d'érable
    n1=en:5-oxoprolinase deficiency | n2=maladie du sirop d'érable | rel=r_associated | relid=0 | w=20
  1914. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> maladie lysosomique de surcharge
    n1=en:5-oxoprolinase deficiency | n2=maladie lysosomique de surcharge | rel=r_associated | relid=0 | w=20
  1915. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> méthémoglobinémie
    n1=en:5-oxoprolinase deficiency | n2=méthémoglobinémie | rel=r_associated | relid=0 | w=20
  1916. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> mucolipidose II
    n1=en:5-oxoprolinase deficiency | n2=mucolipidose II | rel=r_associated | relid=0 | w=20
  1917. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> mucolipidose type ii
    n1=en:5-oxoprolinase deficiency | n2=mucolipidose type ii | rel=r_associated | relid=0 | w=20
  1918. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> mucolipidose type II
    n1=en:5-oxoprolinase deficiency | n2=mucolipidose type II | rel=r_associated | relid=0 | w=20
  1919. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> mucopolysaccharidose de type I
    n1=en:5-oxoprolinase deficiency | n2=mucopolysaccharidose de type I | rel=r_associated | relid=0 | w=20
  1920. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> neuro-acanthocytose
    n1=en:5-oxoprolinase deficiency | n2=neuro-acanthocytose | rel=r_associated | relid=0 | w=20
  1921. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> nystagmus congénital isolé
    n1=en:5-oxoprolinase deficiency | n2=nystagmus congénital isolé | rel=r_associated | relid=0 | w=20
  1922. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> oxalose
    n1=en:5-oxoprolinase deficiency | n2=oxalose | rel=r_associated | relid=0 | w=20
  1923. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> oxalose primitive
    n1=en:5-oxoprolinase deficiency | n2=oxalose primitive | rel=r_associated | relid=0 | w=20
  1924. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> oxaloses
    n1=en:5-oxoprolinase deficiency | n2=oxaloses | rel=r_associated | relid=0 | w=20
  1925. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> polycythemia
    n1=en:5-oxoprolinase deficiency | n2=polycythemia | rel=r_associated | relid=0 | w=20
  1926. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> polyglobulie
    n1=en:5-oxoprolinase deficiency | n2=polyglobulie | rel=r_associated | relid=0 | w=20
  1927. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> progeria
    n1=en:5-oxoprolinase deficiency | n2=progeria | rel=r_associated | relid=0 | w=20
  1928. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> progéria
    n1=en:5-oxoprolinase deficiency | n2=progéria | rel=r_associated | relid=0 | w=20
  1929. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> protoproporphyrie érythropoïétique
    n1=en:5-oxoprolinase deficiency | n2=protoproporphyrie érythropoïétique | rel=r_associated | relid=0 | w=20
  1930. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> pseudo-hypoparathyroïdie
    n1=en:5-oxoprolinase deficiency | n2=pseudo-hypoparathyroïdie | rel=r_associated | relid=0 | w=20
  1931. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> pseudo-hypoparathyroïdisme
    n1=en:5-oxoprolinase deficiency | n2=pseudo-hypoparathyroïdisme | rel=r_associated | relid=0 | w=20
  1932. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> pseudohypoparathyroïdie
    n1=en:5-oxoprolinase deficiency | n2=pseudohypoparathyroïdie | rel=r_associated | relid=0 | w=20
  1933. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> pseudohypoparathyroïdisme
    n1=en:5-oxoprolinase deficiency | n2=pseudohypoparathyroïdisme | rel=r_associated | relid=0 | w=20
  1934. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> réparation défectueuse de l'ADN
    n1=en:5-oxoprolinase deficiency | n2=réparation défectueuse de l'ADN | rel=r_associated | relid=0 | w=20
  1935. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> rétention des chylomicrons (maladie de la)
    n1=en:5-oxoprolinase deficiency | n2=rétention des chylomicrons (maladie de la) | rel=r_associated | relid=0 | w=20
  1936. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> semialdéhyde succinique-déshydrogénase (déficit en)
    n1=en:5-oxoprolinase deficiency | n2=semialdéhyde succinique-déshydrogénase (déficit en) | rel=r_associated | relid=0 | w=20
  1937. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> sirop d'érable (urine à odeur de)
    n1=en:5-oxoprolinase deficiency | n2=sirop d'érable (urine à odeur de) | rel=r_associated | relid=0 | w=20
  1938. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> syndrome de déficit en immunoglobulines
    n1=en:5-oxoprolinase deficiency | n2=syndrome de déficit en immunoglobulines | rel=r_associated | relid=0 | w=20
  1939. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> syndrome de dubin-johnson
    n1=en:5-oxoprolinase deficiency | n2=syndrome de dubin-johnson | rel=r_associated | relid=0 | w=20
  1940. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> syndrome de Dubin-Johnson
    n1=en:5-oxoprolinase deficiency | n2=syndrome de Dubin-Johnson | rel=r_associated | relid=0 | w=20
  1941. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> syndrome de Laurence-Moon
    n1=en:5-oxoprolinase deficiency | n2=syndrome de Laurence-Moon | rel=r_associated | relid=0 | w=20
  1942. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> syndrome de synostose spondylo-carpo-tarsale
    n1=en:5-oxoprolinase deficiency | n2=syndrome de synostose spondylo-carpo-tarsale | rel=r_associated | relid=0 | w=20
  1943. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> syndrome de Zellweger
    n1=en:5-oxoprolinase deficiency | n2=syndrome de Zellweger | rel=r_associated | relid=0 | w=20
  1944. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> thrombocytopénie
    n1=en:5-oxoprolinase deficiency | n2=thrombocytopénie | rel=r_associated | relid=0 | w=20
  1945. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> thrombopénie
    n1=en:5-oxoprolinase deficiency | n2=thrombopénie | rel=r_associated | relid=0 | w=20
  1946. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> v+
    n1=en:5-oxoprolinase deficiency | n2=v+ | rel=r_associated | relid=0 | w=20
  1947. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> V+
    n1=en:5-oxoprolinase deficiency | n2=V+ | rel=r_associated | relid=0 | w=20
  1948. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> van Bogaert (xanthomatose cérébrotendineuse de)
    n1=en:5-oxoprolinase deficiency | n2=van Bogaert (xanthomatose cérébrotendineuse de) | rel=r_associated | relid=0 | w=20
  1949. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> vomissements
    n1=en:5-oxoprolinase deficiency | n2=vomissements | rel=r_associated | relid=0 | w=20
  1950. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> Walker-Warburg (syndrome de)
    n1=en:5-oxoprolinase deficiency | n2=Walker-Warburg (syndrome de) | rel=r_associated | relid=0 | w=20
  1951. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> Warburg
    n1=en:5-oxoprolinase deficiency | n2=Warburg | rel=r_associated | relid=0 | w=20
  1952. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> Wolman (maladie de)
    n1=en:5-oxoprolinase deficiency | n2=Wolman (maladie de) | rel=r_associated | relid=0 | w=20
  1953. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> xanthomatose cérébro-tendineuse
    n1=en:5-oxoprolinase deficiency | n2=xanthomatose cérébro-tendineuse | rel=r_associated | relid=0 | w=20
  1954. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> xanthomatose cérébrotendineuse
    n1=en:5-oxoprolinase deficiency | n2=xanthomatose cérébrotendineuse | rel=r_associated | relid=0 | w=20
  1955. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> xanthomatose cérébrotendineuse de Van Bogaert
    n1=en:5-oxoprolinase deficiency | n2=xanthomatose cérébrotendineuse de Van Bogaert | rel=r_associated | relid=0 | w=20
  1956. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> xeroderma pigmentosum
    n1=en:5-oxoprolinase deficiency | n2=xeroderma pigmentosum | rel=r_associated | relid=0 | w=20
  1957. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> Xeroderma pigmentosum
    n1=en:5-oxoprolinase deficiency | n2=Xeroderma pigmentosum | rel=r_associated | relid=0 | w=20
  1958. en:5-oxoprolinase deficiency -- r_associated #0: 20 / 0.625 -> xérodermite pigmentaire
    n1=en:5-oxoprolinase deficiency | n2=xérodermite pigmentaire | rel=r_associated | relid=0 | w=20
≈ 2247 relations entrantes

  1. en:maple syrup urine disease --- r_associated #0: 699 --> en:5-oxoprolinase deficiency
    n1=en:maple syrup urine disease | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=699
  2. leucinose --- r_associated #0: 566.72 --> en:5-oxoprolinase deficiency
    n1=leucinose | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=566.72
  3. maladie du sirop d'érable --- r_associated #0: 563.79 --> en:5-oxoprolinase deficiency
    n1=maladie du sirop d'érable | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=563.79
  4. en:branched-chain ketoaciduria --- r_associated #0: 520 --> en:5-oxoprolinase deficiency
    n1=en:branched-chain ketoaciduria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=520
  5. en:vomiting --- r_associated #0: 445 --> en:5-oxoprolinase deficiency
    n1=en:vomiting | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=445
  6. vomissement --- r_associated #0: 443 --> en:5-oxoprolinase deficiency
    n1=vomissement | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=443
  7. entérocolite --- r_associated #0: 389 --> en:5-oxoprolinase deficiency
    n1=entérocolite | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=389
  8. en:enterocolitis --- r_associated #0: 385 --> en:5-oxoprolinase deficiency
    n1=en:enterocolitis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=385
  9. entéro-colite --- r_associated #0: 385 --> en:5-oxoprolinase deficiency
    n1=entéro-colite | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=385
  10. en:classical maple syrup urine disease --- r_associated #0: 280 --> en:5-oxoprolinase deficiency
    n1=en:classical maple syrup urine disease | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=280
  11. en:thiamin-responsive maple syrup urine disease --- r_associated #0: 280 --> en:5-oxoprolinase deficiency
    n1=en:thiamin-responsive maple syrup urine disease | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=280
  12. déficit en céto-acide décarboxylase --- r_associated #0: 275 --> en:5-oxoprolinase deficiency
    n1=déficit en céto-acide décarboxylase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=275
  13. maladie des urines à l'odeur de sirop d'érable --- r_associated #0: 275 --> en:5-oxoprolinase deficiency
    n1=maladie des urines à l'odeur de sirop d'érable | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=275
  14. maladie des urines avec odeur de sirop erable --- r_associated #0: 270 --> en:5-oxoprolinase deficiency
    n1=maladie des urines avec odeur de sirop erable | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=270
  15. lactate élevé --- r_associated #0: 215 --> en:5-oxoprolinase deficiency
    n1=lactate élevé | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=215
  16. lactate augmenté --- r_associated #0: 213 --> en:5-oxoprolinase deficiency
    n1=lactate augmenté | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=213
  17. en:lactate high --- r_associated #0: 211 --> en:5-oxoprolinase deficiency
    n1=en:lactate high | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=211
  18. hypophosphatasie infantile --- r_associated #0: 210 --> en:5-oxoprolinase deficiency
    n1=hypophosphatasie infantile | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=210
  19. hypophosphatasie foetale --- r_associated #0: 207 --> en:5-oxoprolinase deficiency
    n1=hypophosphatasie foetale | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=207
  20. en:infantile hypophosphatasia --- r_associated #0: 206 --> en:5-oxoprolinase deficiency
    n1=en:infantile hypophosphatasia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=206
  21. hypo-bêta-lipoprotéinémie --- r_associated #0: 206 --> en:5-oxoprolinase deficiency
    n1=hypo-bêta-lipoprotéinémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=206
  22. hypo-bêtalipoprotéinémie --- r_associated #0: 205 --> en:5-oxoprolinase deficiency
    n1=hypo-bêtalipoprotéinémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=205
  23. hypobêtalipoprotéinémie --- r_associated #0: 205 --> en:5-oxoprolinase deficiency
    n1=hypobêtalipoprotéinémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=205
  24. en:hypobetalipoproteinemias --- r_associated #0: 201 --> en:5-oxoprolinase deficiency
    n1=en:hypobetalipoproteinemias | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=201
  25. déficit en pyruvate carboxylase --- r_associated #0: 199 --> en:5-oxoprolinase deficiency
    n1=déficit en pyruvate carboxylase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=199
  26. carence en vitamine D --- r_associated #0: 195 --> en:5-oxoprolinase deficiency
    n1=carence en vitamine D | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=195
  27. avitaminose D --- r_associated #0: 191 --> en:5-oxoprolinase deficiency
    n1=avitaminose D | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=191
  28. déficit en vitamine D --- r_associated #0: 190 --> en:5-oxoprolinase deficiency
    n1=déficit en vitamine D | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=190
  29. en:pyruvate carboxylase deficiency --- r_associated #0: 190 --> en:5-oxoprolinase deficiency
    n1=en:pyruvate carboxylase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=190
  30. en:xeroderma pigmentosum --- r_associated #0: 184 --> en:5-oxoprolinase deficiency
    n1=en:xeroderma pigmentosum | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=184
  31. xeroderma pigmentosum --- r_associated #0: 183 --> en:5-oxoprolinase deficiency
    n1=xeroderma pigmentosum | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=183
  32. a-bêta-lipoprotéinémie --- r_associated #0: 180 --> en:5-oxoprolinase deficiency
    n1=a-bêta-lipoprotéinémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=180
  33. abêtalipoprotéinémie --- r_associated #0: 180 --> en:5-oxoprolinase deficiency
    n1=abêtalipoprotéinémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=180
  34. carence en vit d --- r_associated #0: 180 --> en:5-oxoprolinase deficiency
    n1=carence en vit d | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=180
  35. en:Zellweger syndrome --- r_associated #0: 180 --> en:5-oxoprolinase deficiency
    n1=en:Zellweger syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=180
  36. en:abetalipoproteinemia --- r_associated #0: 180 --> en:5-oxoprolinase deficiency
    n1=en:abetalipoproteinemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=180
  37. en:vitamin d deficiency --- r_associated #0: 180 --> en:5-oxoprolinase deficiency
    n1=en:vitamin d deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=180
  38. en:walker-warburg syndrome --- r_associated #0: 180 --> en:5-oxoprolinase deficiency
    n1=en:walker-warburg syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=180
  39. syndrome de Walker-Warburg --- r_associated #0: 178 --> en:5-oxoprolinase deficiency
    n1=syndrome de Walker-Warburg | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=178
  40. en:zellweger syndrome --- r_associated #0: 173 --> en:5-oxoprolinase deficiency
    n1=en:zellweger syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=173
  41. hyperoxalurie primitive --- r_associated #0: 160 --> en:5-oxoprolinase deficiency
    n1=hyperoxalurie primitive | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=160
  42. en:primary hyperoxaluria --- r_associated #0: 159 --> en:5-oxoprolinase deficiency
    n1=en:primary hyperoxaluria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=159
  43. en:ketoacidosis --- r_associated #0: 158 --> en:5-oxoprolinase deficiency
    n1=en:ketoacidosis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=158
  44. en:wolman disease --- r_associated #0: 158 --> en:5-oxoprolinase deficiency
    n1=en:wolman disease | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=158
  45. maladie de Wolman --- r_associated #0: 156 --> en:5-oxoprolinase deficiency
    n1=maladie de Wolman | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=156
  46. acidurie glutarique --- r_associated #0: 155 --> en:5-oxoprolinase deficiency
    n1=acidurie glutarique | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=155
  47. cétoacidose --- r_associated #0: 155 --> en:5-oxoprolinase deficiency
    n1=cétoacidose | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=155
  48. en:glutaric aciduria --- r_associated #0: 152 --> en:5-oxoprolinase deficiency
    n1=en:glutaric aciduria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=152
  49. hyperoxalurie primaire --- r_associated #0: 151 --> en:5-oxoprolinase deficiency
    n1=hyperoxalurie primaire | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=151
  50. oxaloses --- r_associated #0: 151 --> en:5-oxoprolinase deficiency
    n1=oxaloses | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=151
  51. oxalose primitive --- r_associated #0: 146 --> en:5-oxoprolinase deficiency
    n1=oxalose primitive | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=146
  52. en:defective DNA repair --- r_associated #0: 140 --> en:5-oxoprolinase deficiency
    n1=en:defective DNA repair | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=140
  53. oxalose --- r_associated #0: 140 --> en:5-oxoprolinase deficiency
    n1=oxalose | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=140
  54. en:defective dna repair --- r_associated #0: 137 --> en:5-oxoprolinase deficiency
    n1=en:defective dna repair | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=137
  55. hypertriglycéridémie --- r_associated #0: 136 --> en:5-oxoprolinase deficiency
    n1=hypertriglycéridémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=136
  56. hydrocortisone diminuée --- r_associated #0: 134 --> en:5-oxoprolinase deficiency
    n1=hydrocortisone diminuée | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=134
  57. en:hypertriglyceridemia --- r_associated #0: 132 --> en:5-oxoprolinase deficiency
    n1=en:hypertriglyceridemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=132
  58. en:hydrocortisone decreased --- r_associated #0: 130 --> en:5-oxoprolinase deficiency
    n1=en:hydrocortisone decreased | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=130
  59. en:methemoglobinemia --- r_associated #0: 124 --> en:5-oxoprolinase deficiency
    n1=en:methemoglobinemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=124
  60. méthémoglobinémie --- r_associated #0: 123 --> en:5-oxoprolinase deficiency
    n1=méthémoglobinémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=123
  61. vomissements --- r_associated #0: 122 --> en:5-oxoprolinase deficiency
    n1=vomissements | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=122
  62. acido-cétose --- r_associated #0: 120 --> en:5-oxoprolinase deficiency
    n1=acido-cétose | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=120
  63. acidocétose --- r_associated #0: 120 --> en:5-oxoprolinase deficiency
    n1=acidocétose | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=120
  64. en:cytochrome-c oxidase deficiency --- r_associated #0: 117 --> en:5-oxoprolinase deficiency
    n1=en:cytochrome-c oxidase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=117
  65. déficit en cytochrome oxydase --- r_associated #0: 114 --> en:5-oxoprolinase deficiency
    n1=déficit en cytochrome oxydase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=114
  66. réparation défectueuse de l'ADN --- r_associated #0: 100 --> en:5-oxoprolinase deficiency
    n1=réparation défectueuse de l'ADN | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=100
  67. déficit en cytochrome-c oxydase --- r_associated #0: 95 --> en:5-oxoprolinase deficiency
    n1=déficit en cytochrome-c oxydase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=95
  68. en:disseminated intravascular coagulation --- r_associated #0: 95 --> en:5-oxoprolinase deficiency
    n1=en:disseminated intravascular coagulation | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=95
  69. hyperplasie congénitale des surrénales --- r_associated #0: 95 --> en:5-oxoprolinase deficiency
    n1=hyperplasie congénitale des surrénales | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=95
  70. en:congenital adrenal hyperplasia --- r_associated #0: 94 --> en:5-oxoprolinase deficiency
    n1=en:congenital adrenal hyperplasia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=94
  71. coagulopathie intravasculaire disséminée --- r_associated #0: 93 --> en:5-oxoprolinase deficiency
    n1=coagulopathie intravasculaire disséminée | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=93
  72. cholestérol normal --- r_associated #0: 91 --> en:5-oxoprolinase deficiency
    n1=cholestérol normal | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=91
  73. progeria --- r_associated #0: 90 --> en:5-oxoprolinase deficiency
    n1=progeria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=90
  74. en:cholesterol normal --- r_associated #0: 87 --> en:5-oxoprolinase deficiency
    n1=en:cholesterol normal | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=87
  75. en:progeria --- r_associated #0: 86 --> en:5-oxoprolinase deficiency
    n1=en:progeria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=86
  76. progéria --- r_associated #0: 84 --> en:5-oxoprolinase deficiency
    n1=progéria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=84
  77. albinisme --- r_associated #0: 79 --> en:5-oxoprolinase deficiency
    n1=albinisme | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=79
  78. congenital --- r_associated #0: 78 --> en:5-oxoprolinase deficiency
    n1=congenital | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=78
  79. en:albinism --- r_associated #0: 75 --> en:5-oxoprolinase deficiency
    n1=en:albinism | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=75
  80. en:congenital --- r_associated #0: 74 --> en:5-oxoprolinase deficiency
    n1=en:congenital | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=74
  81. cholestérol sanguin élevé --- r_associated #0: 65 --> en:5-oxoprolinase deficiency
    n1=cholestérol sanguin élevé | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=65
  82. congénitale --- r_associated #0: 65 --> en:5-oxoprolinase deficiency
    n1=congénitale | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=65
  83. syndrome de Dubin-Johnson --- r_associated #0: 64 --> en:5-oxoprolinase deficiency
    n1=syndrome de Dubin-Johnson | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=64
  84. en:dubin-johnson syndrome --- r_associated #0: 63 --> en:5-oxoprolinase deficiency
    n1=en:dubin-johnson syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=63
  85. en:i-cell disease --- r_associated #0: 63 --> en:5-oxoprolinase deficiency
    n1=en:i-cell disease | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=63
  86. en:hemophilia b --- r_associated #0: 61 --> en:5-oxoprolinase deficiency
    n1=en:hemophilia b | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=61
  87. hyperlipidémie --- r_associated #0: 61 --> en:5-oxoprolinase deficiency
    n1=hyperlipidémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=61
  88. pseudo-hypoparathyroïdie --- r_associated #0: 61 --> en:5-oxoprolinase deficiency
    n1=pseudo-hypoparathyroïdie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=61
  89. en:I-cell disease --- r_associated #0: 60 --> en:5-oxoprolinase deficiency
    n1=en:I-cell disease | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=60
  90. en:hyperlipidaemia --- r_associated #0: 60 --> en:5-oxoprolinase deficiency
    n1=en:hyperlipidaemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=60
  91. pseudo-hypoparathyroïdisme --- r_associated #0: 60 --> en:5-oxoprolinase deficiency
    n1=pseudo-hypoparathyroïdisme | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=60
  92. syndrome de dubin-johnson --- r_associated #0: 60 --> en:5-oxoprolinase deficiency
    n1=syndrome de dubin-johnson | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=60
  93. en:hemophilia B --- r_associated #0: 59 --> en:5-oxoprolinase deficiency
    n1=en:hemophilia B | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=59
  94. pseudohypoparathyroïdie --- r_associated #0: 59 --> en:5-oxoprolinase deficiency
    n1=pseudohypoparathyroïdie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=59
  95. pseudohypoparathyroïdisme --- r_associated #0: 59 --> en:5-oxoprolinase deficiency
    n1=pseudohypoparathyroïdisme | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=59
  96. coagulation intravasculaire disséminée --- r_associated #0: 58 --> en:5-oxoprolinase deficiency
    n1=coagulation intravasculaire disséminée | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=58
  97. congénital --- r_associated #0: 57 --> en:5-oxoprolinase deficiency
    n1=congénital | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=57
  98. en:serum cholesterol raised --- r_associated #0: 57 --> en:5-oxoprolinase deficiency
    n1=en:serum cholesterol raised | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=57
  99. hyperlipémie --- r_associated #0: 56 --> en:5-oxoprolinase deficiency
    n1=hyperlipémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=56
  100. Coagulopathie intravasculaire disséminée --- r_associated #0: 55 --> en:5-oxoprolinase deficiency
    n1=Coagulopathie intravasculaire disséminée | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=55
  101. Xeroderma pigmentosum --- r_associated #0: 55 --> en:5-oxoprolinase deficiency
    n1=Xeroderma pigmentosum | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=55
  102. en:pseudohypoparathyroidism --- r_associated #0: 55 --> en:5-oxoprolinase deficiency
    n1=en:pseudohypoparathyroidism | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=55
  103. en:tay-sachs disease --- r_associated #0: 54 --> en:5-oxoprolinase deficiency
    n1=en:tay-sachs disease | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=54
  104. en:glutaric acidemia type 1 --- r_associated #0: 53 --> en:5-oxoprolinase deficiency
    n1=en:glutaric acidemia type 1 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=53
  105. en:hyperlipidemia --- r_associated #0: 53 --> en:5-oxoprolinase deficiency
    n1=en:hyperlipidemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=53
  106. en:niemann-pick disease --- r_associated #0: 53 --> en:5-oxoprolinase deficiency
    n1=en:niemann-pick disease | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=53
  107. acidurie glutarique de type 1 --- r_associated #0: 50 --> en:5-oxoprolinase deficiency
    n1=acidurie glutarique de type 1 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=50
  108. acrodermatite entéropathique --- r_associated #0: 50 --> en:5-oxoprolinase deficiency
    n1=acrodermatite entéropathique | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=50
  109. en:Niemann-Pick disease --- r_associated #0: 50 --> en:5-oxoprolinase deficiency
    n1=en:Niemann-Pick disease | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=50
  110. en:Tay-Sachs disease --- r_associated #0: 50 --> en:5-oxoprolinase deficiency
    n1=en:Tay-Sachs disease | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=50
  111. en:Wolman's disease --- r_associated #0: 50 --> en:5-oxoprolinase deficiency
    n1=en:Wolman's disease | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=50
  112. syndrome de synostose spondylo-carpo-tarsale --- r_associated #0: 50 --> en:5-oxoprolinase deficiency
    n1=syndrome de synostose spondylo-carpo-tarsale | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=50
  113. xanthomatose cérébrotendineuse de Van Bogaert --- r_associated #0: 50 --> en:5-oxoprolinase deficiency
    n1=xanthomatose cérébrotendineuse de Van Bogaert | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=50
  114. xérodermite pigmentaire --- r_associated #0: 50 --> en:5-oxoprolinase deficiency
    n1=xérodermite pigmentaire | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=50
  115. en:polycythemia --- r_associated #0: 49 --> en:5-oxoprolinase deficiency
    n1=en:polycythemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=49
  116. en:spondylocarpotarsal synostosis syndrome --- r_associated #0: 49 --> en:5-oxoprolinase deficiency
    n1=en:spondylocarpotarsal synostosis syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=49
  117. en:thrombocytopenia --- r_associated #0: 49 --> en:5-oxoprolinase deficiency
    n1=en:thrombocytopenia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=49
  118. polycythemia --- r_associated #0: 48 --> en:5-oxoprolinase deficiency
    n1=polycythemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=48
  119. en:acrodermatitis enteropathica --- r_associated #0: 47 --> en:5-oxoprolinase deficiency
    n1=en:acrodermatitis enteropathica | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=47
  120. maladie de wolman --- r_associated #0: 47 --> en:5-oxoprolinase deficiency
    n1=maladie de wolman | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=47
  121. thrombocytopénie --- r_associated #0: 47 --> en:5-oxoprolinase deficiency
    n1=thrombocytopénie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=47
  122. acidémie glutarique de type 1 --- r_associated #0: 46 --> en:5-oxoprolinase deficiency
    n1=acidémie glutarique de type 1 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=46
  123. calcium normal --- r_associated #0: 46 --> en:5-oxoprolinase deficiency
    n1=calcium normal | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=46
  124. carence en vitamine d --- r_associated #0: 46 --> en:5-oxoprolinase deficiency
    n1=carence en vitamine d | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=46
  125. en:cerebrotendinous xanthomatosis --- r_associated #0: 46 --> en:5-oxoprolinase deficiency
    n1=en:cerebrotendinous xanthomatosis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=46
  126. protoproporphyrie érythropoïétique --- r_associated #0: 46 --> en:5-oxoprolinase deficiency
    n1=protoproporphyrie érythropoïétique | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=46
  127. xanthomatose cérébro-tendineuse --- r_associated #0: 46 --> en:5-oxoprolinase deficiency
    n1=xanthomatose cérébro-tendineuse | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=46
  128. xanthomatose cérébrotendineuse --- r_associated #0: 46 --> en:5-oxoprolinase deficiency
    n1=xanthomatose cérébrotendineuse | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=46
  129. en:erythropoietic protoporphyria --- r_associated #0: 45 --> en:5-oxoprolinase deficiency
    n1=en:erythropoietic protoporphyria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=45
  130. intolérance au fructose --- r_associated #0: 45 --> en:5-oxoprolinase deficiency
    n1=intolérance au fructose | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=45
  131. mucolipidose type II --- r_associated #0: 45 --> en:5-oxoprolinase deficiency
    n1=mucolipidose type II | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=45
  132. mucolipidose type ii --- r_associated #0: 45 --> en:5-oxoprolinase deficiency
    n1=mucolipidose type ii | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=45
  133. polyglobulie --- r_associated #0: 45 --> en:5-oxoprolinase deficiency
    n1=polyglobulie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=45
  134. Maladie de Tay-Sachs --- r_associated #0: 44 --> en:5-oxoprolinase deficiency
    n1=Maladie de Tay-Sachs | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=44
  135. Maladie de Wolman --- r_associated #0: 44 --> en:5-oxoprolinase deficiency
    n1=Maladie de Wolman | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=44
  136. sirop d'érable (urine à odeur de) --- r_associated #0: 44 --> en:5-oxoprolinase deficiency
    n1=sirop d'érable (urine à odeur de) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=44
  137. Warburg --- r_associated #0: 43 --> en:5-oxoprolinase deficiency
    n1=Warburg | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=43
  138. en:abnormal liver enzymes (in some patients) --- r_associated #0: 43 --> en:5-oxoprolinase deficiency
    n1=en:abnormal liver enzymes (in some patients) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=43
  139. en:cytogenetic deletion of the terminal region of chromosome 10 (del(10)(q23.3-qter)) --- r_associated #0: 43 --> en:5-oxoprolinase deficiency
    n1=en:cytogenetic deletion of the terminal region of chromosome 10 (del(10)(q23.3-qter)) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=43
  140. en:decreased cortisol-binding globulin --- r_associated #0: 43 --> en:5-oxoprolinase deficiency
    n1=en:decreased cortisol-binding globulin | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=43
  141. en:decreased csf ferritin despite normal serum ferritin levels --- r_associated #0: 43 --> en:5-oxoprolinase deficiency
    n1=en:decreased csf ferritin despite normal serum ferritin levels | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=43
  142. en:decreased dermal hydroxylysine content --- r_associated #0: 43 --> en:5-oxoprolinase deficiency
    n1=en:decreased dermal hydroxylysine content | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=43
  143. en:decreased plasminogen activity --- r_associated #0: 43 --> en:5-oxoprolinase deficiency
    n1=en:decreased plasminogen activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=43
  144. en:decreased serum follicle-stimulating hormone (fsh) --- r_associated #0: 43 --> en:5-oxoprolinase deficiency
    n1=en:decreased serum follicle-stimulating hormone (fsh) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=43
  145. en:decreased thrombospondin --- r_associated #0: 43 --> en:5-oxoprolinase deficiency
    n1=en:decreased thrombospondin | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=43
  146. en:deficiency of laminin alpha-2 chain of merosin (lama2, 156225) in muscle --- r_associated #0: 43 --> en:5-oxoprolinase deficiency
    n1=en:deficiency of laminin alpha-2 chain of merosin (lama2, 156225) in muscle | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=43
  147. en:disorder due to n-acetyltransferase enzyme variant --- r_associated #0: 43 --> en:5-oxoprolinase deficiency
    n1=en:disorder due to n-acetyltransferase enzyme variant | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=43
  148. en:elevated urinary delta-aminolevulinic acid --- r_associated #0: 43 --> en:5-oxoprolinase deficiency
    n1=en:elevated urinary delta-aminolevulinic acid | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=43
  149. en:hereditary fructose intolerance --- r_associated #0: 43 --> en:5-oxoprolinase deficiency
    n1=en:hereditary fructose intolerance | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=43
  150. en:hla-dqw6 association (dqb1*0602) --- r_associated #0: 43 --> en:5-oxoprolinase deficiency
    n1=en:hla-dqw6 association (dqb1*0602) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=43
  151. en:hypertriglyceridemia (rare) --- r_associated #0: 43 --> en:5-oxoprolinase deficiency
    n1=en:hypertriglyceridemia (rare) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=43
  152. en:hypokalemia during attacks --- r_associated #0: 43 --> en:5-oxoprolinase deficiency
    n1=en:hypokalemia during attacks | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=43
  153. en:hypomagnesemia 1, intestinal --- r_associated #0: 43 --> en:5-oxoprolinase deficiency
    n1=en:hypomagnesemia 1, intestinal | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=43
  154. en:impaired synthesis of fibroblast sulfated proteoglycans --- r_associated #0: 43 --> en:5-oxoprolinase deficiency
    n1=en:impaired synthesis of fibroblast sulfated proteoglycans | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=43
  155. en:increased intracellular fmrp mrna --- r_associated #0: 43 --> en:5-oxoprolinase deficiency
    n1=en:increased intracellular fmrp mrna | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=43
  156. en:increased nasal-potential difference (1 of 3 patients) --- r_associated #0: 43 --> en:5-oxoprolinase deficiency
    n1=en:increased nasal-potential difference (1 of 3 patients) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=43
  157. en:increased serum iduronate sulfatase (10-20x) --- r_associated #0: 43 --> en:5-oxoprolinase deficiency
    n1=en:increased serum iduronate sulfatase (10-20x) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=43
  158. en:median mean platelet volume (mpv) 18fl --- r_associated #0: 43 --> en:5-oxoprolinase deficiency
    n1=en:median mean platelet volume (mpv) 18fl | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=43
  159. en:otoonychoperoneal syndrome --- r_associated #0: 43 --> en:5-oxoprolinase deficiency
    n1=en:otoonychoperoneal syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=43
  160. en:aminomethyltransferase deficiency --- r_associated #0: 42 --> en:5-oxoprolinase deficiency
    n1=en:aminomethyltransferase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=42
  161. en:calcium normal --- r_associated #0: 42 --> en:5-oxoprolinase deficiency
    n1=en:calcium normal | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=42
  162. en:characteristic urinary coproporphyrin pattern (mostly isomer i (80%) instead of isomer iii) --- r_associated #0: 42 --> en:5-oxoprolinase deficiency
    n1=en:characteristic urinary coproporphyrin pattern (mostly isomer i (80%) instead of isomer iii) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=42
  163. en:decreased asparagine levels (in some patients) --- r_associated #0: 42 --> en:5-oxoprolinase deficiency
    n1=en:decreased asparagine levels (in some patients) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=42
  164. en:decreased serum haptoglobin --- r_associated #0: 42 --> en:5-oxoprolinase deficiency
    n1=en:decreased serum haptoglobin | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=42
  165. en:decreased serum l-transferrin (heterozygous patient) --- r_associated #0: 42 --> en:5-oxoprolinase deficiency
    n1=en:decreased serum l-transferrin (heterozygous patient) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=42
  166. en:elevated serum transaminases during infections --- r_associated #0: 42 --> en:5-oxoprolinase deficiency
    n1=en:elevated serum transaminases during infections | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=42
  167. en:fountain syndrome --- r_associated #0: 42 --> en:5-oxoprolinase deficiency
    n1=en:fountain syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=42
  168. en:hair bulbs will pigment when incubated with tyrosine --- r_associated #0: 42 --> en:5-oxoprolinase deficiency
    n1=en:hair bulbs will pigment when incubated with tyrosine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=42
  169. en:hereditary methemoglobinemia, enzymatic type --- r_associated #0: 42 --> en:5-oxoprolinase deficiency
    n1=en:hereditary methemoglobinemia, enzymatic type | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=42
  170. en:high m-component --- r_associated #0: 42 --> en:5-oxoprolinase deficiency
    n1=en:high m-component | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=42
  171. en:hypercalciuria --- r_associated #0: 42 --> en:5-oxoprolinase deficiency
    n1=en:hypercalciuria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=42
  172. en:hyperchloremia (mean 114 mm) --- r_associated #0: 42 --> en:5-oxoprolinase deficiency
    n1=en:hyperchloremia (mean 114 mm) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=42
  173. en:hypoglycosylated serum transferrin --- r_associated #0: 42 --> en:5-oxoprolinase deficiency
    n1=en:hypoglycosylated serum transferrin | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=42
  174. en:lactic acidemia (2p21del) --- r_associated #0: 42 --> en:5-oxoprolinase deficiency
    n1=en:lactic acidemia (2p21del) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=42
  175. en:triglyceride decreased --- r_associated #0: 42 --> en:5-oxoprolinase deficiency
    n1=en:triglyceride decreased | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=42
  176. van Bogaert (xanthomatose cérébrotendineuse de) --- r_associated #0: 42 --> en:5-oxoprolinase deficiency
    n1=van Bogaert (xanthomatose cérébrotendineuse de) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=42
  177. en:appropriately increased serum 1,25-dihydroxyvitamin d3 --- r_associated #0: 41 --> en:5-oxoprolinase deficiency
    n1=en:appropriately increased serum 1,25-dihydroxyvitamin d3 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=41
  178. en:braddock syndrome --- r_associated #0: 41 --> en:5-oxoprolinase deficiency
    n1=en:braddock syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=41
  179. en:brody myopathy --- r_associated #0: 41 --> en:5-oxoprolinase deficiency
    n1=en:brody myopathy | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=41
  180. en:cystathioninuria (lab finding) --- r_associated #0: 41 --> en:5-oxoprolinase deficiency
    n1=en:cystathioninuria (lab finding) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=41
  181. en:decreased levels of coenzyme q10 in skeletal muscle (5-35%) --- r_associated #0: 41 --> en:5-oxoprolinase deficiency
    n1=en:decreased levels of coenzyme q10 in skeletal muscle (5-35%) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=41
  182. en:decreased plasma and urinary ornithine --- r_associated #0: 41 --> en:5-oxoprolinase deficiency
    n1=en:decreased plasma and urinary ornithine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=41
  183. en:decreased plasma esterified cholesterol --- r_associated #0: 41 --> en:5-oxoprolinase deficiency
    n1=en:decreased plasma esterified cholesterol | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=41
  184. en:elevated biopterin in csf --- r_associated #0: 41 --> en:5-oxoprolinase deficiency
    n1=en:elevated biopterin in csf | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=41
  185. en:elevated circulating parathyroid hormone (pth) level --- r_associated #0: 41 --> en:5-oxoprolinase deficiency
    n1=en:elevated circulating parathyroid hormone (pth) level | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=41
  186. en:elevated erythrocyte sedimentation rate (esr) --- r_associated #0: 41 --> en:5-oxoprolinase deficiency
    n1=en:elevated erythrocyte sedimentation rate (esr) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=41
  187. en:elevated fecal levels of protoporphyrin and coproporphyrin at all times --- r_associated #0: 41 --> en:5-oxoprolinase deficiency
    n1=en:elevated fecal levels of protoporphyrin and coproporphyrin at all times | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=41
  188. en:elevated serum phosphate in heterozygotes --- r_associated #0: 41 --> en:5-oxoprolinase deficiency
    n1=en:elevated serum phosphate in heterozygotes | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=41
  189. en:fluorescence in situ hybridization specific probe for mds critical region --- r_associated #0: 41 --> en:5-oxoprolinase deficiency
    n1=en:fluorescence in situ hybridization specific probe for mds critical region | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=41
  190. en:hereditary factor x deficiency --- r_associated #0: 41 --> en:5-oxoprolinase deficiency
    n1=en:hereditary factor x deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=41
  191. en:hyperbilirubinemia in those with liver failure --- r_associated #0: 41 --> en:5-oxoprolinase deficiency
    n1=en:hyperbilirubinemia in those with liver failure | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=41
  192. en:hyperchloridura --- r_associated #0: 41 --> en:5-oxoprolinase deficiency
    n1=en:hyperchloridura | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=41
  193. en:hyperkalemia (6.4 +/- 0.7 mm) --- r_associated #0: 41 --> en:5-oxoprolinase deficiency
    n1=en:hyperkalemia (6.4 +/- 0.7 mm) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=41
  194. en:hypoproteinemia due to hypercatabolism --- r_associated #0: 41 --> en:5-oxoprolinase deficiency
    n1=en:hypoproteinemia due to hypercatabolism | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=41
  195. en:increased csf protein during acute illness --- r_associated #0: 41 --> en:5-oxoprolinase deficiency
    n1=en:increased csf protein during acute illness | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=41
  196. en:platelet aggregation decreased --- r_associated #0: 41 --> en:5-oxoprolinase deficiency
    n1=en:platelet aggregation decreased | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=41
  197. en:secondarily decreased activity of the pyruvate dehydrogenase complex (pdc) --- r_associated #0: 41 --> en:5-oxoprolinase deficiency
    n1=en:secondarily decreased activity of the pyruvate dehydrogenase complex (pdc) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=41
  198. v+ --- r_associated #0: 41 --> en:5-oxoprolinase deficiency
    n1=v+ | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=41
  199. V+ --- r_associated #0: 40 --> en:5-oxoprolinase deficiency
    n1=V+ | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=40
  200. Walker-Warburg (syndrome de) --- r_associated #0: 40 --> en:5-oxoprolinase deficiency
    n1=Walker-Warburg (syndrome de) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=40
  201. en:3-methylglutaconic aciduria type iv --- r_associated #0: 40 --> en:5-oxoprolinase deficiency
    n1=en:3-methylglutaconic aciduria type iv | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=40
  202. en:absent anti-insulin receptor antibodies --- r_associated #0: 40 --> en:5-oxoprolinase deficiency
    n1=en:absent anti-insulin receptor antibodies | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=40
  203. en:acrorenal mandibular syndrome --- r_associated #0: 40 --> en:5-oxoprolinase deficiency
    n1=en:acrorenal mandibular syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=40
  204. en:arthrogryposis multiplex congenita, neurogenic type (disorder) --- r_associated #0: 40 --> en:5-oxoprolinase deficiency
    n1=en:arthrogryposis multiplex congenita, neurogenic type (disorder) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=40
  205. en:broad tissue deposition of amylopectin-like material --- r_associated #0: 40 --> en:5-oxoprolinase deficiency
    n1=en:broad tissue deposition of amylopectin-like material | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=40
  206. en:carbamoyl-phosphate synthetase i deficiency --- r_associated #0: 40 --> en:5-oxoprolinase deficiency
    n1=en:carbamoyl-phosphate synthetase i deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=40
  207. en:citrin deficiency --- r_associated #0: 40 --> en:5-oxoprolinase deficiency
    n1=en:citrin deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=40
  208. en:creatine phosphokinase increased --- r_associated #0: 40 --> en:5-oxoprolinase deficiency
    n1=en:creatine phosphokinase increased | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=40
  209. en:decreased mitochondrial complex v assembly --- r_associated #0: 40 --> en:5-oxoprolinase deficiency
    n1=en:decreased mitochondrial complex v assembly | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=40
  210. en:decreased serum factor i (atypical hus) --- r_associated #0: 40 --> en:5-oxoprolinase deficiency
    n1=en:decreased serum factor i (atypical hus) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=40
  211. en:howell-jolly bodies seen in peripheral blood smear --- r_associated #0: 40 --> en:5-oxoprolinase deficiency
    n1=en:howell-jolly bodies seen in peripheral blood smear | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=40
  212. en:hypouricemia --- r_associated #0: 40 --> en:5-oxoprolinase deficiency
    n1=en:hypouricemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=40
  213. en:increased serum alpha-mannosidase --- r_associated #0: 40 --> en:5-oxoprolinase deficiency
    n1=en:increased serum alpha-mannosidase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=40
  214. en:increased urinary catecholamines --- r_associated #0: 40 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary catecholamines | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=40
  215. en:intermediary metabolism disorder --- r_associated #0: 40 --> en:5-oxoprolinase deficiency
    n1=en:intermediary metabolism disorder | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=40
  216. en:oculocutaneous albinism type 6 --- r_associated #0: 40 --> en:5-oxoprolinase deficiency
    n1=en:oculocutaneous albinism type 6 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=40
  217. en:sonoda syndrome --- r_associated #0: 40 --> en:5-oxoprolinase deficiency
    n1=en:sonoda syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=40
  218. hyperoxalémie --- r_associated #0: 40 --> en:5-oxoprolinase deficiency
    n1=hyperoxalémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=40
  219. maladie de Tay-Sachs --- r_associated #0: 40 --> en:5-oxoprolinase deficiency
    n1=maladie de Tay-Sachs | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=40
  220. maladie de Tay-sachs --- r_associated #0: 40 --> en:5-oxoprolinase deficiency
    n1=maladie de Tay-sachs | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=40
  221. maladie de tay-sachs --- r_associated #0: 40 --> en:5-oxoprolinase deficiency
    n1=maladie de tay-sachs | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=40
  222. nystagmus congénital isolé --- r_associated #0: 40 --> en:5-oxoprolinase deficiency
    n1=nystagmus congénital isolé | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=40
  223. agrégation des plaquettes diminuée --- r_associated #0: 39 --> en:5-oxoprolinase deficiency
    n1=agrégation des plaquettes diminuée | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=39
  224. avitaminose d --- r_associated #0: 39 --> en:5-oxoprolinase deficiency
    n1=avitaminose d | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=39
  225. en:decreased sulfite oxidase activity in fibroblasts --- r_associated #0: 39 --> en:5-oxoprolinase deficiency
    n1=en:decreased sulfite oxidase activity in fibroblasts | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=39
  226. en:defect in retrograde intraflagellar transport in cilia --- r_associated #0: 39 --> en:5-oxoprolinase deficiency
    n1=en:defect in retrograde intraflagellar transport in cilia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=39
  227. en:deficient ribose-s-phosphate isomerase (rpi) in fibroblasts --- r_associated #0: 39 --> en:5-oxoprolinase deficiency
    n1=en:deficient ribose-s-phosphate isomerase (rpi) in fibroblasts | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=39
  228. en:electron microscopy of patient respiratory cells shows loss of ciliary outer dynein arms --- r_associated #0: 39 --> en:5-oxoprolinase deficiency
    n1=en:electron microscopy of patient respiratory cells shows loss of ciliary outer dynein arms | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=39
  229. en:elevated plasma luteinizing hormone (lh) --- r_associated #0: 39 --> en:5-oxoprolinase deficiency
    n1=en:elevated plasma luteinizing hormone (lh) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=39
  230. en:glutathione deficiency --- r_associated #0: 39 --> en:5-oxoprolinase deficiency
    n1=en:glutathione deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=39
  231. en:inactive mutant form of red cell carbonic anhydrase b in one sibship --- r_associated #0: 39 --> en:5-oxoprolinase deficiency
    n1=en:inactive mutant form of red cell carbonic anhydrase b in one sibship | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=39
  232. en:increased plasma dihydroxyphenylacetic acid (dopac) --- r_associated #0: 39 --> en:5-oxoprolinase deficiency
    n1=en:increased plasma dihydroxyphenylacetic acid (dopac) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=39
  233. en:jankovic rivera syndrome --- r_associated #0: 39 --> en:5-oxoprolinase deficiency
    n1=en:jankovic rivera syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=39
  234. en:mesoaxial synostotic syndactyly with phalangeal reduction syndrome --- r_associated #0: 39 --> en:5-oxoprolinase deficiency
    n1=en:mesoaxial synostotic syndactyly with phalangeal reduction syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=39
  235. en:spinal muscular atrophy with respiratory distress 1 --- r_associated #0: 39 --> en:5-oxoprolinase deficiency
    n1=en:spinal muscular atrophy with respiratory distress 1 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=39
  236. en:3-methylglutaconic aciduria --- r_associated #0: 38 --> en:5-oxoprolinase deficiency
    n1=en:3-methylglutaconic aciduria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=38
  237. en:adducted thumbs and arthrogryposis syndrome christian type --- r_associated #0: 38 --> en:5-oxoprolinase deficiency
    n1=en:adducted thumbs and arthrogryposis syndrome christian type | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=38
  238. en:congenital pancreatic enterokinase deficiency --- r_associated #0: 38 --> en:5-oxoprolinase deficiency
    n1=en:congenital pancreatic enterokinase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=38
  239. en:craniodiaphyseal dysplasia --- r_associated #0: 38 --> en:5-oxoprolinase deficiency
    n1=en:craniodiaphyseal dysplasia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=38
  240. en:cutaneous anergy --- r_associated #0: 38 --> en:5-oxoprolinase deficiency
    n1=en:cutaneous anergy | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=38
  241. en:decreased amount and activity of mitochondrial complexes i and iv --- r_associated #0: 38 --> en:5-oxoprolinase deficiency
    n1=en:decreased amount and activity of mitochondrial complexes i and iv | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=38
  242. en:decreased lipid-linked oligosaccharides (llo) --- r_associated #0: 38 --> en:5-oxoprolinase deficiency
    n1=en:decreased lipid-linked oligosaccharides (llo) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=38
  243. en:decreased serum luteinizing hormone (lh) --- r_associated #0: 38 --> en:5-oxoprolinase deficiency
    n1=en:decreased serum luteinizing hormone (lh) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=38
  244. en:elevated plasma insulin --- r_associated #0: 38 --> en:5-oxoprolinase deficiency
    n1=en:elevated plasma insulin | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=38
  245. en:fatty acid hydroxylase-associated neurodegeneration --- r_associated #0: 38 --> en:5-oxoprolinase deficiency
    n1=en:fatty acid hydroxylase-associated neurodegeneration | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=38
  246. en:hyperglycinemia (1 patient) --- r_associated #0: 38 --> en:5-oxoprolinase deficiency
    n1=en:hyperglycinemia (1 patient) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=38
  247. en:hypophosphatasia infantile --- r_associated #0: 38 --> en:5-oxoprolinase deficiency
    n1=en:hypophosphatasia infantile | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=38
  248. en:increased interferon-alpha signal --- r_associated #0: 38 --> en:5-oxoprolinase deficiency
    n1=en:increased interferon-alpha signal | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=38
  249. en:increased serum thymidine --- r_associated #0: 38 --> en:5-oxoprolinase deficiency
    n1=en:increased serum thymidine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=38
  250. en:kuskokwim disease --- r_associated #0: 38 --> en:5-oxoprolinase deficiency
    n1=en:kuskokwim disease | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=38
  251. en:laurence-moon syndrome --- r_associated #0: 38 --> en:5-oxoprolinase deficiency
    n1=en:laurence-moon syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=38
  252. en:low plasma triglyceride level --- r_associated #0: 38 --> en:5-oxoprolinase deficiency
    n1=en:low plasma triglyceride level | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=38
  253. en:low serum alkaline phosphatase in heterozygotes --- r_associated #0: 38 --> en:5-oxoprolinase deficiency
    n1=en:low serum alkaline phosphatase in heterozygotes | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=38
  254. en:maple-tree syrup disease --- r_associated #0: 38 --> en:5-oxoprolinase deficiency
    n1=en:maple-tree syrup disease | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=38
  255. en:Gaucher disease --- r_associated #0: 37 --> en:5-oxoprolinase deficiency
    n1=en:Gaucher disease | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=37
  256. en:abnormal eeg in 25% hospitalized patients --- r_associated #0: 37 --> en:5-oxoprolinase deficiency
    n1=en:abnormal eeg in 25% hospitalized patients | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=37
  257. en:cortisol does not decrease on dexamethasone suppression test --- r_associated #0: 37 --> en:5-oxoprolinase deficiency
    n1=en:cortisol does not decrease on dexamethasone suppression test | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=37
  258. en:decreased levels of cellular and mitochondrial fes-containing proteins --- r_associated #0: 37 --> en:5-oxoprolinase deficiency
    n1=en:decreased levels of cellular and mitochondrial fes-containing proteins | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=37
  259. en:decreased levels of plasma vwf antigen --- r_associated #0: 37 --> en:5-oxoprolinase deficiency
    n1=en:decreased levels of plasma vwf antigen | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=37
  260. en:decreased serum trypsinogen --- r_associated #0: 37 --> en:5-oxoprolinase deficiency
    n1=en:decreased serum trypsinogen | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=37
  261. en:disorder of glycosaminoglycan metabolism --- r_associated #0: 37 --> en:5-oxoprolinase deficiency
    n1=en:disorder of glycosaminoglycan metabolism | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=37
  262. en:distal xp22.3 segmental monosomy --- r_associated #0: 37 --> en:5-oxoprolinase deficiency
    n1=en:distal xp22.3 segmental monosomy | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=37
  263. en:elevated fasting triglycerides (seen in heterozygotes as well) --- r_associated #0: 37 --> en:5-oxoprolinase deficiency
    n1=en:elevated fasting triglycerides (seen in heterozygotes as well) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=37
  264. en:fatty alcohol:nad+ oxidoreductase deficiency in leukocytes and fibroblasts --- r_associated #0: 37 --> en:5-oxoprolinase deficiency
    n1=en:fatty alcohol:nad+ oxidoreductase deficiency in leukocytes and fibroblasts | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=37
  265. en:hereditary factor xii deficiency disease --- r_associated #0: 37 --> en:5-oxoprolinase deficiency
    n1=en:hereditary factor xii deficiency disease | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=37
  266. en:hyperoxalaemia --- r_associated #0: 37 --> en:5-oxoprolinase deficiency
    n1=en:hyperoxalaemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=37
  267. en:increased serum unconjugated bilirubin --- r_associated #0: 37 --> en:5-oxoprolinase deficiency
    n1=en:increased serum unconjugated bilirubin | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=37
  268. en:increased urinary oligosaccharides --- r_associated #0: 37 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary oligosaccharides | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=37
  269. en:lipid metabolism disorder --- r_associated #0: 37 --> en:5-oxoprolinase deficiency
    n1=en:lipid metabolism disorder | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=37
  270. en:low 25-oh-vitamin d level --- r_associated #0: 37 --> en:5-oxoprolinase deficiency
    n1=en:low 25-oh-vitamin d level | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=37
  271. en:low or undetectable insulin --- r_associated #0: 37 --> en:5-oxoprolinase deficiency
    n1=en:low or undetectable insulin | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=37
  272. en:marles greenberg persaud syndrome --- r_associated #0: 37 --> en:5-oxoprolinase deficiency
    n1=en:marles greenberg persaud syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=37
  273. en:reardon hall slaney syndrome --- r_associated #0: 37 --> en:5-oxoprolinase deficiency
    n1=en:reardon hall slaney syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=37
  274. homocystéinémie --- r_associated #0: 37 --> en:5-oxoprolinase deficiency
    n1=homocystéinémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=37
  275. acidurie dicarboxylique --- r_associated #0: 36 --> en:5-oxoprolinase deficiency
    n1=acidurie dicarboxylique | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=36
  276. déficit en prolidase --- r_associated #0: 36 --> en:5-oxoprolinase deficiency
    n1=déficit en prolidase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=36
  277. en:biotinidase deficiency --- r_associated #0: 36 --> en:5-oxoprolinase deficiency
    n1=en:biotinidase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=36
  278. en:brain diseases, metabolic, inborn --- r_associated #0: 36 --> en:5-oxoprolinase deficiency
    n1=en:brain diseases, metabolic, inborn | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=36
  279. en:brown-vialetto-van laere syndrome --- r_associated #0: 36 --> en:5-oxoprolinase deficiency
    n1=en:brown-vialetto-van laere syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=36
  280. en:chondrodysplasia punctata syndrome --- r_associated #0: 36 --> en:5-oxoprolinase deficiency
    n1=en:chondrodysplasia punctata syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=36
  281. en:chromosomal instability --- r_associated #0: 36 --> en:5-oxoprolinase deficiency
    n1=en:chromosomal instability | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=36
  282. en:cytogenetic deletion of chromosome 17p13.3 --- r_associated #0: 36 --> en:5-oxoprolinase deficiency
    n1=en:cytogenetic deletion of chromosome 17p13.3 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=36
  283. en:d-2-hydroxyglutaric aciduria --- r_associated #0: 36 --> en:5-oxoprolinase deficiency
    n1=en:d-2-hydroxyglutaric aciduria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=36
  284. en:diagnosis by exposing muscle biopsy to caffeine and/or halothane --- r_associated #0: 36 --> en:5-oxoprolinase deficiency
    n1=en:diagnosis by exposing muscle biopsy to caffeine and/or halothane | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=36
  285. en:elevated ferritin l subunit --- r_associated #0: 36 --> en:5-oxoprolinase deficiency
    n1=en:elevated ferritin l subunit | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=36
  286. en:elevated serum n,n-dimethylglycine (dmg) --- r_associated #0: 36 --> en:5-oxoprolinase deficiency
    n1=en:elevated serum n,n-dimethylglycine (dmg) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=36
  287. en:gracile syndrome (disorder) --- r_associated #0: 36 --> en:5-oxoprolinase deficiency
    n1=en:gracile syndrome (disorder) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=36
  288. en:homocysteinemia --- r_associated #0: 36 --> en:5-oxoprolinase deficiency
    n1=en:homocysteinemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=36
  289. en:hyperlipemia --- r_associated #0: 36 --> en:5-oxoprolinase deficiency
    n1=en:hyperlipemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=36
  290. en:hypoglycorrhachia (low glucose in csf) --- r_associated #0: 36 --> en:5-oxoprolinase deficiency
    n1=en:hypoglycorrhachia (low glucose in csf) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=36
  291. en:immediate (type i) skin test reactivity --- r_associated #0: 36 --> en:5-oxoprolinase deficiency
    n1=en:immediate (type i) skin test reactivity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=36
  292. en:increased hepatic parenchymal cell stainable iron --- r_associated #0: 36 --> en:5-oxoprolinase deficiency
    n1=en:increased hepatic parenchymal cell stainable iron | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=36
  293. en:increased serum s-adenosylhomocysteine --- r_associated #0: 36 --> en:5-oxoprolinase deficiency
    n1=en:increased serum s-adenosylhomocysteine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=36
  294. en:iron overload (in some patients) --- r_associated #0: 36 --> en:5-oxoprolinase deficiency
    n1=en:iron overload (in some patients) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=36
  295. en:laron syndrome --- r_associated #0: 36 --> en:5-oxoprolinase deficiency
    n1=en:laron syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=36
  296. en:placental steroid sulfatase deficiency --- r_associated #0: 36 --> en:5-oxoprolinase deficiency
    n1=en:placental steroid sulfatase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=36
  297. en:retinitis punctata albescens (disorder) --- r_associated #0: 36 --> en:5-oxoprolinase deficiency
    n1=en:retinitis punctata albescens (disorder) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=36
  298. hypo-albuminémie --- r_associated #0: 36 --> en:5-oxoprolinase deficiency
    n1=hypo-albuminémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=36
  299. hypo-uricémie --- r_associated #0: 36 --> en:5-oxoprolinase deficiency
    n1=hypo-uricémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=36
  300. hypoalbuminémie --- r_associated #0: 36 --> en:5-oxoprolinase deficiency
    n1=hypoalbuminémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=36
  301. Wolman (maladie de) --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=Wolman (maladie de) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  302. bicarbonate sérique augmenté --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=bicarbonate sérique augmenté | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  303. calciurie --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=calciurie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  304. en:'rectilinear profiles' ultrastructurally in cells --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:'rectilinear profiles' ultrastructurally in cells | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  305. en:1,25-dihydroxyvitamin d was elevated in childhood but deficient in adulthood --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:1,25-dihydroxyvitamin d was elevated in childhood but deficient in adulthood | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  306. en:3-methylglutaric aciduria --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:3-methylglutaric aciduria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  307. en:4-hydroxyphenylacetic aciduria --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:4-hydroxyphenylacetic aciduria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  308. en:abnormal bone marrow karyotype, t(8,21) --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:abnormal bone marrow karyotype, t(8,21) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  309. en:abnormal columnization of chondrocytes --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:abnormal columnization of chondrocytes | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  310. en:abnormal glycosylation of serum transferrin, type 1 pattern --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:abnormal glycosylation of serum transferrin, type 1 pattern | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  311. en:abnormal liver function tests (less common) --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:abnormal liver function tests (less common) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  312. en:abnormal nasal potential difference --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:abnormal nasal potential difference | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  313. en:abnormal serum lipoprotein levels (in 3 of 10 patients) --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:abnormal serum lipoprotein levels (in 3 of 10 patients) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  314. en:absent igg2 subclass --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:absent igg2 subclass | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  315. en:absent-decreased prolyl 3-hydroxylation at collagen i alpha-1 pro986 --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:absent-decreased prolyl 3-hydroxylation at collagen i alpha-1 pro986 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  316. en:accumulation of guanidinoacetate in brain --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:accumulation of guanidinoacetate in brain | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  317. en:accumulation of truncated oligosaccharides man(5)glcnac2 and man(9)glcnac(2) --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:accumulation of truncated oligosaccharides man(5)glcnac2 and man(9)glcnac(2) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  318. en:acute hyperammonemia --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:acute hyperammonemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  319. en:acyl-coa dehydrogenase deficiency --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:acyl-coa dehydrogenase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  320. en:aldosterone level increased above normal --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:aldosterone level increased above normal | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  321. en:alkaline phosphatase normal --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:alkaline phosphatase normal | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  322. en:alpha-1 antitrypsin deficiency --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:alpha-1 antitrypsin deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  323. en:alpha-galactosidase a deficiency in plasma, leukocytes, or fibroblasts --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:alpha-galactosidase a deficiency in plasma, leukocytes, or fibroblasts | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  324. en:aminoaciduria (1 patient) --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:aminoaciduria (1 patient) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  325. en:anti-factor viii positive --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:anti-factor viii positive | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  326. en:argininemia --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:argininemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  327. en:ateliotic dwarfism without insulinopenia --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:ateliotic dwarfism without insulinopenia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  328. en:atrial abnormalities on electrocardiogram --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:atrial abnormalities on electrocardiogram | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  329. en:azotemia --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:azotemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  330. en:behr syndrome --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:behr syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  331. en:beta-galactosidase deficiency in fibroblasts and white blood cells --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:beta-galactosidase deficiency in fibroblasts and white blood cells | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  332. en:beta-glucuronidase deficiency in fibroblasts and leukocytes --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:beta-glucuronidase deficiency in fibroblasts and leukocytes | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  333. en:bone marrow hypoplasia (in some patients) --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:bone marrow hypoplasia (in some patients) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  334. en:bothnia retinal dystrophy --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:bothnia retinal dystrophy | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  335. en:brain calcification rajab type --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:brain calcification rajab type | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  336. en:bromosulfophthalein test - secondary rise at 90 minutes --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:bromosulfophthalein test - secondary rise at 90 minutes | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  337. en:calciuria --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:calciuria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  338. en:carnitine palmitoyltransferase ii deficiency (25% of controls) --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:carnitine palmitoyltransferase ii deficiency (25% of controls) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  339. en:cells show defective transcription-coupled nucleotide excision repair (tc-ner) after uv irradiation --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:cells show defective transcription-coupled nucleotide excision repair (tc-ner) after uv irradiation | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  340. en:cerebrospinal fluid lymphocytosis --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:cerebrospinal fluid lymphocytosis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  341. en:childhood myocerebrohepatopathy spectrum --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:childhood myocerebrohepatopathy spectrum | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  342. en:chondroitin 6-sulfate excretion in urine --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:chondroitin 6-sulfate excretion in urine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  343. en:chromosome instability (hypo-/hyperdiploidy, chromosomal breaks, premature centromere division) --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:chromosome instability (hypo-/hyperdiploidy, chromosomal breaks, premature centromere division) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  344. en:chylomicronemia, refractory fasting --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:chylomicronemia, refractory fasting | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  345. en:cilia show nonflexible and hyperkinetic beating of axonemes --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:cilia show nonflexible and hyperkinetic beating of axonemes | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  346. en:congenital cataract with ataxia and deafness syndrome --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:congenital cataract with ataxia and deafness syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  347. en:congenital cataracts, facial dysmorphism, and neuropathy --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:congenital cataracts, facial dysmorphism, and neuropathy | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  348. en:congenital muscular dystrophy with infantile cataract and hypogonadism syndrome --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:congenital muscular dystrophy with infantile cataract and hypogonadism syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  349. en:curvilinear intracellular accumulation of autofluorescent lipopigment storage material --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:curvilinear intracellular accumulation of autofluorescent lipopigment storage material | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  350. en:cystathionine beta-synthase deficiency disease --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:cystathionine beta-synthase deficiency disease | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  351. en:cytogenetic deletion of chromosome 19q13 --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:cytogenetic deletion of chromosome 19q13 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  352. en:cytosolic phosphoenolpyruvate carboxykinase deficiency --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:cytosolic phosphoenolpyruvate carboxykinase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  353. en:decreased activity of aromatic l-amino acid decarboxylase (aadc) --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:decreased activity of aromatic l-amino acid decarboxylase (aadc) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  354. en:decreased beta-galactosidase activity --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:decreased beta-galactosidase activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  355. en:decreased beta-thromboglobulin --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:decreased beta-thromboglobulin | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  356. en:decreased coq10 levels in lymphoblasts or fibroblasts --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:decreased coq10 levels in lymphoblasts or fibroblasts | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  357. en:decreased csf 5-hydroxyindoleacetic acid (5-hiaa) --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:decreased csf 5-hydroxyindoleacetic acid (5-hiaa) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  358. en:decreased csf arginine --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:decreased csf arginine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  359. en:decreased dihydroxyacetonephosphate acyltransferase (dhap-at) activity --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:decreased dihydroxyacetonephosphate acyltransferase (dhap-at) activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  360. en:decreased fumarate hydratase activity --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:decreased fumarate hydratase activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  361. en:decreased heme-heme interaction (e.g. hb kanagawa 141800.0169) --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:decreased heme-heme interaction (e.g. hb kanagawa 141800.0169) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  362. en:decreased methylmalonyl-coa mutase activity --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:decreased methylmalonyl-coa mutase activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  363. en:decreased neopterin and biopterin in urine --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:decreased neopterin and biopterin in urine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  364. en:decreased or absent alpha-n-acetylgalactosaminidase protein --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:decreased or absent alpha-n-acetylgalactosaminidase protein | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  365. en:decreased or absent peroxisome acyl-coa oxidase activity and protein --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:decreased or absent peroxisome acyl-coa oxidase activity and protein | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  366. en:decreased plasma serine --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:decreased plasma serine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  367. en:decreased plasminogen antigen --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:decreased plasminogen antigen | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  368. en:decreased serum alpha-2 macroglobulin levels --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:decreased serum alpha-2 macroglobulin levels | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  369. en:decreased serum cobalamin --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:decreased serum cobalamin | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  370. en:decreased serum factor h (atypical hus) --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:decreased serum factor h (atypical hus) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  371. en:decreased serum free thyroxine --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:decreased serum free thyroxine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  372. en:decreased serum thyroxine (t4) --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:decreased serum thyroxine (t4) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  373. en:decreased serum vitamin a --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:decreased serum vitamin a | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  374. en:decreased short/branched-chain acyl-coa dehydrogenase protein levels and enzyme activity --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:decreased short/branched-chain acyl-coa dehydrogenase protein levels and enzyme activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  375. en:decreased testosterone level --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:decreased testosterone level | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  376. en:decreased tetrahydrobiopterin (bh4) in csf --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:decreased tetrahydrobiopterin (bh4) in csf | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  377. en:decreased urinary calcium and phosphate excretion --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:decreased urinary calcium and phosphate excretion | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  378. en:decreased urinary hva, 5-hiaa, and vanillyl mandelic acid (vma) --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:decreased urinary hva, 5-hiaa, and vanillyl mandelic acid (vma) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  379. en:decreased very long-chain acyl-coa dehydrogenase protein and activity --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:decreased very long-chain acyl-coa dehydrogenase protein and activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  380. en:decreased xanthine dehydrogenase activity --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:decreased xanthine dehydrogenase activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  381. en:defect in oxidative phosphorylation --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:defect in oxidative phosphorylation | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  382. en:defective t-cell proliferative responses (in some patients) --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:defective t-cell proliferative responses (in some patients) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  383. en:delayed plasma clearance of unconjugated bromsulphthalein, an anionic diagnostic dye --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:delayed plasma clearance of unconjugated bromsulphthalein, an anionic diagnostic dye | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  384. en:dentinogenesis imperfecta, short stature, hearing loss, intellectual disability syndrome --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:dentinogenesis imperfecta, short stature, hearing loss, intellectual disability syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  385. en:di- and trihydroxycholestanoic acid accumulation --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:di- and trihydroxycholestanoic acid accumulation | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  386. en:diaphanospondylodysostosis --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:diaphanospondylodysostosis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  387. en:dilated rough endoplasmic reticulum (rer) --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:dilated rough endoplasmic reticulum (rer) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  388. en:electron microscopy of patient respiratory cells shows absent outer dynein arms --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:electron microscopy of patient respiratory cells shows absent outer dynein arms | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  389. en:electron microscopy of patient respiratory cells shows reduced inner dynein arms and nexin links --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:electron microscopy of patient respiratory cells shows reduced inner dynein arms and nexin links | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  390. en:elevated 2-ketoglutarate (urine) --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:elevated 2-ketoglutarate (urine) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  391. en:elevated 3-methylcitric acid --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:elevated 3-methylcitric acid | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  392. en:elevated bilirubin (bilirubinemia) --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:elevated bilirubin (bilirubinemia) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  393. en:elevated creatine kinase (in some patients) --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:elevated creatine kinase (in some patients) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  394. en:elevated fibroblast free sialic acid --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:elevated fibroblast free sialic acid | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  395. en:elevated hdl (2-6x normal) in homozygotes --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:elevated hdl (2-6x normal) in homozygotes | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  396. en:elevated mchc --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:elevated mchc | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  397. en:elevated plasma desmosterol --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:elevated plasma desmosterol | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  398. en:elevated plasma galactose (galactosemia) --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:elevated plasma galactose (galactosemia) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  399. en:elevated pth (parathyroid hormone) --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:elevated pth (parathyroid hormone) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  400. en:elevated sepiapterin in csf --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:elevated sepiapterin in csf | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  401. en:elevated serum parathyroid hormone (pth) --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:elevated serum parathyroid hormone (pth) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  402. en:elevated urinary 3-methylglutarate --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:elevated urinary 3-methylglutarate | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  403. en:elevated urinary n,n-dimethylglycine (dmg) --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:elevated urinary n,n-dimethylglycine (dmg) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  404. en:excretion of dermatan sulfate and heparan sulfate in urine --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:excretion of dermatan sulfate and heparan sulfate in urine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  405. en:familial acantholysis --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:familial acantholysis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  406. en:familial erythrocytosis due to diphosphoglycerate mutase deficiency --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:familial erythrocytosis due to diphosphoglycerate mutase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  407. en:familial hypoaldosteronism --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:familial hypoaldosteronism | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  408. en:farber lipogranulomatosis --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:farber lipogranulomatosis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  409. en:fasting ketosis --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:fasting ketosis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  410. en:fatty acid metabolism disorder --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:fatty acid metabolism disorder | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  411. en:fragmentation of the mitochondrial network --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:fragmentation of the mitochondrial network | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  412. en:fucosidosis --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:fucosidosis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  413. en:fumarase activity (mitochondrial and cytosolic) is decreased --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:fumarase activity (mitochondrial and cytosolic) is decreased | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  414. en:fumarase deficiency --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:fumarase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  415. en:galactocerebroside beta-galactosidase deficiency in serum, leukocytes, and fibroblasts --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:galactocerebroside beta-galactosidase deficiency in serum, leukocytes, and fibroblasts | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  416. en:galactosyltransferase i deficiency in fibroblasts --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:galactosyltransferase i deficiency in fibroblasts | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  417. en:gamma-glutamylcysteine deficiency --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:gamma-glutamylcysteine deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  418. en:gaucher disease, type 1 --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:gaucher disease, type 1 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  419. en:glucosuria, mild, intermittent --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:glucosuria, mild, intermittent | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  420. en:glutathione s-transferase deficiency --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:glutathione s-transferase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  421. en:glycosuria (less common) --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:glycosuria (less common) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  422. en:granular osmiophilic deposits (grod) in cells resulting in 'fingerprint' profiles ultrastructurally --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:granular osmiophilic deposits (grod) in cells resulting in 'fingerprint' profiles ultrastructurally | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  423. en:growth cartilage disorganized, with islands of cells and abnormal collagen arrangement --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:growth cartilage disorganized, with islands of cells and abnormal collagen arrangement | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  424. en:guanidinoacetate methyltransferase (gamt) deficiency --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:guanidinoacetate methyltransferase (gamt) deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  425. en:hepatic glycine cleavage defect --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:hepatic glycine cleavage defect | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  426. en:heteroplasmic partial duplication of mtdna --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:heteroplasmic partial duplication of mtdna | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  427. en:high ebv viral load --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:high ebv viral load | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  428. en:high serum guanosine levels --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:high serum guanosine levels | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  429. en:hnsha due to glutathione synthetase deficiency --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:hnsha due to glutathione synthetase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  430. en:homocarnosinosis --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:homocarnosinosis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  431. en:hyperammonemia --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:hyperammonemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  432. en:hypercholesterolemia --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:hypercholesterolemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  433. en:hyperhomocystinemia --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:hyperhomocystinemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  434. en:hypoalbuminemia --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:hypoalbuminemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  435. en:hypofibrinogenemia --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:hypofibrinogenemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  436. en:hypokalemia during periodic paralysis (most patients) --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:hypokalemia during periodic paralysis (most patients) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  437. en:hyponatremia --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:hyponatremia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  438. en:impaired response to gm-csf --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:impaired response to gm-csf | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  439. en:inborn errors of bilirubin metabolism --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:inborn errors of bilirubin metabolism | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  440. en:inclusion bodies (membrane-bound vacuoles) in fibroblasts --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:inclusion bodies (membrane-bound vacuoles) in fibroblasts | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  441. en:increased 18-ohb to aldosterone ratio --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:increased 18-ohb to aldosterone ratio | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  442. en:increased alpha-fetoprotein in the mother during early pregnancy while carrying an affected fetus --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:increased alpha-fetoprotein in the mother during early pregnancy while carrying an affected fetus | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  443. en:increased aromatase activity --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:increased aromatase activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  444. en:increased cerebrospinal fluid (csf) protein (>100mg/dl) --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:increased cerebrospinal fluid (csf) protein (>100mg/dl) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  445. en:increased csf, plasma, and urinary l-dopa --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:increased csf, plasma, and urinary l-dopa | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  446. en:increased excretion of urobilinogen --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:increased excretion of urobilinogen | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  447. en:increased igm level --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:increased igm level | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  448. en:increased long-chain acylcarnitine --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:increased long-chain acylcarnitine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  449. en:increased prv-1 (162860) mrna --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:increased prv-1 (162860) mrna | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  450. en:increased serum alpha-ketoglutarate --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:increased serum alpha-ketoglutarate | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  451. en:increased serum butyryl carnitine --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:increased serum butyryl carnitine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  452. en:increased serum glutamine (patient a) --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:increased serum glutamine (patient a) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  453. en:increased serum lactate --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:increased serum lactate | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  454. en:increased urinary 7-biopterin (primapterin) --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary 7-biopterin (primapterin) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  455. en:increased urinary formiminoglutamic acid (figlu) --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary formiminoglutamic acid (figlu) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  456. en:increased urinary hydroxyisovaleric acid --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary hydroxyisovaleric acid | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  457. en:increased urinary s-(2-carboxypropyl)cysteine --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary s-(2-carboxypropyl)cysteine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  458. en:increased urinary, plasma, and csf d-2-hydroxyglutaric acid --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary, plasma, and csf d-2-hydroxyglutaric acid | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  459. en:indirect hyperbilirubinemia --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:indirect hyperbilirubinemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  460. en:isaacs syndrome --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:isaacs syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  461. en:isovalericaciduria --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:isovalericaciduria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  462. en:karyomegaly may be found in other visceral organs --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:karyomegaly may be found in other visceral organs | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  463. en:keratan sulfate excretion in urine that decreases with age --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:keratan sulfate excretion in urine that decreases with age | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  464. en:lack of excessive parenchymal iron storage --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:lack of excessive parenchymal iron storage | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  465. en:lethal congenital contracture syndrome type 3 --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:lethal congenital contracture syndrome type 3 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  466. en:leukocyte inclusion bodies (em) - intermediate filaments and ribosome clusters irregularly dispersed in cytoplasm --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:leukocyte inclusion bodies (em) - intermediate filaments and ribosome clusters irregularly dispersed in cytoplasm | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  467. en:leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  468. en:little to absent aspartylglucosaminuria activity --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:little to absent aspartylglucosaminuria activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  469. en:loss of heterozygosity in giant cell astrocytomas, angiomyolipomas, rhabdomyomas --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:loss of heterozygosity in giant cell astrocytomas, angiomyolipomas, rhabdomyomas | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  470. en:low cholesterol esterification rates --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:low cholesterol esterification rates | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  471. en:low csf creatinine --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:low csf creatinine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  472. en:low or absent iga levels --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:low or absent iga levels | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  473. en:low or absent thyrotropin (tsh) --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:low or absent thyrotropin (tsh) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  474. en:low plasma arginine --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:low plasma arginine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  475. en:low plasma tryptophan (inflammatory type b) --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:low plasma tryptophan (inflammatory type b) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  476. en:low serum igg and iga --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:low serum igg and iga | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  477. en:macdermot winter syndrome --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:macdermot winter syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  478. en:marked hypoalphalipoproteinemia (in some patients) --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:marked hypoalphalipoproteinemia (in some patients) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  479. en:mendelian susceptibility to mycobacterial disease due to complete interleukin 12 receptor beta 1 deficiency --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:mendelian susceptibility to mycobacterial disease due to complete interleukin 12 receptor beta 1 deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  480. en:mucopolysaccharidosis i --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:mucopolysaccharidosis i | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  481. en:mucopolysaccharidosis type i --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:mucopolysaccharidosis type i | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  482. en:muscle d-lactate dehydrogenase deficiency --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:muscle d-lactate dehydrogenase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  483. en:neurodegeneration due to cerebral folate transport deficiency --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:neurodegeneration due to cerebral folate transport deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  484. en:neutral lipid storage disease with myopathy --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:neutral lipid storage disease with myopathy | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  485. en:pyruvate dehydrogenase deficiency --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:pyruvate dehydrogenase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  486. en:resistance to activated protein c due to factor v leiden --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:resistance to activated protein c due to factor v leiden | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  487. en:serum bicarbonate increased --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:serum bicarbonate increased | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  488. en:severe early childhood onset retinal dystrophy --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:severe early childhood onset retinal dystrophy | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  489. en:sly syndrome --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:sly syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  490. en:spastic paraplegia 15, autosomal recessive --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:spastic paraplegia 15, autosomal recessive | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  491. en:spondyloenchondrodysplasia --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=en:spondyloenchondrodysplasia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  492. histiocytose sinusale hémophagocytaire --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=histiocytose sinusale hémophagocytaire | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  493. syndrome de Laurence-Moon --- r_associated #0: 35 --> en:5-oxoprolinase deficiency
    n1=syndrome de Laurence-Moon | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=35
  494. déficit en 5-oxoprolinase --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=déficit en 5-oxoprolinase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  495. déficit en semialdéhyde succinique-déshydrogénase --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=déficit en semialdéhyde succinique-déshydrogénase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  496. en:2-oxoadipic aciduria --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:2-oxoadipic aciduria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  497. en:3-methylglutaconic aciduria type 1 --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:3-methylglutaconic aciduria type 1 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  498. en:4-hydroxyphenylactic aciduria --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:4-hydroxyphenylactic aciduria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  499. en:abetalipoproteinemia (lab finding) --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:abetalipoproteinemia (lab finding) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  500. en:abnormal cartilage collagen on em --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:abnormal cartilage collagen on em | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  501. en:abnormal oral glucose tolerance --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:abnormal oral glucose tolerance | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  502. en:abnormal serum glycoproteins --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:abnormal serum glycoproteins | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  503. en:abnormal serum protein electrophoresis (elevated alpha-2 band) --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:abnormal serum protein electrophoresis (elevated alpha-2 band) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  504. en:absence of chylomicrons in lymph and plasma --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:absence of chylomicrons in lymph and plasma | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  505. en:absence of cpt ii protein --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:absence of cpt ii protein | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  506. en:absence of hepatic udp-glucuronyl-transferase --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:absence of hepatic udp-glucuronyl-transferase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  507. en:absent ch50 activity in complete c4 deficiency --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:absent ch50 activity in complete c4 deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  508. en:absent enteric ganglia beginning at rectum and extending proximally by varying degrees --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:absent enteric ganglia beginning at rectum and extending proximally by varying degrees | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  509. en:absent or severely reduced levels of serum immunoglobulins --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:absent or severely reduced levels of serum immunoglobulins | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  510. en:acrocallosal syndrome --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:acrocallosal syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  511. en:agammaglobulinemia, microcephaly, craniosynostosis, severe dermatitis syndrome --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:agammaglobulinemia, microcephaly, craniosynostosis, severe dermatitis syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  512. en:al awadi syndrome --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:al awadi syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  513. en:amorphous hyaline substance (skin biopsy and visceral organs) --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:amorphous hyaline substance (skin biopsy and visceral organs) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  514. en:androgens increased --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:androgens increased | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  515. en:atrophoderma vermiculatum --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:atrophoderma vermiculatum | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  516. en:autosomal recessive asexual dwarfism --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:autosomal recessive asexual dwarfism | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  517. en:autosomal recessive muscular dystrophy with limb girdle distribution --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:autosomal recessive muscular dystrophy with limb girdle distribution | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  518. en:axonemes show normal structure --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:axonemes show normal structure | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  519. en:bardet-biedl syndrome --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:bardet-biedl syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  520. en:cerebellar ataxia ectodermal dysplasia --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:cerebellar ataxia ectodermal dysplasia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  521. en:cerebellar ataxia, cayman type --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:cerebellar ataxia, cayman type | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  522. en:ceruloplasmin decreased --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:ceruloplasmin decreased | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  523. en:cholesterol low --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:cholesterol low | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  524. en:chronic hypoxemia --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:chronic hypoxemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  525. en:cohen syndrome --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:cohen syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  526. en:congenital disorder of glycosylation type ie --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:congenital disorder of glycosylation type ie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  527. en:congenital leptin deficiency --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:congenital leptin deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  528. en:decrease or absence of cathepsin d (ctsd) protein immunostaining --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:decrease or absence of cathepsin d (ctsd) protein immunostaining | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  529. en:decreased activity of 2-methyl-3-hydroxybutyryl co-a dehydrogenase --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:decreased activity of 2-methyl-3-hydroxybutyryl co-a dehydrogenase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  530. en:decreased activity of mitochondrial respiratory complexes --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:decreased activity of mitochondrial respiratory complexes | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  531. en:decreased activity of phosphoglycerate kinase 1 --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:decreased activity of phosphoglycerate kinase 1 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  532. en:decreased aminoacylase-1 activity --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:decreased aminoacylase-1 activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  533. en:decreased coproporphyrinogen oxidase activity (hcp, lymphocytes, 50% of normal) --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:decreased coproporphyrinogen oxidase activity (hcp, lymphocytes, 50% of normal) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  534. en:decreased csf 5-hydroxyindoleacetic acid (5hiaa) --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:decreased csf 5-hydroxyindoleacetic acid (5hiaa) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  535. en:decreased erythrocyte lactate clearance (transport), 40 to 50% of normal values --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:decreased erythrocyte lactate clearance (transport), 40 to 50% of normal values | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  536. en:decreased fibroblast iduronate sulfatase --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:decreased fibroblast iduronate sulfatase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  537. en:decreased hdl cholesterol --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:decreased hdl cholesterol | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  538. en:decreased mitochondrial respiratory complexes i, iii, and iv in brain, heart, and skeletal muscle --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:decreased mitochondrial respiratory complexes i, iii, and iv in brain, heart, and skeletal muscle | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  539. en:decreased or absent udp-glucuronyl-transferase activity --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:decreased or absent udp-glucuronyl-transferase activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  540. en:decreased or low-normal serum parathyroid hormone (pth) --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:decreased or low-normal serum parathyroid hormone (pth) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  541. en:decreased plasmalogens --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:decreased plasmalogens | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  542. en:decreased prpp synthetase activity in erythrocytes and fibroblasts --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:decreased prpp synthetase activity in erythrocytes and fibroblasts | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  543. en:decreased serum glucosyltransferase (ggt) activity --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:decreased serum glucosyltransferase (ggt) activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  544. en:decreased serum leptin --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:decreased serum leptin | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  545. en:deficiency or absence of cytochrome b(-245) --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:deficiency or absence of cytochrome b(-245) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  546. en:dicarboxylicaminoaciduria --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:dicarboxylicaminoaciduria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  547. en:diminished lymphocyte response to phytohemaglutinin --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:diminished lymphocyte response to phytohemaglutinin | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  548. en:direct coombs test negative --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:direct coombs test negative | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  549. en:disorder due to cytochrome p450 enzyme variant --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:disorder due to cytochrome p450 enzyme variant | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  550. en:disorder of sialic acid metabolism --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:disorder of sialic acid metabolism | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  551. en:elevated alkaline phosphatase of bone origin --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:elevated alkaline phosphatase of bone origin | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  552. en:elevated alpha-ketoglutarate (in most patients) --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:elevated alpha-ketoglutarate (in most patients) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  553. en:elevated hepatic transaminases --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:elevated hepatic transaminases | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  554. en:elevated inflammatory markers --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:elevated inflammatory markers | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  555. en:elevated l-2-hydroxyglutaric acid (urine) --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:elevated l-2-hydroxyglutaric acid (urine) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  556. en:elevated levels of vitamin b12 --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:elevated levels of vitamin b12 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  557. en:elevated liver enzymes during episodes --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:elevated liver enzymes during episodes | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  558. en:elevated liver function tests --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:elevated liver function tests | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  559. en:elevated serum levels of adenosine --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:elevated serum levels of adenosine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  560. en:elevated urinary 3-methylglutaconate --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:elevated urinary 3-methylglutaconate | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  561. en:elevated urinary mevalonic acid --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:elevated urinary mevalonic acid | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  562. en:erythrocyte delta-aminolevulinate dehydratase (alad) deficiency --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:erythrocyte delta-aminolevulinate dehydratase (alad) deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  563. en:fibroblasts shows defects in oxidative phosphorylation --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:fibroblasts shows defects in oxidative phosphorylation | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  564. en:foam cells in bone marrow and renal glomeruli --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:foam cells in bone marrow and renal glomeruli | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  565. en:gaucher disease --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:gaucher disease | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  566. en:generalized amyloid deposition --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:generalized amyloid deposition | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  567. en:glutathione synthase deficiency without 5-oxoprolinuria --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:glutathione synthase deficiency without 5-oxoprolinuria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  568. en:glutathione synthetase deficiency --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:glutathione synthetase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  569. en:glycogen storage disease type vii --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:glycogen storage disease type vii | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  570. en:glyoxalase deficiency --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:glyoxalase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  571. en:gonadotrophin increased --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:gonadotrophin increased | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  572. en:granular osmiophilic cytoplasmic deposits ultrastructurally in cells --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:granular osmiophilic cytoplasmic deposits ultrastructurally in cells | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  573. en:green urine --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:green urine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  574. en:gurrieri sammito bellussi syndrome --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:gurrieri sammito bellussi syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  575. en:hepatic argininosuccinase deficiency --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:hepatic argininosuccinase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  576. en:hereditary adrenal unresponsiveness to corticotropin --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:hereditary adrenal unresponsiveness to corticotropin | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  577. en:high plasma asparagine --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:high plasma asparagine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  578. en:high plasma citrulline (100-300 micromolar) --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:high plasma citrulline (100-300 micromolar) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  579. en:high plasma triglyceride levels --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:high plasma triglyceride levels | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  580. en:high sweat sodium and chloride --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:high sweat sodium and chloride | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  581. en:homozygous 122kb deletion 11p15-p14 --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:homozygous 122kb deletion 11p15-p14 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  582. en:hyperbilirubinemia, non-hemolytic unconjugated (may rise with fasting or dehydration) --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:hyperbilirubinemia, non-hemolytic unconjugated (may rise with fasting or dehydration) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  583. en:hyperchloremia (mean 109 mm) --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:hyperchloremia (mean 109 mm) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  584. en:hypercholesterolemia, 350-550 mg/l in heterozygotes, 650-1000 mg/l in homozygotes --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:hypercholesterolemia, 350-550 mg/l in heterozygotes, 650-1000 mg/l in homozygotes | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  585. en:hyperlipoproteinemia type iib --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:hyperlipoproteinemia type iib | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  586. en:hypernatremia --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:hypernatremia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  587. en:hyperprolinemia type 1 --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:hyperprolinemia type 1 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  588. en:hypokalemia occurs during paralytic attacks --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:hypokalemia occurs during paralytic attacks | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  589. en:igg, elevated --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:igg, elevated | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  590. en:increased 18-oxocortisol --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:increased 18-oxocortisol | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  591. en:increased biopterin in urine and csf --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:increased biopterin in urine and csf | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  592. en:increased ck-mb --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:increased ck-mb | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  593. en:increased frequency of premature centromere disjunction (pcd) in cultured fibroblasts, esp. chromosome 3 --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:increased frequency of premature centromere disjunction (pcd) in cultured fibroblasts, esp. chromosome 3 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  594. en:increased gamma-aminobutyric acid in plasma, urine, and cerebrospinal fluid (csf) --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:increased gamma-aminobutyric acid in plasma, urine, and cerebrospinal fluid (csf) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  595. en:increased interleukin 10 --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:increased interleukin 10 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  596. en:increased oxygen affinity (e.g. hb nunobiki 141800.0109) --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:increased oxygen affinity (e.g. hb nunobiki 141800.0109) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  597. en:increased plasma 2-methylbutyrylcarnitine --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:increased plasma 2-methylbutyrylcarnitine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  598. en:increased serum acyl carnitines --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:increased serum acyl carnitines | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  599. en:increased serum alkaline phosphatase activity of skeletal origin --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:increased serum alkaline phosphatase activity of skeletal origin | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  600. en:increased serum and cerebrospinal fluid levels of pipecolic acid --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:increased serum and cerebrospinal fluid levels of pipecolic acid | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  601. en:increased serum and urinary 2-oxoglutarate --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:increased serum and urinary 2-oxoglutarate | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  602. en:increased serum c26-bile-acid intermediates --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:increased serum c26-bile-acid intermediates | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  603. en:increased serum gamma-ggt (231950) --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:increased serum gamma-ggt (231950) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  604. en:increased serum ige --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:increased serum ige | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  605. en:increased serum insulin-like growth factor 1 {comment=hpo:probinson} --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:increased serum insulin-like growth factor 1 {comment=hpo:probinson} | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  606. en:increased serum lactate dehydrogenase (ldh) --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:increased serum lactate dehydrogenase (ldh) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  607. en:increased serum parathyroid hormone (pth) --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:increased serum parathyroid hormone (pth) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  608. en:increased serum total cholesterol --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:increased serum total cholesterol | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  609. en:increased serum triglycerides (in some patients) --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:increased serum triglycerides (in some patients) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  610. en:increased serum uric acid --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:increased serum uric acid | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  611. en:increased serum vitamin b12 --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:increased serum vitamin b12 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  612. en:increased serum, urinary, and csf lysine --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:increased serum, urinary, and csf lysine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  613. en:increased succinyladenosine (s-ado) in serum, urine, and csf --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:increased succinyladenosine (s-ado) in serum, urine, and csf | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  614. en:increased tissue long-chain acylcarnitines --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:increased tissue long-chain acylcarnitines | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  615. en:increased urinary 2-oxoglutaric acid --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary 2-oxoglutaric acid | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  616. en:increased urinary acetoacetic acid --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary acetoacetic acid | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  617. en:increased urinary citric acid cycle intermediates --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary citric acid cycle intermediates | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  618. en:increased urinary cyclic amp (camp) in response to ddavp administration --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary cyclic amp (camp) in response to ddavp administration | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  619. en:increased urinary dicarboxylic acid, transient --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary dicarboxylic acid, transient | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  620. en:increased urinary glyoxylate (1 patient) --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary glyoxylate (1 patient) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  621. en:increased urinary neopterin --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary neopterin | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  622. en:increased urinary organic acids (in some patients) --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary organic acids (in some patients) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  623. en:increased urinary oxylate --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary oxylate | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  624. en:increased urinary potassium --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary potassium | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  625. en:increased urinary tricarboxylic acid intermediates --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary tricarboxylic acid intermediates | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  626. en:indirect bilirubin increased --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:indirect bilirubin increased | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  627. en:intermediate level of cellular sensitivity to uv light --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:intermediate level of cellular sensitivity to uv light | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  628. en:intracellular glycosphingolipid deposition in all tissues of the body --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:intracellular glycosphingolipid deposition in all tissues of the body | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  629. en:ketoses, metabolic --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:ketoses, metabolic | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  630. en:kypokalemia --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:kypokalemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  631. en:low leukocyte alkaline phosphatase activity --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:low leukocyte alkaline phosphatase activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  632. en:low level of c4 and c2 --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:low level of c4 and c2 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  633. en:low levels of serum mg(2+) in the absence of other electrolyte disturbances --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:low levels of serum mg(2+) in the absence of other electrolyte disturbances | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  634. en:low maximal oxygen uptake on exercise testing --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:low maximal oxygen uptake on exercise testing | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  635. en:low or absent adrenocorticotropic hormone (acth) in some patients --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:low or absent adrenocorticotropic hormone (acth) in some patients | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  636. en:low plasma citrulline --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:low plasma citrulline | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  637. en:low rai (radioactive iodine) uptake --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:low rai (radioactive iodine) uptake | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  638. en:low serum alpha-fetoprotein (recessive) --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:low serum alpha-fetoprotein (recessive) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  639. en:low serum levels of ketone bodies --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:low serum levels of ketone bodies | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  640. en:low-to-normal platelet count --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:low-to-normal platelet count | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  641. en:mendelian susceptibility to mycobacterial disease due to complete interleukin 12 subunit beta deficiency --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:mendelian susceptibility to mycobacterial disease due to complete interleukin 12 subunit beta deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  642. en:microcephalic primordial dwarfism toriello type --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:microcephalic primordial dwarfism toriello type | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  643. en:moderate steroid 21-hydroxylase deficiency --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:moderate steroid 21-hydroxylase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  644. en:papillon-lefevre syndrome --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:papillon-lefevre syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  645. en:pseudohypoaldosteronism, type 1, recessive form --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:pseudohypoaldosteronism, type 1, recessive form | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  646. en:reactive hypoglycemia --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:reactive hypoglycemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  647. en:renal dysplasia - limb defects syndrome --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:renal dysplasia - limb defects syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  648. en:rna polymerase iii-related leukodystrophy --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:rna polymerase iii-related leukodystrophy | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  649. en:sarcosinemia --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:sarcosinemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  650. en:serum growth hormone increased --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:serum growth hormone increased | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  651. en:spinocerebellar ataxia, autosomal recessive 2 --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:spinocerebellar ataxia, autosomal recessive 2 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  652. en:spondyloenchondrodysplasia with immune dysregulation --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:spondyloenchondrodysplasia with immune dysregulation | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  653. en:spondyloepiphyseal dysplasia tarda kohn type --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:spondyloepiphyseal dysplasia tarda kohn type | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  654. en:steroid metabolism, inborn errors --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:steroid metabolism, inborn errors | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  655. en:succinic semialdehyde dehydrogenase deficiency --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:succinic semialdehyde dehydrogenase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  656. en:sweat test normal --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:sweat test normal | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  657. en:transcobalamin ii deficiency --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:transcobalamin ii deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  658. en:trichohepatoenteric syndrome --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:trichohepatoenteric syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  659. en:xanthinuria, type i --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:xanthinuria, type i | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  660. en:zellweger-like syndrome without peroxisomal anomaly --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=en:zellweger-like syndrome without peroxisomal anomaly | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  661. lipofuscinose neuronale céroïde infantile finlandaise --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=lipofuscinose neuronale céroïde infantile finlandaise | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  662. thrombopénie --- r_associated #0: 34 --> en:5-oxoprolinase deficiency
    n1=thrombopénie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=34
  663. en:glutaric aciduria, type 1 --- r_associated #0: 33 --> en:5-oxoprolinase deficiency
    n1=en:glutaric aciduria, type 1 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=33
  664. en:neuronal ceroid lipofuscinosis --- r_associated #0: 33 --> en:5-oxoprolinase deficiency
    n1=en:neuronal ceroid lipofuscinosis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=33
  665. en:nystagmus --- r_associated #0: 33 --> en:5-oxoprolinase deficiency
    n1=en:nystagmus | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=33
  666. en:prolidase deficiency --- r_associated #0: 33 --> en:5-oxoprolinase deficiency
    n1=en:prolidase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=33
  667. maladie lysosomique de surcharge --- r_associated #0: 33 --> en:5-oxoprolinase deficiency
    n1=maladie lysosomique de surcharge | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=33
  668. en:3-methylglutaconic aciduria type 7 --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:3-methylglutaconic aciduria type 7 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  669. en:abnormal isoelectric focusing of serum transferrin (type 1 pattern without increase of asialotransferrin) --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:abnormal isoelectric focusing of serum transferrin (type 1 pattern without increase of asialotransferrin) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  670. en:abnormal isoelectric focusing of serum transferrin (type 1 pattern) --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:abnormal isoelectric focusing of serum transferrin (type 1 pattern) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  671. en:abnormal myelination in sural nerve biopsies --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:abnormal myelination in sural nerve biopsies | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  672. en:abnormal phospholipid profile --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:abnormal phospholipid profile | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  673. en:abnormal serum liver enzyme levels --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:abnormal serum liver enzyme levels | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  674. en:absent alkyl-dhap synthase activity --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:absent alkyl-dhap synthase activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  675. en:absent axonal flare response to intradermal histamine injection --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:absent axonal flare response to intradermal histamine injection | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  676. en:absent pro alpha 2(i) chain synthesis (fibroblasts) --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:absent pro alpha 2(i) chain synthesis (fibroblasts) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  677. en:adenylosuccinate lyase deficiency (disorder) --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:adenylosuccinate lyase deficiency (disorder) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  678. en:alkaline phosphatase decreased --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:alkaline phosphatase decreased | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  679. en:alpha, alpha-trehalase deficiency --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:alpha, alpha-trehalase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  680. en:amino acid transport disorders, inborn --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:amino acid transport disorders, inborn | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  681. en:aminoacylase 1 deficiency --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:aminoacylase 1 deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  682. en:anti-ssb positive --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:anti-ssb positive | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  683. en:antineutrophil antibody positivity --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:antineutrophil antibody positivity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  684. en:argininosuccinic aciduria --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:argininosuccinic aciduria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  685. en:ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  686. en:autosomal recessive inheritance --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:autosomal recessive inheritance | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  687. en:beta-aminoisobutyricaciduria --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:beta-aminoisobutyricaciduria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  688. en:bicarbonaturia --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:bicarbonaturia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  689. en:cerebroretinal microangiopathy with calcifications and cysts (disorder) --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:cerebroretinal microangiopathy with calcifications and cysts (disorder) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  690. en:chromosomal mosaicism in fibroblast and/or peripheral lymphocytes no consistent karyotypic finding --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:chromosomal mosaicism in fibroblast and/or peripheral lymphocytes no consistent karyotypic finding | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  691. en:cilia may also be static, with slow activity --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:cilia may also be static, with slow activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  692. en:complex organic aciduria --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:complex organic aciduria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  693. en:congenital dyserythropoietic anemia, type ii --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:congenital dyserythropoietic anemia, type ii | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  694. en:cytoplasmic lamellar inclusions consistent with neuronal ceroid lipofuscinosis (in some patients) --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:cytoplasmic lamellar inclusions consistent with neuronal ceroid lipofuscinosis (in some patients) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  695. en:decreased acetyl-coa carboxylase activity --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:decreased acetyl-coa carboxylase activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  696. en:decreased acid sphingomyelinase activity --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:decreased acid sphingomyelinase activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  697. en:decreased activity of ampd1 in skeletal muscle increased serum creatine kinase --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:decreased activity of ampd1 in skeletal muscle increased serum creatine kinase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  698. en:decreased activity of cytochrome c oxidase in muscle and fibroblasts --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:decreased activity of cytochrome c oxidase in muscle and fibroblasts | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  699. en:decreased activity of thiopurine s-methyltransferase --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:decreased activity of thiopurine s-methyltransferase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  700. en:decreased atp synthase in muscle, heart, liver, and brain --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:decreased atp synthase in muscle, heart, liver, and brain | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  701. en:decreased csf glycine --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:decreased csf glycine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  702. en:decreased csf methyltetrahydrofolate (mthf) --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:decreased csf methyltetrahydrofolate (mthf) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  703. en:decreased erythrocyte 2,3-diphosphoglycerate (2,3-dpg) --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:decreased erythrocyte 2,3-diphosphoglycerate (2,3-dpg) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  704. en:decreased fibroblast beta-hexosaminidase --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:decreased fibroblast beta-hexosaminidase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  705. en:decreased hexokinase activity in red blood cells --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:decreased hexokinase activity in red blood cells | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  706. en:decreased high molecular weight plasma factor viii/ vwf multimers --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:decreased high molecular weight plasma factor viii/ vwf multimers | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  707. en:decreased intracellular fmr protein --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:decreased intracellular fmr protein | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  708. en:decreased levels of cpt2 protein --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:decreased levels of cpt2 protein | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  709. en:decreased levels of plasma factor viii --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:decreased levels of plasma factor viii | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  710. en:decreased mitochondrial complex iii activity (in liver, muscle, and fibroblasts) --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:decreased mitochondrial complex iii activity (in liver, muscle, and fibroblasts) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  711. en:decreased n-acetylglucosamine-1-phosphotransferase (glcnac - phosphotransferase) using lysosomal enzymes --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:decreased n-acetylglucosamine-1-phosphotransferase (glcnac - phosphotransferase) using lysosomal enzymes | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  712. en:decreased or normal serum c3 --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:decreased or normal serum c3 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  713. en:decreased phosphoglycerate mutase 1 (pgam2) activity (2 to 6% of normal values) --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:decreased phosphoglycerate mutase 1 (pgam2) activity (2 to 6% of normal values) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  714. en:decreased plasma lysine, glutamic acid, and glutamine --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:decreased plasma lysine, glutamic acid, and glutamine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  715. en:decreased renal calcium excretion --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:decreased renal calcium excretion | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  716. en:decreased serum 18-ohb --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:decreased serum 18-ohb | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  717. en:decreased serum androgens --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:decreased serum androgens | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  718. en:decreased transferrin increased serum iron --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:decreased transferrin increased serum iron | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  719. en:defective (ca2+) mobilization in t cells --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:defective (ca2+) mobilization in t cells | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  720. en:defective dna repair after ultraviolet radiation damage --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:defective dna repair after ultraviolet radiation damage | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  721. en:defective glcnac-pi synthesis --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:defective glcnac-pi synthesis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  722. en:deficiency of mitochondrial isovaleryl-coa dehydrogenase in fibroblasts --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:deficiency of mitochondrial isovaleryl-coa dehydrogenase in fibroblasts | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  723. en:dehydroepiandrosterone (dhea) at upper level of normal range --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:dehydroepiandrosterone (dhea) at upper level of normal range | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  724. en:delayed oxidation of acetaldehyde --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:delayed oxidation of acetaldehyde | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  725. en:dermatan sulfate excretion in urine --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:dermatan sulfate excretion in urine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  726. en:desmosterolosis --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:desmosterolosis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  727. en:dicarboxylic aciduria --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:dicarboxylic aciduria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  728. en:donnai-barrow syndrome --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:donnai-barrow syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  729. en:dyskeratosis congenita, autosomal recessive --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:dyskeratosis congenita, autosomal recessive | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  730. en:electron microscopy of patient respiratory cells shows absent outer dynein arms in the axoneme --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:electron microscopy of patient respiratory cells shows absent outer dynein arms in the axoneme | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  731. en:elevated androstenedione --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:elevated androstenedione | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  732. en:elevated crp --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:elevated crp | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  733. en:elevated d-2-hydroxyglutaric acid (urine, plasma, csf) --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:elevated d-2-hydroxyglutaric acid (urine, plasma, csf) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  734. en:elevated gamma-glutamyltransferase (ggt) --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:elevated gamma-glutamyltransferase (ggt) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  735. en:elevated gastrin concentration --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:elevated gastrin concentration | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  736. en:elevated il1-beta --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:elevated il1-beta | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  737. en:elevated plasma adrenocorticotropic hormone (acth) --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:elevated plasma adrenocorticotropic hormone (acth) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  738. en:elevated plasma and urine inorganic pyrophosphate (ppi) --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:elevated plasma and urine inorganic pyrophosphate (ppi) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  739. en:elevated plasma propionylcarnitine --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:elevated plasma propionylcarnitine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  740. en:elevated serum insulin-to-c-peptide ratio --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:elevated serum insulin-to-c-peptide ratio | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  741. en:elevated serum lactate --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:elevated serum lactate | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  742. en:elevated serum phosphorus --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:elevated serum phosphorus | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  743. en:elevated serum very long chain fatty acids (vlcfa) --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:elevated serum very long chain fatty acids (vlcfa) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  744. en:elevated sweat chloride --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:elevated sweat chloride | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  745. en:elevated sweat chloride (some) --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:elevated sweat chloride (some) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  746. en:elevated testosterone --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:elevated testosterone | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  747. en:elevated urinary free sialic acid (n-acetylneuraminic acid) --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:elevated urinary free sialic acid (n-acetylneuraminic acid) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  748. en:erythrocyte porphobilinogen (pbg) deaminase deficiency (exception: type ii aip) --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:erythrocyte porphobilinogen (pbg) deaminase deficiency (exception: type ii aip) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  749. en:erythroid colony-forming units show spontaneous growth in the absence of epo --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:erythroid colony-forming units show spontaneous growth in the absence of epo | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  750. en:euvolemia --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:euvolemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  751. en:fasting hypoglycemia (early in disease course) --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:fasting hypoglycemia (early in disease course) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  752. en:fatty acid pattern of serum lecithin shows increased arachidonic acid and decreased linoleic acid --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:fatty acid pattern of serum lecithin shows increased arachidonic acid and decreased linoleic acid | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  753. en:fibroblasts show decreased mitochondrial complex v activity --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:fibroblasts show decreased mitochondrial complex v activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  754. en:fluorescence of red blood cells by uv microscopy --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:fluorescence of red blood cells by uv microscopy | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  755. en:folic acid deficiency --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:folic acid deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  756. en:galactosuria --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:galactosuria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  757. en:gamma-glutamyltransferase deficiency --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:gamma-glutamyltransferase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  758. en:gangrene --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:gangrene | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  759. en:giant cells (degenerating chondrocytes) in resting zone of epiphyseal cartilage --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:giant cells (degenerating chondrocytes) in resting zone of epiphyseal cartilage | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  760. en:glucose-6-phosphate dehydrogenase deficiency --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:glucose-6-phosphate dehydrogenase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  761. en:glucose-6-phosphate dehydrogenase deficiency anemia --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:glucose-6-phosphate dehydrogenase deficiency anemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  762. en:glycine dehydrogenase (decarboxylating) deficiency --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:glycine dehydrogenase (decarboxylating) deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  763. en:granular osmiophilic cytoplasmic deposits (grod) ultrastructurally in cells --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:granular osmiophilic cytoplasmic deposits (grod) ultrastructurally in cells | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  764. en:hall riggs syndrome --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:hall riggs syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  765. en:heparan sulfate excretion in urine --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:heparan sulfate excretion in urine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  766. en:hepatic ornithine transcarbamylase deficiency --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:hepatic ornithine transcarbamylase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  767. en:hereditary hyperbilirubinemia --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:hereditary hyperbilirubinemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  768. en:high deoxypyridinoline/creatinine (in some patients) --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:high deoxypyridinoline/creatinine (in some patients) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  769. en:high newborn serum levels of immunoreactive trypsinogen --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:high newborn serum levels of immunoreactive trypsinogen | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  770. en:high sister chromatid exchange (sce) rate --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:high sister chromatid exchange (sce) rate | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  771. en:high urinary orotic acid --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:high urinary orotic acid | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  772. en:hnsha due to nadh diaphorase deficiency --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:hnsha due to nadh diaphorase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  773. en:hypercholesterolemia (10%) --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:hypercholesterolemia (10%) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  774. en:hyperimmunoglobulin e syndrome --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:hyperimmunoglobulin e syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  775. en:hyperinsulinemic hypoglycemia, familial, 7 --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:hyperinsulinemic hypoglycemia, familial, 7 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  776. en:hypermethioninemia, progressive --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:hypermethioninemia, progressive | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  777. en:hyperphenylalaninemia --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:hyperphenylalaninemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  778. en:hypertryptophanemia --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:hypertryptophanemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  779. en:hypospadias-mental retardation syndrome --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:hypospadias-mental retardation syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  780. en:impaired mitochondrial translation --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:impaired mitochondrial translation | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  781. en:impairment of urinary concentration --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:impairment of urinary concentration | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  782. en:inappropriately normal to low-normal serum 1,25-dihydroxyvitamin d3 --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:inappropriately normal to low-normal serum 1,25-dihydroxyvitamin d3 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  783. en:inborn error of lipoprotein metabolism --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:inborn error of lipoprotein metabolism | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  784. en:increased 18-hydroxycortisol --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:increased 18-hydroxycortisol | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  785. en:increased chromosomal rearrangements (bone marrow and fibroblast culture) --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:increased chromosomal rearrangements (bone marrow and fibroblast culture) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  786. en:increased csf and plasma ghb --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:increased csf and plasma ghb | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  787. en:increased csf immunoglobulin levels --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:increased csf immunoglobulin levels | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  788. en:increased disialotransferrin and asialotransferrin levels --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:increased disialotransferrin and asialotransferrin levels | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  789. en:increased ferritin --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:increased ferritin | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  790. en:increased fibroblast free sialic acid --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:increased fibroblast free sialic acid | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  791. en:increased fractional excretion of uric acid --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:increased fractional excretion of uric acid | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  792. en:increased ige level --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:increased ige level | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  793. en:increased il-6 --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:increased il-6 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  794. en:increased levels of dihydroxyacetone phosphate (dhap) in tissues and red cells --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:increased levels of dihydroxyacetone phosphate (dhap) in tissues and red cells | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  795. en:increased osmotic fragility --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:increased osmotic fragility | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  796. en:increased plasma phytanic acid --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:increased plasma phytanic acid | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  797. en:increased serum 1,25-dihydroxyvitamin d --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:increased serum 1,25-dihydroxyvitamin d | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  798. en:increased serum acylcarnitines --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:increased serum acylcarnitines | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  799. en:increased serum aryl-sulfatase a (10-20x) --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:increased serum aryl-sulfatase a (10-20x) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  800. en:increased serum creatine kinase (1 family) --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:increased serum creatine kinase (1 family) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  801. en:increased serum creatine kinase in acute stage --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:increased serum creatine kinase in acute stage | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  802. en:increased serum erythropoietin (epo, 133170) --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:increased serum erythropoietin (epo, 133170) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  803. en:increased serum glutamine --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:increased serum glutamine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  804. en:increased serum thyroid-stimulating hormone (tsh) --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:increased serum thyroid-stimulating hormone (tsh) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  805. en:increased total bilirubin may occur --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:increased total bilirubin may occur | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  806. en:increased uracil and dihydrouracil in bodily fluids --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:increased uracil and dihydrouracil in bodily fluids | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  807. en:increased urinary dopamine --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary dopamine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  808. en:increased urinary dopamine and dopamine metabolites (paradoxical) --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary dopamine and dopamine metabolites (paradoxical) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  809. en:increased urinary excretion of coproporphyrin i --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary excretion of coproporphyrin i | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  810. en:increased urinary hga --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary hga | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  811. en:increased urinary sialylglycopeptides --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary sialylglycopeptides | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  812. en:increased urinary thymine --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary thymine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  813. en:interstitial or terminal deletion of 18q --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:interstitial or terminal deletion of 18q | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  814. en:intracellular fingerprint profiles on ultrastructural analysis --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:intracellular fingerprint profiles on ultrastructural analysis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  815. en:isolated hypoplasia of the right ventricle --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:isolated hypoplasia of the right ventricle | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  816. en:lethal congenital contracture syndrome 1 --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:lethal congenital contracture syndrome 1 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  817. en:lethal congenital contracture syndrome 2 --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:lethal congenital contracture syndrome 2 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  818. en:lethal larsen-like syndrome --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:lethal larsen-like syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  819. en:leucinosis --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:leucinosis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  820. en:low ldl cholesterol --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:low ldl cholesterol | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  821. en:low or absent thyroid-stimulating hormone (tsh) --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:low or absent thyroid-stimulating hormone (tsh) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  822. en:low or normal serum igm --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:low or normal serum igm | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  823. en:low-normal igm --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:low-normal igm | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  824. en:lysosomal storage disease --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:lysosomal storage disease | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  825. en:marked elevation of serum c-reactive protein level (crp 123260) --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:marked elevation of serum c-reactive protein level (crp 123260) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  826. en:markedly reduced igg levels --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:markedly reduced igg levels | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  827. en:megalencephalic leukoencephalopathy with subcortical cysts --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:megalencephalic leukoencephalopathy with subcortical cysts | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  828. en:methylene thf reductase deficiency and homocystinuria --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:methylene thf reductase deficiency and homocystinuria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  829. en:microcephaly cervical spine fusion anomalies --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:microcephaly cervical spine fusion anomalies | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  830. en:microcephaly, amish type (disorder) --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:microcephaly, amish type (disorder) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  831. en:muscle l-lactate dehydrogenase deficiency --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:muscle l-lactate dehydrogenase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  832. en:najjar syndrome --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:najjar syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  833. en:neuroacanthocytosis --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:neuroacanthocytosis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  834. en:oplah, val1089ile (dbsnp rs185836803) --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:oplah, val1089ile (dbsnp rs185836803) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  835. en:palmoplantar keratoderma, 46,xx sex reversal, predisposition to squamous cell carcinoma syndrome --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:palmoplantar keratoderma, 46,xx sex reversal, predisposition to squamous cell carcinoma syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  836. en:peroxisomal disorder --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:peroxisomal disorder | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  837. en:presentey anomaly --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:presentey anomaly | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  838. en:prickle1-related progressive myoclonus epilepsy with ataxia --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:prickle1-related progressive myoclonus epilepsy with ataxia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  839. en:propionic acidemia --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:propionic acidemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  840. en:prothrombin time increased --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:prothrombin time increased | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  841. en:pseudotrisomy 13 syndrome --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:pseudotrisomy 13 syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  842. en:sanfilippo syndrome --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:sanfilippo syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  843. en:specific enzyme deficiency --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:specific enzyme deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  844. en:spinocerebellar ataxia with epilepsy --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:spinocerebellar ataxia with epilepsy | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  845. en:transaminitis --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:transaminitis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  846. en:xanthine nephrolithiasis --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=en:xanthine nephrolithiasis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  847. hérédité autosomale récessive --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=hérédité autosomale récessive | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  848. maladie de Niemann-Pick --- r_associated #0: 32 --> en:5-oxoprolinase deficiency
    n1=maladie de Niemann-Pick | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=32
  849. agrégation plaquettaire sai diminuée --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=agrégation plaquettaire sai diminuée | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  850. dysplasie craniodiaphysaire --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=dysplasie craniodiaphysaire | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  851. déficit en neuraminidase --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=déficit en neuraminidase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  852. en:1.61- and 1.76-mb microduplication of 3q29 --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:1.61- and 1.76-mb microduplication of 3q29 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  853. en:3-methylglutaconic aciduria (3-mgc) --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:3-methylglutaconic aciduria (3-mgc) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  854. en:3-methylglutaconic aciduria type 3 --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:3-methylglutaconic aciduria type 3 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  855. en:5-hiaa csf may be normal or decreased --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:5-hiaa csf may be normal or decreased | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  856. en:a small minority of patients have translocations and inversions involving 16p13.3 --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:a small minority of patients have translocations and inversions involving 16p13.3 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  857. en:a subset of group b patients have absence of pc protein and mrna --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:a subset of group b patients have absence of pc protein and mrna | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  858. en:abnormal lipid profile --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:abnormal lipid profile | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  859. en:abnormal liver function tests (in some patients) --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:abnormal liver function tests (in some patients) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  860. en:abnormal liver function tests (sgot, sgpt) --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:abnormal liver function tests (sgot, sgpt) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  861. en:abnormal phosphatidylglycerol profile (increased 34-to-1 and decreased 36-to-1 ratio) --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:abnormal phosphatidylglycerol profile (increased 34-to-1 and decreased 36-to-1 ratio) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  862. en:abnormality of superoxide metabolism --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:abnormality of superoxide metabolism | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  863. en:absence of cd59 expression on red cells --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:absence of cd59 expression on red cells | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  864. en:absent platelet agglutination in presence of ristocetin --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:absent platelet agglutination in presence of ristocetin | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  865. en:absent/reduced free proteins and absent total protein s --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:absent/reduced free proteins and absent total protein s | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  866. en:allelic loss on 16p13.3 in angiomyolipoma, cardiac rhabdomyoma, cortical tuber, and giant cell astrocytoma --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:allelic loss on 16p13.3 in angiomyolipoma, cardiac rhabdomyoma, cortical tuber, and giant cell astrocytoma | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  867. en:allgrove syndrome --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:allgrove syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  868. en:anomalies of cholesterol levels --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:anomalies of cholesterol levels | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  869. en:antiribonuclear protein positive --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:antiribonuclear protein positive | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  870. en:associated with serum anti-phospholipid antibodies in about 50% of patients --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:associated with serum anti-phospholipid antibodies in about 50% of patients | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  871. en:ataxia telangiectasia syndrome --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:ataxia telangiectasia syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  872. en:balanced translocation carrier 46,xy,+(11:18)(p13:q21)mat --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:balanced translocation carrier 46,xy,+(11:18)(p13:q21)mat | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  873. en:ballooned neurons --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:ballooned neurons | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  874. en:blood glucose normal --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:blood glucose normal | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  875. en:c-band karyotype shows 'railroad track' appearance --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:c-band karyotype shows 'railroad track' appearance | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  876. en:carriers have balanced constitutional translocation - 46,xx(or xy), +(11:22)(q23:q11) --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:carriers have balanced constitutional translocation - 46,xx(or xy), +(11:22)(q23:q11) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  877. en:cd4+/cd8+ ratio often reversed --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:cd4+/cd8+ ratio often reversed | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  878. en:circulating enzyme deficiency --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:circulating enzyme deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  879. en:congenital disorder of glycosylation type ig --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:congenital disorder of glycosylation type ig | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  880. en:congenital plasminogen activator inhibitor deficiency type 1 --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:congenital plasminogen activator inhibitor deficiency type 1 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  881. en:congenital sucrase-isomaltase deficiency --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:congenital sucrase-isomaltase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  882. en:craniofacial ulnar renal syndrome --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:craniofacial ulnar renal syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  883. en:creatine kinase levels may normalize with disease progression --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:creatine kinase levels may normalize with disease progression | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  884. en:decreased 5-hydroxyindoleacetic acid (5-hiaa) in csf --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:decreased 5-hydroxyindoleacetic acid (5-hiaa) in csf | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  885. en:decreased activity of branched-chain ketoacid dehydrogenase (bckdh) --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:decreased activity of branched-chain ketoacid dehydrogenase (bckdh) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  886. en:decreased activity of coenzyme q10-dependent respiratory chain complexes --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:decreased activity of coenzyme q10-dependent respiratory chain complexes | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  887. en:decreased activity of succinic semialdehyde dehydrogenase (ssadh, aldh5a1), less than 5% of control values --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:decreased activity of succinic semialdehyde dehydrogenase (ssadh, aldh5a1), less than 5% of control values | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  888. en:decreased activity of the pyruvate dehydrogenase (pdh) complex --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:decreased activity of the pyruvate dehydrogenase (pdh) complex | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  889. en:decreased adiponectin --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:decreased adiponectin | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  890. en:decreased agt activity --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:decreased agt activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  891. en:decreased alpha-n-acetylgalactosaminidase activity (less than 2% of control) --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:decreased alpha-n-acetylgalactosaminidase activity (less than 2% of control) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  892. en:decreased alpha-n-acetylgalactosaminidase protein --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:decreased alpha-n-acetylgalactosaminidase protein | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  893. en:decreased b cells --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:decreased b cells | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  894. en:decreased cholesterol (less common) --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:decreased cholesterol (less common) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  895. en:decreased complement factor d --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:decreased complement factor d | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  896. en:decreased cytochrome c oxidase activity in skin fibroblasts, liver, and skeletal muscle --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:decreased cytochrome c oxidase activity in skin fibroblasts, liver, and skeletal muscle | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  897. en:decreased free t(3)/free t(4) --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:decreased free t(3)/free t(4) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  898. en:decreased glutamine in bodily fluids --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:decreased glutamine in bodily fluids | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  899. en:decreased grhpr activity --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:decreased grhpr activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  900. en:decreased lecithin:cholesterol acyltransferase mass and activity --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:decreased lecithin:cholesterol acyltransferase mass and activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  901. en:decreased mitochondrial complex iii activity in liver and fibroblasts --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:decreased mitochondrial complex iii activity in liver and fibroblasts | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  902. en:decreased mitochondrial complex iii activity seen in muscle --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:decreased mitochondrial complex iii activity seen in muscle | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  903. en:decreased mitochondrial respiratory chain complex (2p21del) --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:decreased mitochondrial respiratory chain complex (2p21del) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  904. en:decreased mucosal alkaline phosphatase --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:decreased mucosal alkaline phosphatase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  905. en:decreased nk cells (in some patients) --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:decreased nk cells (in some patients) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  906. en:decreased numbers of t regulatory cells --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:decreased numbers of t regulatory cells | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  907. en:decreased or absent serum and urinary chenodeoxycholic acid and cholic acid --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:decreased or absent serum and urinary chenodeoxycholic acid and cholic acid | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  908. en:decreased plasma total cholesterol --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:decreased plasma total cholesterol | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  909. en:decreased plasma zinc levels --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:decreased plasma zinc levels | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  910. en:decreased pyruvate carboxylase (pc) activity (less than 5%) --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:decreased pyruvate carboxylase (pc) activity (less than 5%) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  911. en:decreased serum c3 (atypical hus) --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:decreased serum c3 (atypical hus) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  912. en:decreased udp-glcnac --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:decreased udp-glcnac | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  913. en:decreased von willebrand factor --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:decreased von willebrand factor | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  914. en:decreased whole blood serotonin --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:decreased whole blood serotonin | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  915. en:decreased-absent intestinal mucosa lactase activity --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:decreased-absent intestinal mucosa lactase activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  916. en:defective bile acid metabolism --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:defective bile acid metabolism | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  917. en:deficiency of alpha-1,4-glucosidase (acid maltase) --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:deficiency of alpha-1,4-glucosidase (acid maltase) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  918. en:deficiency or absence of p22-phox (608508) protein --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:deficiency or absence of p22-phox (608508) protein | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  919. en:deficient fibroblast aicar-tf activity --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:deficient fibroblast aicar-tf activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  920. en:dehydration --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:dehydration | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  921. en:dhea sulfotransferase below limit of detection --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:dhea sulfotransferase below limit of detection | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  922. en:dihydropyrimidinase deficiency --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:dihydropyrimidinase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  923. en:disorder of pyruvate metabolism and mitochondrial respiratory chain --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:disorder of pyruvate metabolism and mitochondrial respiratory chain | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  924. en:dolichyl-p-glc:man(9)glcnac(2)-pp-dolichyl glucosyltransferase deficiency --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:dolichyl-p-glc:man(9)glcnac(2)-pp-dolichyl glucosyltransferase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  925. en:dolichyl-p-man:man(5)glcnac(2)-pp-dolichyl mannosyltransferase deficiency --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:dolichyl-p-man:man(5)glcnac(2)-pp-dolichyl mannosyltransferase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  926. en:double stranded anti dna antibody --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:double stranded anti dna antibody | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  927. en:east (epilepsy, ataxia, sensorineural deafness, and tubulopathy) syndrome --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:east (epilepsy, ataxia, sensorineural deafness, and tubulopathy) syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  928. en:ehlers-danlos syndrome, type vi --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:ehlers-danlos syndrome, type vi | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  929. en:electron microscopy of patient respiratory cells shows defects in inner and outer dynein arms --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:electron microscopy of patient respiratory cells shows defects in inner and outer dynein arms | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  930. en:elevated alkaline phosphatase (varies from 1.3-20 times age-adjusted upper limit of normal) --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:elevated alkaline phosphatase (varies from 1.3-20 times age-adjusted upper limit of normal) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  931. en:elevated antinuclear antibody (ana) (speckled pattern) --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:elevated antinuclear antibody (ana) (speckled pattern) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  932. en:elevated dihydrobiopterin in csf --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:elevated dihydrobiopterin in csf | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  933. en:elevated hcg or afp or both (embryonal carcinoma) --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:elevated hcg or afp or both (embryonal carcinoma) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  934. en:elevated long-chain acylcarnitine species (in some patients) --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:elevated long-chain acylcarnitine species (in some patients) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  935. en:elevated plasma alloisoleucine --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:elevated plasma alloisoleucine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  936. en:elevated plasma cholestanol --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:elevated plasma cholestanol | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  937. en:elevated plasma methionine (methioninemia) --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:elevated plasma methionine (methioninemia) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  938. en:elevated propionate --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:elevated propionate | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  939. en:elevated serum angiotensin-converting enzyme (ace) --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:elevated serum angiotensin-converting enzyme (ace) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  940. en:elevated serum glutamic pyruvic transaminase (sgpt) --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:elevated serum glutamic pyruvic transaminase (sgpt) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  941. en:elevated serum iron and iron binding capacity --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:elevated serum iron and iron binding capacity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  942. en:elevated serum levels of luteinizing hormone (lh) --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:elevated serum levels of luteinizing hormone (lh) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  943. en:elevated serum protein --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:elevated serum protein | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  944. en:elevated serum transaminase levels --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:elevated serum transaminase levels | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  945. en:elevated urinary pge(2) levels --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:elevated urinary pge(2) levels | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  946. en:ethylmalonic aciduria --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:ethylmalonic aciduria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  947. en:excessive urinary 5-oxo-l-proline --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:excessive urinary 5-oxo-l-proline | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  948. en:exercise-induced myoglobinuria --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:exercise-induced myoglobinuria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  949. en:factor v and factor viii, combined deficiency of --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:factor v and factor viii, combined deficiency of | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  950. en:ferritin decreased --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:ferritin decreased | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  951. en:fibroblasts demonstrate rapid growth with increased dna synthesis --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:fibroblasts demonstrate rapid growth with increased dna synthesis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  952. en:fibroblasts show decreased activity of mitochondrial respiratory complex i, complex iii, complex iv, and complex v --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:fibroblasts show decreased activity of mitochondrial respiratory complex i, complex iii, complex iv, and complex v | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  953. en:foam cells in visceral organs and cns --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:foam cells in visceral organs and cns | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  954. en:fronto-facio-nasal dysplasia --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:fronto-facio-nasal dysplasia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  955. en:globulin gamma serum plasma increased result --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:globulin gamma serum plasma increased result | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  956. en:glucose breath hydrogen test shows malabsorption of glucose and galactose --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:glucose breath hydrogen test shows malabsorption of glucose and galactose | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  957. en:glucosidase i deficiency in liver and fibroblasts --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:glucosidase i deficiency in liver and fibroblasts | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  958. en:glycogen storage disease type v --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:glycogen storage disease type v | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  959. en:granular osmiophilic deposits (grod) in cells --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:granular osmiophilic deposits (grod) in cells | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  960. en:hemoglobin f increased --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:hemoglobin f increased | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  961. en:hyperlysinemia --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:hyperlysinemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  962. en:hypermanganesemia with dystonia polycythemia and cirrhosis --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:hypermanganesemia with dystonia polycythemia and cirrhosis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  963. en:hyperthreoninemia --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:hyperthreoninemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  964. en:hypoalbuminemia (in 83%) --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:hypoalbuminemia (in 83%) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  965. en:hypogammaglobulinemia --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:hypogammaglobulinemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  966. en:hypoketotic hypoglycemia --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:hypoketotic hypoglycemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  967. en:hyponatremia in infancy --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:hyponatremia in infancy | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  968. en:hyponatremic dehydration, rarely --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:hyponatremic dehydration, rarely | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  969. en:iiga and igg antigliadin antibodies (aga) --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:iiga and igg antigliadin antibodies (aga) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  970. en:immotile or weakly motile cilia --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:immotile or weakly motile cilia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  971. en:impaired oxidation of pyruvate --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:impaired oxidation of pyruvate | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  972. en:inborn errors of porphyrin metabolism --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:inborn errors of porphyrin metabolism | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  973. en:increased activity of the prpp synthetase 1 enzyme --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:increased activity of the prpp synthetase 1 enzyme | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  974. en:increased bilirubin (patient b) --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:increased bilirubin (patient b) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  975. en:increased bone serum acid phosphatase --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:increased bone serum acid phosphatase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  976. en:increased csf threonine --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:increased csf threonine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  977. en:increased d-glyceric acid in serum, urine, and csf --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:increased d-glyceric acid in serum, urine, and csf | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  978. en:increased erythrocyte-membrane calcium-magnesium-atpase --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:increased erythrocyte-membrane calcium-magnesium-atpase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  979. en:increased fractional excretion of urate (greater than 50%) --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:increased fractional excretion of urate (greater than 50%) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  980. en:increased lactate: pyruvate ratio (group b) --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:increased lactate: pyruvate ratio (group b) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  981. en:increased plasma and urinary pipecolic acid --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:increased plasma and urinary pipecolic acid | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  982. en:increased plasma free cholesterol --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:increased plasma free cholesterol | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  983. en:increased plasma pristanic acid --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:increased plasma pristanic acid | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  984. en:increased serum and csf lactate --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:increased serum and csf lactate | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  985. en:increased serum c-reactive protein, episodic --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:increased serum c-reactive protein, episodic | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  986. en:increased serum c4 and c5 acylcarnitine esters --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:increased serum c4 and c5 acylcarnitine esters | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  987. en:increased serum citrulline (group b) --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:increased serum citrulline (group b) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  988. en:increased serum fgf23 --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:increased serum fgf23 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  989. en:increased serum lactate dehydrogenase (in 1 family) --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:increased serum lactate dehydrogenase (in 1 family) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  990. en:increased serum serotonin in 25% --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:increased serum serotonin in 25% | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  991. en:increased serum transaminases (in 1 of 3 patients) --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:increased serum transaminases (in 1 of 3 patients) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  992. en:increased serum, cerebrospinal fluid, and urinary levels of alpha-aminoadipic semialdehyde --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:increased serum, cerebrospinal fluid, and urinary levels of alpha-aminoadipic semialdehyde | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  993. en:increased thyroid-stimulating hormone (tsh) --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:increased thyroid-stimulating hormone (tsh) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  994. en:increased toxic thioguanine nucleotides (tgns) on standard doses of thiopurine drugs --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:increased toxic thioguanine nucleotides (tgns) on standard doses of thiopurine drugs | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  995. en:increased urinary carnitine esters --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary carnitine esters | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  996. en:increased urinary cystine, arginine, lysine, and ornithine (hcs and 2p21del) --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary cystine, arginine, lysine, and ornithine (hcs and 2p21del) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  997. en:increased urinary levels of maoa substrates (endogenous bioamines) --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary levels of maoa substrates (endogenous bioamines) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  998. en:increased urinary malic acid --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary malic acid | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  999. en:increased urinary orotic acid (in some patients) --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary orotic acid (in some patients) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1000. en:incresased urinary pyruvate --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:incresased urinary pyruvate | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1001. en:infantile globoid cell leukodystrophy --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:infantile globoid cell leukodystrophy | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1002. en:inherited disorder of folate metabolism --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:inherited disorder of folate metabolism | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1003. en:intermittent increase of urinary ethylmalonic acid --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:intermittent increase of urinary ethylmalonic acid | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1004. en:intracellular accumulation of unesterified cholesterol --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:intracellular accumulation of unesterified cholesterol | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1005. en:isolated hyperchlorhidrosis --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:isolated hyperchlorhidrosis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1006. en:ketonuria (1 patient) --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:ketonuria (1 patient) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1007. en:lactase deficiency, congenital --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:lactase deficiency, congenital | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1008. en:lipid metabolism, inborn errors --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:lipid metabolism, inborn errors | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1009. en:low acth level --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:low acth level | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1010. en:low or undetectable c-peptide --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:low or undetectable c-peptide | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1011. en:low serum magnesium --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:low serum magnesium | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1012. en:low to normal tsh (values may vary depending on the measurement methods used) --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:low to normal tsh (values may vary depending on the measurement methods used) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1013. en:low-normal platelet count (89-290 x 10(9)/l) --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:low-normal platelet count (89-290 x 10(9)/l) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1014. en:lysyl hydroxylase deficiency --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:lysyl hydroxylase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1015. en:methionine adenosyltransferase deficiency --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:methionine adenosyltransferase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1016. en:microcephaly-capillary malformation syndrome --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:microcephaly-capillary malformation syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1017. en:moyamoya disease with early onset achalasia --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:moyamoya disease with early onset achalasia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1018. en:muscle amp deaminase deficiency --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:muscle amp deaminase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1019. en:myoglobinuria, recurrent --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:myoglobinuria, recurrent | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1020. en:nonaka myopathy --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:nonaka myopathy | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1021. en:nonketotic hypoglycemia --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:nonketotic hypoglycemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1022. en:pancreatic alpha-amylase deficiency --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:pancreatic alpha-amylase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1023. en:pelizaeus merzbacher like disease --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:pelizaeus merzbacher like disease | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1024. en:persistent mullerian duct syndrome --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:persistent mullerian duct syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1025. en:premature separation of centromeric heterochromatin --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:premature separation of centromeric heterochromatin | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1026. en:primary immunodeficiency syndrome due to p14 deficiency --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:primary immunodeficiency syndrome due to p14 deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1027. en:serum transaminase increased --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:serum transaminase increased | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1028. en:sinus histiocytosis with massive lymphadenopathy --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:sinus histiocytosis with massive lymphadenopathy | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1029. en:smith-mccort dysplasia --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:smith-mccort dysplasia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1030. en:spastic ataxia, charlevoix-saguenay type --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:spastic ataxia, charlevoix-saguenay type | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1031. en:split-hand/foot malformation 3 --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:split-hand/foot malformation 3 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1032. en:tyrosinemia, type iii --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:tyrosinemia, type iii | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1033. en:warsaw breakage syndrome --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=en:warsaw breakage syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1034. fucosidose --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=fucosidose | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1035. galactosurie --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=galactosurie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1036. glutathionémie --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=glutathionémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1037. histidinémie --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=histidinémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1038. homocarnosinose --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=homocarnosinose | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1039. hypercalciurie --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=hypercalciurie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1040. hyperphosphatémie --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=hyperphosphatémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1041. hypofibrinogénémie --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=hypofibrinogénémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1042. hypogammaglobulinémie --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=hypogammaglobulinémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1043. hématurie microscopique --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=hématurie microscopique | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1044. lipofuscinose neuronale céroïde --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=lipofuscinose neuronale céroïde | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1045. mucolipidose II --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=mucolipidose II | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1046. neuro-acanthocytose --- r_associated #0: 31 --> en:5-oxoprolinase deficiency
    n1=neuro-acanthocytose | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=31
  1047. Coagulation intravasculaire disséminée --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=Coagulation intravasculaire disséminée | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1048. en:2-hydroxyglutaric aciduria --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:2-hydroxyglutaric aciduria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1049. en:4-hydroxycyclohexylacetic aciduria (adults) --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:4-hydroxycyclohexylacetic aciduria (adults) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1050. en:5 alpha steroid reductase 2 deficiency --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:5 alpha steroid reductase 2 deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1051. en:5-alpha-reductase-2 enzyme deficiency --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:5-alpha-reductase-2 enzyme deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1052. en:abnormal extrarenal response to ddavp (no increase in von willebrand factor or factor viii) --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:abnormal extrarenal response to ddavp (no increase in von willebrand factor or factor viii) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1053. en:abnormal igfr1 function --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:abnormal igfr1 function | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1054. en:abnormal response of 25-hydroxyvitamin d-1-alpha-hydroxylase activity (609506) to hypophosphatemia --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:abnormal response of 25-hydroxyvitamin d-1-alpha-hydroxylase activity (609506) to hypophosphatemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1055. en:abnormal urinary oligosaccharides --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:abnormal urinary oligosaccharides | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1056. en:abnormality of nucleobase metabolism --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:abnormality of nucleobase metabolism | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1057. en:abnormally low cerebrospinal fluid cystatin c --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:abnormally low cerebrospinal fluid cystatin c | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1058. en:absence of protein-bound lipoic acid --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:absence of protein-bound lipoic acid | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1059. en:absent 7-dehydrocholesterol --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:absent 7-dehydrocholesterol | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1060. en:accumulation of cholesterol esters in various tissues --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:accumulation of cholesterol esters in various tissues | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1061. en:accumulation of sulfatides, glycosaminoglycans, sphingolipids, and steroid sulfates in tissues and body fluids --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:accumulation of sulfatides, glycosaminoglycans, sphingolipids, and steroid sulfates in tissues and body fluids | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1062. en:acyl-coa:dihydroxyacetonephosphate acyltransferase deficiency --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:acyl-coa:dihydroxyacetonephosphate acyltransferase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1063. en:acylglycinuria --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:acylglycinuria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1064. en:adenine phosphoribosyltransferase deficiency --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:adenine phosphoribosyltransferase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1065. en:amelogenesis imperfecta - recessive - rough --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:amelogenesis imperfecta - recessive - rough | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1066. en:aminoaciduria, intermittent --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:aminoaciduria, intermittent | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1067. en:aminoaciduria, mild (in some patients) --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:aminoaciduria, mild (in some patients) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1068. en:anti-ds dna antibody --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:anti-ds dna antibody | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1069. en:autosomal recessive distal osteolysis syndrome --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:autosomal recessive distal osteolysis syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1070. en:autosomal recessive idiopathic familial dystonia --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:autosomal recessive idiopathic familial dystonia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1071. en:autosomal recessive ocular albinism --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:autosomal recessive ocular albinism | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1072. en:autosomal recessive spastic paraplegia type 11 --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:autosomal recessive spastic paraplegia type 11 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1073. en:bilirubin conjugated increased --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:bilirubin conjugated increased | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1074. en:blunted cortisol response to adrenocorticotropic hormone (acth) --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:blunted cortisol response to adrenocorticotropic hormone (acth) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1075. en:cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1076. en:chromosome 11q23.3 deletion --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:chromosome 11q23.3 deletion | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1077. en:cilia show inner and outer dynein arm defects --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:cilia show inner and outer dynein arm defects | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1078. en:coagulopathy (inr = 2.2 - 3.5) --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:coagulopathy (inr = 2.2 - 3.5) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1079. en:congenital disorder of glycosylation type 1h --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:congenital disorder of glycosylation type 1h | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1080. en:congenital disorder of glycosylation type ic --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:congenital disorder of glycosylation type ic | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1081. en:congenital disorder of glycosylation, type if --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:congenital disorder of glycosylation, type if | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1082. en:congenital dyserythropoietic anemia, type i --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:congenital dyserythropoietic anemia, type i | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1083. en:deafness, congenital, with inner ear agenesis, microtia, and microdontia --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:deafness, congenital, with inner ear agenesis, microtia, and microdontia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1084. en:deafness, sensorineural, and male infertility --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:deafness, sensorineural, and male infertility | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1085. en:decreased acid sphingomyelinase activity (less than 5%) --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:decreased acid sphingomyelinase activity (less than 5%) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1086. en:decreased activity of 2-oxoacid dehydrogenases --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:decreased activity of 2-oxoacid dehydrogenases | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1087. en:decreased activity of complement factor d --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:decreased activity of complement factor d | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1088. en:decreased activity of glycosylceramidase, galactosylceramidase, ceramidase, and other lysosomal enzymes --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:decreased activity of glycosylceramidase, galactosylceramidase, ceramidase, and other lysosomal enzymes | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1089. en:decreased activity of mitochondrial complex i --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:decreased activity of mitochondrial complex i | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1090. en:decreased axonal flare response after intradermal histamine injection --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:decreased axonal flare response after intradermal histamine injection | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1091. en:decreased carnitine palmitoyltransferase ii (cpt2) activity --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:decreased carnitine palmitoyltransferase ii (cpt2) activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1092. en:decreased conversion of beta-carotene to vitamin a (retinol) --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:decreased conversion of beta-carotene to vitamin a (retinol) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1093. en:decreased dna polymerase-gamma (polg, 174763) activity --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:decreased dna polymerase-gamma (polg, 174763) activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1094. en:decreased expression of gpi-anchored proteins on blood cells --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:decreased expression of gpi-anchored proteins on blood cells | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1095. en:decreased factor xi --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:decreased factor xi | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1096. en:decreased number of igf1 receptors (igf1r, 147370) on cell surface --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:decreased number of igf1 receptors (igf1r, 147370) on cell surface | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1097. en:decreased or absent apolipoprotein a-i --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:decreased or absent apolipoprotein a-i | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1098. en:decreased or absent dihydropteridine reductase activity --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:decreased or absent dihydropteridine reductase activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1099. en:decreased or normal serum factor b --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:decreased or normal serum factor b | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1100. en:decreased phosphoglucomutase 1 (pgm1) activity (less than 10% of normal values) --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:decreased phosphoglucomutase 1 (pgm1) activity (less than 10% of normal values) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1101. en:decreased phytanic acid oxidase activity --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:decreased phytanic acid oxidase activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1102. en:decreased plasma and urinary guanidinoacetate (gaa) --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:decreased plasma and urinary guanidinoacetate (gaa) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1103. en:decreased plasma free carnitine --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:decreased plasma free carnitine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1104. en:decreased platelet derived growth factor --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:decreased platelet derived growth factor | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1105. en:decreased serum igm --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:decreased serum igm | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1106. en:decreased serum thiamine pyrophosphate --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:decreased serum thiamine pyrophosphate | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1107. en:decreased tissue total and free carnitine --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:decreased tissue total and free carnitine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1108. en:defect in chylomicron secretion --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:defect in chylomicron secretion | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1109. en:deficiency of fat-soluble vitamins --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:deficiency of fat-soluble vitamins | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1110. en:deficiency of glycoprotein (gp)iib-iiia complex --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:deficiency of glycoprotein (gp)iib-iiia complex | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1111. en:deficiency of prolidase activity in erythrocytes, leukocytes, or fibroblasts --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:deficiency of prolidase activity in erythrocytes, leukocytes, or fibroblasts | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1112. en:deficiency of serum properdin p factor --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:deficiency of serum properdin p factor | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1113. en:deficiency of steryl-sulfatase --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:deficiency of steryl-sulfatase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1114. en:deficiency or absence of p91-phox protein --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:deficiency or absence of p91-phox protein | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1115. en:delta-1-pyrroline-5-carboxylate dehydrogenase activity decreased in fibroblasts or leukocytes --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:delta-1-pyrroline-5-carboxylate dehydrogenase activity decreased in fibroblasts or leukocytes | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1116. en:dermatan and heparan sulfate excretion in urine --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:dermatan and heparan sulfate excretion in urine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1117. en:disproportionate work-related increase in blood lactate and pyruvate --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:disproportionate work-related increase in blood lactate and pyruvate | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1118. en:dyskinetic ciliary motility --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:dyskinetic ciliary motility | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1119. en:electrolyte disturbances from intractable diarrhea --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:electrolyte disturbances from intractable diarrhea | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1120. en:elevated 17-hydroxyprogesterone --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:elevated 17-hydroxyprogesterone | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1121. en:elevated 8-dehydrocholesterol --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:elevated 8-dehydrocholesterol | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1122. en:elevated ast (aspartate aminotransferase) and cpk (creatine phosphokinase) --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:elevated ast (aspartate aminotransferase) and cpk (creatine phosphokinase) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1123. en:elevated cholesta-8,14-dien-3-beta-ol in cultured fibroblasts --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:elevated cholesta-8,14-dien-3-beta-ol in cultured fibroblasts | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1124. en:elevated lathosterol --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:elevated lathosterol | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1125. en:elevated plasma and urine succinylacetone --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:elevated plasma and urine succinylacetone | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1126. en:elevated plasma stigmasterol --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:elevated plasma stigmasterol | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1127. en:elevated serum alpha-fetoprotein (dominant) --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:elevated serum alpha-fetoprotein (dominant) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1128. en:elevated total cholesterol (seen in heterozygotes as well) --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:elevated total cholesterol (seen in heterozygotes as well) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1129. en:elevated uric acid on urinalysis (in some patients) --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:elevated uric acid on urinalysis (in some patients) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1130. en:elevated urinary 7 alpha-hydroxylated bile alcohols --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:elevated urinary 7 alpha-hydroxylated bile alcohols | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1131. en:elevated urinary phosphoethanolamine --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:elevated urinary phosphoethanolamine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1132. en:elevated white blood cell cystine --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:elevated white blood cell cystine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1133. en:encephalopathy due to sulfite oxidase deficiency --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:encephalopathy due to sulfite oxidase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1134. en:enterokinase deficiency --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:enterokinase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1135. en:epiphyseal dysplasia, multiple, 4 --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:epiphyseal dysplasia, multiple, 4 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1136. en:fibroblasts have increased activity of serine palmitoyltransferase (spt, 605712) --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:fibroblasts have increased activity of serine palmitoyltransferase (spt, 605712) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1137. en:fibroblasts show decreased peroxisomes arranged in rows --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:fibroblasts show decreased peroxisomes arranged in rows | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1138. en:foam cells contain polymorphic cytoplasmic inclusions consisting of lamellar osmiophilic membranes on electron microscopy --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:foam cells contain polymorphic cytoplasmic inclusions consisting of lamellar osmiophilic membranes on electron microscopy | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1139. en:frequent deletions of chromosome 9 in melanoma --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:frequent deletions of chromosome 9 in melanoma | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1140. en:galactosuria without galactosemia --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:galactosuria without galactosemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1141. en:generalized peeling skin syndrome --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:generalized peeling skin syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1142. en:glutamate-cysteine ligase deficiency --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:glutamate-cysteine ligase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1143. en:glutathionemia --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:glutathionemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1144. en:granular osmiophilic deposits (grod) in cells resulting in 'curvilinear' profiles ultrastructurally --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:granular osmiophilic deposits (grod) in cells resulting in 'curvilinear' profiles ultrastructurally | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1145. en:granular osmiophilic deposits (grod) in cells resulting in 'rectilinear' profiles ultrastructurally --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:granular osmiophilic deposits (grod) in cells resulting in 'rectilinear' profiles ultrastructurally | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1146. en:green serum --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:green serum | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1147. en:hepatic carbamoylphosphate synthetase i deficiency --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:hepatic carbamoylphosphate synthetase i deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1148. en:hereditary angioedema --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:hereditary angioedema | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1149. en:hereditary orotic aciduria --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:hereditary orotic aciduria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1150. en:high resolution g- and t- banding karyotype shows reciprocal translocation of distal 9p-6q --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:high resolution g- and t- banding karyotype shows reciprocal translocation of distal 9p-6q | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1151. en:high urinary copper --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:high urinary copper | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1152. en:hmg-coa lyase deficiency --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:hmg-coa lyase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1153. en:hydroxykynureninuria --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:hydroxykynureninuria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1154. en:hyperarginemia --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:hyperarginemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1155. en:hyperbilirubinemia, unconjugated, <20mg/dl --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:hyperbilirubinemia, unconjugated, <20mg/dl | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1156. en:hypercalcemia --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:hypercalcemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1157. en:hyperchloremia (mean >110 mm in both dominant and recessive) --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:hyperchloremia (mean >110 mm in both dominant and recessive) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1158. en:hyperkalemia (5.8 +/- 0.8 mm) --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:hyperkalemia (5.8 +/- 0.8 mm) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1159. en:hyperlipoproteinemia type i --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:hyperlipoproteinemia type i | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1160. en:hyperphosphatemia, transient --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:hyperphosphatemia, transient | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1161. en:hypertriglyceridemia, transient --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:hypertriglyceridemia, transient | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1162. en:hypogammaglobulinemia (in some patients) --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:hypogammaglobulinemia (in some patients) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1163. en:hypogammaglobulinemia, profound --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:hypogammaglobulinemia, profound | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1164. en:hypophosphatemic rickets with hypercalciuria, hereditary --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:hypophosphatemic rickets with hypercalciuria, hereditary | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1165. en:impaired carnitine uptake in muscle, heart, kidney, fibroblasts, and lymphocytes --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:impaired carnitine uptake in muscle, heart, kidney, fibroblasts, and lymphocytes | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1166. en:impaired long-chain fatty acid oxidation during prolonged, low-intensity exercise --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:impaired long-chain fatty acid oxidation during prolonged, low-intensity exercise | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1167. en:inappropriately low urine osmolality --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:inappropriately low urine osmolality | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1168. en:increased c10:2-carnitine --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:increased c10:2-carnitine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1169. en:increased neopterin in urine and csf --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:increased neopterin in urine and csf | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1170. en:increased plasma long-chain acylcarnitines --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:increased plasma long-chain acylcarnitines | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1171. en:increased plasma proglucagon --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:increased plasma proglucagon | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1172. en:increased sensitivity to adrenergic and cholinergic agents --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:increased sensitivity to adrenergic and cholinergic agents | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1173. en:increased serum acylcarnitine during febrile crisis --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:increased serum acylcarnitine during febrile crisis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1174. en:increased serum alpha-alanine (patient b) --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:increased serum alpha-alanine (patient b) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1175. en:increased serum beta-hexosaminidase --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:increased serum beta-hexosaminidase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1176. en:increased serum methionine (reported in 2 cases) --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:increased serum methionine (reported in 2 cases) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1177. en:increased serum osteocalcin --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:increased serum osteocalcin | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1178. en:increased tissue levels of free fatty acids --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:increased tissue levels of free fatty acids | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1179. en:increased urinary 2-methylacetoacetic acid --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary 2-methylacetoacetic acid | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1180. en:increased urinary 3-methylglutaconic acid --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary 3-methylglutaconic acid | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1181. en:increased urinary adenosine --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary adenosine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1182. en:increased urinary and serum glycine --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary and serum glycine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1183. en:increased urinary carnitine --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary carnitine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1184. en:increased urinary free sialic acid (n-acetylneuraminic acid, 20-200x normal) --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary free sialic acid (n-acetylneuraminic acid, 20-200x normal) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1185. en:increased urinary o-linked sialopeptides --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary o-linked sialopeptides | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1186. en:increased urinary thiosulfate --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary thiosulfate | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1187. en:increased vitamin e (alpha-tocopherol) levels --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:increased vitamin e (alpha-tocopherol) levels | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1188. en:interleukin-1 receptor-associated kinase 4 deficiency --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:interleukin-1 receptor-associated kinase 4 deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1189. en:intracellular pas-positive polyglucosan inclusion bodies ('lafora' bodies) can be found in various tissues (brain, liver, muscle, heart, skin) --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:intracellular pas-positive polyglucosan inclusion bodies ('lafora' bodies) can be found in various tissues (brain, liver, muscle, heart, skin) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1190. en:intracellular redox disturbance (reduced cytoplasm and oxidized mitochondria (group b)) --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:intracellular redox disturbance (reduced cytoplasm and oxidized mitochondria (group b)) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1191. en:isochromosome 12p (i(12p)) --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:isochromosome 12p (i(12p)) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1192. en:kallman syndrome with heart disease --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:kallman syndrome with heart disease | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1193. en:keratan sulfaturia in some patients --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:keratan sulfaturia in some patients | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1194. en:lack of ciliary motility --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:lack of ciliary motility | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1195. en:lissencephaly syndrome, norman-roberts type --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:lissencephaly syndrome, norman-roberts type | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1196. en:lissencephaly type 3 familial fetal akinesia sequence syndrome --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:lissencephaly type 3 familial fetal akinesia sequence syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1197. en:low or low-normal serum t4 --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:low or low-normal serum t4 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1198. en:low or normal serum calcium --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:low or normal serum calcium | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1199. en:low urinary orotic acid --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:low urinary orotic acid | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1200. en:lower total cholesterol --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:lower total cholesterol | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1201. en:macular corneal dystrophy --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:macular corneal dystrophy | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1202. en:mean platelet volume (mpv) 12.6fl --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:mean platelet volume (mpv) 12.6fl | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1203. en:miller-mckusick-malvaux-syndrome (3m syndrome) --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:miller-mckusick-malvaux-syndrome (3m syndrome) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1204. en:mitochondrial neurogastrointestinal encephalomyopathy syndrome --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:mitochondrial neurogastrointestinal encephalomyopathy syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1205. en:multiple sulfatase deficiency disease --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:multiple sulfatase deficiency disease | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1206. en:n-acetylglutamate synthase deficiency --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:n-acetylglutamate synthase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1207. en:netherton syndrome --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:netherton syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1208. en:northern epilepsy syndrome --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:northern epilepsy syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1209. en:oculocutaneous albinism type 4 --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:oculocutaneous albinism type 4 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1210. en:ornithine carbamoyltransferase deficiency disease --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:ornithine carbamoyltransferase deficiency disease | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1211. en:pancreatic triacylglycerol lipase deficiency --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:pancreatic triacylglycerol lipase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1212. en:parathyroid hormone level increased --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:parathyroid hormone level increased | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1213. en:peeling skin syndrome, acral type --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:peeling skin syndrome, acral type | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1214. en:polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1215. en:positive antinuclear antibody test --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:positive antinuclear antibody test | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1216. en:pseudocholinesterase deficiency --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:pseudocholinesterase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1217. en:purine-pyrimidine metabolism, inborn errors --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:purine-pyrimidine metabolism, inborn errors | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1218. en:rapadilino syndrome --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:rapadilino syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1219. en:robinow-like syndrome --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:robinow-like syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1220. en:sudden infant death with dysgenesis of the testes syndrome --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:sudden infant death with dysgenesis of the testes syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1221. en:thrombopenia --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:thrombopenia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1222. en:thyroid dyshormonogenesis 5 --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:thyroid dyshormonogenesis 5 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1223. en:transferase deficiency galactosemia --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:transferase deficiency galactosemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1224. en:tungland bellman syndrome --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:tungland bellman syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1225. en:tyrosinemia type II --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:tyrosinemia type II | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1226. en:tyrosinemia type ii --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:tyrosinemia type ii | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1227. en:unclassified metabolic disorder --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=en:unclassified metabolic disorder | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1228. glycogénose --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=glycogénose | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1229. hypercalcémie --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=hypercalcémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1230. hypo-intense (signal IRM) --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=hypo-intense (signal IRM) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1231. nystagmus --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=nystagmus | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1232. syndrome de Zellweger --- r_associated #0: 30 --> en:5-oxoprolinase deficiency
    n1=syndrome de Zellweger | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=30
  1233. déficit congénital en mégacaryocytes --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=déficit congénital en mégacaryocytes | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1234. déficit en sulfite-oxydase --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=déficit en sulfite-oxydase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1235. en:2-aminoadipic aciduria --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:2-aminoadipic aciduria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1236. en:21-hydroxylase deficiency --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:21-hydroxylase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1237. en:3-methylglutaconic aciduria type 5 --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:3-methylglutaconic aciduria type 5 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1238. en:4-hydroxyphenylpyruvic acid dioxygenase deficiency (hpd) --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:4-hydroxyphenylpyruvic acid dioxygenase deficiency (hpd) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1239. en:4-hydroxyphenylpyruvic aciduria --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:4-hydroxyphenylpyruvic aciduria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1240. en:abacterial leukocyturia --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:abacterial leukocyturia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1241. en:abnormal isoelectric focusing of serum transferrin (type 1 pattern) (in 1 patient) --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:abnormal isoelectric focusing of serum transferrin (type 1 pattern) (in 1 patient) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1242. en:abnormal liver enzymes (1 patient) --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:abnormal liver enzymes (1 patient) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1243. en:abnormal response to human chorionic gonadotropin indicates decreased testosterone --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:abnormal response to human chorionic gonadotropin indicates decreased testosterone | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1244. en:abnormal serum transferrin pattern (in some patients) --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:abnormal serum transferrin pattern (in some patients) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1245. en:abnormal urinary mucopolysaccharides (elevated unsaturated nonsulfated disaccharides and decreased unsaturated 6-sulfated disaccharides) --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:abnormal urinary mucopolysaccharides (elevated unsaturated nonsulfated disaccharides and decreased unsaturated 6-sulfated disaccharides) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1246. en:acetylcholinesterase staining reveals nerve trunk hypertrophy --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:acetylcholinesterase staining reveals nerve trunk hypertrophy | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1247. en:agammaglobulinemia --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:agammaglobulinemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1248. en:aldolase a deficiency --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:aldolase a deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1249. en:alkaptonuria --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:alkaptonuria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1250. en:amino acid metabolism disorder --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:amino acid metabolism disorder | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1251. en:aminoaciduria (less common) --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:aminoaciduria (less common) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1252. en:aminoadipic semialdehyde synthase (aass) deficiency --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:aminoadipic semialdehyde synthase (aass) deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1253. en:amylo(1,4 - 1,6) transglucosidase deficiency (brancher enzyme) --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:amylo(1,4 - 1,6) transglucosidase deficiency (brancher enzyme) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1254. en:antineutrophil cytoplasmic antibody --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:antineutrophil cytoplasmic antibody | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1255. en:antiphospholipid antibody --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:antiphospholipid antibody | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1256. en:arterial tortuosity syndrome --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:arterial tortuosity syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1257. en:autosomal recessive primary microcephaly --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:autosomal recessive primary microcephaly | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1258. en:autosomal recessive spastic paraplegia type 39 --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:autosomal recessive spastic paraplegia type 39 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1259. en:basal ganglia disease, biotin-responsive --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:basal ganglia disease, biotin-responsive | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1260. en:bisphosphoglycerate mutase deficiency --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:bisphosphoglycerate mutase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1261. en:branched chain ketoaciduria (alpha-keto isocaproate, alpha-keto-beta methylisovalerate, alpha-keto isovalerate) --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:branched chain ketoaciduria (alpha-keto isocaproate, alpha-keto-beta methylisovalerate, alpha-keto isovalerate) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1262. en:carnitine palmitoyltransferase deficiency --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:carnitine palmitoyltransferase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1263. en:characteristic spheroids can be found in peripheral tissue, such as skin and conjunctiva --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:characteristic spheroids can be found in peripheral tissue, such as skin and conjunctiva | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1264. en:childhood hypophosphatasia (disorder) --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:childhood hypophosphatasia (disorder) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1265. en:chitty hall baraitser syndrome --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:chitty hall baraitser syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1266. en:chromosomal translocations involving c-myc (190080, 8q24) and the immunoglobin heavy chain (147100, 14q32) locus --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:chromosomal translocations involving c-myc (190080, 8q24) and the immunoglobin heavy chain (147100, 14q32) locus | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1267. en:congenital disorder of glycosylation type 2e --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:congenital disorder of glycosylation type 2e | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1268. en:congenital disorder of glycosylation type ia --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:congenital disorder of glycosylation type ia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1269. en:congenital disorder of glycosylation type id --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:congenital disorder of glycosylation type id | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1270. en:cooper jabs syndrome --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:cooper jabs syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1271. en:corpus callosum agenesis neuronopathy --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:corpus callosum agenesis neuronopathy | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1272. en:creatine kinase normal between episodes --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:creatine kinase normal between episodes | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1273. en:cutaneous photosensitivity and lethal colitis syndrome --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:cutaneous photosensitivity and lethal colitis syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1274. en:cytoplasmic lamellar concentric inclusions --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:cytoplasmic lamellar concentric inclusions | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1275. en:decreased activity of ppt1 --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:decreased activity of ppt1 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1276. en:decreased activity of tyrosine hydroxylase --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:decreased activity of tyrosine hydroxylase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1277. en:decreased apoa-i and apoa-ii --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:decreased apoa-i and apoa-ii | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1278. en:decreased blood levels of cationic amino acids --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:decreased blood levels of cationic amino acids | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1279. en:decreased cerebrospinal fluid folic acid --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:decreased cerebrospinal fluid folic acid | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1280. en:decreased circulating aldosterone level --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:decreased circulating aldosterone level | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1281. en:decreased circulating renin level --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:decreased circulating renin level | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1282. en:decreased clot retraction --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:decreased clot retraction | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1283. en:decreased cpt1 activity --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:decreased cpt1 activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1284. en:decreased csf folate --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:decreased csf folate | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1285. en:decreased dihydroxyacetone phosphate acyltransferase (dhap-at) activity --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:decreased dihydroxyacetone phosphate acyltransferase (dhap-at) activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1286. en:decreased fibroblast arylsulfatase a --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:decreased fibroblast arylsulfatase a | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1287. en:decreased homovanillic acid (hva) and 5-hydroxyindoleacetic acid (5hiaa) in csf --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:decreased homovanillic acid (hva) and 5-hydroxyindoleacetic acid (5hiaa) in csf | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1288. en:decreased levels of the e2 subunit protein --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:decreased levels of the e2 subunit protein | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1289. en:decreased lysosomal alpha-mannosidase activity in plasma and leukocytes --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:decreased lysosomal alpha-mannosidase activity in plasma and leukocytes | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1290. en:decreased nasal nitric oxide --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:decreased nasal nitric oxide | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1291. en:decreased or absent dihydropyrimidine dehydrogenase activity --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:decreased or absent dihydropyrimidine dehydrogenase activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1292. en:decreased or absent glycogen branching enzyme activity --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:decreased or absent glycogen branching enzyme activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1293. en:decreased or normal plasma insulin --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:decreased or normal plasma insulin | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1294. en:decreased serum insulin-like growth factor-1 (igf1, 147440) --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:decreased serum insulin-like growth factor-1 (igf1, 147440) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1295. en:decreased serum iron (in some patients) --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:decreased serum iron (in some patients) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1296. en:decreased tetrasialo-transferrin --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:decreased tetrasialo-transferrin | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1297. en:decreased tetrasialotransferrin levels --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:decreased tetrasialotransferrin levels | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1298. en:decreased urocanic acid in blood, urine, and skin cells --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:decreased urocanic acid in blood, urine, and skin cells | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1299. en:defect in double-stranded dna repair --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:defect in double-stranded dna repair | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1300. en:diffuse deposition of calcium oxalate in various tissues --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:diffuse deposition of calcium oxalate in various tissues | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1301. en:electrolyturia (1 patient) --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:electrolyturia (1 patient) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1302. en:electron microscopy of foam cells shows lamellar inclusions --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:electron microscopy of foam cells shows lamellar inclusions | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1303. en:elevated 1,25(oh)2 d3 --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:elevated 1,25(oh)2 d3 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1304. en:elevated acth --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:elevated acth | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1305. en:elevated ammonia --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:elevated ammonia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1306. en:elevated blood spot hydroxybutyryl carnitine --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:elevated blood spot hydroxybutyryl carnitine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1307. en:elevated hcg (choriocarcinoma) --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:elevated hcg (choriocarcinoma) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1308. en:elevated plasma ammonia --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:elevated plasma ammonia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1309. en:elevated plasma branched chain amino acids (leucine, isoleucine, valine) --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:elevated plasma branched chain amino acids (leucine, isoleucine, valine) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1310. en:elevated plasma campesterol --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:elevated plasma campesterol | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1311. en:elevated plasma citrulline (citrullinemia) --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:elevated plasma citrulline (citrullinemia) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1312. en:elevated pregnenolone --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:elevated pregnenolone | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1313. en:elevated serum alkaline phosphatase during hyperplastic callus formation --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:elevated serum alkaline phosphatase during hyperplastic callus formation | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1314. en:elevated serum alpha-fetoprotein --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:elevated serum alpha-fetoprotein | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1315. en:elevated serum transferrin saturation --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:elevated serum transferrin saturation | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1316. en:enzyme replacement therapy has not been effective --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:enzyme replacement therapy has not been effective | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1317. en:factor viii deficiency --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:factor viii deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1318. en:familial c3b inhibitor deficiency syndrome --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:familial c3b inhibitor deficiency syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1319. en:fibroblasts attach poorly --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:fibroblasts attach poorly | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1320. en:fibroblasts show lamellar lysosomal inclusions on electron microscopy --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:fibroblasts show lamellar lysosomal inclusions on electron microscopy | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1321. en:fibronectin decreased --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:fibronectin decreased | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1322. en:fryns macrocephaly --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:fryns macrocephaly | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1323. en:gaucher cells, diffuse, in spleen, liver, lymph nodes, bone marrow, central nervous system --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:gaucher cells, diffuse, in spleen, liver, lymph nodes, bone marrow, central nervous system | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1324. en:gaze palsy, familial horizontal, with progressive scoliosis --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:gaze palsy, familial horizontal, with progressive scoliosis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1325. en:glomerular filtration rate decreased --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:glomerular filtration rate decreased | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1326. en:glucose-6-phosphate deficiency --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:glucose-6-phosphate deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1327. en:glycogen accumulation in both liver and muscle --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:glycogen accumulation in both liver and muscle | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1328. en:gm2-ganglioside accumulation --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:gm2-ganglioside accumulation | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1329. en:hematuria (less common) --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:hematuria (less common) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1330. en:hematuria, macroscopic and microscopic --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:hematuria, macroscopic and microscopic | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1331. en:hemizygous deletion at 7q11.23 --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:hemizygous deletion at 7q11.23 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1332. en:hereditary spastic paralysis, infantile onset ascending --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:hereditary spastic paralysis, infantile onset ascending | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1333. en:hexose-6-phosphate dehydrogenase deficiency --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:hexose-6-phosphate dehydrogenase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1334. en:high ft3/ft4 ratio --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:high ft3/ft4 ratio | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1335. en:high ornithine --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:high ornithine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1336. en:high-normal plasma triglyceride concentration (in heterozygotes) --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:high-normal plasma triglyceride concentration (in heterozygotes) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1337. en:histidinemia --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:histidinemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1338. en:hnsha due to aldolase a deficiency --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:hnsha due to aldolase a deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1339. en:hnsha due to glutathione reductase deficiency --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:hnsha due to glutathione reductase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1340. en:hyperammonemia after protein intake --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:hyperammonemia after protein intake | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1341. en:hyperkalemia --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:hyperkalemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1342. en:hypertriglyceridemia (in some patients) --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:hypertriglyceridemia (in some patients) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1343. en:hypocalcemia, transient --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:hypocalcemia, transient | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1344. en:hypocalciuria or normocalciuria --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:hypocalciuria or normocalciuria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1345. en:hypokalemia, familial --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:hypokalemia, familial | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1346. en:hypomethylation of alpha-satellite repeats on chromosome 9 --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:hypomethylation of alpha-satellite repeats on chromosome 9 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1347. en:hypomyelination and congenital cataract --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:hypomyelination and congenital cataract | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1348. en:hypoprebetalipoproteinemia --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:hypoprebetalipoproteinemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1349. en:iduronate sulfatase deficiency in fibroblasts, amniocytes and white blood cells --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:iduronate sulfatase deficiency in fibroblasts, amniocytes and white blood cells | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1350. en:igg, decreased --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:igg, decreased | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1351. en:impaired creatine uptake in fibroblasts --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:impaired creatine uptake in fibroblasts | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1352. en:in untreated patients - elevated blood galactose urine reducing substances (galactosuria), hyperchloremic metabolic acidosis, aminoaciduria, elevated liver enzymes, albuminuria --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:in untreated patients - elevated blood galactose urine reducing substances (galactosuria), hyperchloremic metabolic acidosis, aminoaciduria, elevated liver enzymes, albuminuria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1353. en:inappropriately normal serum 1,25-dihydroxyvitamin d3 --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:inappropriately normal serum 1,25-dihydroxyvitamin d3 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1354. en:increased 11-deoxycortisol --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:increased 11-deoxycortisol | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1355. en:increased acetylcholinesterase (ache) in amniotic fluid --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:increased acetylcholinesterase (ache) in amniotic fluid | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1356. en:increased blood alanine --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:increased blood alanine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1357. en:increased csf lactate during acute episodes --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:increased csf lactate during acute episodes | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1358. en:increased igg level --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:increased igg level | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1359. en:increased ketone body or lactate/pyruvate plasma ratios --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:increased ketone body or lactate/pyruvate plasma ratios | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1360. en:increased renal tubular phosphate reabsorption --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:increased renal tubular phosphate reabsorption | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1361. en:increased serum alpha-interferon (ifna1, 147660) --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:increased serum alpha-interferon (ifna1, 147660) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1362. en:increased serum creatine kinase during episodes --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:increased serum creatine kinase during episodes | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1363. en:increased serum creatine kinase, mild --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:increased serum creatine kinase, mild | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1364. en:increased serum lactate during metabolic crisis --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:increased serum lactate during metabolic crisis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1365. en:increased serum lysine (group b) --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:increased serum lysine (group b) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1366. en:increased urinary collagen type i n-telopeptide excretion (ntx) during hyperplastic callus formation --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary collagen type i n-telopeptide excretion (ntx) during hyperplastic callus formation | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1367. en:increased urinary creatine-to-creatinine ratio --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary creatine-to-creatinine ratio | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1368. en:increased urinary excretion of cystine --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary excretion of cystine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1369. en:increased urinary vanillylmandelic acid (vma) --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary vanillylmandelic acid (vma) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1370. en:inherited disorder of thyroid metabolism --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:inherited disorder of thyroid metabolism | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1371. en:interstitial deletion of 17p11.2 (most common is 3.7mb) --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:interstitial deletion of 17p11.2 (most common is 3.7mb) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1372. en:isovaleric acidemia --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:isovaleric acidemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1373. en:lack of lysosomal inclusions in visceral organs --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:lack of lysosomal inclusions in visceral organs | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1374. en:large spermatozoa --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:large spermatozoa | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1375. en:lipoid congenital adrenal hyperplasia --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:lipoid congenital adrenal hyperplasia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1376. en:liver enzymes abnormal --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:liver enzymes abnormal | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1377. en:low alkaline phosphatase --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:low alkaline phosphatase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1378. en:low serum ceruloplasmin --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:low serum ceruloplasmin | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1379. en:low-molecular-weight proteinuria --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:low-molecular-weight proteinuria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1380. en:lysosomal-like storage vacuoles in various tissues --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:lysosomal-like storage vacuoles in various tissues | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1381. en:markedly increased serum creatine kinase --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:markedly increased serum creatine kinase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1382. en:microscopic hematuria --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:microscopic hematuria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1383. en:mitochondrial dna depletion syndrome 2 (myopathic type) --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:mitochondrial dna depletion syndrome 2 (myopathic type) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1384. en:morquio syndrome --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:morquio syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1385. en:multicentric osteolysis nodulosis arthropathy spectrum --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:multicentric osteolysis nodulosis arthropathy spectrum | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1386. en:muscle-eye-brain disease, congenital muscular dystrophy --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:muscle-eye-brain disease, congenital muscular dystrophy | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1387. en:neonatal progeroid syndrome --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:neonatal progeroid syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1388. en:plasma aldosterone normal --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:plasma aldosterone normal | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1389. en:pontocerebellar hypoplasia type 2 --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:pontocerebellar hypoplasia type 2 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1390. en:premature aging syndrome --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:premature aging syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1391. en:pyruvate kinase deficiency --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:pyruvate kinase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1392. en:serum iron normal --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:serum iron normal | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1393. en:sitosterolemia with xanthomatosis --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:sitosterolemia with xanthomatosis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1394. en:spondylometaphyseal dysplasia with cone-rod dystrophy syndrome --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:spondylometaphyseal dysplasia with cone-rod dystrophy syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1395. en:syndrome of apparent mineralocorticoid excess --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:syndrome of apparent mineralocorticoid excess | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1396. en:transferrin saturation increased --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:transferrin saturation increased | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1397. en:type a 14 --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:type a 14 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1398. en:uv-sensitive syndrome --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=en:uv-sensitive syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1399. syndrome de déficit en immunoglobulines --- r_associated #0: 29 --> en:5-oxoprolinase deficiency
    n1=syndrome de déficit en immunoglobulines | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=29
  1400. dyslipémie --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=dyslipémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1401. déficit en pyroglutamate hydrolase --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=déficit en pyroglutamate hydrolase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1402. en:'ghost' peroxisomes in fibroblasts seen on immunofluorescence microscopy --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:'ghost' peroxisomes in fibroblasts seen on immunofluorescence microscopy | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1403. en:abnormal isoelectric focusing of serum transferrin --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:abnormal isoelectric focusing of serum transferrin | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1404. en:abnormal liver enzymes in those with hepatic cysts or fibrosis --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:abnormal liver enzymes in those with hepatic cysts or fibrosis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1405. en:abnormal urinary collagen-derived pyridinium crosslinks (absent glc-gal-pyd) --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:abnormal urinary collagen-derived pyridinium crosslinks (absent glc-gal-pyd) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1406. en:abnormally triglyceride-rich low and high density lipoproteins and beta-migrating very low density lipoproteins --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:abnormally triglyceride-rich low and high density lipoproteins and beta-migrating very low density lipoproteins | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1407. en:absent dystrophin on muscle biopsy --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:absent dystrophin on muscle biopsy | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1408. en:acetyl coa:alpha-glucosaminidase n-acetyltransferase deficiency in fibroblasts --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:acetyl coa:alpha-glucosaminidase n-acetyltransferase deficiency in fibroblasts | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1409. en:acid phosphatase deficiency --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:acid phosphatase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1410. en:acid-base imbalance --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:acid-base imbalance | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1411. en:adrenocorticotropic hormone, increased --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:adrenocorticotropic hormone, increased | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1412. en:amelogenesis imperfecta and gingival hyperplasia syndrome --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:amelogenesis imperfecta and gingival hyperplasia syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1413. en:amyloidosis, (iowa type 107680.0010, nonneuropathic 107680.0016) --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:amyloidosis, (iowa type 107680.0010, nonneuropathic 107680.0016) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1414. en:arylsulfatase b deficiency in fibroblasts and white blood cells --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:arylsulfatase b deficiency in fibroblasts and white blood cells | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1415. en:ataxia with vitamin e deficiency --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:ataxia with vitamin e deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1416. en:autosomal recessive scid --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:autosomal recessive scid | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1417. en:bamforth syndrome --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:bamforth syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1418. en:becker generalized myotonia --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:becker generalized myotonia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1419. en:bile shows increased cholesterol/phospholipid ratio --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:bile shows increased cholesterol/phospholipid ratio | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1420. en:chondroitin 4-, 6-sulfate excretion in urine --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:chondroitin 4-, 6-sulfate excretion in urine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1421. en:chorioretinal dystrophy, spinocerebellar ataxia, and hypogonadotropic hypogonadism --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:chorioretinal dystrophy, spinocerebellar ataxia, and hypogonadotropic hypogonadism | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1422. en:chromosomal mosaicism in cultured cells --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:chromosomal mosaicism in cultured cells | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1423. en:chromosome inversion - inv2(p12q14) in 2 patients --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:chromosome inversion - inv2(p12q14) in 2 patients | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1424. en:chronic hypercapnia --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:chronic hypercapnia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1425. en:cleft lip/palate-ectodermal dysplasia syndrome --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:cleft lip/palate-ectodermal dysplasia syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1426. en:congenital analbuminemia --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:congenital analbuminemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1427. en:congenital bowing of long bone --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:congenital bowing of long bone | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1428. en:cryptophthalmos syndrome --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:cryptophthalmos syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1429. en:cytochrome c oxidase deficiency in skeletal muscle and brain --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:cytochrome c oxidase deficiency in skeletal muscle and brain | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1430. en:decreased 3-beta-hydroxysteroid-delta-5-desaturase (sc5d) --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:decreased 3-beta-hydroxysteroid-delta-5-desaturase (sc5d) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1431. en:decreased activity of mitochondrial respiratory complexes i, ii+iii, iv, and v --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:decreased activity of mitochondrial respiratory complexes i, ii+iii, iv, and v | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1432. en:decreased activity of mitochondrial respiratory complexes i, iii, and iv --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:decreased activity of mitochondrial respiratory complexes i, iii, and iv | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1433. en:decreased activity of nadph oxidase --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:decreased activity of nadph oxidase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1434. en:decreased activity of the e2 subunit (lipoyl transacetylase, 608770) of the pdh --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:decreased activity of the e2 subunit (lipoyl transacetylase, 608770) of the pdh | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1435. en:decreased activity of thymidine phosphorylase --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:decreased activity of thymidine phosphorylase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1436. en:decreased arylsulfatase a (arsa) activity in urine, leukocytes, fibroblasts --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:decreased arylsulfatase a (arsa) activity in urine, leukocytes, fibroblasts | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1437. en:decreased beta-mannosidase activity in plasma, fibroblasts, and leukocytes --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:decreased beta-mannosidase activity in plasma, fibroblasts, and leukocytes | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1438. en:decreased ciliary motility --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:decreased ciliary motility | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1439. en:decreased circulating cortisol level --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:decreased circulating cortisol level | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1440. en:decreased cobalamin in liver, kidney, and cultured fibroblasts --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:decreased cobalamin in liver, kidney, and cultured fibroblasts | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1441. en:decreased csf homovanillic acid (hva) --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:decreased csf homovanillic acid (hva) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1442. en:decreased csf hypocretin --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:decreased csf hypocretin | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1443. en:decreased csf serine --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:decreased csf serine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1444. en:decreased iga, igg, igm --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:decreased iga, igg, igm | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1445. en:decreased insulin receptor binding --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:decreased insulin receptor binding | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1446. en:decreased levels of csf hypocretin (hcrt, 602358) --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:decreased levels of csf hypocretin (hcrt, 602358) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1447. en:decreased levels of serum vitamin b12 --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:decreased levels of serum vitamin b12 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1448. en:decreased long-chain fatty acid oxidation --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:decreased long-chain fatty acid oxidation | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1449. en:decreased metabolism of thiopurine drugs --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:decreased metabolism of thiopurine drugs | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1450. en:decreased or absent d-bifunctional protein activity and protein --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:decreased or absent d-bifunctional protein activity and protein | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1451. en:decreased or increased serum testosterone --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:decreased or increased serum testosterone | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1452. en:decreased plasma apolipoprotein c-ii --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:decreased plasma apolipoprotein c-ii | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1453. en:decreased plasma arginine --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:decreased plasma arginine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1454. en:decreased plasma triglycerides --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:decreased plasma triglycerides | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1455. en:decreased serum acth --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:decreased serum acth | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1456. en:decreased serum and salivary lactoferrin has been described in 1 family --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:decreased serum and salivary lactoferrin has been described in 1 family | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1457. en:decreased serum ceruloplasmin --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:decreased serum ceruloplasmin | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1458. en:decreased serum complement factor h --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:decreased serum complement factor h | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1459. en:decreased serum iga --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:decreased serum iga | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1460. en:decreased serum rt3 --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:decreased serum rt3 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1461. en:decreased telomerase activity --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:decreased telomerase activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1462. en:decreased tissue and serum alkaline phosphatase --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:decreased tissue and serum alkaline phosphatase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1463. en:decreased transcobalamin i in saliva, serum, gastric juice, and cerebrospinal fluid --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:decreased transcobalamin i in saliva, serum, gastric juice, and cerebrospinal fluid | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1464. en:deficiency of creatine phosphate in brain --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:deficiency of creatine phosphate in brain | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1465. en:deficiency or absence of p91-phox (300481) protein --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:deficiency or absence of p91-phox (300481) protein | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1466. en:deficient efflux of intracellular cholesterol --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:deficient efflux of intracellular cholesterol | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1467. en:deficient hepatic 4-hydroxyphenylpyruvate dioxygenase --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:deficient hepatic 4-hydroxyphenylpyruvate dioxygenase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1468. en:deletion (78kb to 1mb) of chromosome 8q24.3 including the scrib (607733) and puf60 (604819) genes --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:deletion (78kb to 1mb) of chromosome 8q24.3 including the scrib (607733) and puf60 (604819) genes | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1469. en:delta-1-pyrroline-5-carboxylate (p5c) levels increased in plasma --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:delta-1-pyrroline-5-carboxylate (p5c) levels increased in plasma | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1470. en:depletion of mtdna (skeletal muscle, fibroblasts) --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:depletion of mtdna (skeletal muscle, fibroblasts) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1471. en:detection by rt-pcr, southern blot analysis, and fish for primary diagnosis and follow up for residual disease --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:detection by rt-pcr, southern blot analysis, and fish for primary diagnosis and follow up for residual disease | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1472. en:diarrhea --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:diarrhea | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1473. en:dimethylglycine dehydrogenase (dmgdh) deficiency --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:dimethylglycine dehydrogenase (dmgdh) deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1474. en:dystonia, dopa-responsive, due to sepiapterin reductase deficiency --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:dystonia, dopa-responsive, due to sepiapterin reductase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1475. en:electroretinogram is abnormal--rod responses are mildly abnormal and cone responses are markedly diminished --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:electroretinogram is abnormal--rod responses are mildly abnormal and cone responses are markedly diminished | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1476. en:elevated afp (endodermal sinus tumor) --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:elevated afp (endodermal sinus tumor) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1477. en:elevated alkaline phosphatase (if more than one affected site) --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:elevated alkaline phosphatase (if more than one affected site) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1478. en:elevated calcitonin --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:elevated calcitonin | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1479. en:elevated erythrocyte adenosine deaminase --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:elevated erythrocyte adenosine deaminase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1480. en:elevated erythrocyte aicar (zmp) --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:elevated erythrocyte aicar (zmp) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1481. en:elevated free carnitine --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:elevated free carnitine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1482. en:elevated gamma-glutamyltransferase --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:elevated gamma-glutamyltransferase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1483. en:elevated plasma acth --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:elevated plasma acth | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1484. en:elevated plasma estrogen --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:elevated plasma estrogen | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1485. en:elevated resting serum lactate, increased with exercise --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:elevated resting serum lactate, increased with exercise | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1486. en:elevated serum bile acids --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:elevated serum bile acids | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1487. en:elevated serum levels of follicle stimulating hormone (fsh) --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:elevated serum levels of follicle stimulating hormone (fsh) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1488. en:elevated urinary ornithine, lysine, arginine --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:elevated urinary ornithine, lysine, arginine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1489. en:epidermolysis bullosa simplex with pyloric atresia --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:epidermolysis bullosa simplex with pyloric atresia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1490. en:familial median cleft of upper and lower lip --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:familial median cleft of upper and lower lip | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1491. en:fasting chylomicronemia --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:fasting chylomicronemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1492. en:fatal infantile lactic acidosis with methylmalonic aciduria --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:fatal infantile lactic acidosis with methylmalonic aciduria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1493. en:fibroblasts have decreased levels of ceramide, sphingomyelin, lactosylceramide, ceramide trihexoside, and globoside --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:fibroblasts have decreased levels of ceramide, sphingomyelin, lactosylceramide, ceramide trihexoside, and globoside | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1494. en:fibroblasts show global defects in multiple mitochondrial respiratory chain activities --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:fibroblasts show global defects in multiple mitochondrial respiratory chain activities | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1495. en:fibular hypoplasia and complex brachydactyly --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:fibular hypoplasia and complex brachydactyly | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1496. en:folate-dependent fragile site at xq28 --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:folate-dependent fragile site at xq28 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1497. en:frequent inv(10)(q11.2q21) producing chimeric transforming sequence ret/ptc --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:frequent inv(10)(q11.2q21) producing chimeric transforming sequence ret/ptc | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1498. en:galactosylation defects --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:galactosylation defects | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1499. en:geroderma osteodysplastica --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:geroderma osteodysplastica | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1500. en:glutamate formiminotransferase deficiency --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:glutamate formiminotransferase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1501. en:glycoamino aciduria --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:glycoamino aciduria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1502. en:glycogen storage disease with severe cardiomyopathy due to glycogenin deficiency --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:glycogen storage disease with severe cardiomyopathy due to glycogenin deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1503. en:heart defects limb shortening --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:heart defects limb shortening | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1504. en:hemizygous deletion at 4p16.3 --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:hemizygous deletion at 4p16.3 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1505. en:hereditary factor xi deficiency disease --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:hereditary factor xi deficiency disease | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1506. en:high plasma citrulline (1000-5000 micromolar) --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:high plasma citrulline (1000-5000 micromolar) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1507. en:high serum inosine levels --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:high serum inosine levels | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1508. en:histiocytic infiltration of liver, spleen, and lungs --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:histiocytic infiltration of liver, spleen, and lungs | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1509. en:hnsha due to glucose phosphate isomerase deficiency --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:hnsha due to glucose phosphate isomerase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1510. en:hnsha due to hexokinase deficiency --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:hnsha due to hexokinase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1511. en:holocarboxylase synthetase deficiency --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:holocarboxylase synthetase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1512. en:homocitrullinuria --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:homocitrullinuria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1513. en:homocysteinemia (in some patients) --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:homocysteinemia (in some patients) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1514. en:hyperammonemia during episodes --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:hyperammonemia during episodes | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1515. en:hyperbilirubinemia, unconjugated, 20-30mg/dl --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:hyperbilirubinemia, unconjugated, 20-30mg/dl | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1516. en:hypercholesterolemia (in 75%) --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:hypercholesterolemia (in 75%) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1517. en:hypercholesterolemia (reported in 2 patients) --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:hypercholesterolemia (reported in 2 patients) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1518. en:hyperglycinuria (disorder) --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:hyperglycinuria (disorder) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1519. en:hyperphosphatemia --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:hyperphosphatemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1520. en:hyperprolinemia (5-10 times normal) --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:hyperprolinemia (5-10 times normal) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1521. en:hypocalcemia (64% of adults) --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:hypocalcemia (64% of adults) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1522. en:hypocalcemia (male) --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:hypocalcemia (male) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1523. en:hypoglycosylation of plasma glycoproteins --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:hypoglycosylation of plasma glycoproteins | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1524. en:hypophosphatemia (less common) --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:hypophosphatemia (less common) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1525. en:iga antiendomysial antibodies (ema) --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:iga antiendomysial antibodies (ema) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1526. en:impaired n-glycosylation --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:impaired n-glycosylation | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1527. en:inborn errors of steroid synthesis --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:inborn errors of steroid synthesis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1528. en:increased cholesterol --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:increased cholesterol | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1529. en:increased creatine kinase, mild to moderate --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:increased creatine kinase, mild to moderate | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1530. en:increased erythrocyte sedimentation rate, episodic --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:increased erythrocyte sedimentation rate, episodic | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1531. en:increased growth hormone (in 1 of 2 patients) --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:increased growth hormone (in 1 of 2 patients) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1532. en:increased n-acetyl-l-aspartic acid (naa) in urine, csf, and blood --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:increased n-acetyl-l-aspartic acid (naa) in urine, csf, and blood | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1533. en:increased plasma renin activity --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:increased plasma renin activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1534. en:increased pyruvate in serum and csf --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:increased pyruvate in serum and csf | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1535. en:increased serum beta-carotene --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:increased serum beta-carotene | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1536. en:increased serum lactate in acute stage --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:increased serum lactate in acute stage | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1537. en:increased serum levels of free plasma thyroid hormones --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:increased serum levels of free plasma thyroid hormones | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1538. en:increased serum pyruvate --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:increased serum pyruvate | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1539. en:increased serum thrombopoietin may occur --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:increased serum thrombopoietin may occur | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1540. en:increased sodium-potassium pump activity --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:increased sodium-potassium pump activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1541. en:increased thymine and dihydrothymine in bodily fluids --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:increased thymine and dihydrothymine in bodily fluids | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1542. en:increased urinary 2-methyl-3 hydroxybutyrate --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary 2-methyl-3 hydroxybutyrate | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1543. en:increased urinary 2-methyl-3-hydroxybutyric acid --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary 2-methyl-3-hydroxybutyric acid | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1544. en:increased urinary cross-linked n-telopetide of type i collagen --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary cross-linked n-telopetide of type i collagen | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1545. en:increased urinary dihydropyrimidines --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary dihydropyrimidines | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1546. en:increased urinary homovanillic acid (hva) --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary homovanillic acid (hva) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1547. en:increased urinary porphyrin precursors porphobilinogen (pbg) and delta-aminolevulinic acid (ala) during acute attacks --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary porphyrin precursors porphobilinogen (pbg) and delta-aminolevulinic acid (ala) during acute attacks | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1548. en:insulin growth factor i deficiency --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:insulin growth factor i deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1549. en:isovalerylglycinuria --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:isovalerylglycinuria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1550. en:ketonuria, acute --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:ketonuria, acute | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1551. en:knobloch syndrome --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:knobloch syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1552. en:laboratory abnormalities --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:laboratory abnormalities | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1553. en:lacunar halos around chondrocytes in skeletal cartilage --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:lacunar halos around chondrocytes in skeletal cartilage | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1554. en:lipopigment in extraneuronal cells --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:lipopigment in extraneuronal cells | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1555. en:low fasting glucose (in some patients) --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:low fasting glucose (in some patients) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1556. en:low growth hormone levels --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:low growth hormone levels | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1557. en:low serum levels of branched-chain amino acids --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:low serum levels of branched-chain amino acids | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1558. en:majeed syndrome --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:majeed syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1559. en:mannosidosis --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:mannosidosis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1560. en:methylmalonyl-coenzyme a mutase deficiency --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:methylmalonyl-coenzyme a mutase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1561. en:morm syndrome --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:morm syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1562. en:myopathy with exercise intolerance, swedish type --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:myopathy with exercise intolerance, swedish type | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1563. en:naxos disease --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:naxos disease | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1564. en:neurodegeneration with brain iron accumulation 4 --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:neurodegeneration with brain iron accumulation 4 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1565. en:north american indian childhood cirrhosis --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:north american indian childhood cirrhosis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1566. en:oplah, 1-bp ins, 2601c --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:oplah, 1-bp ins, 2601c | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1567. en:pelviscapular dysplasia --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:pelviscapular dysplasia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1568. en:platelet function test normal --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:platelet function test normal | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1569. en:porphobilinogen synthase deficiency --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:porphobilinogen synthase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1570. en:prader-willi habitus, osteopenia, and camptodactyly --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:prader-willi habitus, osteopenia, and camptodactyly | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1571. en:prolonged partial thromboplastin time --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:prolonged partial thromboplastin time | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1572. en:pyridoxine dependency syndrome --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:pyridoxine dependency syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1573. en:raised tsh level --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:raised tsh level | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1574. en:reticulocytosis --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:reticulocytosis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1575. en:severe steroid 21-hydroxylase deficiency --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:severe steroid 21-hydroxylase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1576. en:urea cycle metabolism disorder --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:urea cycle metabolism disorder | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1577. en:vomitus --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:vomitus | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1578. en:vrozené poruchy metabolismu nec in mdrcze18_1 --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=en:vrozené poruchy metabolismu nec in mdrcze18_1 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1579. hyponatrémie --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=hyponatrémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1580. maladie de dubin-johnson --- r_associated #0: 28 --> en:5-oxoprolinase deficiency
    n1=maladie de dubin-johnson | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=28
  1581. acrodermatitis enteropathica --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=acrodermatitis enteropathica | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1582. en:'cloudy' or 'pink' blood (lipemia) --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:'cloudy' or 'pink' blood (lipemia) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1583. en:'compensated hypothyroidism' with increased tsh and normal t4 --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:'compensated hypothyroidism' with increased tsh and normal t4 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1584. en:2,8-dihydroxyadenine (dha) urinary stones --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:2,8-dihydroxyadenine (dha) urinary stones | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1585. en:3-methylglutaric aciduria (3-mga) --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:3-methylglutaric aciduria (3-mga) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1586. en:Dubin-Sprinz disease --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:Dubin-Sprinz disease | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1587. en:Laurence-Moon's syndrome --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:Laurence-Moon's syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1588. en:Leroy's i-cell disease --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:Leroy's i-cell disease | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1589. en:abnormal cholesterol homeostasis --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:abnormal cholesterol homeostasis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1590. en:abnormal dystrophin on muscle biopsy --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:abnormal dystrophin on muscle biopsy | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1591. en:abnormal karyotype in 3 patients involving distal 6p --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:abnormal karyotype in 3 patients involving distal 6p | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1592. en:abnormal liver enzymes, intermittent --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:abnormal liver enzymes, intermittent | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1593. en:abnormal n-glycosylation of transferrin --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:abnormal n-glycosylation of transferrin | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1594. en:abnormal serum transferrin pattern by isoelectric focusing (hyposialylation) --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:abnormal serum transferrin pattern by isoelectric focusing (hyposialylation) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1595. en:absence of emerin by immunohistochemistry on muscle biopsy --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:absence of emerin by immunohistochemistry on muscle biopsy | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1596. en:adenylosuccinase deficiency (finding) --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:adenylosuccinase deficiency (finding) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1597. en:affected mother has reduced zinc levels in breast milk (may be up to 40% less than normal breast milk) --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:affected mother has reduced zinc levels in breast milk (may be up to 40% less than normal breast milk) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1598. en:alpha-fetoprotein deficiency --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:alpha-fetoprotein deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1599. en:anauxetic dysplasia --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:anauxetic dysplasia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1600. en:arginine:glycine amidinotransferase deficiency --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:arginine:glycine amidinotransferase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1601. en:avitaminosis D --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:avitaminosis D | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1602. en:behrens baumann dust syndrome --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:behrens baumann dust syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1603. en:bilirubin may or may not be increased --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:bilirubin may or may not be increased | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1604. en:borderline elevated low-density lipoprotein --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:borderline elevated low-density lipoprotein | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1605. en:breastfed offspring have transient decrease of plasma zinc levels --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:breastfed offspring have transient decrease of plasma zinc levels | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1606. en:carbohydrate metabolism, inborn errors --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:carbohydrate metabolism, inborn errors | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1607. en:cell studies show increased dna breakage --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:cell studies show increased dna breakage | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1608. en:cellular arrest at g2 of the cell cycle --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:cellular arrest at g2 of the cell cycle | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1609. en:cervical hypertrichosis and peripheral neuropathy syndrome --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:cervical hypertrichosis and peripheral neuropathy syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1610. en:congenital alpha-2-antiplasmin deficiency --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:congenital alpha-2-antiplasmin deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1611. en:creatine phosphokinase serum increased --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:creatine phosphokinase serum increased | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1612. en:crigler-najjar syndrome --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:crigler-najjar syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1613. en:csf pleocytosis, particularly of lymphocytes --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:csf pleocytosis, particularly of lymphocytes | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1614. en:cytogenetic breakpoints range from 10q23.3-q26.2 --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:cytogenetic breakpoints range from 10q23.3-q26.2 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1615. en:deafness and myopia syndrome --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:deafness and myopia syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1616. en:deafness, progressive, with stapes fixation --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:deafness, progressive, with stapes fixation | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1617. en:decreased activities of multiple sulfatases --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:decreased activities of multiple sulfatases | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1618. en:decreased activity of alpha-ketoglutarate dehydrogenase (alpha-kgdh) --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:decreased activity of alpha-ketoglutarate dehydrogenase (alpha-kgdh) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1619. en:decreased activity of dihydrofolate reductase --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:decreased activity of dihydrofolate reductase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1620. en:decreased activity of long-chain 3-hydroxyacyl-coa dehydrogenase, long-chain 3-oxoacyl-coa thiolase, and long-chain 2-enoyl-coa hydratase --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:decreased activity of long-chain 3-hydroxyacyl-coa dehydrogenase, long-chain 3-oxoacyl-coa thiolase, and long-chain 2-enoyl-coa hydratase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1621. en:decreased activity of triosephosphate isomerase --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:decreased activity of triosephosphate isomerase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1622. en:decreased adenosylcobalamin --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:decreased adenosylcobalamin | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1623. en:decreased copper, iron, zinc --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:decreased copper, iron, zinc | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1624. en:decreased csf tetrahydrofolate and 5-methyltetrahydrofolate --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:decreased csf tetrahydrofolate and 5-methyltetrahydrofolate | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1625. en:decreased erythrocyte plasmalogen --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:decreased erythrocyte plasmalogen | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1626. en:decreased glomerular filtration rate (gfr) --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:decreased glomerular filtration rate (gfr) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1627. en:decreased glycerol kinase activity --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:decreased glycerol kinase activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1628. en:decreased gtp cyclohydrolase i activity (about 20% of normal) --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:decreased gtp cyclohydrolase i activity (about 20% of normal) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1629. en:decreased hepatic udp-glucuronyl-transferase activity --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:decreased hepatic udp-glucuronyl-transferase activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1630. en:decreased levels of component x protein of the pdh complex --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:decreased levels of component x protein of the pdh complex | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1631. en:decreased mitochondrial nadp(h) --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:decreased mitochondrial nadp(h) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1632. en:decreased or absent alpha-n-acetylgalactosaminidase activity --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:decreased or absent alpha-n-acetylgalactosaminidase activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1633. en:decreased or absent serum citrulline --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:decreased or absent serum citrulline | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1634. en:decreased or normal serum factor i --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:decreased or normal serum factor i | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1635. en:decreased palmitate oxidation --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:decreased palmitate oxidation | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1636. en:decreased phgdh activity (fibroblasts) --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:decreased phgdh activity (fibroblasts) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1637. en:decreased plasma hdl (<1/10 of normal levels) --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:decreased plasma hdl (<1/10 of normal levels) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1638. en:decreased plasma total and free carnitine --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:decreased plasma total and free carnitine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1639. en:decreased reversible oxygen-binding capacity (e.g. hb l (bombay) 141800.9999) --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:decreased reversible oxygen-binding capacity (e.g. hb l (bombay) 141800.9999) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1640. en:decreased scad activity --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:decreased scad activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1641. en:decreased serum bun --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:decreased serum bun | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1642. en:decreased sulfite oxidase activity --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:decreased sulfite oxidase activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1643. en:decreased t cells --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:decreased t cells | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1644. en:decreased urinary sulfate --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:decreased urinary sulfate | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1645. en:deficiency of glucosyltransferase 1 --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:deficiency of glucosyltransferase 1 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1646. en:deficiency or absence of p67-phox protein (type ii) --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:deficiency or absence of p67-phox protein (type ii) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1647. en:dihydropyrimidine dehydrogenase deficiency --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:dihydropyrimidine dehydrogenase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1648. en:disorganized growth plate cartilage --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:disorganized growth plate cartilage | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1649. en:duplication or deletion at 11p15.5 --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:duplication or deletion at 11p15.5 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1650. en:elevated 3-hydroxypropionic acid --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:elevated 3-hydroxypropionic acid | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1651. en:elevated 7-dehydrocholesterol --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:elevated 7-dehydrocholesterol | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1652. en:elevated 8(9)-cholestenol --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:elevated 8(9)-cholestenol | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1653. en:elevated alkaline phosphatase --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:elevated alkaline phosphatase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1654. en:elevated androstenedione and testosterone --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:elevated androstenedione and testosterone | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1655. en:elevated apoa-i (1.8x normal) in homozygotes --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:elevated apoa-i (1.8x normal) in homozygotes | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1656. en:elevated erythrocyte sedimentation rate (mean 90mm/h) --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:elevated erythrocyte sedimentation rate (mean 90mm/h) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1657. en:elevated fasting glucose --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:elevated fasting glucose | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1658. en:elevated il6 --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:elevated il6 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1659. en:elevated leukotriene e(4) --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:elevated leukotriene e(4) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1660. en:elevated long chain fatty acids --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:elevated long chain fatty acids | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1661. en:elevated plasma ornithine (~10-fold) --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:elevated plasma ornithine (~10-fold) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1662. en:elevated serum acid phosphatase --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:elevated serum acid phosphatase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1663. en:elevated serum parathyroid hormone (pth) level --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:elevated serum parathyroid hormone (pth) level | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1664. en:elevated serum uric acid concentrations --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:elevated serum uric acid concentrations | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1665. en:elevated urinary pyridinoline and deoxypyridinoline --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:elevated urinary pyridinoline and deoxypyridinoline | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1666. en:eosinophilia, mild --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:eosinophilia, mild | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1667. en:erythrocyte enolase deficiency --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:erythrocyte enolase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1668. en:ethanolaminosis --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:ethanolaminosis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1669. en:excessive iodide trapping --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:excessive iodide trapping | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1670. en:exercise-induced myoglobinuria in adults --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:exercise-induced myoglobinuria in adults | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1671. en:extremely low creatine excretion --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:extremely low creatine excretion | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1672. en:factor vii deficiency --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:factor vii deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1673. en:fibroblasts show hypersensitivity to uv irradiation due to defect in transcription-coupled nucleotide excision repair (tc-ner) --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:fibroblasts show hypersensitivity to uv irradiation due to defect in transcription-coupled nucleotide excision repair (tc-ner) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1674. en:fibroblasts show increased sensitivity to apoptosis --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:fibroblasts show increased sensitivity to apoptosis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1675. en:fumarylacetoacetate hydrolase (fah) deficiency --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:fumarylacetoacetate hydrolase (fah) deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1676. en:gamma-glutamylcysteine synthetase (glutamate-cysteine ligase) deficiency --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:gamma-glutamylcysteine synthetase (glutamate-cysteine ligase) deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1677. en:glcnac-transferase ii deficiency in fibroblast and mononuclear cells --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:glcnac-transferase ii deficiency in fibroblast and mononuclear cells | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1678. en:glycogen storage disease type i --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:glycogen storage disease type i | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1679. en:glycogen storage disease type vi --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:glycogen storage disease type vi | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1680. en:hair bulb tyrosinase present --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:hair bulb tyrosinase present | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1681. en:hawkinsinuria --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:hawkinsinuria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1682. en:hepatic lipase deficiency (disorder) --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:hepatic lipase deficiency (disorder) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1683. en:high nonceruloplasmin-bound serum copper --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:high nonceruloplasmin-bound serum copper | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1684. en:histidinaemia --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:histidinaemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1685. en:hla-b27 haplotype association (95% patients) --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:hla-b27 haplotype association (95% patients) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1686. en:hnsha due to diphosphoglycerate mutase deficiency --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:hnsha due to diphosphoglycerate mutase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1687. en:hnsha due to pyrimidine-5'-nucleotidase deficiency --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:hnsha due to pyrimidine-5'-nucleotidase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1688. en:homocystinemia --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:homocystinemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1689. en:hyperammonemia, asymptomatic (2-5 times normal) --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:hyperammonemia, asymptomatic (2-5 times normal) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1690. en:hypercholesterolemia (disorder) --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:hypercholesterolemia (disorder) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1691. en:hyperglutaminemia --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:hyperglutaminemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1692. en:hyperglycolic aciduria --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:hyperglycolic aciduria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1693. en:hyperkalemia (7.5 +/- 0.9 mm) --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:hyperkalemia (7.5 +/- 0.9 mm) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1694. en:hyperkalemia (>6.2 mm in both dominant and recessive) --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:hyperkalemia (>6.2 mm in both dominant and recessive) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1695. en:hyperkalemia during attacks --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:hyperkalemia during attacks | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1696. en:hyperkaliaemia --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:hyperkaliaemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1697. en:hypoglycemia, fasting --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:hypoglycemia, fasting | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1698. en:hypomandibular faciocranial dysostosis --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:hypomandibular faciocranial dysostosis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1699. en:immunoglobulin a decreased --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:immunoglobulin a decreased | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1700. en:immunoreactive pc protein --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:immunoreactive pc protein | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1701. en:increased bile acid intermediates (dhca and thca) --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:increased bile acid intermediates (dhca and thca) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1702. en:increased chromosomal breaks in response to cross-linking agents and ionizing radiation --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:increased chromosomal breaks in response to cross-linking agents and ionizing radiation | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1703. en:increased creatinine --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:increased creatinine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1704. en:increased csf homovanillic acid (hva) --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:increased csf homovanillic acid (hva) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1705. en:increased csf taurine --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:increased csf taurine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1706. en:increased csf transferrin despite normal serum transferrin levels --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:increased csf transferrin despite normal serum transferrin levels | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1707. en:increased csf, plasma, and urinary 5-hydroxytryptophan (5htp) --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:increased csf, plasma, and urinary 5-hydroxytryptophan (5htp) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1708. en:increased free erythrocyte protoporphyrin --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:increased free erythrocyte protoporphyrin | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1709. en:increased l-2-hydroxyglutaric acid in urine, serum, and csf --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:increased l-2-hydroxyglutaric acid in urine, serum, and csf | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1710. en:increased lactate in spinal fluid --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:increased lactate in spinal fluid | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1711. en:increased platelet aggregation with ristocetin --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:increased platelet aggregation with ristocetin | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1712. en:increased serum 18-hydroxycorticosterone (18-ohb) --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:increased serum 18-hydroxycorticosterone (18-ohb) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1713. en:increased serum arylsulfatase a (10-20x) --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:increased serum arylsulfatase a (10-20x) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1714. en:increased serum bile acid concentration during pregnancy, resolves postpartum --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:increased serum bile acid concentration during pregnancy, resolves postpartum | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1715. en:increased serum bile acids --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:increased serum bile acids | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1716. en:increased serum bilirubin due to hemolysis --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:increased serum bilirubin due to hemolysis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1717. en:increased serum pancreatic secretory trypsin inhibitor (psti) --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:increased serum pancreatic secretory trypsin inhibitor (psti) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1718. en:increased serum plasminogen activator inhibitor-1 (pai1, 173360) --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:increased serum plasminogen activator inhibitor-1 (pai1, 173360) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1719. en:increased serum pyruvate in acute stage --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:increased serum pyruvate in acute stage | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1720. en:increased tissue levels of triglycerides --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:increased tissue levels of triglycerides | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1721. en:increased urinary 2-butanone --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary 2-butanone | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1722. en:increased urinary 2-hydroxybutyrate --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary 2-hydroxybutyrate | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1723. en:increased urinary uracil --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary uracil | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1724. en:increased urinary, plasma, and csf dihydrothymine --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary, plasma, and csf dihydrothymine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1725. en:increased urinary, plasma, and csf n-carbamyl-beta-alanine --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary, plasma, and csf n-carbamyl-beta-alanine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1726. en:inherited disorder of bilirubin metabolism --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:inherited disorder of bilirubin metabolism | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1727. en:intermittent 3-methylglutaconic aciduria --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:intermittent 3-methylglutaconic aciduria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1728. en:isochromosome often missing in lymphocyte --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:isochromosome often missing in lymphocyte | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1729. en:karyotype analysis normal finding --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:karyotype analysis normal finding | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1730. en:liver phosphorylase kinase (phk) deficiency --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:liver phosphorylase kinase (phk) deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1731. en:low or absent follicle stimulating hormone (fsh) --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:low or absent follicle stimulating hormone (fsh) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1732. en:low or absent prolactin (pl) --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:low or absent prolactin (pl) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1733. en:low or normal serum erythropoietin --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:low or normal serum erythropoietin | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1734. en:low to very low hdl cholesterol --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:low to very low hdl cholesterol | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1735. en:markedly decreased or absent serum 1,25-dihydroxyvitamin d3 --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:markedly decreased or absent serum 1,25-dihydroxyvitamin d3 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1736. en:median mean platelet volume (mpv) 12.5fl --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:median mean platelet volume (mpv) 12.5fl | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1737. en:microcephaly albinism digital anomalies syndrome --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:microcephaly albinism digital anomalies syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1738. en:multiple acyl-coa dehydrogenase deficiency --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:multiple acyl-coa dehydrogenase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1739. en:myopathy, early-onset, with fatal cardiomyopathy --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:myopathy, early-onset, with fatal cardiomyopathy | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1740. en:nathalie syndrome --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:nathalie syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1741. en:neuraminidase deficiency --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:neuraminidase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1742. en:oculocerebral hypopigmentation syndrome type preus --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:oculocerebral hypopigmentation syndrome type preus | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1743. en:phenylketonuria ii --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:phenylketonuria ii | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1744. en:pili torti onychodysplasia syndrome --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:pili torti onychodysplasia syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1745. en:purine-nucleoside phosphorylase deficiency --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:purine-nucleoside phosphorylase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1746. en:richards-rundle syndrome --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:richards-rundle syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1747. en:sensory ataxic neuropathy, dysarthria, and ophthalmoparesis --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:sensory ataxic neuropathy, dysarthria, and ophthalmoparesis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1748. en:spondylo-ocular syndrome --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:spondylo-ocular syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1749. en:spondyloepiphyseal dysplasia tarda, toledo type --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:spondyloepiphyseal dysplasia tarda, toledo type | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1750. en:sulfite oxidase deficiency --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:sulfite oxidase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1751. en:thomas syndrome --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:thomas syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1752. en:thyroid dyshormonogenesis 3 --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:thyroid dyshormonogenesis 3 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1753. en:thyroid dyshormonogenesis 4 --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:thyroid dyshormonogenesis 4 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1754. en:type ii acrocephalopolysyndactyly --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:type ii acrocephalopolysyndactyly | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1755. en:upper limb defect with eye and ear abnormalities syndrome --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:upper limb defect with eye and ear abnormalities syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1756. en:urocanase deficiency --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:urocanase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1757. en:valinemia --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:valinemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1758. en:wolman's disease --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:wolman's disease | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1759. en:yemenite deaf-blind hypopigmentation syndrome --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=en:yemenite deaf-blind hypopigmentation syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1760. mucopolysaccharidose de type I --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=mucopolysaccharidose de type I | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1761. semialdéhyde succinique-déshydrogénase (déficit en) --- r_associated #0: 27 --> en:5-oxoprolinase deficiency
    n1=semialdéhyde succinique-déshydrogénase (déficit en) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=27
  1762. cétoacidurie à chaînes ramifiées --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=cétoacidurie à chaînes ramifiées | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1763. en:abnormal isoelectric focusing of serum transferrin (type 2 pattern) --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:abnormal isoelectric focusing of serum transferrin (type 2 pattern) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1764. en:abnormal isoelectric focusing of serum transferrin, type 2 pattern --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:abnormal isoelectric focusing of serum transferrin, type 2 pattern | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1765. en:abnormal liver enzymes (rare) --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:abnormal liver enzymes (rare) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1766. en:abnormal liver enzymes, intermittent (1 patient) --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:abnormal liver enzymes, intermittent (1 patient) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1767. en:abnormal schilling test (not normalized by addition of intrinsic factor) --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:abnormal schilling test (not normalized by addition of intrinsic factor) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1768. en:abnormal secretin test --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:abnormal secretin test | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1769. en:abnormal spinocerebellar tracts, dorsal columns, pyramidal tracts, cerebellum and brainstem --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:abnormal spinocerebellar tracts, dorsal columns, pyramidal tracts, cerebellum and brainstem | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1770. en:abnormal transaminases (1 patient) --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:abnormal transaminases (1 patient) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1771. en:accumulation of unprocessed mt-trna intermediates in skeletal muscle cells and fibroblasts --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:accumulation of unprocessed mt-trna intermediates in skeletal muscle cells and fibroblasts | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1772. en:acquired lactase deficiency --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:acquired lactase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1773. en:acth normal --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:acth normal | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1774. en:acute infantile liver failure due to synthesis defect of mitochondrial deoxyribonucleic acid encoded protein --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:acute infantile liver failure due to synthesis defect of mitochondrial deoxyribonucleic acid encoded protein | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1775. en:aldosterone synthase deficiency --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:aldosterone synthase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1776. en:alkaline phosphatase serum increased --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:alkaline phosphatase serum increased | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1777. en:alpha fetoprotein increased --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:alpha fetoprotein increased | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1778. en:alpha ketoadipic aciduria --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:alpha ketoadipic aciduria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1779. en:alpha-methylacyl-coa racemase deficiency --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:alpha-methylacyl-coa racemase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1780. en:anemia, hypochromic microcytic, with iron overload --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:anemia, hypochromic microcytic, with iron overload | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1781. en:anti-tissue transglutaminase antibodies (anti-ttg) --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:anti-tissue transglutaminase antibodies (anti-ttg) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1782. en:arakawa syndrome ii --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:arakawa syndrome ii | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1783. en:autosomal recessive sideroblastic anemia --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:autosomal recessive sideroblastic anemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1784. en:b lymphocytopenia --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:b lymphocytopenia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1785. en:bestrophinopathy, autosomal recessive --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:bestrophinopathy, autosomal recessive | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1786. en:bietti crystalline corneoretinal dystrophy --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:bietti crystalline corneoretinal dystrophy | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1787. en:blood urea nitrogen increased --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:blood urea nitrogen increased | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1788. en:bowen-conradi syndrome --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:bowen-conradi syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1789. en:charcot-marie-tooth disease type 4 --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:charcot-marie-tooth disease type 4 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1790. en:chromosomal rearrangement --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:chromosomal rearrangement | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1791. en:chromosomal translocations involving c-myc (190080, 8q24) and the immunoglobin lambda light chain (147220, 22q11.2) locus --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:chromosomal translocations involving c-myc (190080, 8q24) and the immunoglobin lambda light chain (147220, 22q11.2) locus | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1792. en:chromosome deletion extending from 8q24.11 to 8q24.13 --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:chromosome deletion extending from 8q24.11 to 8q24.13 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1793. en:chylomicron retention disease --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:chylomicron retention disease | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1794. en:combined malonic and methylmalonic aciduria --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:combined malonic and methylmalonic aciduria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1795. en:congenital amegakaryocytic thrombocytopenia --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:congenital amegakaryocytic thrombocytopenia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1796. en:congenital nonspherocytic hemolytic anemia due to inborn error of metabolism --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:congenital nonspherocytic hemolytic anemia due to inborn error of metabolism | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1797. en:congenital transferrin deficiency --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:congenital transferrin deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1798. en:continuous urinary iodine loss --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:continuous urinary iodine loss | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1799. en:crisponi syndrome --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:crisponi syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1800. en:cutis laxa, autosomal recessive --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:cutis laxa, autosomal recessive | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1801. en:cytogenetics - recombinant chromosome 8 characterized by duplication of 8q22.1-qter and deletion of 8pter-p23.1 --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:cytogenetics - recombinant chromosome 8 characterized by duplication of 8q22.1-qter and deletion of 8pter-p23.1 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1802. en:decreased acid beta galactosidase protein and activity --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:decreased acid beta galactosidase protein and activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1803. en:decreased activities of the pyruvate dehydrogenase complex, the alpha-ketoglutarate dehydrogenase complex, and the branched-chain alpha-keto acid dehydrogenase complex --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:decreased activities of the pyruvate dehydrogenase complex, the alpha-ketoglutarate dehydrogenase complex, and the branched-chain alpha-keto acid dehydrogenase complex | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1804. en:decreased activity of 3-hydroxyacyl-coa dehydrogenase in various tissues (liver, muscle, fibroblasts) --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:decreased activity of 3-hydroxyacyl-coa dehydrogenase in various tissues (liver, muscle, fibroblasts) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1805. en:decreased activity of 3-methylcrotonyl-coa carboxylase (less than 2%) --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:decreased activity of 3-methylcrotonyl-coa carboxylase (less than 2%) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1806. en:decreased activity of galactocerebrosidase --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:decreased activity of galactocerebrosidase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1807. en:decreased activity of mitochondrial respiratory chain complex i --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:decreased activity of mitochondrial respiratory chain complex i | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1808. en:decreased activity of pyruvate dehydrogenase complex --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:decreased activity of pyruvate dehydrogenase complex | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1809. en:decreased activity of the pdh phosphatase --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:decreased activity of the pdh phosphatase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1810. en:decreased beta-glucocerebrosidase protein and activity --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:decreased beta-glucocerebrosidase protein and activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1811. en:decreased c3 antigen --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:decreased c3 antigen | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1812. en:decreased csf 3-methoxy-4-hydroxyphenylethyleneglycol (mhpg) --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:decreased csf 3-methoxy-4-hydroxyphenylethyleneglycol (mhpg) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1813. en:decreased csf pyridoxal --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:decreased csf pyridoxal | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1814. en:decreased dna excision repair --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:decreased dna excision repair | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1815. en:decreased expression of glycosylphosphatidylinositol-linked proteins (e.g., cd59 107271 and cd24 600274) on hematopoietic cells --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:decreased expression of glycosylphosphatidylinositol-linked proteins (e.g., cd59 107271 and cd24 600274) on hematopoietic cells | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1816. en:decreased fbp1 enzyme activity --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:decreased fbp1 enzyme activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1817. en:decreased fibrillin-1 immunostaining in the dermis --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:decreased fibrillin-1 immunostaining in the dermis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1818. en:decreased fibrinogen (in some patients) --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:decreased fibrinogen (in some patients) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1819. en:decreased fibroblast alpha-mannosidase --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:decreased fibroblast alpha-mannosidase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1820. en:decreased formation of complex (tri-, tetra-antennary) n-glycans --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:decreased formation of complex (tri-, tetra-antennary) n-glycans | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1821. en:decreased galactokinase activity --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:decreased galactokinase activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1822. en:decreased liver homogentisate 1,2-dioxygenase activity --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:decreased liver homogentisate 1,2-dioxygenase activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1823. en:decreased methionine synthase activity --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:decreased methionine synthase activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1824. en:decreased natural killer cells --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:decreased natural killer cells | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1825. en:decreased or absent histidase activity --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:decreased or absent histidase activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1826. en:decreased or absent pts activity --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:decreased or absent pts activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1827. en:decreased peroxisomal fatty acid beta-oxidation --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:decreased peroxisomal fatty acid beta-oxidation | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1828. en:decreased phk activity in liver --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:decreased phk activity in liver | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1829. en:decreased plasma glycine --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:decreased plasma glycine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1830. en:decreased serum carnitine in acute stage --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:decreased serum carnitine in acute stage | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1831. en:decreased serum cholesterol (in some) --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:decreased serum cholesterol (in some) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1832. en:decreased serum factor b (atypical hus) --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:decreased serum factor b (atypical hus) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1833. en:decreased serum insulin-like growth factor-1 (igf1) --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:decreased serum insulin-like growth factor-1 (igf1) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1834. en:decreased switched memory b cells --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:decreased switched memory b cells | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1835. en:decreased ubiquinone-10 --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:decreased ubiquinone-10 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1836. en:defect in mitochondrial and peroxisomal fission --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:defect in mitochondrial and peroxisomal fission | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1837. en:defect in n- and o-glycosylation --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:defect in n- and o-glycosylation | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1838. en:defect in post-translational modification of lysosomal enzymes --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:defect in post-translational modification of lysosomal enzymes | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1839. en:deficiency aspects --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:deficiency aspects | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1840. en:deficiency in enzyme complexes of mitochondrial respiratory chain --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:deficiency in enzyme complexes of mitochondrial respiratory chain | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1841. en:deficiency of laminin in basement membranes --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:deficiency of laminin in basement membranes | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1842. en:deficiency of saposins a, b, c, and d --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:deficiency of saposins a, b, c, and d | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1843. en:deficiency or absence of p47-phox protein (type i) --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:deficiency or absence of p47-phox protein (type i) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1844. en:delta-1-pyrroline-3-hydroxy-5-carboxylate levels increased in urine --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:delta-1-pyrroline-3-hydroxy-5-carboxylate levels increased in urine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1845. en:detection by rt-pcr and southern blot analysis for primary diagnosis and follow up for residual disease --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:detection by rt-pcr and southern blot analysis for primary diagnosis and follow up for residual disease | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1846. en:diaminoaciduria (arginuria, lysinuria, cystinuria, ornithinuria) --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:diaminoaciduria (arginuria, lysinuria, cystinuria, ornithinuria) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1847. en:disturbed visual and brainstem auditory evoked responses indicative of cns demyelination --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:disturbed visual and brainstem auditory evoked responses indicative of cns demyelination | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1848. en:diverse tissue cell types (vascular endothelial cells, adipocytes, schwann cells, leukocytes) have membrane-lined cytoplasmic vacuoles with amorphous and filamentous material --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:diverse tissue cell types (vascular endothelial cells, adipocytes, schwann cells, leukocytes) have membrane-lined cytoplasmic vacuoles with amorphous and filamentous material | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1849. en:ectodermal dysplasia with blindness syndrome --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:ectodermal dysplasia with blindness syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1850. en:ectodermal dysplasia/ skin fragility syndrome --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:ectodermal dysplasia/ skin fragility syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1851. en:ehlers-danlos syndrome kyphoscoliotic and deafness type --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:ehlers-danlos syndrome kyphoscoliotic and deafness type | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1852. en:elevated ast and ldh, especially infantile-onset --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:elevated ast and ldh, especially infantile-onset | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1853. en:elevated cerebrospinal fluid (csf) protein --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:elevated cerebrospinal fluid (csf) protein | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1854. en:elevated csf amino acids (arginine, ornithine, aspartate, threonine, glycine, and methionine) --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:elevated csf amino acids (arginine, ornithine, aspartate, threonine, glycine, and methionine) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1855. en:elevated csf/plasma glycine ratio --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:elevated csf/plasma glycine ratio | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1856. en:elevated erythrocyte adenosine deaminase (eada) --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:elevated erythrocyte adenosine deaminase (eada) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1857. en:elevated erythrocyte adenosine deaminase activity --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:elevated erythrocyte adenosine deaminase activity | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1858. en:elevated liver transaminases --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:elevated liver transaminases | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1859. en:elevated plasma beta-sitosterol (sitosterolemia or phytosterolemia) --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:elevated plasma beta-sitosterol (sitosterolemia or phytosterolemia) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1860. en:elevated plasma follicle stimulating hormone (fsh) --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:elevated plasma follicle stimulating hormone (fsh) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1861. en:elevated progesterone --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:elevated progesterone | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1862. en:elevated sed rate --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:elevated sed rate | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1863. en:elevated serum glutamic oxaloacetic transaminase (sgot) --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:elevated serum glutamic oxaloacetic transaminase (sgot) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1864. en:elevated urinary 2-ethylhydracrylate --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:elevated urinary 2-ethylhydracrylate | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1865. en:elevated urinary and csf ribitol and d-arabitol --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:elevated urinary and csf ribitol and d-arabitol | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1866. en:elevated urinary delta-aminolevulinic acid and porphyrins --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:elevated urinary delta-aminolevulinic acid and porphyrins | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1867. en:elevated urine ceramide levels --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:elevated urine ceramide levels | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1868. en:familial renal iminoglycinuria --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:familial renal iminoglycinuria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1869. en:fasting hyperinsulinemia --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:fasting hyperinsulinemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1870. en:fibroblasts accumulate dol-pp-glcnac2man5 --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:fibroblasts accumulate dol-pp-glcnac2man5 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1871. en:fibroblasts show elongated, tangled, tubular mitochondria --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:fibroblasts show elongated, tangled, tubular mitochondria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1872. en:fingerprint intracellular accumulation of autofluorescent lipopigment storage material --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:fingerprint intracellular accumulation of autofluorescent lipopigment storage material | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1873. en:folinic acid responsive seizure syndrome --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:folinic acid responsive seizure syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1874. en:fructose-1,6-bisphosphatase deficiency --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:fructose-1,6-bisphosphatase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1875. en:generalized aminoaciduria --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:generalized aminoaciduria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1876. en:glycogen storage disease --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:glycogen storage disease | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1877. en:glycogen storage disease type x --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:glycogen storage disease type x | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1878. en:greatly increased dopamine in plasma, urine, csf (approximately 10-fold increase) --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:greatly increased dopamine in plasma, urine, csf (approximately 10-fold increase) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1879. en:hematuria --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:hematuria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1880. en:hemolytic anemia due to pyruvate kinase deficiency --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:hemolytic anemia due to pyruvate kinase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1881. en:heparin cofactor ii deficiency (disorder) --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:heparin cofactor ii deficiency (disorder) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1882. en:hepatic argininosuccinate synthetase deficiency --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:hepatic argininosuccinate synthetase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1883. en:hereditary factor x deficiency disease --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:hereditary factor x deficiency disease | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1884. en:hereditary palmoplantar keratoderma gamborg nielsen type --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:hereditary palmoplantar keratoderma gamborg nielsen type | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1885. en:high serum osmolality --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:high serum osmolality | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1886. en:high urinary excretion of inosine, 2'deoxyinosine, guanosine, and 2'deoxyguanosine --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:high urinary excretion of inosine, 2'deoxyinosine, guanosine, and 2'deoxyguanosine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1887. en:homocystinuria (in some patients) --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:homocystinuria (in some patients) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1888. en:hyperandrogenism due to non-classic 21-hydroxylase deficiency --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:hyperandrogenism due to non-classic 21-hydroxylase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1889. en:hypercalciuria (in childhood) --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:hypercalciuria (in childhood) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1890. en:hyperchloremia (mean 111 mm) --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:hyperchloremia (mean 111 mm) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1891. en:hyperglycemias, postprandial --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:hyperglycemias, postprandial | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1892. en:hyperphosphatasia with mental retardation --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:hyperphosphatasia with mental retardation | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1893. en:hyperprolinemia (10-15 times normal) --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:hyperprolinemia (10-15 times normal) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1894. en:hyperprolinemia type 2 --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:hyperprolinemia type 2 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1895. en:hyperprostaglandinuria --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:hyperprostaglandinuria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1896. en:hyperthreoninuria --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:hyperthreoninuria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1897. en:hypocalcemia --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:hypocalcemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1898. en:hypoketotic dicarboxylic aciduria (in some patients) --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:hypoketotic dicarboxylic aciduria (in some patients) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1899. en:hypomethylation of satellite repeats on chromosome 1, 9, and 16 --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:hypomethylation of satellite repeats on chromosome 1, 9, and 16 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1900. en:hypoproteinemia (in 1 patient) --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:hypoproteinemia (in 1 patient) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1901. en:hyposthenuria (inability to concentrate urine normally) --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:hyposthenuria (inability to concentrate urine normally) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1902. en:igg deficiency --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:igg deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1903. en:igm deficiency --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:igm deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1904. en:increased ammonia with exercise --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:increased ammonia with exercise | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1905. en:increased lysine in serum and csf --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:increased lysine in serum and csf | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1906. en:increased phytanic acid in body tissues and fluids --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:increased phytanic acid in body tissues and fluids | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1907. en:increased serum 1,25-dihydroxyvitamin d3 --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:increased serum 1,25-dihydroxyvitamin d3 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1908. en:increased serum cholesterol (in 3 of 10 patients) --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:increased serum cholesterol (in 3 of 10 patients) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1909. en:increased serum creatine kinase (less common) --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:increased serum creatine kinase (less common) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1910. en:increased serum lipoproteins --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:increased serum lipoproteins | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1911. en:increased serum triiodothyronine (t3) --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:increased serum triiodothyronine (t3) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1912. en:increased triglycerides (less common) --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:increased triglycerides (less common) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1913. en:increased urinary 2-methylbutyryl glycine --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary 2-methylbutyryl glycine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1914. en:increased urinary alpha-ketoglutaric acid, intermittent --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary alpha-ketoglutaric acid, intermittent | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1915. en:increased urinary delta-aminolevulinic acid (ala) and porphobilinogen (pbg) during acute attacks --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary delta-aminolevulinic acid (ala) and porphobilinogen (pbg) during acute attacks | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1916. en:increased urinary excretion of camp --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary excretion of camp | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1917. en:increased urinary glycerol --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary glycerol | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1918. en:increased urinary hypoxanthine --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary hypoxanthine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1919. en:increased urinary ketones --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary ketones | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1920. en:increased urinary n-acetylated amino acids --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary n-acetylated amino acids | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1921. en:increased urinary o-hydroxyphenylacetic acid, phenylpyruvic acid, phenylacetic acid and phenylacetylglutamine --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary o-hydroxyphenylacetic acid, phenylpyruvic acid, phenylacetic acid and phenylacetylglutamine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1922. en:increased urinary prostaglandin e2 --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary prostaglandin e2 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1923. en:increased urinary succinic acid --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:increased urinary succinic acid | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1924. en:increased urine vanillactic acid (vla) --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:increased urine vanillactic acid (vla) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1925. en:intermittent ethylmalonic aciduria --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:intermittent ethylmalonic aciduria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1926. en:iodine depletion --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:iodine depletion | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1927. en:iron low --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:iron low | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1928. en:irregular distribution of chondrocytes, enlarged chondrocyte lacunae, excessive fibrous matrix, perilacunar loss of glycosaminoglycan, excessive collagen aggregation --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:irregular distribution of chondrocytes, enlarged chondrocyte lacunae, excessive fibrous matrix, perilacunar loss of glycosaminoglycan, excessive collagen aggregation | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1929. en:jervell and lange nielsen syndrome --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:jervell and lange nielsen syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1930. en:lactate dehydrogenase increased --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:lactate dehydrogenase increased | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1931. en:lactose intolerance, adult type --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:lactose intolerance, adult type | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1932. en:late-onset junctional epidermolysis bullosa --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:late-onset junctional epidermolysis bullosa | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1933. en:leukotriene c4 synthase deficiency --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:leukotriene c4 synthase deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1934. en:long-chain dicarboxylic aciduria --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:long-chain dicarboxylic aciduria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1935. en:low copper and ceruloplasmin --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:low copper and ceruloplasmin | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1936. en:low csf creatine --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:low csf creatine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1937. en:low free carnitine --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:low free carnitine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1938. en:low plasma methionine --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:low plasma methionine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1939. en:low pyruvate carboxylase activity in liver and cultured fibroblasts --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:low pyruvate carboxylase activity in liver and cultured fibroblasts | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1940. en:low to normal plasma methionine --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:low to normal plasma methionine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1941. en:low urinary excretion of neutral 17-ketosteroids --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:low urinary excretion of neutral 17-ketosteroids | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1942. en:manouvrier syndrome --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:manouvrier syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1943. en:marked elevation of erythrocyte sedimentation rate --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:marked elevation of erythrocyte sedimentation rate | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1944. en:marked hypobetalipoproteinemia --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:marked hypobetalipoproteinemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1945. en:markedly decreased coproporphyrinogen oxidase activity (harderoporphyria, lymphocytes) --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:markedly decreased coproporphyrinogen oxidase activity (harderoporphyria, lymphocytes) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1946. en:maroteaux-lamy syndrome --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:maroteaux-lamy syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1947. en:mendelian susceptibility to mycobacterial disease due to complete interferon gamma receptor 1 deficiency --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:mendelian susceptibility to mycobacterial disease due to complete interferon gamma receptor 1 deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1948. en:odontohypophosphatasia (disorder) --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:odontohypophosphatasia (disorder) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1949. en:oplah gene --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:oplah gene | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1950. en:oplah, ser323arg --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:oplah, ser323arg | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1951. en:prolonged electroretinal response suppression --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:prolonged electroretinal response suppression | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1952. en:pyogenic bacterial infection due to deficiency of myeloid differentiation primary response 88 --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:pyogenic bacterial infection due to deficiency of myeloid differentiation primary response 88 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1953. en:renal tubulopathy with encephalopathy and liver failure syndrome --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:renal tubulopathy with encephalopathy and liver failure syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1954. en:saito kuba tsuruta syndrome --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:saito kuba tsuruta syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1955. en:spondyloepiphyseal dysplasia, omani type --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:spondyloepiphyseal dysplasia, omani type | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1956. en:tmem70 related mitochondrial encephalo-cardio-myopathy --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:tmem70 related mitochondrial encephalo-cardio-myopathy | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1957. en:ugt1a1*28 polymorphism --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:ugt1a1*28 polymorphism | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1958. en:verloes bourguignon syndrome --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:verloes bourguignon syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1959. en:waardenburg anophthalmia syndrome --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:waardenburg anophthalmia syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1960. en:werdnig-hoffmann disease --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=en:werdnig-hoffmann disease | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1961. hypocalcémie --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=hypocalcémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1962. hématurie macroscopique --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=hématurie macroscopique | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1963. rétention des chylomicrons (maladie de la) --- r_associated #0: 26 --> en:5-oxoprolinase deficiency
    n1=rétention des chylomicrons (maladie de la) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=26
  1964. albinisme avec pigmentation minime --- r_associated #0: 25 --> en:5-oxoprolinase deficiency
    n1=albinisme avec pigmentation minime | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=25
  1965. en:Dubin-Johnson's syndrome --- r_associated #0: 25 --> en:5-oxoprolinase deficiency
    n1=en:Dubin-Johnson's syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=25
  1966. en:disseminated intravascular coagulation syndrome --- r_associated #0: 25 --> en:5-oxoprolinase deficiency
    n1=en:disseminated intravascular coagulation syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=25
  1967. en:glutaric aciduria type 1 --- r_associated #0: 25 --> en:5-oxoprolinase deficiency
    n1=en:glutaric aciduria type 1 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=25
  1968. en:hyperlipoproteinemia --- r_associated #0: 25 --> en:5-oxoprolinase deficiency
    n1=en:hyperlipoproteinemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=25
  1969. hyperornithinémie, hyperammoniémie, homocitrullinurie (syndrome) --- r_associated #0: 25 --> en:5-oxoprolinase deficiency
    n1=hyperornithinémie, hyperammoniémie, homocitrullinurie (syndrome) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=25
  1970. adénite sinusale cytophagique --- r_associated #0: 24 --> en:5-oxoprolinase deficiency
    n1=adénite sinusale cytophagique | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=24
  1971. albinisme oculocutané avec mèches noires, troubles intestinaux et surdité congénitale de perception --- r_associated #0: 24 --> en:5-oxoprolinase deficiency
    n1=albinisme oculocutané avec mèches noires, troubles intestinaux et surdité congénitale de perception | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=24
  1972. en:calcinuria --- r_associated #0: 24 --> en:5-oxoprolinase deficiency
    n1=en:calcinuria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=24
  1973. en:emesia --- r_associated #0: 24 --> en:5-oxoprolinase deficiency
    n1=en:emesia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=24
  1974. en:hyperlipaemia --- r_associated #0: 24 --> en:5-oxoprolinase deficiency
    n1=en:hyperlipaemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=24
  1975. en:muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) --- r_associated #0: 24 --> en:5-oxoprolinase deficiency
    n1=en:muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=24
  1976. xanthique (lithiase) --- r_associated #0: 24 --> en:5-oxoprolinase deficiency
    n1=xanthique (lithiase) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=24
  1977. abêtalipoprotéinémie normotriglycéridémique de type Steinberg --- r_associated #0: 23 --> en:5-oxoprolinase deficiency
    n1=abêtalipoprotéinémie normotriglycéridémique de type Steinberg | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=23
  1978. contractures congénitales et arachnodactylie --- r_associated #0: 23 --> en:5-oxoprolinase deficiency
    n1=contractures congénitales et arachnodactylie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=23
  1979. cétose de jeûne --- r_associated #0: 23 --> en:5-oxoprolinase deficiency
    n1=cétose de jeûne | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=23
  1980. en:Bassen-Kornzweig's disease --- r_associated #0: 23 --> en:5-oxoprolinase deficiency
    n1=en:Bassen-Kornzweig's disease | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=23
  1981. en:defibrination syndrome --- r_associated #0: 23 --> en:5-oxoprolinase deficiency
    n1=en:defibrination syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=23
  1982. en:diffuse intravascular coagulation --- r_associated #0: 23 --> en:5-oxoprolinase deficiency
    n1=en:diffuse intravascular coagulation | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=23
  1983. en:hyperlipoidaemia --- r_associated #0: 23 --> en:5-oxoprolinase deficiency
    n1=en:hyperlipoidaemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=23
  1984. en:oxalosis --- r_associated #0: 23 --> en:5-oxoprolinase deficiency
    n1=en:oxalosis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=23
  1985. en:vitamin D deficiency --- r_associated #0: 23 --> en:5-oxoprolinase deficiency
    n1=en:vitamin D deficiency | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=23
  1986. en:zinc-deficiency type --- r_associated #0: 23 --> en:5-oxoprolinase deficiency
    n1=en:zinc-deficiency type | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=23
  1987. azotémie --- r_associated #0: 22 --> en:5-oxoprolinase deficiency
    n1=azotémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=22
  1988. en:hypercalcaemia --- r_associated #0: 22 --> en:5-oxoprolinase deficiency
    n1=en:hypercalcaemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=22
  1989. en:hyperlipoproteinemia type I --- r_associated #0: 22 --> en:5-oxoprolinase deficiency
    n1=en:hyperlipoproteinemia type I | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=22
  1990. en:hypernatraemia --- r_associated #0: 22 --> en:5-oxoprolinase deficiency
    n1=en:hypernatraemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=22
  1991. en:thrombopeny --- r_associated #0: 22 --> en:5-oxoprolinase deficiency
    n1=en:thrombopeny | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=22
  1992. hypercholestérolémie --- r_associated #0: 22 --> en:5-oxoprolinase deficiency
    n1=hypercholestérolémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=22
  1993. hématurie --- r_associated #0: 22 --> en:5-oxoprolinase deficiency
    n1=hématurie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=22
  1994. remaniement chromosomique --- r_associated #0: 22 --> en:5-oxoprolinase deficiency
    n1=remaniement chromosomique | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=22
  1995. acidurie argininosuccinique --- r_associated #0: 21 --> en:5-oxoprolinase deficiency
    n1=acidurie argininosuccinique | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=21
  1996. acidémie isovalérique --- r_associated #0: 21 --> en:5-oxoprolinase deficiency
    n1=acidémie isovalérique | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=21
  1997. agammaglobulinémie --- r_associated #0: 21 --> en:5-oxoprolinase deficiency
    n1=agammaglobulinémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=21
  1998. albinisme oculocutané de type mutant jaune --- r_associated #0: 21 --> en:5-oxoprolinase deficiency
    n1=albinisme oculocutané de type mutant jaune | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=21
  1999. alcaptonurie --- r_associated #0: 21 --> en:5-oxoprolinase deficiency
    n1=alcaptonurie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=21
  2000. argininémie --- r_associated #0: 21 --> en:5-oxoprolinase deficiency
    n1=argininémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=21
  2001. déficit en biotinidase --- r_associated #0: 21 --> en:5-oxoprolinase deficiency
    n1=déficit en biotinidase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=21
  2002. déficit enzymatique partiel de la surrénale --- r_associated #0: 21 --> en:5-oxoprolinase deficiency
    n1=déficit enzymatique partiel de la surrénale | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=21
  2003. en:Bassen-Kornzweig disease --- r_associated #0: 21 --> en:5-oxoprolinase deficiency
    n1=en:Bassen-Kornzweig disease | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=21
  2004. en:Laron syndrome --- r_associated #0: 21 --> en:5-oxoprolinase deficiency
    n1=en:Laron syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=21
  2005. en:Nathalie syndrome --- r_associated #0: 21 --> en:5-oxoprolinase deficiency
    n1=en:Nathalie syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=21
  2006. en:emesis --- r_associated #0: 21 --> en:5-oxoprolinase deficiency
    n1=en:emesis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=21
  2007. hyperkaliémie --- r_associated #0: 21 --> en:5-oxoprolinase deficiency
    n1=hyperkaliémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=21
  2008. hypernatrémie --- r_associated #0: 21 --> en:5-oxoprolinase deficiency
    n1=hypernatrémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=21
  2009. hémophilie B --- r_associated #0: 21 --> en:5-oxoprolinase deficiency
    n1=hémophilie B | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=21
  2010. idiosyncrasie au fructose --- r_associated #0: 21 --> en:5-oxoprolinase deficiency
    n1=idiosyncrasie au fructose | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=21
  2011. mannosidose --- r_associated #0: 21 --> en:5-oxoprolinase deficiency
    n1=mannosidose | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=21
  2012. mucopolysaccharidose de type 1 --- r_associated #0: 21 --> en:5-oxoprolinase deficiency
    n1=mucopolysaccharidose de type 1 | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=21
  2013. Thrombopénie --- r_associated #0: 20 --> en:5-oxoprolinase deficiency
    n1=Thrombopénie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=20
  2014. syndrome de Warburg --- r_associated #0: 16 --> en:5-oxoprolinase deficiency
    n1=syndrome de Warburg | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=16
  2015. syndrome de coagulation intravasculaire disséminée --- r_associated #0: 16 --> en:5-oxoprolinase deficiency
    n1=syndrome de coagulation intravasculaire disséminée | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=16
  2016. Albert (position d') --- r_associated #0: 15 --> en:5-oxoprolinase deficiency
    n1=Albert (position d') | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=15
  2017. Avellis (syndrome d') --- r_associated #0: 15 --> en:5-oxoprolinase deficiency
    n1=Avellis (syndrome d') | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=15
  2018. Fuchs (syndrome de) --- r_associated #0: 15 --> en:5-oxoprolinase deficiency
    n1=Fuchs (syndrome de) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=15
  2019. His (faisceau de) --- r_associated #0: 15 --> en:5-oxoprolinase deficiency
    n1=His (faisceau de) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=15
  2020. Hyperplasie congénitale des surrénales --- r_associated #0: 15 --> en:5-oxoprolinase deficiency
    n1=Hyperplasie congénitale des surrénales | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=15
  2021. Hypogammaglobulinémie --- r_associated #0: 15 --> en:5-oxoprolinase deficiency
    n1=Hypogammaglobulinémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=15
  2022. Intolérance au fructose --- r_associated #0: 15 --> en:5-oxoprolinase deficiency
    n1=Intolérance au fructose | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=15
  2023. Maladie de Niemann-Pick --- r_associated #0: 15 --> en:5-oxoprolinase deficiency
    n1=Maladie de Niemann-Pick | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=15
  2024. Syndrome de Walker-Warburg --- r_associated #0: 15 --> en:5-oxoprolinase deficiency
    n1=Syndrome de Walker-Warburg | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=15
  2025. TCT --- r_associated #0: 15 --> en:5-oxoprolinase deficiency
    n1=TCT | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=15
  2026. Vomissement --- r_associated #0: 15 --> en:5-oxoprolinase deficiency
    n1=Vomissement | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=15
  2027. acidoses lactiques (classification selon Cohen et Woods) --- r_associated #0: 15 --> en:5-oxoprolinase deficiency
    n1=acidoses lactiques (classification selon Cohen et Woods) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=15
  2028. coagulation intravasculaire disséminée (syndrome de) --- r_associated #0: 15 --> en:5-oxoprolinase deficiency
    n1=coagulation intravasculaire disséminée (syndrome de) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=15
  2029. céto-acidose --- r_associated #0: 15 --> en:5-oxoprolinase deficiency
    n1=céto-acidose | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=15
  2030. en:hypocalcaemia --- r_associated #0: 15 --> en:5-oxoprolinase deficiency
    n1=en:hypocalcaemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=15
  2031. glucose sanguin normal --- r_associated #0: 15 --> en:5-oxoprolinase deficiency
    n1=glucose sanguin normal | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=15
  2032. hyperintense (signal IRM) --- r_associated #0: 15 --> en:5-oxoprolinase deficiency
    n1=hyperintense (signal IRM) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=15
  2033. hyperkératose nævoïde (hamartomateuse) du mamelon --- r_associated #0: 15 --> en:5-oxoprolinase deficiency
    n1=hyperkératose nævoïde (hamartomateuse) du mamelon | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=15
  2034. hypermobilité articulaire (syndrome d') --- r_associated #0: 15 --> en:5-oxoprolinase deficiency
    n1=hypermobilité articulaire (syndrome d') | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=15
  2035. hyperperméabilité capillaire (syndrome d') --- r_associated #0: 15 --> en:5-oxoprolinase deficiency
    n1=hyperperméabilité capillaire (syndrome d') | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=15
  2036. hyperthyroïdie (manifestations neuromusculaires dans l') --- r_associated #0: 15 --> en:5-oxoprolinase deficiency
    n1=hyperthyroïdie (manifestations neuromusculaires dans l') | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=15
  2037. vomitus --- r_associated #0: 15 --> en:5-oxoprolinase deficiency
    n1=vomitus | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=15
  2038. A-bêta-lipoprotéinémie --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=A-bêta-lipoprotéinémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2039. Aberfeld (syndrome d') --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=Aberfeld (syndrome d') | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2040. Acidocétose --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=Acidocétose | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2041. Albinisme --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=Albinisme | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2042. CONGENITAL --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=CONGENITAL | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2043. CONGÉNITALE --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=CONGÉNITALE | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2044. Congenital --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=Congenital | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2045. Cétoacidose --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=Cétoacidose | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2046. Dubin-Johnson (syndrome de) --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=Dubin-Johnson (syndrome de) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2047. Entérocolite --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=Entérocolite | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2048. Fucosidose --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=Fucosidose | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2049. Glycogénose --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=Glycogénose | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2050. Histidinémie --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=Histidinémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2051. Hypercalcémie --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=Hypercalcémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2052. Hypercholestérolémie --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=Hypercholestérolémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2053. Hyperkaliémie --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=Hyperkaliémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2054. Hyperlipidémie --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=Hyperlipidémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2055. Hyperlipémie --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=Hyperlipémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2056. Hypernatrémie --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=Hypernatrémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2057. Hypocalcémie --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=Hypocalcémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2058. Hyponatrémie --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=Hyponatrémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2059. Laurence-Moon (syndrome de) --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=Laurence-Moon (syndrome de) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2060. Manning (score de) --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=Manning (score de) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2061. Mannosidose --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=Mannosidose | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2062. Méthémoglobinémie --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=Méthémoglobinémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2063. Niemann-Pick (maladie de) --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=Niemann-Pick (maladie de) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2064. Progéria --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=Progéria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2065. Thrombocytopénie --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=Thrombocytopénie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2066. VOMISSEMENTS --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=VOMISSEMENTS | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2067. Vomissements --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=Vomissements | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2068. absence d'anticorps anti-récepteurs de l'insuline --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=absence d'anticorps anti-récepteurs de l'insuline | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2069. alcalose métabolique (classification) --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=alcalose métabolique (classification) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2070. calcul matriciel en imagerie --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=calcul matriciel en imagerie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2071. cornée et tyrosinose de type II --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=cornée et tyrosinose de type II | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2072. déficience en bêta-galactosidase dans les fibroblastes et les globules blancs --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=déficience en bêta-galactosidase dans les fibroblastes et les globules blancs | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2073. en:Albert's position --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=en:Albert's position | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2074. en:HHH syndrome --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=en:HHH syndrome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2075. en:Tay Sachs' disease --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=en:Tay Sachs' disease | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2076. en:agammaglobulinaemia --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=en:agammaglobulinaemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2077. en:alcaptonuria --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=en:alcaptonuria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2078. en:bloody urine --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=en:bloody urine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2079. en:contractural arachnodactyly --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=en:contractural arachnodactyly | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2080. en:dyslipaemia --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=en:dyslipaemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2081. en:glycogenosis --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=en:glycogenosis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2082. en:gross hematuria --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=en:gross hematuria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2083. en:haemophilia B --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=en:haemophilia B | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2084. en:homogentisuria --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=en:homogentisuria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2085. en:hypercholesterolaemia --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=en:hypercholesterolaemia | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2086. en:hyperintense --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=en:hyperintense | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2087. en:hyperkeratosis of nipple and areola --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=en:hyperkeratosis of nipple and areola | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2088. en:hyperornithinemia hyperammoniemia homocitrullinuria --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=en:hyperornithinemia hyperammoniemia homocitrullinuria | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2089. en:hypointense --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=en:hypointense | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2090. en:infantile finnish type --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=en:infantile finnish type | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2091. en:minimal pigment type --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=en:minimal pigment type | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2092. en:phosphatide thesaurismosis --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=en:phosphatide thesaurismosis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2093. en:xanthine lithiasis --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=en:xanthine lithiasis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2094. glycogénique (surcharge et infiltration) --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=glycogénique (surcharge et infiltration) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2095. hyperlipoprotéinémie de type I --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=hyperlipoprotéinémie de type I | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2096. hyperostose vertébrale ankylosante --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=hyperostose vertébrale ankylosante | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2097. hypo-osmie --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=hypo-osmie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2098. hypo-osmolalité plasmatique --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=hypo-osmolalité plasmatique | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2099. hypo-osmolarité plasmatique --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=hypo-osmolarité plasmatique | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2100. hypo-uricémiant --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=hypo-uricémiant | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2101. hypoaction d'un muscle oculomoteur --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=hypoaction d'un muscle oculomoteur | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2102. hypoactivité vésicale --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=hypoactivité vésicale | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2103. hypoadrénocorticisme avec hypoparathyroïdie et moniliase superficielle --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=hypoadrénocorticisme avec hypoparathyroïdie et moniliase superficielle | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2104. hypoaminoacidémie --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=hypoaminoacidémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2105. hypoazoturie --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=hypoazoturie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2106. hypobare --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=hypobare | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2107. hypovitaminose D --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=hypovitaminose D | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2108. maladie de Bassen-Kornzweig --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=maladie de Bassen-Kornzweig | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2109. maladie de Gaucher --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=maladie de Gaucher | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2110. maladie de niemann-pick --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=maladie de niemann-pick | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2111. méthémoglobine (aspect IRM de la) --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=méthémoglobine (aspect IRM de la) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2112. nanisme de type Laron --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=nanisme de type Laron | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2113. neuraminidase (déficit en) --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=neuraminidase (déficit en) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2114. nystagmus héréditaire vertical --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=nystagmus héréditaire vertical | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2115. nystagmus lié au sexe --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=nystagmus lié au sexe | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2116. nystagmus myoclonies --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=nystagmus myoclonies | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2117. profondeur de l'anesthésie (stade de) --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=profondeur de l'anesthésie (stade de) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2118. prolidase (déficit en) --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=prolidase (déficit en) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2119. rétention hydrochlorurée sodique --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=rétention hydrochlorurée sodique | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2120. rétention membraneuse --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=rétention membraneuse | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2121. rétention placentaire --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=rétention placentaire | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2122. rétention placentaire du postabortum --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=rétention placentaire du postabortum | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2123. rétention sudorale --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=rétention sudorale | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2124. rétentionniste --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=rétentionniste | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2125. sirtuine --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=sirtuine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2126. sisi-test --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=sisi-test | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2127. sismothérapie --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=sismothérapie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2128. syndrome de Nathalie --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=syndrome de Nathalie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2129. syndrome de warburg --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=syndrome de warburg | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2130. syndrome de zellweger --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=syndrome de zellweger | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2131. taux sériques élevés d'hormones thyroïdiennes libres plasmatiques --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=taux sériques élevés d'hormones thyroïdiennes libres plasmatiques | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2132. thrombolytique (traitement) --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=thrombolytique (traitement) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2133. xanthomatose familiale primitive --- r_associated #0: 10 --> en:5-oxoprolinase deficiency
    n1=xanthomatose familiale primitive | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=10
  2134. hyperphénylalaninémie --- r_associated #0: 6 --> en:5-oxoprolinase deficiency
    n1=hyperphénylalaninémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=6
  2135. Acinetobacter --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=Acinetobacter | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2136. Hématurie --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=Hématurie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2137. Polyglobulie --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=Polyglobulie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2138. Syndrome de coagulation intravasculaire disséminée --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=Syndrome de coagulation intravasculaire disséminée | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2139. Tay-Sachs (maladie de) --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=Tay-Sachs (maladie de) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2140. acidurie --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=acidurie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2141. acidurie 3-hydroxy-3-méthyl-glutarique --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=acidurie 3-hydroxy-3-méthyl-glutarique | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2142. acidurie 3-méthylglutaconique --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=acidurie 3-méthylglutaconique | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2143. acidurie 4-hydroxybutyrique --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=acidurie 4-hydroxybutyrique | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2144. acidurie paradoxale --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=acidurie paradoxale | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2145. acineux --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=acineux | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2146. acini --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=acini | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2147. acinus --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=acinus | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2148. acinus hépatique de Rappaport --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=acinus hépatique de Rappaport | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2149. albinisme avec immunodéficience et troubles hématologiques --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=albinisme avec immunodéficience et troubles hématologiques | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2150. albinisme avec surdité --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=albinisme avec surdité | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2151. calcitriol --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=calcitriol | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2152. calcium calmodulin-dependent serine threonine protein kinase --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=calcium calmodulin-dependent serine threonine protein kinase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2153. calcium ionisé --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=calcium ionisé | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2154. calcium radioactif --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=calcium radioactif | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2155. calcul coralliforme --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=calcul coralliforme | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2156. calcul fécaloïde --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=calcul fécaloïde | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2157. calcul salivaire --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=calcul salivaire | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2158. coagulation prostatique endoscopique par laser --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=coagulation prostatique endoscopique par laser | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2159. coagulation sanguine --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=coagulation sanguine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2160. coagulation tubaire --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=coagulation tubaire | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2161. coagulopathie --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=coagulopathie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2162. coagulopathie de consommation --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=coagulopathie de consommation | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2163. coagulopathie de dilution --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=coagulopathie de dilution | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2164. déficience en arylsulfatase B dans les fibroblastes et les globules blancs --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=déficience en arylsulfatase B dans les fibroblastes et les globules blancs | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2165. en:Sachs' disease --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=en:Sachs' disease | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2166. faisceau de His --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=faisceau de His | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2167. fuchsine --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=fuchsine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2168. fucose --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=fucose | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2169. fucosidase --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=fucosidase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2170. fucoside --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=fucoside | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2171. histaminergie --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=histaminergie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2172. histaminergique --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=histaminergique | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2173. histaminique --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=histaminique | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2174. histaminolibération --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=histaminolibération | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2175. histaminolytique --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=histaminolytique | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2176. histaminopexie --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=histaminopexie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2177. histaminurie --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=histaminurie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2178. histaminémie --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=histaminémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2179. histidase --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=histidase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2180. histidinase --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=histidinase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2181. histidine --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=histidine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2182. histidine-ammoniac-lyase --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=histidine-ammoniac-lyase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2183. histidine-décarboxylase --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=histidine-décarboxylase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2184. histidine-désaminase --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=histidine-désaminase | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2185. hyperkeratosis follicularis et parafollicularis in cutem penetrans de Kyrle --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=hyperkeratosis follicularis et parafollicularis in cutem penetrans de Kyrle | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2186. hyperkeratosis lenticularis perstans de Flegel --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=hyperkeratosis lenticularis perstans de Flegel | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2187. hyperkinésie --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=hyperkinésie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2188. hyperkinésie volitionnelle --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=hyperkinésie volitionnelle | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2189. hyperlacrymie --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=hyperlacrymie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2190. hyperlactacidémie --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=hyperlactacidémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2191. hyperlaxité articulaire familiale --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=hyperlaxité articulaire familiale | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2192. hyperlaxité ligamentaire --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=hyperlaxité ligamentaire | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2193. hyperleucocytose --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=hyperleucocytose | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2194. hyperosmie --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=hyperosmie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2195. hyperostose corticale --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=hyperostose corticale | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2196. hyperostose corticale déformante juvénile --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=hyperostose corticale déformante juvénile | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2197. hyperostose corticale infantile --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=hyperostose corticale infantile | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2198. hyperostose crânienne interne --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=hyperostose crânienne interne | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2199. hyperostose endostale --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=hyperostose endostale | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2200. hyperostose frontale interne --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=hyperostose frontale interne | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2201. hyperoxalurie --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=hyperoxalurie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2202. hyperoxémie --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=hyperoxémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2203. hyperparathyroïdie --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=hyperparathyroïdie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2204. hyperphorie --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=hyperphorie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2205. hyperphorie alternante --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=hyperphorie alternante | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2206. hyperphosphatasie --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=hyperphosphatasie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2207. hyperphosphatasémie --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=hyperphosphatasémie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2208. hyperphosphatasémie chronique congénitale idiopathique --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=hyperphosphatasémie chronique congénitale idiopathique | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2209. hypertrichose congénitale des cils --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=hypertrichose congénitale des cils | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2210. hypertrichose lanugineuse acquise --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=hypertrichose lanugineuse acquise | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2211. hypertrichose lanugineuse congénitale --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=hypertrichose lanugineuse congénitale | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2212. hypertrichose nævoïde --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=hypertrichose nævoïde | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2213. hypertrichose-atrophie cutanée-ectropion et macrostomie --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=hypertrichose-atrophie cutanée-ectropion et macrostomie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2214. hypertrichosis universalis congenita --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=hypertrichosis universalis congenita | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2215. hypoabsorbant --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=hypoabsorbant | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2216. hypoaccommodation --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=hypoaccommodation | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2217. hypoacousie --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=hypoacousie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2218. hypoacousie chez l'enfant --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=hypoacousie chez l'enfant | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2219. isochromosome souvent absent dans les lymphocytes --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=isochromosome souvent absent dans les lymphocytes | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2220. neurinome bilatéral du nerf cochléaire (VIII) --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=neurinome bilatéral du nerf cochléaire (VIII) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2221. nystagmus (zone de moindre) --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=nystagmus (zone de moindre) | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2222. réponse lymphocytaire diminuée à la phytohémagglutinine --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=réponse lymphocytaire diminuée à la phytohémagglutinine | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2223. semidominance --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=semidominance | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2224. semiquinone --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=semiquinone | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2225. syndrome d'Avellis --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=syndrome d'Avellis | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2226. syndrome d'hypermobilité articulaire --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=syndrome d'hypermobilité articulaire | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2227. syndrome d'hyperperméabilité capillaire --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=syndrome d'hyperperméabilité capillaire | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2228. syndrome de Fuchs --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=syndrome de Fuchs | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2229. séminal --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=séminal | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2230. séminifère --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=séminifère | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2231. séminomateux --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=séminomateux | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2232. séminome --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=séminome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2233. séminome de l'ovaire --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=séminome de l'ovaire | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2234. séminome du médiastin --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=séminome du médiastin | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2235. séminome spermatocytaire --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=séminome spermatocytaire | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2236. sémiochimique --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=sémiochimique | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2237. sémiologie extrapyramidale --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=sémiologie extrapyramidale | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2238. xanthoastrocytome pléomorphe --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=xanthoastrocytome pléomorphe | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2239. xanthochromie --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=xanthochromie | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2240. xanthochromie caroténique --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=xanthochromie caroténique | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2241. xanthoerythrodermia perstans --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=xanthoerythrodermia perstans | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2242. xanthogranulome juvénile --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=xanthogranulome juvénile | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2243. xanthogranulome nécrobiotique --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=xanthogranulome nécrobiotique | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2244. xanthogranulome palpébral --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=xanthogranulome palpébral | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2245. xanthohistiocytome --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=xanthohistiocytome | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2246. xanthoma disseminatum --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=xanthoma disseminatum | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
  2247. xanthomatose --- r_associated #0: 5 --> en:5-oxoprolinase deficiency
    n1=xanthomatose | n2=en:5-oxoprolinase deficiency | rel=r_associated | relid=0 | w=5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr